10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549 

FORM 10-Q

(Mark One)

ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2024

OR

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number: 000-56133

NUVEEN CHURCHILL DIRECT LENDING CORP.

(Exact name of registrant as specified in its charter)

Maryland	84-3613224
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
375 Park Avenue, 9th Floor, New York, NY	10152
(Address of principal executive offices)	(Zip Code)

(212) 478-9200

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class	Trading Symbol(s)	Name of Each Exchange on Which Registered
Common Stock, par value $0.01	NCDL	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes ý No ¨ 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes ý No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer	¨	Accelerated filer	¨
Non-accelerated filer	ý	Smaller reporting company	¨
		Emerging growth company	ý

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes ¨ No ý

As of May 8, 2024, the registrant had 55,037,886 shares of common stock, $0.01 par value, outstanding.

TABLE OF CONTENTS

PART I	FINANCIAL INFORMATION
Item 1.	Consolidated Financial Statements (Unaudited)	3
	Consolidated Statements of Assets and Liabilities as of March 31, 2024 (Unaudited) and December 31, 2023	3
	Consolidated Statements of Operations for the Three Months Ended March 31, 2024 and 2023 (Unaudited)	4
	Consolidated Statements of Changes in Net Assets for the Three Months Ended March 31, 2024 and 2023 (Unaudited)	5
	Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2024 and 2023 (Unaudited)	6
	Consolidated Schedules of Investments as of March 31, 2024 (Unaudited) and December 31, 2023	8
	Notes to Consolidated Financial Statements (Unaudited)	49
Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	75
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	97
Item 4.	Controls and Procedures	99
PART II	OTHER INFORMATION	100
Item 1.	Legal Proceedings	100
Item 1A.	Risk Factors	100
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	100
Item 3.	Defaults Upon Senior Securities	100
Item 4.	Mine Safety Disclosures	101
Item 5.	Other Information	101
Item 6.	Exhibits	102
Signatures		103

FORWARD-LOOKING STATEMENTS

This report contains forward-looking statements that involve substantial risks and uncertainties. Such statements involve known and unknown risks, uncertainties and other factors and undue reliance should not be placed thereon. These forward-looking statements are not historical facts, but rather are based on our current expectations and estimates, our current and prospective portfolio investments, our industry, our beliefs and opinions, and our assumptions. Words such as “anticipates,” “expects,” “intends,” “plans,” “will,” “may,” “continue,” “believes,” “seeks,” “estimates,” “would,” “could,” “should,” “targets,” “projects,” “outlook,” “potential,” “predicts” and variations of these words and similar expressions are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements, including without limitation:

•our future operating results;

•our business prospects and the prospects of our portfolio companies;

•the dependence of our future success on the general economy and its impact on the industries in which we invest;

•the impact of a protracted decline in the liquidity of credit markets on our business;

•the impact of increased competition;

•an economic downturn and its impact on the ability of our portfolio companies to operate and the investment opportunities available to us;

•the impact of interest rate volatility on our business and our portfolio companies;

•the impact of supply chain constraints and labor difficulties on our portfolio companies and the global economy;

•the elevated level of inflation, and its impact on our portfolio companies and on the industries in which we invest;

•general economic, political and industry trends and other external factors, including uncertainty surrounding the financial and political stability of the United States and other countries;

•our contractual arrangements and relationships with third parties;

•the valuation of our investments in portfolio companies, particularly those having no liquid trading market;

•actual and potential conflicts of interest with the Advisers, and/or their respective affiliates;

•the ability of our portfolio companies to achieve their objectives;

•the use of borrowed money to finance a portion of our investments;

•the adequacy of our financing sources and working capital;

•the timing of cash flows, if any, from the operations of our portfolio companies;

•the ability of the Advisers, to locate suitable investments for us and to monitor and administer our investments;

•the ability of the Advisers or their respective affiliates to attract and retain highly talented professionals;

•our ability to qualify and maintain our qualification as a regulated investment company (a “RIC”) and operate as a business development company ("BDC"); and

•the impact of future legislation and regulation on our business and our portfolio companies.

1

Although we believe that the assumptions on which these forward-looking statements are based on are reasonable, any of those assumptions could prove to be inaccurate, and as a result, the forward-looking statements based on those assumptions also could be inaccurate. Important assumptions include our ability to originate new loans and investments, certain margins and levels of profitability and the availability of additional capital. In light of these and other uncertainties, the inclusion of forward-looking statement in this report should not be regarded as a representation by us that our plans and objectives will be achieved. These forward-looking statements apply only as of the date of this report. Moreover, we assume no duty and do not undertake to update the forward-looking statements except as otherwise provided by law.

2

PART I. FINANCIAL INFORMATION

ITEM 1. CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NUVEEN CHURCHILL DIRECT LENDING CORP.

CONSOLIDATED STATEMENTS OF ASSETS AND LIABILITIES

(dollars in thousands, except share and per share data)

	March 31, 2024		December 31, 2023
Assets	(Unaudited)
Investments
Non-controlled/non-affiliated company investments, at fair value (amortized cost of $1,814,985 and $1,666,169, respectively)	$	1,794,559	$	1,641,686
Cash and cash equivalents	64,146		67,395
Restricted cash	50		50
Interest receivable	16,067		17,674
Receivable for investments sold	422		3,919
Prepaid expenses	118		13
Other assets	$	125	$	127
Total assets	$	1,875,487	$	1,730,864
Liabilities
Secured borrowings (net of $8,286 and $7,941 deferred financing costs, respectively) (See Note 6)	$	817,214	$	943,936
Payable for investments purchased	16,877		—
Interest payable	11,022		9,837
Due to adviser expense support (See Note 5)	—		632
Management fees payable	3,264		3,006
Distributions payable	24,684		22,683
Directors’ fees payable	128		96
Accounts payable and accrued expenses	4,065		2,789
Total liabilities	$	877,254	$	982,979
Commitments and contingencies (See Note 7)
Net Assets: (See Note 8)
Common shares, $0.01 par value, 500,000,000 and 500,000,000 shares authorized, 54,815,740 and 41,242,105 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively	$	548	$	412
Paid-in-capital in excess of par value	1,021,573		776,719
Total distributable earnings (loss)	(23,888)		(29,246)
Total net assets	$	998,233	$	747,885
Total liabilities and net assets	$	1,875,487	$	1,730,864
Net asset value per share (See Note 9)	$	18.21	$	18.13

See Notes to Consolidated Financial Statements

3

NUVEEN CHURCHILL DIRECT LENDING CORP.

CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

(dollars in thousands, except share and per share data)

	Three Months Ended March 31,
	2024		2023
Investment income:
Non-controlled/non-affiliated company investments:
Interest income	$	49,078	$	33,387
Payment-in-kind interest income	1,992		321
Dividend income	308		16
Other income	217		236
Total investment income	51,595		33,960
Expenses:
Interest and debt financing expenses	16,941		12,743
Management fees (See Note 5)	3,264		2,306
Incentive fees on net investment income	4,459		—
Professional fees	710		590
Directors' fees	128		96
Administration fees (See Note 5)	542		309
Other general and administrative expenses	277		171
Total expenses before expense support and Incentive fees waived	26,321		16,215
Expense support (See Note 5)	—		(14)
Incentive fees waived (See Note 5)	(4,459)		—
Net Expenses	21,862		16,201
Net investment income	29,733		17,759
Realized and unrealized gain (loss) on investments:
Net realized gain (loss) on non-controlled/non-affiliated company investments	(3,625)		6,481
Net change in unrealized appreciation (depreciation):
Non-controlled/non-affiliated company investments	4,057		(11,137)
Income tax (provision) benefit	(141)		(386)
Total net change in unrealized gain (loss)	3,916		(11,523)
Total net realized and unrealized gain (loss) on investments	291		(5,042)
Net increase (decrease) in net assets resulting from operations	$	30,024	$	12,717
Per share data:
Net investment income per share - basic and diluted	$	0.56	$	0.62
Net increase (decrease) in net assets resulting from operations per share - basic and diluted	$	0.57	$	0.44
Weighted average common shares outstanding - basic and diluted	52,758,353		28,727,285

See Notes to Consolidated Financial Statements

4

NUVEEN CHURCHILL DIRECT LENDING CORP.

CONSOLIDATED STATEMENTS OF CHANGES IN NET ASSETS (UNAUDITED)

(dollars in thousands, except share and per share data)

	Three Months Ended March 31,
	2024		2023
Increase (decrease) in net assets resulting from operations:
Net investment income	$	29,733	$	17,759
Net realized gain (loss) on investments	(3,625)		6,481
Net change in unrealized appreciation (depreciation) on investments	3,916		(11,523)
Net increase (decrease) in net assets resulting from operations	30,024		12,717
Shareholder distributions:
Distributions declared from net investment income	(24,667)		(21,845)
Net increase (decrease) in net assets resulting from shareholder distributions	(24,667)		(21,845)
Capital share transactions:
Issuance of common shares, net	241,657		—
Reinvestment of shareholder distributions, net	3,334		1,715
Net increase (decrease) in net assets resulting from capital share transactions	244,991		1,715
Total increase (decrease) in net assets	250,348		(7,413)
Net assets, at beginning of period	747,885		524,957
Net assets, at end of period	$	998,233	$	517,544

See Notes to Consolidated Financial Statements

5

NUVEEN CHURCHILL DIRECT LENDING CORP.

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

(dollars in thousands, except share and per share data)

	Three Months Ended March 31,
	2024		2023
Cash flows from operating activities:
Net increase (decrease) in net assets resulting from operations	$	30,024	$	12,717
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities
Purchase of investments	(204,329)		(99,914)
Proceeds from principal repayments and sales of investments	54,896		39,602
Payment-in-kind interest	(1,992)		(321)
Amortization of premium/accretion of discount, net	(1,016)		(905)
Net realized (gain) loss on investments	3,625		(6,481)
Net change in unrealized (appreciation) depreciation on investments	(4,057)		11,137
Amortization of deferred financing costs	1,296		435
Amortization of offering costs	—		(15)
Changes in operating assets and liabilities:
Due from adviser expense support	—		182
Interest receivable	1,607		(2)
Receivable for investments sold	3,497		98
Prepaid expenses	(105)		(85)
Other assets	2		—
Payable for investments purchased	16,877		—
Interest payable	1,185		1,345
Due to adviser expense support	(632)		(182)
Management fees payable	258		95
Directors’ fees payable	32		—
Accounts payable and accrued expenses	1,276		1,229
Net cash provided by (used in) operating activities	(97,556)		(41,065)
Cash flows from financing activities:
Proceeds from issuance of common shares	241,657		473
Shareholder distributions	(19,332)		(12,610)
Proceeds from secured borrowings	323,000		85,000
Repayments of secured borrowings	(449,377)		(21,500)
Payments of deferred financing costs	(1,641)		—
Net cash provided by (used in) financing activities	94,307		51,363
Net increase (decrease) in Cash and Cash Equivalents and Restricted Cash	(3,249)		10,298
Cash and Cash Equivalents and Restricted Cash, beginning of period	67,445		39,320
Cash and Cash Equivalents and Restricted Cash, end of period	$	64,196	$	49,618
Supplemental disclosure of cash flow information:
Cash paid during the period for interest	$	14,460	$	10,963
Cash paid during the period for excise taxes	$	6	$	—
Supplemental disclosure of non-cash flow Information:
Reinvestment of shareholder distributions	$	3,334	$	1,730

See Notes to Consolidated Financial Statements

6

The following tables provide a reconciliation of cash and cash equivalents and restricted cash reported on the consolidated statements of assets and liabilities that sum to the total of comparable amounts on the consolidated statements of cash flows (dollars in thousands):

	March 31, 2024		March 31, 2023
Cash and cash equivalents	$	64,146	$	49,568
Restricted cash	50		50
Total cash and cash equivalents and restricted cash shown on the Consolidated Statements of Cash Flows	$	64,196	$	49,618

See Notes to Consolidated Financial Statements

7

NUVEEN CHURCHILL DIRECT LENDING CORP.

CONSOLIDATED SCHEDULE OF INVESTMENTS (UNAUDITED)

March 31, 2024

(dollar amounts in thousands)

Portfolio Company (1) (2)	Footnotes	Investment	Spread Above Reference Rate (3)	Interest Rate (3)		Maturity Date	Par Amount		Amortized Cost		Fair Value (4)		% of Net Assets (5)
Investments
Debt Investments
Aerospace & Defense
AEgis Technologies	(6) (12) (13)	First Lien Term Loan	S + 4.75%	10.05	%	10/31/2025	$	14,623	$	14,570	$	14,483	1.45	%
AEgis Technologies	(6) (12) (13)	First Lien Term Loan	S + 4.75%	10.05	%	10/31/2025	3,038		3,009		3,009		0.30	%
Arotech	(6) (12)	First Lien Term Loan	S + 6.25%	11.66	%	10/22/2026	9,178		9,109		8,962		0.90	%
Arotech (Delayed Draw)	(6) (12)	First Lien Term Loan	S + 6.25%	11.66	%	10/22/2026	446		445		436		0.04	%
Loc Performance Products	(6)	First Lien Term Loan	S + 5.25%	10.68	%	12/22/2026	6,539		6,489		6,312		0.63	%
Precision Aviation Group	(6) (12) (13)	First Lien Term Loan	S + 5.75%	11.06	%	12/21/2029	15,002		14,714		14,830		1.50	%
Precision Aviation Group (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 5.75%	11.06	%	12/21/2029	4,961		(47)		(57)		(0.01	%)
Turbine Engine Specialist, Inc	(12)	Subordinated Debt	S + 9.50%	14.93	%	3/1/2029	2,550		2,491		2,517		0.25	%
Valkyrie	(12)	Subordinated Debt	N/A	10.50% (Cash) 1.00% (PIK)		11/17/2027	2,843		2,802		2,773		0.28	%
Total Aerospace & Defense									53,582		53,265		5.34	%
Automotive
Classic Collision (Delayed Draw) (Incremental Tranche A-4)	(11) (12)	First Lien Term Loan	S + 5.75%	10.50	%	1/14/2027	25,202		9,049		8,766		0.88	%
Classic Collision (Delayed Draw) (Incremental)	(6) (12) (13)	First Lien Term Loan	S + 5.75%	10.50	%	1/14/2027	6,923		6,923		6,833		0.68	%
Classic Collision (Incremental)	(6)	First Lien Term Loan	S + 5.75%	10.50	%	1/14/2027	7,731		7,693		7,630		0.76	%
Covercraft	(12)	Subordinated Debt	N/A	10.00% (Cash) 0.75% (PIK)		2/20/2028	7,492		7,393		6,932		0.69	%
Covercraft (Delayed Draw)	(11) (12)	Subordinated Debt	N/A	10.00% (Cash) 0.75% (PIK)		8/20/2027	4,386		—		(328)		(0.03	%)
High Bar Brands	(12)	Subordinated Debt	N/A	9.00% (Cash) 4.00% (PIK)		6/19/2030	2,088		2,038		2,037		0.20	%
High Bar Brands (Delayed Draw)	(11) (12)	Subordinated Debt	N/A	9.00% (Cash) 4.00% (PIK)		6/19/2030	596		(7)		(14)		—	%
JEGS Automotive	(6)	First Lien Term Loan	S + 6.00%	11.47	%	12/22/2027	3,978		3,951		2,864		0.29	%
OEP Glass Purchaser	(6) (13)	First Lien Term Loan	S + 5.25%	10.45	%	4/18/2028	12,563		12,472		12,563		1.27	%
Randys Holdings, Inc	(6) (9) (12) (13)	First Lien Term Loan	S + 6.50%	11.81	%	11/1/2028	11,109		10,926		10,975		1.10	%
Randys Holdings, Inc (Delayed Draw)	(9) (11) (12)	First Lien Term Loan	S + 6.50%	11.81	%	11/1/2028	3,750		450		405		0.04	%
S&S Truck Parts	(6)	First Lien Term Loan	S + 4.75%	10.22	%	3/1/2029	6,841		6,788		6,693		0.67	%
S&S Truck Parts	(6)	First Lien Term Loan	S + 4.75%	10.22	%	3/1/2029	1,156		1,147		1,131		0.11	%
S&S Truck Parts (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 4.75%	10.22	%	3/1/2029	98		—		(2)		—	%

See Notes to Consolidated Financial Statements

8

NUVEEN CHURCHILL DIRECT LENDING CORP.

CONSOLIDATED SCHEDULE OF INVESTMENTS (UNAUDITED)

March 31, 2024

(dollar amounts in thousands)

Portfolio Company (1) (2)	Footnotes	Investment	Spread Above Reference Rate (3)	Interest Rate (3)		Maturity Date	Par Amount	Amortized Cost	Fair Value (4)	% of Net Assets (5)
S&S Truck Parts (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 4.75%	10.22	%	3/1/2029	1,720	1,572	1,535	0.15	%
Total Automotive								70,395	68,020	6.81	%
Banking, Finance, Insurance, Real Estate
Coding Solutions Acquisitions	(6) (9)	First Lien Term Loan	S + 5.50%	10.83	%	5/11/2028	6,415	6,368	6,347	0.64	%
Coding Solutions Acquisitions (Delayed Draw)	(6) (9)	First Lien Term Loan	S + 5.50%	10.83	%	5/11/2028	1,961	1,961	1,940	0.19	%
Long Term Care Group	(6) (9) (12)	First Lien Term Loan	S + 1.26%	6.57% (Cash) 6.00% (PIK)		9/8/2027	6,963	6,920	5,762	0.58	%
Patriot Growth Insurance Service (Delayed Draw) (Incremental)	(9) (12)	First Lien Term Loan	S + 5.75%	11.20	%	10/16/2028	7,150	7,096	7,022	0.70	%
Risk Strategies (Delayed Draw)	(6) (9) (12)	First Lien Term Loan	S + 5.75%	10.96	%	11/1/2029	14,831	14,831	14,537	1.46	%
Vensure Employer Services	(6) (13)	First Lien Term Loan	S + 4.75%	10.08	%	3/26/2027	14,619	14,595	14,399	1.44	%
World Insurance Associates	(6) (9) (12)	First Lien Term Loan	S + 6.00%	11.31	%	4/3/2028	14,843	14,832	14,586	1.46	%
Total Banking, Finance, Insurance, Real Estate								66,603	64,593	6.47	%
Beverage, Food & Tobacco
Bakeovations Intermediate, LLC (d/b/a Commercial Bakeries)	(6) (7) (10) (12) (13)	First Lien Term Loan	S + 6.25%	11.31	%	9/25/2029	17,239	16,927	16,911	1.69	%
Bardstown PPC Holdings LLC	(12)	Subordinated Debt	S + 7.75%	13.18	%	8/30/2027	9,300	9,163	9,234	0.93	%
Death Wish Coffee	(6) (9) (13)	First Lien Term Loan	S + 4.75%	10.16	%	9/28/2027	9,775	9,718	9,775	0.98	%
Dessert Holdings	(6) (9) (12)	Subordinated Debt	S + 7.25%	12.69	%	6/8/2029	9,000	8,881	7,938	0.80	%
Fresh Edge	(12)	Subordinated Debt	S + 4.50%	10.07% (Cash) 5.13% (PIK)		4/3/2029	3,904	3,826	3,818	0.38	%
Fresh Edge (Incremental)	(12)	Subordinated Debt	S + 4.50%	9.76% (Cash) 5.13% (PIK)		4/3/2029	922	900	902	0.09	%
Fresh Edge (Incremental)	(12)	Subordinated Debt	S + 4.50%	9.76% (Cash) 5.13% (PIK)		4/3/2029	780	762	762	0.08	%
Handgards	(6) (13)	First Lien Term Loan	S + 7.00%	12.49	%	10/14/2026	14,475	14,339	14,475	1.45	%
KSLB Holdings LLC	(13)	First Lien Term Loan	S + 4.50%	9.96	%	7/30/2025	2,850	2,839	2,736	0.27	%
Palmetto Acquisitionco, Inc.	(6) (12) (13)	First Lien Term Loan	S + 5.75%	11.06	%	9/18/2029	13,281	13,066	13,062	1.31	%
Palmetto Acquisitionco, Inc. (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 5.75%	11.06	%	9/18/2029	4,839	1,271	1,208	0.12	%
Rise Baking	(6) (9) (13)	First Lien Term Loan	S + 6.25%	11.68	%	8/13/2027	14,663	14,530	14,875	1.49	%
Rise Baking (Delayed Draw)	(9) (12)	First Lien Term Loan	S + 6.25%	11.68	%	8/13/2027	4,443	4,424	4,413	0.44	%
Summit Hill Foods	(6)	First Lien Term Loan	S + 6.00%	11.34	%	11/29/2029	9,811	9,669	9,669	0.97	%
Sunny Sky Products (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 5.25%	10.55	%	12/23/2028	1,773	—	(17)	—	%
Sunny Sky Products	(6) (12) (13)	First Lien Term Loan	S + 5.25%	10.55	%	12/23/2028	7,076	7,010	7,009	0.70	%
Watermill Express (Incremental)	(6) (9) (13)	First Lien Term Loan	S + 5.75%	11.21	%	7/5/2029	6,359	6,298	6,300	0.63	%

See Notes to Consolidated Financial Statements

9

NUVEEN CHURCHILL DIRECT LENDING CORP.

CONSOLIDATED SCHEDULE OF INVESTMENTS (UNAUDITED)

March 31, 2024

(dollar amounts in thousands)

Portfolio Company (1) (2)	Footnotes	Investment	Spread Above Reference Rate (3)	Interest Rate (3)		Maturity Date	Par Amount	Amortized Cost	Fair Value (4)	% of Net Assets (5)
Watermill Express (Delayed Draw) (Incremental)	(9) (11) (12)	First Lien Term Loan	S + 5.75%	11.21	%	7/5/2029	3,179	445	416	0.04	%
Watermill Express, LLC	(6) (9) (10)	First Lien Term Loan	S + 5.75%	11.21	%	7/5/2029	3,247	3,228	3,217	0.32	%
Watermill Express, LLC (Delayed Draw)	(6) (9)	First Lien Term Loan	S + 5.75%	11.21	%	7/5/2029	314	314	311	0.03	%
Total Beverage, Food & Tobacco								127,610	127,014	12.72	%
Capital Equipment
Crete Mechanical Group	(6)	First Lien Term Loan	S + 5.00%	10.31	%	5/19/2028	4,810	4,776	4,790	0.48	%
Crete Mechanical Group (Delayed Draw)	(6)	First Lien Term Loan	S + 5.00%	10.31	%	5/19/2028	2,839	2,802	2,827	0.28	%
Crete Mechanical Group (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 5.00%	10.31	%	5/19/2028	7,135	6,987	6,957	0.70	%
EFC Holdings, LLC	(12)	Subordinated Debt	N/A	11.00% (Cash) 2.50% (PIK)		5/1/2028	3,187	3,108	3158	0.32	%
Heartland Home Services	(6) (9) (13)	First Lien Term Loan	S + 6.00%	11.31	%	12/15/2026	6,450	6,416	6,312	0.63	%
Heartland Home Services (Delayed Draw)	(6) (9) (13)	First Lien Term Loan	S + 6.00%	11.31	%	12/15/2026	5,593	5,577	5,473	0.55	%
Heartland Home Services (Delayed Draw)	(6) (9) (13)	First Lien Term Loan	S + 6.00%	11.31	%	12/15/2026	2,565	2,565	2,510	0.25	%
Hyperion	(12) (13) (14)	First Lien Term Loan	S + 4.50%	9.94	%	8/30/2028	2,647	2,644	2,650	0.27	%
MSHC Inc	(6) (9)	First Lien Term Loan	S + 4.00%	9.57	%	10/29/2027	7,979	7,999	7,999	0.80	%
Ovation Holdings, Inc.	(6) (13)	First Lien Term Loan	S + 6.25%	11.71	%	2/5/2029	8,015	7,864	8,007	0.80	%
Ovation Holdings, Inc. (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 6.25%	11.71	%	2/5/2029	1,895	1,532	1,550	0.16	%
Precision Surfacing	(12)	First Lien Term Loan	N/A	15.00	%	6/26/2024	713	713	713	0.07	%
PT Intermediate Holdings III, LLC	(6) (9) (13)	First Lien Term Loan	S + 5.98%	11.43	%	11/1/2028	8,713	8,692	8,713	0.86	%
PT Intermediate Holdings III, LLC (Incremental)	(6) (9) (13)	First Lien Term Loan	S + 5.98%	11.43	%	11/1/2028	1,065	1,057	1,065	0.11	%
Repipe Specialists	(12)	Subordinated Debt	N/A	10.00% (Cash) 1.00% (PIK)		3/18/2029	2,439	2,401	2,201	0.22	%
Repipe Specialists (Delayed Draw)	(11) (12)	Subordinated Debt	N/A	10.00% (Cash) 1.00% (PIK)		3/18/2029	902	211	123	0.01	%
Rhino Tool House	(6) (12) (13)	First Lien Term Loan	S + 6.25%	11.73	%	4/4/2029	8,031	7,888	8,044	0.81	%
Rhino Tool House (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 6.25%	11.73	%	4/4/2029	1,880	1,837	1,848	0.19	%
Total Capital Equipment								75,069	74,940	7.51	%

See Notes to Consolidated Financial Statements

10

NUVEEN CHURCHILL DIRECT LENDING CORP.

CONSOLIDATED SCHEDULE OF INVESTMENTS (UNAUDITED)

March 31, 2024

(dollar amounts in thousands)

Portfolio Company (1) (2)	Footnotes	Investment	Spread Above Reference Rate (3)	Interest Rate (3)		Maturity Date	Par Amount	Amortized Cost	Fair Value (4)	% of Net Assets (5)
Chemicals, Plastics, & Rubber
Ascensus Specialties	(6) (9) (13)	First Lien Term Loan	S + 4.35%	9.68	%	6/30/2028	9,706	9,573	8,877	0.89	%
Boulder Scientific Company LLC	(6)	First Lien Term Loan	S + 4.50%	10.48	%	12/28/2025	2,058	2,067	1,999	0.20	%
Chroma Color Corporation (dba Chroma Color)	(6)	First Lien Term Loan	S + 6.00%	11.32	%	4/23/2029	6,298	6,186	6,188	0.62	%
Chroma Color Corporation (dba Chroma Color) (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 6.00%	11.32	%	4/23/2029	1,379	(12)	(24)	—	%
Spartech	(6) (9) (12) (13)	First Lien Term Loan	S + 4.75%	10.07	%	5/6/2028	14,731	14,667	11,868	1.19	%
Total Chemicals, Plastics, & Rubber								32,481	28,908	2.90	%
Construction & Building
Allstar Holdings	(12)	Subordinated Debt	N/A	10.00% (Cash) 3.00% (PIK)		4/26/2030	2,130	2,068	2,071	0.21	%
Allstar Holdings (Delayed Draw)	(11) (12)	Subordinated Debt	N/A	10.00% (Cash) 3.00% (PIK)		4/26/2030	4,065	2,826	2,769	0.28	%
Allstar Holdings (Delayed Draw)	(11) (12)	Subordinated Debt	N/A	10.00% (Cash) 3.00% (PIK)		4/26/2030	6,188	(85)	(170)	(0.02	%)
Erie Construction	(6) (13)	First Lien Term Loan	S + 4.75%	10.15	%	7/30/2027	10,016	9,951	9,956	1.00	%
Gannett Fleming	(6) (13)	First Lien Term Loan	S + 6.60%	11.90	%	12/20/2028	9,875	9,712	9,888	0.99	%
MEI Rigging & Crating	(6) (12) (13)	First Lien Term Loan	S + 6.50%	11.83	%	6/29/2029	11,402	11,195	11,305	1.12	%
MEI Rigging & Crating (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 6.50%	11.83	%	6/29/2029	1,814	(8)	(15)	—	%
ICE USA Infrastructure	(10) (12) (13)	First Lien Term Loan	S + 5.75%	11.08	%	3/15/2030	6,605	6,539	6,539	0.66	%
RMA Companies (Delayed Draw)	(12)	First Lien Term Loan	S + 5.75%	11.18	%	12/30/2027	4,616	4,608	4,553	0.46	%
RMA Companies (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 5.75%	11.18	%	12/30/2027	3,134	(7)	(43)	—	%
Royal Holdco Corporation (Incremental)	(6) (10)	First Lien Term Loan	S + 5.75%	11.18	%	12/30/2027	3,110	3,069	3,068	0.31	%
Sciens Building Solutions, LLC	(6) (9)	First Lien Term Loan	S + 5.75%	11.18	%	12/15/2027	9,291	9,167	9,200	0.92	%
Sciens Building Solutions, LLC (Delayed Draw)	(6) (9) (11) (12) (13)	First Lien Term Loan	S + 5.75%	11.18	%	12/15/2027	4,907	3,253	3,236	0.32	%
Tencate	(6) (9) (12) (13)	First Lien Term Loan	S + 4.00%	9.31	%	2/21/2031	7,034	6,999	7,001	0.70	%
Tencate (Delayed Draw)	(9) (11) (12)	First Lien Term Loan	S + 4.00%	9.31	%	2/21/2031	1,540	—	(7)	—	%
WSB Engineering Holdings Inc.	(6) (12)	First Lien Term Loan	S + 6.00%	11.34	%	8/31/2029	6,503	6,413	6,412	0.64	%
WSB Engineering Holdings Inc. (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 6.00%	11.34	%	8/31/2029	4,350	3,013	2,981	0.30	%
Total Construction & Building								78,713	78,744	7.89	%
Consumer Goods: Durable
Halo Buyer Inc	(6) (14)	First Lien Term Loan	S + 4.50%	9.93	%	6/30/2025	5,652	5,631	4,143	0.42	%

See Notes to Consolidated Financial Statements

11

NUVEEN CHURCHILL DIRECT LENDING CORP.

CONSOLIDATED SCHEDULE OF INVESTMENTS (UNAUDITED)

March 31, 2024

(dollar amounts in thousands)

Portfolio Company (1) (2)	Footnotes	Investment	Spread Above Reference Rate (3)	Interest Rate (3)		Maturity Date	Par Amount	Amortized Cost	Fair Value (4)	% of Net Assets (5)
SmartSign	(6) (13)	First Lien Term Loan	S + 5.50%	10.93	%	9/7/2028	9,850	9,776	9,742	0.97	%
SmartSign	(6)	First Lien Term Loan	S + 5.75%	11.17	%	9/7/2028	5,012	4,924	5,001	0.50	%
Total Consumer Goods: Durable								20,331	18,886	1.89	%
Consumer Goods: Non-durable
Arcadia Consumer Health	(6) (9) (13)	First Lien Term Loan	S + 4.50%	9.91	%	9/10/2027	12,572	12,496	12,249	1.23	%
Arcadia Consumer Health (Incremental)	(6) (9)	First Lien Term Loan	S + 5.75%	11.16	%	9/10/2027	2,160	2,124	2,181	0.22	%
Elevation Labs	(6) (13)	First Lien Term Loan	S + 5.75%	11.00	%	6/30/2028	6,772	6,720	6,675	0.67	%
Elevation Labs (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 5.75%	11.00	%	6/30/2028	3,125	915	893	0.09	%
FoodScience	(6) (12)	First Lien Term Loan	S + 6.00%	11.54	%	3/1/2027	7,724	7,680	7,356	0.74	%
FoodScience	(6) (12)	First Lien Term Loan	S + 6.00%	11.54	%	3/1/2027	6,863	6,815	6,536	0.65	%
Market Performance Group	(6) (13)	First Lien Term Loan	S + 5.25%	10.56	%	1/8/2030	12,620	12,498	12,503	1.25	%
Market Performance Group (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 5.25%	10.56	%	1/8/2030	3,086	—	(29)	—	%
Protective Industrial Products (“PIP”)	(6)	First Lien Term Loan	S + 4.00%	9.44	%	12/29/2027	3,800	3,796	3,797	0.38	%
Protective Industrial Products (“PIP”)	(6) (12)	First Lien Term Loan	S + 5.00%	10.44	%	12/29/2027	4,848	4,682	4,896	0.49	%
Ultima Health Holdings, LLC	(12)	Subordinated Debt	N/A	11.00% (Cash) 1.50% (PIK)		3/12/2029	1,740	1,713	1,745	0.17	%
Total Consumer Goods: Non-durable								59,439	58,802	5.89	%
Containers, Packaging & Glass
B2B Packaging	(6) (13)	First Lien Term Loan	S + 6.75%	12.21	%	10/7/2026	14,659	14,630	14,276	1.43	%
B2B Packaging (Delayed Draw)	(6)	First Lien Term Loan	S + 6.75%	12.24	%	10/7/2026	116	114	113	0.01	%
Five Star Packing	(6) (13) (14)	First Lien Term Loan	S + 4.25%	9.57	%	5/5/2029	7,557	7,467	7,505	0.75	%
Good2Grow	(6) (12) (13)	First Lien Term Loan	S + 6.00%	11.04	%	12/1/2027	6,346	6,260	6,409	0.64	%
Good2Grow	(6) (13)	First Lien Term Loan	S + 4.50%	9.99	%	12/1/2027	9,265	9,205	9,252	0.93	%
Oliver Packaging	(12)	Subordinated Debt	N/A	10.00% (Cash) 1.00% (PIK)		1/6/2029	2,510	2,473	2,378	0.24	%
Online Labels Group	(13)	First Lien Term Loan	S + 5.25%	10.61	%	12/19/2029	3,320	3,289	3,303	0.33	%
Online Labels Group (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 5.25%	10.61	%	12/19/2029	403	—	(2)	—	%
Online Labels Group (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 5.25%	10.61	%	12/19/2029	403	—	(2)	—	%
Proampac	(9) (12) (13)	First Lien Term Loan	S + 4.00%	9.30%		9/15/2028	4,514	4,514	4,545	0.46	%
Specialized Packaging Group	(6) (7) (10) (13)	First Lien Term Loan	S + 5.50%	11.04	%	12/17/2025	2,975	2,962	2,929	0.29	%

See Notes to Consolidated Financial Statements

12

NUVEEN CHURCHILL DIRECT LENDING CORP.

CONSOLIDATED SCHEDULE OF INVESTMENTS (UNAUDITED)

March 31, 2024

(dollar amounts in thousands)

Portfolio Company (1) (2)	Footnotes	Investment	Spread Above Reference Rate (3)	Interest Rate (3)		Maturity Date	Par Amount	Amortized Cost	Fair Value (4)	% of Net Assets (5)
Specialized Packaging Group	(6) (7) (10) (13)	First Lien Term Loan	S + 5.50%	11.04	%	12/17/2025	7,256	7,221	7,143	0.71	%
Specialized Packaging Group (Incremental)	(7) (10) (13)	First Lien Term Loan	S + 6.25%	11.79	%	12/17/2025	4,398	4,350	4,381	0.44	%
Specialized Packaging Group (Incremental)	(6) (7) (10) (12) (13)	First Lien Term Loan	S + 6.25%	11.79	%	12/17/2025	6,877	6,793	6,850	0.69	%
Total Containers, Packaging & Glass								69,278	69,080	6.92	%
Energy: Electricity
MGM Transformer Company	(6) (12) (13)	First Lien Term Loan	S + 6.00%	11.33	%	10/31/2029	23,553	23,217	23,403	2.33	%
MGM Transformer Company (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 6.00%	11.33	%	10/31/2029	6,388	(15)	(41)	—	%
National Power	(6) (12)	First Lien Term Loan	S + 6.00%	11.34	%	10/22/2029	5,660	5,578	5,579	0.56	%
National Power (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 6.00%	11.34	%	10/22/2029	3,051	(7)	(44)	—	%
Total Energy: Electricity								28,773	28,897	2.89	%
Environmental Industries
Contract Land Staff	(12) (13)	First Lien Term Loan	S + 5.00%	10.31	%	3/27/2030	7,564	7,488	7,488	0.75	%
Contract Land Staff (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 5.00%	10.31	%	3/27/2030	3,025	(8)	(30)	—	%
Impact Environmental Group	(6) (12)	First Lien Term Loan	S + 6.00%	11.41	%	3/23/2029	6,759	6,638	6,771	0.68	%
Impact Environmental Group (Delayed Draw)	(12)	First Lien Term Loan	S + 6.00%	11.41	%	3/23/2029	3,158	3,143	3,163	0.32	%
Impact Environmental Group (Incremental)	(12)	First Lien Term Loan	S + 6.00%	11.41	%	3/23/2029	1,732	1,700	1,735	0.17	%
Impact Environmental Group (Delayed Draw) (Incremental)	(11) (12)	First Lien Term Loan	S + 6.00%	11.41	%	3/23/2029	6,815	2,693	2,734	0.27	%
Nutrition 101 Buyer LLC (a/k/a 101, Inc.)	(6)	First Lien Term Loan	S + 5.25%	10.66	%	8/31/2028	6,631	6,582	6,386	0.64	%
Orion Group FM Holdings, LLC (dba Leo Facilities Maintenance)	(6) (12)	First Lien Term Loan	S + 6.25%	11.56	%	7/3/2029	8,529	8,409	8,412	0.84	%
Orion Group FM Holdings, LLC (dba Leo Facilities Maintenance) (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 6.25%	11.56	%	7/3/2029	6,429	1,100	1,026	0.10	%
The Facilities Group	(6) (9)	First Lien Term Loan	S + 5.75%	11.16	%	11/30/2027	4,859	4,830	4,859	0.49	%
The Facilities Group (Delayed Draw)	(9) (11) (12)	First Lien Term Loan	S + 5.75%	11.15	%	11/30/2027	5,028	167	167	0.02	%

See Notes to Consolidated Financial Statements

13

NUVEEN CHURCHILL DIRECT LENDING CORP.

CONSOLIDATED SCHEDULE OF INVESTMENTS (UNAUDITED)

March 31, 2024

(dollar amounts in thousands)

Portfolio Company (1) (2)	Footnotes	Investment	Spread Above Reference Rate (3)	Interest Rate (3)		Maturity Date	Par Amount	Amortized Cost	Fair Value (4)	% of Net Assets (5)
The Facilities Group	(6) (9) (13)	First Lien Term Loan	S + 5.75%	11.15	%	11/30/2027	9,026	8,944	9,026	0.91	%
The Facilities Group (Delayed Draw)	(6) (9) (12)	First Lien Term Loan	S + 5.75%	11.16	%	11/30/2027	4,939	4,939	4,939	0.49	%
Total Environmental Industries								56,625	56,676	5.68	%
Healthcare & Pharmaceuticals
Affinity Hospice	(6) (12)	First Lien Term Loan	S + 4.75%	10.15	%	12/17/2027	7,852	7,800	6,583	0.66	%
Anne Arundel	(12) (16)	Subordinated Debt	N/A	12.75% (PIK)		10/16/2026	3,282	3,252	713	0.07	%
Anne Arundel	(12) (16)	Subordinated Debt	N/A	11.00% (PIK)		4/16/2026	1,972	1,959	894	0.09	%
Anne Arundel (Delayed Draw)	(11) (12) (16)	Subordinated Debt	N/A	11.00% (PIK)		4/16/2026	2,396	2,023	719	0.07	%
Forefront Dermatology	(6) (9) (14)	First Lien Term Loan	S + 4.25%	9.56	%	3/30/2029	3,306	3,262	3,236	0.32	%
Genesee Scientific	(6) (9)	First Lien Term Loan	S + 5.50%	10.93	%	9/30/2027	5,943	5,909	5,756	0.58	%
Genesee Scientific (Delayed Draw)	(9) (12)	First Lien Term Loan	S + 5.50%	10.93	%	9/30/2027	1,556	1,556	1,507	0.15	%
GHR Healthcare	(6) (9)	First Lien Term Loan	S + 5.00%	10.46	%	12/9/2027	6,385	6,345	6,251	0.63	%
GHR Healthcare (Delayed Draw)	(6) (9) (13)	First Lien Term Loan	S + 5.00%	10.46	%	12/9/2027	1,997	1,997	1,955	0.20	%
GHR Healthcare (Incremental)	(6) (9) (13)	First Lien Term Loan	S + 5.00%	10.46	%	12/9/2027	4,970	4,896	4,866	0.49	%
Health Management Associates	(6) (12) (13)	First Lien Term Loan	S + 6.25%	11.69	%	3/30/2029	8,285	8,139	8,262	0.83	%
Health Management Associates (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 6.25%	11.69	%	3/30/2029	1,498	444	468	0.05	%
Heartland Veterinary Partners LLC (Incremental)	(12)	Subordinated Debt	N/A	7.50% (Cash) 7.00% (PIK)		12/10/2027	1,900	1,875	1,853	0.19	%
Heartland Veterinary Partners (Delayed Draw) (Incremental)	(11) (12)	Subordinated Debt	N/A	7.50% (Cash) 7.00% (PIK)		12/10/2027	3,600	—	(90)	(0.01	%)
Heartland Veterinary Partners LLC (Delayed Draw) (Incremental)	(12)	Subordinated Debt	N/A	7.50% (Cash) 7.00% (PIK)		12/10/2027	9,500	9,500	9,263	0.93	%
HemaSource Inc.	(12)	Subordinated Debt	N/A	8.50% (Cash) 5.00% (PIK)		2/28/2030	5,292	5,158	5,154	0.52	%
InfuCare RX	(6) (12) (13)	First Lien Term Loan	S + 4.50%	9.91	%	1/4/2028	9,248	9,186	9,226	0.92	%
MDC Intermediate Holdings II, LLC	(12)	Subordinated Debt	N/A	10.00% (Cash) 2.25% (PIK)		2/7/2030	1,759	1,722	1,701	0.17	%
MDC Intermediate Holdings II, LLC (Delayed Draw)	(11) (12)	Subordinated Debt	N/A	10.00% (Cash) 2.25% (PIK)		2/7/2030	723	462	445	0.04	%
Midwest Eye Consultants	(6) (13)	First Lien Term Loan	S + 4.50%	9.96	%	8/20/2027	8,998	8,945	8,936	0.90	%
PromptCare	(6) (9)	First Lien Term Loan	S + 6.00%	11.45	%	9/1/2027	8,183	8,110	8,087	0.81	%
PromptCare (Delayed Draw)	(6) (9)	First Lien Term Loan	S + 6.00%	11.45	%	9/1/2027	1,275	1,269	1,260	0.13	%
Quorum Health Resources, LLC	(6) (13)	First Lien Term Loan	S + 5.75%	11.29	%	5/28/2027	7,660	7,610	7,500	0.75	%
Quorum Health Resources, LLC (Delayed Draw) (Incremental)	(6) (10)	First Lien Term Loan	S + 6.25%	11.68	%	5/28/2027	3,240	3,232	3,215	0.32	%
Quorum Health Resources, LLC (Incremental)	(6) (10) (13)	First Lien Term Loan	S + 6.25%	11.68	%	5/28/2027	3,240	3,195	3,215	0.32	%
Sandlot Buyer, LLC (Prime Time Healthcare)	(6) (12) (13)	First Lien Term Loan	S + 6.00%	11.28	%	9/19/2028	8,625	8,414	8,543	0.86	%

See Notes to Consolidated Financial Statements

14

NUVEEN CHURCHILL DIRECT LENDING CORP.

CONSOLIDATED SCHEDULE OF INVESTMENTS (UNAUDITED)

March 31, 2024

(dollar amounts in thousands)

Portfolio Company (1) (2)	Footnotes	Investment	Spread Above Reference Rate (3)	Interest Rate (3)		Maturity Date	Par Amount	Amortized Cost	Fair Value (4)	% of Net Assets (5)
Sandlot Buyer, LLC (Prime Time Healthcare) (Incremental))	(12) (13)	First Lien Term Loan	S + 6.00%	11.27	%	9/19/2028	9,994	9,806	9,899	0.99	%
SCP Eye Care Holdco, LLC (DBA EyeSouth Partners)	(6) (13)	First Lien Term Loan	S + 5.75%	11.18	%	10/5/2029	7,455	7,392	7,367	0.74	%
SCP Eye Care Holdco, LLC (DBA EyeSouth Partners) (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 5.75%	11.18	%	10/5/2029	2,439	1,554	1,525	0.15	%
SM Wellness Holdings, Inc	(6) (12) (13)	First Lien Term Loan	S + 4.50%	10.07	%	4/17/2028	14,627	14,542	14,149	1.42	%
Southern Veterinary Partners	(9)	First Lien Term Loan	S + 4.00%	9.44	%	10/5/2027	2,118	2,113	2,113	0.21	%
Team Services Group	(6)	First Lien Term Loan	S + 5.00%	10.58%		12/20/2027	6,650	6,617	6,620	0.66	%
Thorne HealthTech	(6) (12) (13)	First Lien Term Loan	S + 6.00%	11.06	%	10/16/2030	10,625	10,525	10,522	1.05	%
TIDI Products	(6) (9) (12) (13)	First Lien Term Loan	S + 5.50%	10.83	%	12/19/2029	15,484	15,337	15,427	1.55	%
TIDI Products (Delayed Draw)	(9) (11) (12)	First Lien Term Loan	S + 5.50%	10.83	%	12/19/2029	4,085	—	(15)	—	%
US Fertility	(12)	Subordinated Debt	N/A	13.75% (PIK)		6/21/2028	12,831	12,543	12,652	1.27	%
Wellspring Pharmaceutical	(6)	First Lien Term Loan	S + 5.75%	11.03	%	8/22/2028	3,370	3,317	3,317	0.33	%
Wellspring Pharmaceutical (Delayed Draw)	(12)	First Lien Term Loan	S + 5.75%	11.03	%	8/22/2028	1,567	1,558	1,543	0.15	%
Wellspring Pharmaceutical (Delayed Draw) (Incremental)	(11) (12)	First Lien Term Loan	S + 6.00%	11.33	%	8/22/2028	3,756	(15)	(26)	—	%
Wellspring Pharmaceutical (Incremental)	(6) (12) (13)	First Lien Term Loan	S + 6.00%	11.33	%	8/22/2028	1,243	1,221	1,234	0.12	%
Young Innovations	(6) (9) (13)	First Lien Term Loan	S + 5.75%	11.07	%	12/3/2029	16,510	16,354	16,352	1.63	%
Young Innovations (Delayed Draw)	(9) (11) (12)	First Lien Term Loan	S + 5.75%	11.07	%	12/3/2029	3,448	—	(33)	—	%
Total Healthcare & Pharmaceuticals								219,124	212,164	21.26	%
High Tech Industries
Acclaim MidCo, LLC (dba ClaimLogiQ)	(6) (12)	First Lien Term Loan	S + 6.00%	11.31	%	6/13/2029	8,001	7,856	7,934	0.79	%
Acclaim MidCo, LLC (dba ClaimLogiQ) (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 6.00%	11.31	%	6/13/2029	3,225	(14)	(27)	—	%
Ahead Data Blue LLC	(6)	First Lien Term Loan	S + 4.25%	9.56	%	2/1/2031	5,118	5,069	5,069	0.51	%
Argano, LLC	(6)	First Lien Term Loan	S + 6.00%	11.68	%	6/10/2026	5,619	5,591	5,551	0.56	%
Argano, LLC (Delayed Draw)	(6) (13)	First Lien Term Loan	S + 6.00%	11.68	%	6/10/2026	2,488	2,489	2,459	0.25	%
Argano, LLC (Delayed Draw) (Incremental)	(6)	First Lien Term Loan	S + 6.00%	11.68	%	6/10/2026	1,700	1,674	1,680	0.17	%
Diligent Corporation	(6) (9)	First Lien Term Loan	S + 6.25%	11.71	%	8/4/2025	12,437	12,422	12,422	1.24	%
Diligent Corporation	(6) (9) (12) (13)	First Lien Term Loan	S + 5.75%	11.21	%	8/4/2025	3,378	3,366	3,353	0.34	%
Diligent Corporation	(9) (12)	First Lien Term Loan	S + 5.75%	11.21	%	8/4/2025	1,472	1,467	1,461	0.15	%
Diligent Corporation (Delayed Draw)	(9) (12)	First Lien Term Loan	S + 6.25%	11.71	%	8/4/2025	167	167	167	0.02	%
Diligent Corporation (Delayed Draw)	(9) (12)	First Lien Term Loan	S + 6.25%	11.71	%	8/4/2025	106	106	105	0.01	%

See Notes to Consolidated Financial Statements

15

NUVEEN CHURCHILL DIRECT LENDING CORP.

CONSOLIDATED SCHEDULE OF INVESTMENTS (UNAUDITED)

March 31, 2024

(dollar amounts in thousands)

Portfolio Company (1) (2)	Footnotes	Investment	Spread Above Reference Rate (3)	Interest Rate (3)		Maturity Date	Par Amount	Amortized Cost	Fair Value (4)	% of Net Assets (5)
Eliassen Group LLC	(6) (9) (13)	First Lien Term Loan	S + 5.50%	10.81	%	4/14/2028	12,039	11,950	12,054	1.21	%
Eliassen Group LLC (Delayed Draw)	(9) (11) (12)	First Lien Term Loan	S + 5.50%	10.81	%	4/14/2028	2,769	862	870	0.09	%
Evergreen Services Group II	(6) (9) (12) (13)	First Lien Term Loan	S + 6.25%	11.31	%	10/4/2030	16,115	15,884	16,067	1.60	%
Evergreen Services Group II (Delayed Draw)	(9) (11) (12)	First Lien Term Loan	S + 6.25%	11.31	%	10/4/2030	13,014	11,863	11,853	1.19	%
Exterro	(6) (13)	First Lien Term Loan	S + 5.50%	10.99	%	6/1/2027	9,474	9,470	9,590	0.96	%
Fineline Merger	(12)	Subordinated Debt	S + 9.26%	14.31	%	8/19/2028	2,453	2,430	2,453	0.25	%
Go Engineer	(6) (9) (13)	First Lien Term Loan	S + 5.38%	10.83	%	12/21/2027	11,543	11,466	11,491	1.15	%
Go Engineer (Delayed Draw)	(6) (9)	First Lien Term Loan	S + 5.38%	10.83	%	12/21/2027	3,144	3,123	3,129	0.31	%
Infinite Electronics (Incremental)	(6) (9)	First Lien Term Loan	S + 6.25%	11.83	%	3/2/2028	6,297	6,144	6,096	0.61	%
Infobase Acquisition, Inc.	(6)	First Lien Term Loan	S + 5.50%	10.98	%	6/14/2028	4,320	4,288	4,310	0.43	%
ITSavvy LLC	(6)	First Lien Term Loan	S + 5.25%	10.89	%	8/8/2028	7,774	7,715	7,774	0.77	%
ITSavvy LLC (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 5.25%	10.89	%	8/8/2028	1,049	884	891	0.09	%
North Haven CS Acquisition Inc	(6)	First Lien Term Loan	S + 5.50%	10.97	%	1/23/2025	5,769	5,769	5,742	0.58	%
North Haven CS Acquisition Inc (Incremental)	(12) (13)	First Lien Term Loan	S + 5.50%	10.97	%	1/22/2027	22,355	22,135	22,251	2.23	%
Prosci, Inc.	(6)	First Lien Term Loan	S + 4.50%	9.93	%	10/21/2026	4,733	4,707	4,733	0.47	%
Quickbase	(12) (13)	First Lien Term Loan	S + 4.00%	9.30	%	10/2/2028	6,353	6,322	6,322	0.63	%
Revalize (Delayed Draw)	(6) (9) (13)	First Lien Term Loan	S + 5.75%	11.21	%	4/15/2027	4,232	4,222	4,002	0.40	%
Revalize (Delayed Draw)	(6) (9) (12)	First Lien Term Loan	S + 5.75%	11.21	%	4/15/2027	1,087	1,080	1,028	0.10	%
Revalize (Delayed Draw)	(9) (12)	First Lien Term Loan	S + 5.75%	11.21	%	4/15/2027	244	243	231	0.02	%
SmartWave	(6) (12)	First Lien Term Loan	S + 6.00%	11.46	%	11/5/2026	9,190	9,128	7,599	0.76	%
Solve Industrial Motion Group	(12)	Subordinated Debt	N/A	5.00% (Cash) 8.00% (PIK)		6/30/2028	1,823	1,798	1,735	0.17	%
Solve Industrial Motion Group	(12)	Subordinated Debt	N/A	5.00% (Cash) 8.00% (PIK)		6/30/2028	779	767	755	0.08	%
Solve Industrial Motion Group (Delayed Draw)	(12)	Subordinated Debt	N/A	5.00% (Cash) 8.00% (PIK)		6/30/2028	2,088	2,088	1,987	0.20	%
Velosio	(6) (9) (13)	First Lien Term Loan	S + 5.25%	10.58	%	3/1/2030	6,248	6,187	6,187	0.62	%
Velosio (Delayed Draw)	(9) (11) (12)	First Lien Term Loan	S + 5.25%	10.58	%	3/1/2030	1,284	—	(12)	—	%
Total High Tech Industries								190,718	189,312	18.96	%
Media: Advertising, Printing & Publishing
Tinuiti	(6) (9)	First Lien Term Loan	S + 5.25%	10.65	%	12/10/2026	2,940	2,922	2,842	0.28	%
Tinuiti (Delayed Draw)	(6) (9)	First Lien Term Loan	S + 5.25%	10.65	%	12/10/2026	1,922	1,921	1,857	0.19	%
Tinuiti (Delayed Draw) (Incremental)	(6) (9) (12)	First Lien Term Loan	S + 5.25%	10.65	%	12/10/2026	9,838	9,838	9,509	0.95	%
Wpromote	(6) (13)	First Lien Term Loan	S + 5.75%	11.18	%	10/23/2028	4,368	4,297	4,373	0.44	%

See Notes to Consolidated Financial Statements

16

NUVEEN CHURCHILL DIRECT LENDING CORP.

CONSOLIDATED SCHEDULE OF INVESTMENTS (UNAUDITED)

March 31, 2024

(dollar amounts in thousands)

Portfolio Company (1) (2)	Footnotes	Investment	Spread Above Reference Rate (3)	Interest Rate (3)		Maturity Date	Par Amount	Amortized Cost	Fair Value (4)	% of Net Assets (5)
Wpromote (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 5.75%	11.18	%	10/23/2028	588	(3)	1	—	%
Total Media: Advertising, Printing & Publishing								18,975	18,582	1.86	%
Media: Diversified & Production
Corporate Visions	(6)	First Lien Term Loan	S + 4.50%	9.93	%	8/12/2027	2,879	2,862	2,635	0.26	%
Corporate Visions	(6)	First Lien Term Loan	S + 4.50%	9.93	%	8/12/2027	2,531	2,505	2,316	0.23	%
Spectrio II	(6) (9) (12) (13)	First Lien Term Loan	S + 6.00%	6.50% (Cash) 5.00% (PIK)		12/9/2026	8,225	8,187	7,608	0.77	%
Spectrio II (Delayed Draw)	(6) (9) (12)	First Lien Term Loan	S + 6.00%	6.33% (Cash) 5.00% (PIK)		12/9/2026	2,922	2,905	2,703	0.27	%
Spectrio II (Delayed Draw)	(9) (13)	First Lien Term Loan	S + 6.00%	6.33% (Cash) 5.00% (PIK)		12/9/2026	446	444	410	0.04	%
Total Media: Diversified & Production								16,903	15,672	1.57	%
Retail
Syndigo	(6)	First Lien Term Loan	S + 4.50%	9.94	%	12/15/2027	5,820	5,834	5,789	0.59	%
Total Retail								5,834	5,789	0.59	%
Services: Business
ALKU Intermediate Holdings, LLC	(12) (13)	First Lien Term Loan	S + 6.25%	11.58	%	5/23/2029	4,508	4,428	4,553	0.46	%
Apex Companies Holdings, LLC	(12)	Subordinated Debt	N/A	10.00% (Cash) 2.50% (PIK)		1/31/2029	3,989	3,908	3,979	0.40	%
Apex Companies Holdings, LLC (Delayed Draw)	(11) (12)	Subordinated Debt	N/A	10.00% (Cash) 2.50% (PIK)		1/31/2029	1,085	71	80	0.01	%
Aramsco	(6) (9)	First Lien Term Loan	S + 4.75%	10.06	%	10/10/2030	1,703	1,703	1,703	0.17	%
Aramsco (Delayed Draw)	(9) (11) (12)	First Lien Term Loan	S + 4.75%	10.06	%	10/10/2030	297	—	—	—	%
ARMstrong	(6) (12) (13)	First Lien Term Loan	S + 6.25%	11.66	%	10/8/2029	11,418	11,256	11,371	1.13	%
ARMstrong (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 6.25%	11.66	%	10/8/2029	3,847	(27)	(16)	—	%
Big Truck Rental	(12)	Subordinated Debt	S + 8.00%	13.44	%	9/30/2027	10,000	9,869	10,000	1.00	%
Big Truck Rental	(12)	Subordinated Debt	S + 8.00%	13.44	%	9/30/2027	2,500	2,500	2,500	0.25	%
Bounteous	(6) (12) (13)	First Lien Term Loan	S + 5.25%	10.69	%	8/2/2027	5,334	5,299	5,307	0.53	%
Bounteous	(6) (12)	First Lien Term Loan	S + 5.25%	10.69	%	8/2/2027	2,183	2,169	2,172	0.22	%
Bounteous (Delayed Draw)	(6) (12)	First Lien Term Loan	S + 5.25%	10.69	%	8/2/2027	2,761	2,745	2,746	0.28	%
Bounteous (Delayed Draw)	(12)	First Lien Term Loan	S + 5.25%	10.69	%	8/2/2027	3,567	3,567	3,549	0.36	%
BroadcastMed Holdco, LLC	(12)	Subordinated Debt	N/A	10.00% (Cash) 3.75% (PIK)		11/12/2027	3,615	3,560	3,475	0.35	%
Bullhorn Inc	(6) (9) (12) (13)	First Lien Term Loan	S + 5.50%	10.93	%	9/30/2026	13,671	13,585	13,671	1.36	%
BusinesSolver	(6) (9)	First Lien Term Loan	S + 5.50%	10.91	%	12/1/2027	7,721	7,671	7,721	0.77	%

See Notes to Consolidated Financial Statements

17

NUVEEN CHURCHILL DIRECT LENDING CORP.

CONSOLIDATED SCHEDULE OF INVESTMENTS (UNAUDITED)

March 31, 2024

(dollar amounts in thousands)

Portfolio Company (1) (2)	Footnotes	Investment	Spread Above Reference Rate (3)	Interest Rate (3)		Maturity Date	Par Amount	Amortized Cost	Fair Value (4)	% of Net Assets (5)
BusinesSolver (Delayed Draw)	(9) (11) (12)	First Lien Term Loan	S + 5.50%	10.91	%	12/1/2027	1,149	272	276	0.03	%
Career Now	(12)	Subordinated Debt	N/A	13.00% (PIK)		3/30/2027	3,393	3,355	2,313	0.23	%
Cornerstone Advisors of Arizona LLC	(6)	First Lien Term Loan	S + 5.50%	10.83	%	9/24/2026	308	306	308	0.03	%
Cornerstone Advisors of Arizona LLC	(6)	First Lien Term Loan	S + 5.50%	10.83	%	9/24/2026	2,289	2,279	2,289	0.23	%
Cornerstone Advisors of Arizona LLC (Delayed Draw)	(6) (10)	First Lien Term Loan	S + 5.50%	10.83	%	9/24/2026	210	209	210	0.02	%
Cornerstone Advisors of Arizona LLC (Incremental)	(6)	First Lien Term Loan	S + 5.50%	10.89	%	9/24/2026	3,449	3,415	3,449	0.35	%
CrossCountry Consulting	(6) (9)	First Lien Term Loan	S + 5.75%	11.17	%	6/1/2029	8,154	8,023	8,235	0.82	%
CrossCountry Consulting (Delayed Draw)	(9) (11) (12)	First Lien Term Loan	S + 5.75%	11.17	%	6/1/2029	3,320	(25)	33	—	%
D&H United Fueling Solutions	(6) (13)	First Lien Term Loan	S + 6.00%	10.98	%	9/15/2028	7,472	7,356	7,309	0.73	%
D&H United Fueling Solutions (Delayed Draw)	(6)	First Lien Term Loan	S + 6.00%	10.98	%	9/15/2028	2,378	2,360	2,326	0.23	%
D&H United Fueling Solutions (Delayed Draw) (Incremental)	(11) (12)	First Lien Term Loan	S + 6.00%	11.46	%	9/15/2028	1,567	167	167	0.02	%
D&H United Fueling Solutions (Incremental)	(6) (13)	First Lien Term Loan	S + 6.00%	11.46	%	9/15/2028	3,457	3,395	3,441	0.34	%
E78	(6)	First Lien Term Loan	S + 5.50%	10.93	%	12/1/2027	5,586	5,549	5,573	0.56	%
E78	(13)	First Lien Term Loan	S + 5.75%	10.93	%	12/1/2027	1,434	1,424	1,431	0.14	%
E78 (Delayed Draw)	(6) (13)	First Lien Term Loan	S + 5.50%	10.93	%	12/1/2027	4,200	4,172	4,190	0.42	%
E78 (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 5.75%	10.93	%	12/1/2027	3,547	977	969	0.10	%
Evergreen Services Group	(6) (9) (12) (13)	First Lien Term Loan	S + 6.25%	11.66	%	6/15/2029	11,936	11,743	11,773	1.17	%
Evergreen Services Group (Delayed Draw)	(9) (12)	First Lien Term Loan	S + 6.25%	11.66	%	6/15/2029	2,856	2,833	2,817	0.28	%
Gabriel Partners LLC	(6) (9) (13)	First Lien Term Loan	S + 6.25%	11.74	%	9/21/2026	9,168	9,125	9,168	0.92	%
Gabriel Partners LLC (Delayed Draw)	(6) (9) (13)	First Lien Term Loan	S + 6.25%	11.74	%	9/21/2026	1,527	1,527	1,527	0.15	%
Gabriel Partners LLC (Incremental)	(6) (9) (13)	First Lien Term Loan	S + 5.75%	11.74	%	9/21/2026	3,784	3,764	3,784	0.38	%
HireRight	(12) (13)	First Lien Term Loan	S + 4.00%	9.33	%	9/27/2030	6,754	6,686	6,687	0.67	%
Image First	(6) (12) (13)	First Lien Term Loan	S + 4.25%	9.57	%	4/27/2028	7,668	7,650	7,649	0.77	%
Image First (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 4.25%	9.57	%	4/27/2028	143	—	—	—	%
Keng Acquisition, Inc. (Engage Group Holdings, LLC)	(6) (9) (12) (13)	First Lien Term Loan	S + 6.25%	11.56	%	8/1/2029	9,643	9,507	9,605	0.96	%
Keng Acquisition, Inc. (Engage Group Holdings, LLC) (Delayed Draw)	(9) (11) (12)	First Lien Term Loan	S + 6.25%	11.56	%	8/1/2029	9,311	1,177	1,162	0.12	%
KRIV Acquisition, Inc	(6) (12) (13)	First Lien Term Loan	S + 6.50%	11.80	%	7/6/2029	10,737	10,459	10,439	1.05	%
KRIV Acquisition, Inc (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 6.50%	11.80	%	7/6/2029	1,607	(18)	(45)	—	%
Lion Merger Sub Inc	(9) (13)	First Lien Term Loan	S + 6.00%	11.41	%	12/17/2025	7,323	7,293	7,295	0.73	%

See Notes to Consolidated Financial Statements

18

NUVEEN CHURCHILL DIRECT LENDING CORP.

CONSOLIDATED SCHEDULE OF INVESTMENTS (UNAUDITED)

March 31, 2024

(dollar amounts in thousands)

Portfolio Company (1) (2)	Footnotes	Investment	Spread Above Reference Rate (3)	Interest Rate (3)		Maturity Date	Par Amount	Amortized Cost	Fair Value (4)	% of Net Assets (5)
Lion Merger Sub Inc (Incremental)	(9) (12) (13)	First Lien Term Loan	S + 6.00%	11.41	%	12/17/2025	7,298	7,241	7,270	0.73	%
LSCS Holdings Inc.	(6) (13) (14)	First Lien Term Loan	S + 4.50%	9.94	%	12/16/2028	9,775	9,742	9,650	0.97	%
Lynx Franchising, LLC	(6) (9)	First Lien Term Loan	S + 6.75%	12.23	%	12/23/2026	9,775	9,700	9,759	0.98	%
Micronics	(12)	Subordinated Debt	S + 5.25%	10.84	%	2/17/2027	2,450	2,405	2,405	0.24	%
Output Services Group, Inc.	(10) (12)	First Lien Term Loan	S + 8.00%	13.29	%	5/30/2028	155	155	155	0.02	%
Output Services Group, Inc.	(12)	First Lien Term Loan	S + 6.25%	7.22% (Cash) 4.75% (PIK)		11/30/2028	837	837	837	0.08	%
Phaidon International	(6) (7) (10) (12) (13)	First Lien Term Loan	S + 5.50%	10.93	%	8/22/2029	13,823	13,715	13,660	1.36	%
Plaze	(12)	Subordinated Debt	S + 7.50%	12.94	%	7/7/2028	13,500	13,218	12,574	1.26	%
Propark Mobility	(6)	First Lien Term Loan	S + 6.25%	11.40	%	1/31/2029	6,806	6,694	6,816	0.68	%
Propark Mobility (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 6.25%	11.40	%	1/31/2029	3,122	1,274	1,329	0.13	%
Scaled Agile	(6) (9)	First Lien Term Loan	S + 5.50%	10.91	%	12/15/2028	7,915	7,858	7,461	0.75	%
Scaled Agile (Delayed Draw)	(9) (12)	First Lien Term Loan	S + 5.50%	10.91	%	12/15/2028	389	389	367	0.04	%
Smile Brands	(12)	Subordinated Debt	S + 8.50%	14.95% (PIK)		4/12/2026	10,325	10,255	8,763	0.88	%
Soliant Health	(6)	First Lien Term Loan	S + 4.00%	9.44	%	3/31/2028	5,353	5,350	5,370	0.54	%
System One	(6) (9) (12)	First Lien Term Loan	S + 4.00%	9.46	%	3/2/2028	2,253	2,250	2,249	0.23	%
Technical Safety Services	(6)	First Lien Term Loan	S + 5.50%	10.95	%	6/22/2029	6,755	6,701	6,755	0.68	%
Technical Safety Services (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 5.50%	10.95	%	6/22/2029	6,394	3,982	4,051	0.41	%
Technical Safety Services (Incremental)	(6) (12)	First Lien Term Loan	S + 5.50%	10.95	%	6/22/2029	1,885	1,859	1,885	0.19	%
TouchTunes Interactive	(6) (13)	First Lien Term Loan	S + 5.00%	10.30	%	4/2/2029	9,850	9,772	9,899	0.99	%
Trilon Group, LLC	(13)	First Lien Term Loan	S + 6.25%	11.71	%	5/25/2029	2,970	2,951	2,941	0.29	%
Trilon Group, LLC	(6) (13)	First Lien Term Loan	S + 6.00%	11.71	%	5/25/2029	7,388	7,328	7,315	0.73	%
Trilon Group, LLC	(12) (13)	First Lien Term Loan	S + 6.25%	11.72	%	5/25/2029	3,724	3,654	3,687	0.37	%
Trilon Group, LLC (Delayed Draw)	(12)	First Lien Term Loan	S + 6.00%	11.71	%	5/25/2029	7,406	7,406	7,333	0.73	%
Trilon Group, LLC (Delayed Draw)	(12)	First Lien Term Loan	S + 6.25%	11.71	%	5/25/2029	1,980	1,980	1,960	0.20	%
Trilon Group, LLC (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 6.25%	11.72	%	5/25/2029	6,373	4,469	4,436	0.44	%
Vistage	(6) (9)	First Lien Term Loan	S + 4.75%	10.05	%	7/13/2029	6,982	6,948	6,947	0.70	%
Vital Records Control	(6) (9)	First Lien Term Loan	S + 5.50%	11.07	%	6/29/2027	4,571	4,536	4,542	0.46	%
Vital Records Control	(6) (9)	First Lien Term Loan	S + 5.75%	11.07	%	6/29/2027	333	330	333	0.03	%
Total Services: Business								340,283	337,940	33.85	%
Services: Consumer
360 Training	(13)	First Lien Term Loan	S + 5.00%	10.33	%	8/2/2028	3,465	3,431	3,431	0.34	%
360 Training (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 5.00%	10.33	%	8/2/2028	3,093	—	(30)	—	%
All My Sons	(6)	First Lien Term Loan	S + 4.75%	10.31	%	10/25/2028	5,247	5,210	5,247	0.53	%
COP Exterminators Acquisition, Inc.	(12)	Subordinated Debt	N/A	9.00% (Cash) 4.00% (PIK)		1/28/2030	847	825	825	0.08	%

See Notes to Consolidated Financial Statements

19

NUVEEN CHURCHILL DIRECT LENDING CORP.

CONSOLIDATED SCHEDULE OF INVESTMENTS (UNAUDITED)

March 31, 2024

(dollar amounts in thousands)

Portfolio Company (1) (2)	Footnotes	Investment	Spread Above Reference Rate (3)	Interest Rate (3)		Maturity Date	Par Amount	Amortized Cost	Fair Value (4)	% of Net Assets (5)
COP Exterminators Acquisition, Inc. (Delayed Draw)	(11) (12)	Subordinated Debt	N/A	9.00% (Cash) 4.00% (PIK)		1/28/2030	652	535	526	0.05	%
Excel Fitness	(6) (13)	First Lien Term Loan	S + 5.25%	10.70	%	4/27/2029	9,850	9,757	9,689	0.97	%
Fairway Lawns	(12)	Subordinated Debt	N/A	8.00% (Cash) 5.00% (PIK)		5/17/2029	2,766	2,701	2,695	0.27	%
Fairway Lawns (Delayed Draw)	(12)	Subordinated Debt	N/A	8.00% (Cash) 5.00% (PIK)		5/17/2029	5,944	5,944	5,794	0.58	%
Legacy Service Partners, LLC (“LSP”)	(6) (12) (13)	First Lien Term Loan	S + 6.50%	11.96	%	1/9/2029	10,136	9,965	10,237	1.02	%
Legacy Service Partners, LLC (“LSP”) (Delayed Draw)	(12)	First Lien Term Loan	S + 6.50%	11.96	%	1/9/2029	4,724	4,704	4,771	0.48	%
Liberty Buyer	(6) (9) (13)	First Lien Term Loan	S + 5.75%	11.18	%	6/15/2028	3,919	3,890	3,926	0.39	%
Liberty Buyer (Delayed Draw)	(9) (11) (12)	First Lien Term Loan	S + 5.75%	11.18	%	6/15/2028	743	295	296	0.03	%
NearU	(6) (9) (12) (13)	First Lien Term Loan	S + 6.00%	11.51	%	8/16/2028	8,452	8,452	7,895	0.79	%
NearU (Delayed Draw)	(9) (11) (12)	First Lien Term Loan	S + 6.00%	11.51	%	8/16/2028	1,577	—	(104)	(0.01	%)
NearU (Delayed Draw)	(9) (11) (12)	First Lien Term Loan	S + 6.00%	11.51	%	8/16/2028	1,714	—	(113)	(0.01	%)
NJEye LLC	(6)	First Lien Term Loan	S + 4.75%	10.17	%	3/14/2025	5,326	5,321	5,306	0.53	%
NJEye LLC (Delayed Draw)	(6)	First Lien Term Loan	S + 4.75%	10.17	%	3/14/2025	698	698	695	0.07	%
NJEye LLC (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 4.75%	10.17	%	9/14/2024	1,373	884	879	0.09	%
NJEye LLC (Delayed Draw)	(6)	First Lien Term Loan	S + 4.75%	10.44	%	9/14/2024	888	888	885	0.09	%
North Haven Spartan US Holdco LLC	(6)	First Lien Term Loan	S + 6.25%	11.57	%	6/8/2026	2,496	2,495	2,466	0.25	%
North Haven Spartan US Holdco LLC (Delayed Draw)	(6)	First Lien Term Loan	S + 6.25%	11.57	%	6/8/2026	216	216	214	0.02	%
North Haven Spartan US Holdco LLC (Delayed Draw) (Incremental)	(11) (13)	First Lien Term Loan	S + 6.25%	11.57	%	6/8/2026	3,260	(8)	(40)	—	%
One World Fitness PFF LLC	(6)	First Lien Term Loan	S + 5.25%	10.66% (Cash) 1.00% (PIK)		11/26/2025	3,874	3,875	3,686	0.37	%
Perennial Services, Group, LLC	(6)	First Lien Term Loan	S + 6.00%	11.44	%	9/7/2029	6,716	6,624	6,688	0.67	%
Perennial Services, Group, LLC (Delayed Draw)	(6) (12)	First Lien Term Loan	S + 6.00%	11.44	%	9/7/2029	6,010	5,997	5,985	0.60	%
Wrench Group	(9) (13)	First Lien Term Loan	S + 4.00%	9.57	%	10/30/2028	4,500	4,490	4,491	0.45	%
Total Services: Consumer								87,189	86,340	8.65	%
Sovereign & Public Finance
LMI Renaissance	(6) (12) (13)	First Lien Term Loan	S + 5.50%	10.84	%	7/18/2028	12,224	12,125	12,174	1.22	%
Total Sovereign & Public Finance								12,125	12,174	1.22	%

See Notes to Consolidated Financial Statements

20

NUVEEN CHURCHILL DIRECT LENDING CORP.

CONSOLIDATED SCHEDULE OF INVESTMENTS (UNAUDITED)

March 31, 2024

(dollar amounts in thousands)

Portfolio Company (1) (2)	Footnotes	Investment	Spread Above Reference Rate (3)	Interest Rate (3)		Maturity Date	Par Amount	Amortized Cost	Fair Value (4)	% of Net Assets (5)
Telecommunications
BCM One	(6)	First Lien Term Loan	S + 4.50%	9.92	%	11/17/2027	5,942	5,942	5,918	0.59	%
BCM One (Delayed Draw)	(6)	First Lien Term Loan	S + 4.50%	9.92	%	11/17/2027	1,822	1,822	1,815	0.18	%
MBS Holdings, Inc.	(6) (9)	First Lien Term Loan	S + 6.25%	11.68	%	4/16/2027	1,823	1,795	1,833	0.18	%
Mobile Communications America Inc	(6) (12) (13)	First Lien Term Loan	S + 6.00%	11.31	%	10/16/2029	18,459	18,196	18,229	1.84	%
Mobile Communications America Inc (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 6.00%	11.31	%	10/16/2029	5,970	(42)	(74)	(0.01	%)
Momentum Telecom II	(6) (9) (13)	First Lien Term Loan	S + 5.75%	11.18	%	4/16/2027	10,028	9,973	9,950	1.00	%
Momentum Telecom II (Incremental)	(6) (9)	First Lien Term Loan	S + 6.50%	11.93	%	4/16/2027	1,311	1,289	1,326	0.13	%
Sapphire Telecom Inc	(6) (9)	First Lien Term Loan	S + 6.00%	11.47	%	11/20/2025	6,633	6,613	6,633	0.66	%
Tyto Athene, LLC	(6) (12)	First Lien Term Loan	S + 5.50%	10.98	%	4/3/2028	7,157	7,108	6,610	0.66	%
Total Telecommunications								52,696	52,240	5.23	%
Transportation: Cargo
AIT Logistics	(6) (14)	First Lien Term Loan	S + 4.75%	10.17	%	4/6/2028	1,281	1,280	1,286	0.13	%
FSK Pallet Holding Corp. (DBA Kamps Pallets)	(6) (13)	First Lien Term Loan	S + 6.00%	11.46	%	12/23/2026	9,850	9,713	9,500	0.94	%
Kenco Group, Inc.	(6) (13)	First Lien Term Loan	S + 5.00%	10.29	%	11/15/2029	8,476	8,334	8,476	0.85	%
Kenco Group, Inc. (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 5.00%	10.29	%	11/15/2029	1,416	(23)	—	—	%
Quantix (Incremental)	(6) (9)	First Lien Term Loan	S + 6.50%	12.23	%	8/3/2026	257	256	251	0.03	%
Quantix (Incremental)	(6) (9)	First Lien Term Loan	S + 6.00%	11.73	%	8/3/2026	892	889	870	0.09	%
Quantix (Incremental)	(6) (9)	First Lien Term Loan	S + 6.50%	12.23	%	8/3/2026	180	180	176	0.02	%
Quantix (Incremental)	(6) (9)	First Lien Term Loan	S + 6.50%	12.23	%	8/3/2026	4,356	4,341	4,247	0.43	%
Quantix (Incremental)	(9) (13)	First Lien Term Loan	S + 6.50%	11.90	%	8/3/2026	1,355	1,342	1,321	0.13	%
RoadOne	(12)	Subordinated Debt	N/A	8.75% (Cash) 5.00% (PIK)		6/30/2029	4,759	4,642	4,637	0.46	%
RoadOne (Delayed Draw)	(11) (12)	Subordinated Debt	N/A	8.75% (Cash) 5.00% (PIK)		6/30/2029	1,397	(17)	(36)	—	%
SEKO Global Logistics	(12)	Subordinated Debt	S + 5.00%	10.50% (Cash) 4.50% (PIK)		6/30/2027	5,905	5,835	5,288	0.53	%
SEKO Global Logistics	(12)	Subordinated Debt	S + 5.00%	10.50% (Cash) 4.50% (PIK)		6/30/2027	4,098	4,046	3,670	0.37	%
SEKO Global Logistics	(6)	First Lien Term Loan	S + 5.00%	10.46	%	12/30/2026	1,122	1,116	1,045	0.10	%
SEKO Global Logistics (Delayed Draw)	(12)	Subordinated Debt	S + 5.00%	10.50% (Cash) 4.50% (PIK)		6/30/2027	923	923	826	0.08	%
SEKO Global Logistics (Delayed Draw) (Incremental)	(6) (12)	First Lien Term Loan	S + 5.00%	10.46	%	12/30/2026	4,473	4,473	4,164	0.42	%

See Notes to Consolidated Financial Statements

21

NUVEEN CHURCHILL DIRECT LENDING CORP.

CONSOLIDATED SCHEDULE OF INVESTMENTS (UNAUDITED)

March 31, 2024

(dollar amounts in thousands)

Portfolio Company (1) (2)	Footnotes	Investment	Spread Above Reference Rate (3)	Interest Rate (3)		Maturity Date	Par Amount	Amortized Cost	Fair Value (4)	% of Net Assets (5)
SEKO Global Logistics (Incremental)	(6)	First Lien Term Loan	S + 5.00%	10.46	%	12/30/2026	1,513	1,503	1,409	0.14	%
TI ACQUISITION NC LLC	(6)	First Lien Term Loan	S + 4.75%	10.04	%	3/19/2027	2,773	2,715	2,666	0.27	%
Worldwide Express	(6) (14)	First Lien Term Loan	S + 4.00%	9.57	%	7/26/2028	2,494	2,457	2,485	0.25	%
Total Transportation: Cargo								54,005	52,281	5.24	%
Transportation: Consumer
Alternative Logistics Technologies Buyer, LLC	(6) (9) (12) (13)	First Lien Term Loan	S + 5.50%	10.83	%	2/14/2031	10,640	10,539	10,538	1.06	%
Alternative Logistics Technologies Buyer, LLC (Delayed Draw)	(9) (11) (12)	First Lien Term Loan	S + 5.50%	10.83	%	2/14/2031	3,040	—	(29)	—	%
American Student Transportaton Partners, Inc	(12)	Subordinated Debt	N/A	6.00% (Cash) 8.50% (PIK)		9/11/2029	2,125	2,073	2,033	0.20	%
Total Transportation: Consumer								12,612	12,542	1.26	%
Utilities: Electric
DMC HoldCo LLC (DMC Power)	(6)	First Lien Term Loan	S + 6.00%	11.31	%	7/13/2029	4,988	4,918	4,969	0.50	%
DMC HoldCo LLC (DMC Power) (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 6.00%	11.31	%	7/13/2029	1,671	(4)	(6)	—	%
Pinnacle Supply Partners, LLC	(6)	First Lien Term Loan	S + 6.25%	11.68	%	4/3/2030	6,316	6,203	6,273	0.62	%
Pinnacle Supply Partners, LLC (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 6.25%	11.68	%	4/3/2030	3,636	(28)	(25)	—	%
TPC Wire & Cable	(12)	Subordinated Debt	N/A	11.00% (Cash) 1.50% (PIK)		2/16/2028	2,244	2,225	2,204	0.22	%
TPC Wire & Cable (Delayed Draw)	(11) (12)	Subordinated Debt	N/A	11.00% (Cash) 1.50% (PIK)		2/16/2028	918	916	901	0.09	%
TPC Wire & Cable Corp (Delayed Draw) (Incremental)	(11) (12)	Subordinated Debt	N/A	11.00% (Cash) 1.50% (PIK)		2/16/2028	1,714	—	(30)	—	%
Total Utilities: Electric								14,230	14,286	1.43	%
Utilities: Water
USA Water	(6) (12)	First Lien Term Loan	S + 4.75%	10.06	%	2/21/2031	7,897	7,822	7,821	0.78	%
USA Water (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 4.75%	10.06	%	2/21/2031	3,037	—	(29)	—	%
Total Utilities: Water								7,822	7,792	0.78	%
Wholesale
Industrial Service Group	(6)	First Lien Term Loan	S + 6.25%	11.56	%	12/7/2028	6,509	6,400	6,550	0.66	%
Industrial Service Group (Delayed Draw)	(6) (12)	First Lien Term Loan	S + 6.25%	11.56	%	12/7/2028	3,389	3,375	3,410	0.34	%
INS Intermediate II, LLC (Ergotech Controls, Inc. – d/b/a INS)	(6) (13)	First Lien Term Loan	S + 6.50%	11.96	%	1/19/2029	7,941	7,809	7,952	0.79	%

See Notes to Consolidated Financial Statements

22

NUVEEN CHURCHILL DIRECT LENDING CORP.

CONSOLIDATED SCHEDULE OF INVESTMENTS (UNAUDITED)

March 31, 2024

(dollar amounts in thousands)

Portfolio Company (1) (2)	Footnotes	Investment	Spread Above Reference Rate (3)	Interest Rate (3)		Maturity Date	Par Amount	Amortized Cost	Fair Value (4)	% of Net Assets (5)
INS Intermediate II, LLC (Ergotech Controls, Inc. – d/b/a INS) (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 6.50%	11.96	%	1/19/2029	1,979	(32)	3	—	%
Total Wholesale								17,552	17,915	1.79	%
Total Debt Investments								1,788,967	1,762,854	176.60	%

Portfolio Company (1) (2)	Footnotes	Investment	Acquisition Date	Shares/Units	Amortized Cost	Fair Value (4)	% of Net Assets (5)
Equity Investments
Aerospace & Defense
BPC Kodiak LLC (Turbine Engine Specialist, Inc)	(8) (12) (15)	Class A-1 Units	9/1/2023	1,530,000	1,530	1,859	0.19	%
Total Aerospace & Defense					1,530	1,859	0.19	%
Automotive
Covercraft	(8) (12)	LP Interests	8/20/2021	768	768	330	0.03	%
High Bar Brands	(8) (10) (12)	Class A Units	12/19/2023	303,000	303	294	0.03	%
S&S Truck Parts	(8) (12)	Partnership Units	3/1/2022	4	378	288	0.03	%
S&S Truck Parts	(8) (12)	Common Units	8/1/2022	78,541	79	60	0.01	%
Total Automotive					1,528	972	0.10	%
Beverage, Food & Tobacco
Bardstown PPC Holdings LLC	(8) (10) (12)	Common Units	7/13/2022	14,777	1,860	2,207	0.22	%
Fresh Edge - Common	(8) (12)	Class B Common Units	10/3/2022	682	3	46	—	%
Fresh Edge - Preferred	(8) (12)	Class A Preferred Units	10/3/2022	682	682	790	0.08	%
Tech24	(8) (12)	Company Unit	10/5/2023	954	954	983	0.10	%
Total Beverage, Food & Tobacco					3,499	4,026	0.40	%
Capital Equipment
Crete Mechanical Group	(8) (12)	Equity Co-Investment	5/7/2022	23	230	616	0.06	%
EFC Holdings, LLC	(8) (10) (12)	Class A Common Units	2/28/2023	148	60	120	0.01	%
EFC Holdings, LLC	(8) (10) (12)	Series A Preferred Units	2/28/2023	148	148	161	0.02	%

See Notes to Consolidated Financial Statements

23

NUVEEN CHURCHILL DIRECT LENDING CORP.

CONSOLIDATED SCHEDULE OF INVESTMENTS (UNAUDITED)

March 31, 2024

(dollar amounts in thousands)

Portfolio Company (1) (2)	Footnotes	Investment	Acquisition Date	Shares/Units	Amortized Cost	Fair Value (4)	% of Net Assets (5)
Precision Surfacing - Common	(8) (10) (12)	Common Units	10/3/2022	3,750,000	3,750	7,126	0.71	%
Repipe Specialists	(8) (12)	Purchased Units	3/18/2022	239	239	3	—	%
Total Capital Equipment					4,427	8,026	0.80	%
Construction & Building
Erie Construction	(8) (12)	Common Units	7/27/2021	166	166	521	0.05	%
Gannett Fleming	(8) (12)	Series F Units	5/26/2023	569,505	570	830	0.08	%
Gannett Fleming	(8) (12) (15)	Limited Partnership Interests	12/20/2022	424,742	425	619	0.06	%
Total Construction & Building					1,161	1,970	0.19	%
Consumer Goods: Non-durable
FoodScience	(8) (12)	Class B Units	3/1/2021	5,168	5	—	—	%
FoodScience	(8) (12)	Class A Units	3/1/2021	98	98	80	0.01	%
Ultima Health Holdings, LLC	(8) (12)	Preferred Units	9/12/2022	15	170	182	0.02	%
Total Consumer Goods: Non-durable					273	262	0.03	%
Containers, Packaging & Glass
Oliver Packaging	(8) (12)	Class A Common Units	7/6/2022	10,230	1,023	606	0.06	%
Specialized Packaging Group	(7) (8) (10) (12)	Class A Units	12/17/2020	147,708	148	177	0.02	%
Total Containers, Packaging & Glass					1,171	783	0.08	%
Healthcare & Pharmaceuticals
AG MDC Holdings, Inc	(8) (10) (12)	Class A2 Units	2/7/2023	245	245	204	0.02	%
Anne Arundel	(8) (12)	AA Equity Co-Invest	9/14/2023	12,175	880	—	—	%
Health Management Associates	(8) (12)	Class A Common Units	3/31/2023	399,904	400	489	0.05	%
REP HS Topco Holdings (HemaSource Inc.)	(8) (12)	LP Interests	8/31/2023	577,000	577	652	0.06	%
Total Healthcare & Pharmaceuticals					2,102	1,345	0.13	%
High Tech Industries
ITSavvy LLC	(8) (12)	Class A Common Units	8/8/2022	522	522	1,377	0.14	%
Solve Industrial Motion Group	(8) (12)	LP Interests	6/30/2021	313	313	183	0.02	%
Total High Tech Industries					835	1,560	0.16	%
Services: Business

See Notes to Consolidated Financial Statements

24

NUVEEN CHURCHILL DIRECT LENDING CORP.

CONSOLIDATED SCHEDULE OF INVESTMENTS (UNAUDITED)

March 31, 2024

(dollar amounts in thousands)

Portfolio Company (1) (2)	Footnotes	Investment	Acquisition Date	Shares/Units	Amortized Cost	Fair Value (4)	% of Net Assets (5)
Apex Companies Holdings, LLC	(8) (10) (12)	Class A Membership Interests	1/31/2023	1,173	117	127	0.01	%
BroadcastMed Holdco, LLC	(8) (12)	Series A-3 Preferred Units	10/4/2022	56,899	853	790	0.08	%
Career Now	(8) (12)	Series B Limited Partnership Units	10/14/2023	222	22	—	—	%
Career Now	(8) (12)	Common Equity	9/30/2021	624	624	—	—	%
E78	(8) (12)	Class A Common Units	12/1/2021	816	860	894	0.09	%
KRIV Acquisition, Inc	(8) (12)	Class A Units	7/17/2023	790	790	734	0.07	%
Output Services Group, Inc.	(8) (10) (12)	Class A Units	11/30/2023	47,021	833	908	0.09	%
Total Services: Business					4,099	3,453	0.34	%
Services: Consumer
COP Exterminators Investment, LLC	(8) (12)	Class A Units	7/31/2023	997,000	1,117	1,201	0.12	%
Legacy Service Partners, LLC (“LSP”)	(8) (12)	Class B Units	1/9/2023	4,907	491	597	0.06	%
NearU	(8) (9) (12)	Limited Partnership Interests	8/8/2022	2,432	243	159	0.02	%
Perennial Services Investors LLC	(8) (10) (12)	Class A Units	9/8/2023	7,784	778	1,095	0.11	%
Total Services: Consumer					2,629	3,052	0.31	%
Sovereign & Public Finance
LMI Renaissance	(8) (12)	Limited Partnership Interests	7/18/2022	633,980	634	1,421	0.14	%
Total Sovereign & Public Finance					634	1,421	0.14	%
Transportation: Cargo
RoadOne - Common	(8) (12)	Partnership Units	12/29/2022	1,173,220	939	1,471	0.15	%
SEKO Global Logistics	(8) (12)	Equity Co-Invest	12/30/2020	671,203	332	681	0.07	%
Total Transportation: Cargo					1,271	2,152	0.22	%

See Notes to Consolidated Financial Statements

25

NUVEEN CHURCHILL DIRECT LENDING CORP.

CONSOLIDATED SCHEDULE OF INVESTMENTS (UNAUDITED)

March 31, 2024

(dollar amounts in thousands)

Portfolio Company (1) (2)	Footnotes	Investment	Acquisition Date	Shares/Units	Amortized Cost	Fair Value (4)	% of Net Assets (5)
Transportation: Consumer
ASTP Holdings Co-Investment LP	(8) (12)	Limited Partnership Interest	9/11/2023	101,041	101	82	0.01	%
Total Transportation: Consumer					101	82	0.01	%
Utilities: Electric
Pinnacle Supply Partners, LLC	(8) (12)	Limited Partnership Units	4/3/2023	279,687	280	264	0.03	%
Total Utilities: Electric					280	264	0.03	%
Utilities: Water
USA Water	(8) (10) (12)	Common Units	2/21/2024	4,781	478	478	0.05	%
Total Utilities: Water					478	478	0.05	%
Total Equity Investments					26,018	31,705	3.18	%

Portfolio Company (1) (2)	Interest Rate	Shares/Units	Amortized Cost		Fair Value (4)		% of Net Assets (5)
Cash Equivalents
BlackRock Liquidity Funds Treasury	5.17%	52,743	52,743		52,743		5.28	%
First American Government Obligations Fund	5.17%	30	30		30		—	%
Total Cash Equivalents			$	52,773	$	52,773	5.28	%
Total Investments and Cash Equivalents			$	1,867,758	$	1,847,332	185.06	%

_______________

(1)All investments are non-controlled/non-affiliated investments as defined by the Investment Company Act of 1940, as amended (the "1940 Act"). The 1940 Act classifies investments based on the level of control that the Company maintains in a particular portfolio company. As defined in the 1940 Act, a portfolio company is generally presumed to be “non-controlled” when the Company owns 25% or less of the portfolio company’s voting securities and “controlled” when the Company owns more than 25% of the portfolio company’s voting securities. The 1940 Act also classifies investments further based on the level of ownership that the Company maintains in a particular portfolio company. As defined in the 1940 Act, a company is generally deemed as “non-affiliated” when the Company owns less than 5% of a portfolio company’s voting securities and “affiliated” when the Company owns 5% or more of a portfolio company’s voting securities.

(2)Unless otherwise indicated, issuers of debt and equity held by the Company are domiciled in the United States.

(3)The majority of the investments bear interest at rates that may be determined by reference to Secured Overnight Financing Rate ("SOFR" or "S"), which reset monthly or quarterly. For each such investment, the Company has provided the spread over SOFR and the current contractual interest rate in effect at March 31, 2024. As of March 31, 2024, rates for 1M S, 3M S, 6M S, 12M S ("SOFR") are 5.33%, 5.30%, 5.22%, and 5.00% respectively. Certain investments are subject to a SOFR floor. For fixed rate loans, a spread above a reference rate is not applicable.

(4)Investment valued using unobservable inputs (Level 3). See Note 2 “Significant Accounting Policies – Valuation of Portfolio Investments” and Note 4 "Fair Value Measurements" for more information.

(5)Percentage is based on net assets of $998,233 as of March 31, 2024.

(6)Denotes that all or a portion of the assets are owned by CLO-I, CLO-II and/or CLO-III (each as defined in Note 1 "Organization"), which serve as collateral for the 2022 Debt Securitization, the 2023 Debt Securitization, and 2024 Debt Securitization (each as defined in the Notes). See Note 6 "Secured Borrowings".

(7)This portfolio company is not domiciled in the United States. The principal place of business for Specialized Packing Group and Bakeovations Intermediate is Canada and the principal place of business for Phaidon International is the United Kingdom.

(8)Security acquired in transaction exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”), and may be deemed to be a “restricted security” under the Securities Act. As of March 31, 2024, the Company held forty-four restricted securities with an aggregate fair value of $31,705, or 3.18% of the Company’s net assets.

See Notes to Consolidated Financial Statements

26

NUVEEN CHURCHILL DIRECT LENDING CORP.

CONSOLIDATED SCHEDULE OF INVESTMENTS (UNAUDITED)

March 31, 2024

(dollar amounts in thousands)

(9)Investment is a unitranche position.

(10)The investment is considered a non-qualifying asset under Section 55(a) of the 1940 Act. Under the 1940 Act, the Company cannot acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Company's total assets. As of March 31, 2024, total non-qualifying assets at fair value represented 4.50% of the Company's total assets calculated in accordance with the 1940 Act.

(11)Position or portion thereof is an unfunded loan commitment, and no interest is being earned on the unfunded portion. See Note 7 "Commitments and Contingencies". The investment may be subject to unused commitment fees.

(12)Denotes that all or a portion of the assets are owned by the Company or NCDL Equity Holdings (each as defined in Note 1 "Organization"). The Company entered into a senior secured revolving credit agreement (the “Revolving Credit Facility”). The Revolving Credit Facility is guaranteed by NCDL Equity Holdings and will be guaranteed by certain subsidiaries of the Company that are formed or acquired by the Company in the future.

(13)Denotes that all or a portion of the assets are owned by SPV IV and/or SPV V (each as defined in Note 1 "Organization"). SPV IV has entered into a senior secured revolving credit facility (the “SMBC Financing Facility”). The lenders of the SMBC Financing Facility have a first lien security interest in substantially all of the assets of SPV IV. Accordingly, such assets are not available to other creditors of the Company. SPV V has entered into a senior secured revolving credit facility (the “Wells Fargo Financing Facility”). The lenders of the Wells Fargo Financing Facility have a first lien security interest in substantially all of the assets of SPV V. Accordingly, such assets are not available to other creditors of the Company.

(14)Investments valued using observable inputs (Level 2). See Note 2 “Significant Accounting Policies – Valuation of Portfolio Investments” and Note 4 "Fair Value Measurements" for more information.

(15)Represents an investment held through an aggregator vehicle organized as a pooled investment vehicle.

(16)Loan was on non-accrual status as of March 31, 2024.

See Notes to Consolidated Financial Statements

27

NUVEEN CHURCHILL DIRECT LENDING CORP.

CONSOLIDATED SCHEDULE OF INVESTMENTS

December 31, 2023

(dollar amounts in thousands, including share data)

Portfolio Company (1) (2)	Footnotes	Investment	Spread Above Reference Rate (3)	Interest Rate (3)		Maturity Date	Par Amount		Amortized Cost		Fair Value (4)		% of Net Assets (5)
Investments
Debt Investments
Aerospace & Defense
AEgis Technologies	(6) (12) (13)	First Lien Term Loan	S + 6.50%	12.04	%	10/31/2025	$	14,657	$	14,592	$	14,311	1.91	%
Arotech	(6) (12)	First Lien Term Loan	S + 6.25%	11.70	%	10/22/2026	9,202		9,127		8,945		1.20	%
Arotech (Delayed Draw)	(6) (12) (13)	First Lien Term Loan	S + 6.25%	11.70	%	10/22/2026	448		446		435		0.06	%
Loc Performance Products	(6) (12)	First Lien Term Loan	S + 5.25%	10.71	%	12/22/2026	6,557		6,502		6,270		0.84	%
Precision Aviation Group	(6) (12) (13)	First Lien Term Loan	S + 5.75%	11.12	%	12/21/2029	15,039		14,740		14,740		1.97	%
Precision Aviation Group (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 5.75%	11.12	%	12/21/2029	4,961		(49)		(99)		(0.01	%)
Turbine Engine Specialist, Inc	(12)	Subordinated Debt	S + 9.50%	14.96	%	3/1/2029	2,556		2,494		2,509		0.33	%
Valkyrie	(12)	Subordinated Debt	N/A	10.50% (Cash) 1.00% (PIK)		11/17/2027	2,836		2,792		2,740		0.37	%
Total Aerospace & Defense									50,644		49,851		6.67	%
Automotive
American Auto Auction Group	(6) (12)	First Lien Term Loan	S + 5.00%	10.50	%	12/30/2027	10,520		10,443		10,266		1.37	%
Classic Collision (Delayed Draw) (Incremental Tranche A-4)	(11) (12)	First Lien Term Loan	S + 5.75%	11.29	%	1/14/2026	25,225		3,304		3,016		0.40	%
Classic Collision (Delayed Draw) (Incremental)	(6) (12) (13)	First Lien Term Loan	S + 5.75%	11.29	%	1/14/2026	6,941		6,941		6,847		0.92	%
Classic Collision (Incremental)	(6) (12)	First Lien Term Loan	S + 5.75%	11.29	%	1/14/2026	7,751		7,707		7,646		1.02	%
Collision Right	(6) (12) (13)	First Lien Term Loan	S + 5.25%	10.50	%	4/14/2028	5,294		5,269		5,282		0.71	%
Collision Right	(12)	Subordinated Debt	N/A	9.00% (Cash) 3.75% (PIK)		10/14/2028	1,411		1,380		1,371		0.18	%
Collision Right (Delayed Draw)	(12)	Subordinated Debt	N/A	9.00% (Cash) 3.75% (PIK)		10/14/2028	996		985		968		0.13	%
Covercraft	(12)	Subordinated Debt	N/A	10.00% (Cash) 0.75% (PIK)		2/20/2028	7,478		7,373		6,892		0.92	%
Covercraft (Delayed Draw)	(11) (12)	Subordinated Debt	N/A	10.00% (Cash) 0.75% (PIK)		2/20/2028	4,386		—		(344)		(0.04	%)
High Bar Brands	(12)	Subordinated Debt	N/A	9.00% (Cash) 4.00% (PIK)		6/19/2030	2,088		2,035		2,036		0.27	%
High Bar Brands (Delayed Draw)	(11) (12)	Subordinated Debt	N/A	9.00% (Cash) 4.00% (PIK)		6/19/2030	596		(7)		(15)		—	%
JEGS Automotive	(6)	First Lien Term Loan	S + 6.00%	11.46	%	12/22/2027	3,999		3,970		3,381		0.45	%

See Notes to Consolidated Financial Statements

28

NUVEEN CHURCHILL DIRECT LENDING CORP.

CONSOLIDATED SCHEDULE OF INVESTMENTS

December 31, 2023

(dollar amounts in thousands, including share data)

Portfolio Company (1) (2)	Footnotes	Investment	Spread Above Reference Rate (3)	Interest Rate (3)		Maturity Date	Par Amount	Amortized Cost	Fair Value (4)	% of Net Assets (5)
OEP Glass Purchaser	(6) (12) (13)	First Lien Term Loan	S + 5.25%	10.55	%	4/18/2028	12,563	12,467	12,508	1.67	%
Randys Holdings, Inc	(6) (9) (12) (13)	First Lien Term Loan	S + 6.50%	11.88	%	11/1/2028	11,138	10,943	10,997	1.47	%
Randys Holdings, Inc (Delayed Draw)	(9) (11) (12)	First Lien Term Loan	S + 6.50%	11.88	%	11/1/2028	3,750	—	(47)	(0.01	%)
S&S Truck Parts	(6)	First Lien Term Loan	S + 5.00%	10.19	%	3/1/2029	6,858	6,803	6,779	0.91	%
S&S Truck Parts	(13)	First Lien Term Loan	S + 5.00%	10.19	%	3/1/2029	1,159	1,150	1,146	0.15	%
S&S Truck Parts (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 5.00%	10.19	%	3/1/2029	98	—	(1)	—	%
S&S Truck Parts (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 5.00%	10.19	%	3/1/2029	1,724	1,576	1,556	0.21	%
Total Automotive								82,339	80,284	10.73	%
Banking, Finance, Insurance, Real Estate
Coding Solutions Acquisitions	(6) (9)	First Lien Term Loan	S + 5.75%	11.11	%	5/11/2028	6,432	6,380	6,304	0.84	%
Coding Solutions Acquisitions (Delayed Draw)	(9) (12)	First Lien Term Loan	S + 5.75%	11.11	%	5/11/2028	1,966	1,966	1,927	0.26	%
Long Term Care Group	(6) (9) (12)	First Lien Term Loan	S + 1.00%	6.66% (Cash) 6.00% (PIK)		9/8/2027	6,858	6,812	5,916	0.79	%
Patriot Growth Insurance Service (Delayed Draw) (Incremental)	(9) (12)	First Lien Term Loan	S + 5.75%	11.25	%	10/14/2028	7,166	7,109	7,003	0.94	%
Risk Strategies (Delayed Draw)	(9) (12)	First Lien Term Loan	S + 5.50%	11.00	%	11/2/2026	14,869	14,869	14,606	1.95	%
Vensure Employer Services	(6) (13)	First Lien Term Loan	S + 4.75%	10.12	%	3/26/2027	14,656	14,628	14,326	1.92	%
World Insurance Associates (Delayed Draw)	(6) (9) (12)	First Lien Term Loan	S + 6.00%	11.35	%	4/3/2028	14,881	14,869	14,841	1.98	%
Total Banking, Finance, Insurance, Real Estate								66,633	64,923	8.68	%
Beverage, Food & Tobacco
Bakeovations Intermediate, LLC (d/b/a Commercial Bakeries)	(6) (7) (10) (12) (13)	First Lien Term Loan	S + 6.25%	11.60	%	9/25/2029	17,282	16,958	16,940	2.27	%
Bardstown PPC Holdings LLC	(12)	Subordinated Debt	S + 7.75%	13.18	%	8/28/2027	9,300	9,154	9,154	1.22	%
Death Wish Coffee	(6) (9) (13)	First Lien Term Loan	S + 4.75%	10.20	%	9/28/2027	9,800	9,739	9,800	1.31	%
Dessert Holdings		Subordinated Debt	S + 7.25%	12.72	%	6/10/2029	9,000	8,874	7,628	1.02	%
Fresh Edge	(12)	Subordinated Debt	S + 4.50%	10.07% (Cash) 5.13% (PIK)		4/3/2029	3,853	3,772	3,765	0.50	%

See Notes to Consolidated Financial Statements

29

NUVEEN CHURCHILL DIRECT LENDING CORP.

CONSOLIDATED SCHEDULE OF INVESTMENTS

December 31, 2023

(dollar amounts in thousands, including share data)

Portfolio Company (1) (2)	Footnotes	Investment	Spread Above Reference Rate (3)	Interest Rate (3)		Maturity Date	Par Amount	Amortized Cost	Fair Value (4)	% of Net Assets (5)
Fresh Edge (Incremental)	(12)	Subordinated Debt	S + 4.50%	9.98% (Cash) 5.13% (PIK)		4/3/2029	914	891	893	0.12	%
Fresh Edge (Incremental)	(12)	Subordinated Debt	S + 4.50%	9.76% (Cash) 5.13% (PIK)		4/3/2029	769	752	752	0.10	%
Handgards	(6) (13)	First Lien Term Loan	S + 7.00%	12.54	%	10/14/2026	14,513	14,364	14,513	1.94	%
Harvest Hill Beverage Company	(12)	Subordinated Debt	S + 9.00%	14.46	%	2/28/2029	3,640	3,540	3,573	0.48	%
KSLB Holdings LLC	(13)	First Lien Term Loan	S + 4.50%	10.03	%	7/30/2025	2,858	2,844	2,712	0.36	%
Palmetto Acquisitionco, Inc.	(6) (12) (13)	First Lien Term Loan	S + 5.75%	11.10	%	9/18/2029	13,314	13,091	13,085	1.74	%
Palmetto Acquisitionco, Inc. (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 5.75%	11.10	%	9/18/2029	4,842	1,169	1,103	0.15	%
Rise Baking	(6) (9) (13)	First Lien Term Loan	S + 6.25%	11.71	%	8/13/2027	14,700	14,554	14,852	1.99	%
Rise Baking (Delayed Draw)	(9) (12)	First Lien Term Loan	S +5.50%	10.96	%	8/13/2027	4,454	4,432	4,400	0.59	%
Summit Hill Foods	(6)	First Lien Term Loan	S + 6.00%	11.39	%	11/29/2029	9,835	9,689	9,690	1.30	%
Sunny Sky Products (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 5.25%	10.60	%	12/23/2028	1,773	—	(17)	—	%
Sunny Sky Products	(12) (13)	First Lien Term Loan	S + 5.25%	10.60	%	12/23/2028	7,093	7,025	7,026	0.94	%
Watermill Express, LLC	(6) (9)	First Lien Term Loan	S + 5.00%	10.50	%	4/20/2027	3,256	3,236	3,241	0.43	%
Watermill Express, LLC (Delayed Draw)	(9) (12)	First Lien Term Loan	S + 5.00%	10.50	%	4/20/2027	314	315	313	0.04	%
Total Beverage, Food & Tobacco								124,399	123,423	16.50	%
Capital Equipment
Crete Mechanical Group	(6)	First Lien Term Loan	S +5.00%	10.37	%	5/19/2028	4,823	4,785	4,708	0.63	%
Crete Mechanical Group (Delayed Draw)	(6)	First Lien Term Loan	S +5.00%	10.37	%	5/19/2028	2,846	2,807	2,778	0.37	%
Crete Mechanical Group (Delayed Draw)	(11) (12)	First Lien Term Loan	S +5.00%	10.37	%	5/19/2028	7,153	5,710	5,539	0.74	%
EFC Holdings, LLC	(12)	Subordinated Debt	N/A	11.00% (Cash) 2.50% (PIK)		5/1/2028	3,167	3,083	3,137	0.42	%
Heartland Home Services	(6) (9) (13)	First Lien Term Loan	S + 6.00%	11.36	%	12/15/2026	6,467	6,428	6,382	0.85	%
Heartland Home Services (Delayed Draw)	(6) (9) (13)	First Lien Term Loan	S + 6.00%	11.36	%	12/15/2026	5,608	5,589	5,533	0.74	%
Heartland Home Services (Delayed Draw)	(6) (9) (13)	First Lien Term Loan	S + 6.00%	11.36	%	12/15/2026	2,571	2,571	2,537	0.34	%
Ovation Holdings, Inc.	(6) (13)	First Lien Term Loan	S +6.25%	11.78	%	2/3/2029	8,035	7,876	7,949	1.06	%
Ovation Holdings, Inc. (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 6.25%	11.78	%	2/3/2029	1,899	1,535	1,536	0.21	%
Precision Surfacing	(12)	First Lien Term Loan	N/A	15.00	%	6/30/2024	713	713	713	0.09	%
PT Intermediate Holdings III, LLC	(6) (9) (13)	First Lien Term Loan	S + 5.98%	11.52	%	11/1/2028	8,735	8,711	8,664	1.16	%

See Notes to Consolidated Financial Statements

30

NUVEEN CHURCHILL DIRECT LENDING CORP.

CONSOLIDATED SCHEDULE OF INVESTMENTS

December 31, 2023

(dollar amounts in thousands, including share data)

Portfolio Company (1) (2)	Footnotes	Investment	Spread Above Reference Rate (3)	Interest Rate (3)		Maturity Date	Par Amount	Amortized Cost	Fair Value (4)	% of Net Assets (5)
PT Intermediate Holdings III, LLC (Incremental)	(6) (9) (13)	First Lien Term Loan	S + 5.98%	11.47	%	11/1/2028	1,068	1,059	1,059	0.14	%
Repipe Specialists	(12)	Subordinated Debt	N/A	10.00% (Cash) 1.00% (PIK)		3/18/2029	2,433	2,393	2,207	0.30	%
Repipe Specialists (Delayed Draw)	(11) (12)	Subordinated Debt	N/A	10.00% (Cash) 1.00% (PIK)		3/18/2029	901	210	126	0.01	%
RTH Buyer LLC (dba Rhino Tool House)	(12) (13)	First Lien Term Loan	S + 6.25%	11.97	%	4/4/2029	8,052	7,902	7,986	1.07	%
RTH Buyer LLC (dba Rhino Tool House) (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 6.25%	11.97	%	4/4/2029	1,885	956	949	0.13	%
Total Capital Equipment								62,328	61,803	8.26	%
Chemicals, Plastics, & Rubber
Ascensus	(12) (15)	Subordinated Debt	S + 6.50%	12.18	%	8/2/2029	9,000	8,935	8,691	1.16	%
Ascensus Specialties	(6) (9) (13)	First Lien Term Loan	S + 4.25%	9.71	%	6/30/2028	9,731	9,589	8,776	1.17	%
Boulder Scientific Company LLC	(6)	First Lien Term Loan	S + 4.50%	10.04	%	12/28/2025	2,064	2,073	1,996	0.27	%
Chroma Color Corporation (dba Chroma Color)	(6) (13)	First Lien Term Loan	S + 6.00%	11.41	%	4/21/2029	6,314	6,197	6,199	0.83	%
Chroma Color Corporation (dba Chroma Color) (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 6.00%	11.41	%	4/21/2029	1,379	(12)	(25)	—	%
Spartech	(6) (9) (12) (13)	First Lien Term Loan	S + 4.75%	10.16	%	5/6/2028	14,768	14,699	11,898	1.59	%
Total Chemicals, Plastics, & Rubber								41,481	37,535	5.02	%
Construction & Building
Allstar Holdings	(12)	Subordinated Debt	N/A	10.00% (Cash) 3.00% (PIK)		4/26/2030	2,114	2,053	2,054	0.27	%
Allstar Holdings (Delayed Draw)	(11) (12)	Subordinated Debt	N/A	10.00% (Cash) 3.00% (PIK)		4/26/2030	4,043	2,803	2,745	0.37	%
Allstar Holdings (Delayed Draw)	(11) (12)	Subordinated Debt	N/A	10.00% (Cash) 3.00% (PIK)		4/26/2030	6,188	(88)	(175)	(0.02	%)
Erie Construction	(6) (13)	First Lien Term Loan	S + 4.75%	10.21	%	7/30/2027	10,153	10,083	10,153	1.36	%
Gannett Fleming	(6) (13)	First Lien Term Loan	S + 6.60%	11.95	%	12/20/2028	9,900	9,730	9,913	1.32	%
MEI Rigging & Crating	(6) (12) (13)	First Lien Term Loan	S + 6.50%	11.86	%	6/30/2029	11,431	11,212	11,329	1.51	%
MEI Rigging & Crating (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 6.50%	11.86	%	6/30/2029	1,814	(8)	(16)	—	%
Royal Holdco Corporation (Delayed Draw A)	(11) (12)	First Lien Term Loan	S + 5.75%	11.21	%	12/30/2027	4,690	4,303	4,246	0.57	%
Royal Holdco Corporation (Delayed Draw B)	(11) (12)	First Lien Term Loan	S + 5.75%	11.21	%	12/30/2027	3,134	(7)	(45)	(0.01	%)

See Notes to Consolidated Financial Statements

31

NUVEEN CHURCHILL DIRECT LENDING CORP.

CONSOLIDATED SCHEDULE OF INVESTMENTS

December 31, 2023

(dollar amounts in thousands, including share data)

Portfolio Company (1) (2)	Footnotes	Investment	Spread Above Reference Rate (3)	Interest Rate (3)		Maturity Date	Par Amount	Amortized Cost	Fair Value (4)	% of Net Assets (5)
Royal Holdco Corporation (Incremental)	(10) (12) (13)	First Lien Term Loan	S + 5.75%	11.21	%	12/30/2027	3,118	3,074	3,073	0.41	%
Sciens Building Solutions, LLC	(6) (9) (13)	First Lien Term Loan	S + 5.75%	11.23	%	12/15/2027	9,315	9,183	9,128	1.22	%
Sciens Building Solutions, LLC (Delayed Draw)	(6) (9) (11) (12) (13)	First Lien Term Loan	S + 5.75%	11.23	%	12/15/2027	4,915	3,259	3,193	0.43	%
WSB Engineering Holdings Inc.	(12) (13)	First Lien Term Loan	S + 6.00%	11.39	%	8/31/2029	6,519	6,426	6,424	0.86	%
WSB Engineering Holdings Inc. (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 6.00%	11.39	%	8/31/2029	4,357	(31)	(64)	(0.01	%)
Total Construction & Building								61,992	61,958	8.28	%
Consumer Goods: Durable
Halo Buyer Inc	(6) (15)	First Lien Term Loan	S + 4.50%	9.96	%	6/28/2025	5,668	5,641	4,284	0.57	%
Petmate	(6) (9) (12)	First Lien Term Loan	S + 5.50%	11.23	%	9/15/2028	9,825	9,753	5,846	0.78	%
Xpressmyself.com LLC (a/k/a SmartSign)	(6) (13)	First Lien Term Loan	S + 5.50%	10.98	%	9/7/2028	9,875	9,796	9,701	1.30	%
Xpressmyself.com LLC (a/k/a SmartSign)	(6)	First Lien Term Loan	S + 5.75%	11.22	%	9/7/2028	5,025	4,932	4,983	0.67	%
Total Consumer Goods: Durable								30,122	24,814	3.32	%
Consumer Goods: Non-durable
Arcadia Consumer Health	(6) (9) (13)	First Lien Term Loan	S + 4.50%	9.98	%	9/10/2027	12,604	12,522	12,192	1.63	%
Arcadia Consumer Health (Incremental)	(9) (12) (13)	First Lien Term Loan	S + 5.75%	11.23	%	9/10/2027	2,256	2,216	2,251	0.30	%
Badger Sportswear Acquisition Inc	(6)	First Lien Term Loan	S + 4.50%	10.03	%	1/7/2024	3,800	3,800	3,800	0.51	%
FoodScience	(6) (12)	First Lien Term Loan	S + 6.00%	11.73	%	3/1/2027	7,744	7,696	7,081	0.95	%
FoodScience	(6) (12)	First Lien Term Loan	S + 6.00%	12.23	%	3/1/2027	6,880	6,831	6,291	0.84	%
Protective Industrial Products (“PIP”)	(6) (9) (12) (13)	First Lien Term Loan	S + 5.00%	10.47	%	12/29/2027	4,860	4,684	4,909	0.66	%
Elevation Labs	(6) (13)	First Lien Term Loan	S + 5.75%	11.23	%	6/30/2028	6,789	6,733	6,335	0.85	%
Elevation Labs (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 5.75%	11.23	%	6/30/2028	3,125	(24)	(209)	(0.03	%)
Market Performance Group	(6) (13)	First Lien Term Loan	S + 5.50%	11.03	%	12/29/2026	2,505	2,489	2,505	0.33	%
Market Performance Group	(6) (13)	First Lien Term Loan	S + 5.50%	11.03	%	12/29/2026	7,275	7,256	7,275	0.97	%

See Notes to Consolidated Financial Statements

32

NUVEEN CHURCHILL DIRECT LENDING CORP.

CONSOLIDATED SCHEDULE OF INVESTMENTS

December 31, 2023

(dollar amounts in thousands, including share data)

Portfolio Company (1) (2)	Footnotes	Investment	Spread Above Reference Rate (3)	Interest Rate (3)		Maturity Date	Par Amount	Amortized Cost	Fair Value (4)	% of Net Assets (5)
Ultima Health Holdings, LLC	(12)	Subordinated Debt	N/A	11.00% (Cash) 1.50% (PIK)		3/12/2029	1,734	1,706	1,704	0.23	%
Total Consumer Goods: Non-durable								55,909	54,134	7.24	%
Containers, Packaging & Glass
B2B Packaging	(6) (13)	First Lien Term Loan	S + 6.75%	12.28	%	10/7/2026	14,696	14,663	14,398	1.93	%
B2B Packaging (Delayed Draw)	(6)	First Lien Term Loan	S + 6.75%	12.29	%	10/7/2026	116	114	114	0.02	%
Five Star Packing	(6) (13) (15)	First Lien Term Loan	S + 4.25%	9.63	%	5/6/2029	7,576	7,482	7,482	1.00	%
Good2Grow	(12) (13)	First Lien Term Loan	S + 5.50%	11.04	%	12/1/2027	6,362	6,270	6,362	0.85	%
Good2Grow	(6) (13)	First Lien Term Loan	S + 4.50%	10.04	%	12/1/2027	9,265	9,201	9,137	1.22	%
Oliver Packaging	(12)	Subordinated Debt	N/A	10.00% (Cash) 1.00% (PIK)		1/6/2029	2,510	2,471	2,377	0.32	%
Online Labels Group	(13)	First Lien Term Loan	S + 5.25%	10.61	%	12/19/2029	3,328	3,295	3,296	0.44	%
Online Labels Group (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 5.25%	10.61	%	12/19/2029	403	—	(4)	—	%
Online Labels Group (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 5.25%	10.61	%	12/19/2029	403	—	(4)	—	%
Specialized Packaging Group	(6) (7) (10) (13)	First Lien Term Loan	S + 5.50%	11.23	%	12/17/2025	2,983	2,968	2,921	0.39	%
Specialized Packaging Group	(6) (7) (10) (13)	First Lien Term Loan	S + 5.50%	11.23	%	12/17/2025	7,275	7,236	7,123	0.95	%
Specialized Packaging Group (Incremental)	(7) (10) (13)	First Lien Term Loan	S + 6.25%	11.98	%	12/17/2025	4,409	4,354	4,375	0.58	%
Specialized Packaging Group (Incremental)	(7) (10) (12) (13)	First Lien Term Loan	S + 6.25%	11.78	%	12/17/2025	6,894	6,798	6,751	0.90	%
Total Containers, Packaging & Glass								64,852	64,328	8.60	%
Energy: Electricity
MGM Transformer Company (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 6.00%	11.38	%	10/31/2029	6,388	(16)	(92)	(0.01	%)
MGM Transformer Company	(6) (12) (13)	First Lien Term Loan	S + 6.00%	11.38	%	10/31/2029	23,612	23,259	23,271	3.11	%
National Power	(12) (13)	First Lien Term Loan	S + 6.00%	11.36	%	10/20/2029	5,674	5,589	5,593	0.75	%
National Power (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 6.00%	11.36	%	10/20/2029	3,051	(7)	(44)	(0.01	%)
Total Energy: Electricity								28,825	28,728	3.84	%
Environmental Industries
Impact Environmental Group	(12) (13)	First Lien Term Loan	S + 6.00%	11.28	%	3/23/2029	6,776	6,650	6,721	0.90	%

See Notes to Consolidated Financial Statements

33

NUVEEN CHURCHILL DIRECT LENDING CORP.

CONSOLIDATED SCHEDULE OF INVESTMENTS

December 31, 2023

(dollar amounts in thousands, including share data)

Portfolio Company (1) (2)	Footnotes	Investment	Spread Above Reference Rate (3)	Interest Rate (3)		Maturity Date	Par Amount	Amortized Cost	Fair Value (4)	% of Net Assets (5)
Impact Environmental Group (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 6.00%	11.28	%	3/23/2029	3,166	2,770	2,759	0.37	%
Impact Environmental Group (Incremental)	(12)	First Lien Term Loan	S + 6.00%	11.28	%	3/23/2029	1,736	1,703	1,722	0.23	%
Impact Environmental Group (Delayed Draw) (Incremental)	(11) (12)	First Lien Term Loan	S + 6.00%	11.28	%	3/23/2029	6,822	(32)	(55)	(0.01	%)
Nutrition 101 Buyer LLC (a/k/a 101, Inc.)	(6) (13)	First Lien Term Loan	S + 5.25%	10.73	%	8/31/2028	6,648	6,596	6,518	0.87	%
Orion Group FM Holdings, LLC (dba Leo Facilities Maintenance)	(6) (12) (13)	First Lien Term Loan	S + 6.25%	11.65	%	7/1/2029	8,550	8,426	8,429	1.13	%
Orion Group FM Holdings, LLC (dba Leo Facilities Maintenance) (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 6.25%	11.65	%	7/1/2029	6,429	(15)	(91)	(0.01	%)
The Facilities Group	(6) (9)	First Lien Term Loan	S + 5.75%	11.23	%	11/30/2027	4,872	4,840	4,847	0.64	%
The Facilities Group (Delayed Draw)	(9) (11) (12)	First Lien Term Loan	S + 5.75%	11.22	%	11/30/2027	5,028	—	(25)	—	%
The Facilities Group	(9) (13)	First Lien Term Loan	S + 5.75%	11.22	%	11/30/2027	9,051	8,963	9,006	1.20	%
The Facilities Group (Delayed Draw)	(6) (9) (12)	First Lien Term Loan	S + 5.75%	11.22	%	11/30/2027	4,952	4,952	4,927	0.66	%
Total Environmental Industries								44,853	44,758	5.98	%
Healthcare & Pharmaceuticals
Affinity Hospice	(6) (12)	First Lien Term Loan	S + 4.75%	10.20	%	12/17/2027	7,872	7,817	7,048	0.94	%
Anne Arundel	(12)	Subordinated Debt	N/A	12.75% (PIK)		10/16/2026	3,282	3,247	2,656	0.36	%
Anne Arundel	(12)	Subordinated Debt	N/A	11.00% (PIK)		4/16/2026	1,972	1,957	1,776	0.24	%
Anne Arundel (Delayed Draw)	(11) (12)	Subordinated Debt	N/A	11.00% (PIK)		4/16/2026	2,396	2,022	1,790	0.24	%
Forefront Dermatology	(6) (9) (12) (15)	First Lien Term Loan	S + 4.25%	9.63	%	4/1/2029	3,315	3,268	3,215	0.43	%
Genesee Scientific	(6) (9)	First Lien Term Loan	S + 5.50%	10.95	%	9/30/2027	5,959	5,922	5,839	0.78	%
Genesee Scientific (Delayed Draw)	(9) (12)	First Lien Term Loan	S + 5.50%	10.95	%	9/30/2027	1,560	1,560	1,528	0.20	%
GHR Healthcare	(6) (9)	First Lien Term Loan	S + 5.00%	10.50	%	12/8/2027	6,401	6,359	6,255	0.84	%
GHR Healthcare (Delayed Draw)	(6) (9) (13)	First Lien Term Loan	S + 5.00%	10.50	%	12/9/2027	2,002	2,002	1,957	0.26	%
GHR Healthcare (Incremental)	(13)	First Lien Term Loan	S + 5.00%	10.50	%	12/9/2027	4,983	4,904	4,869	0.65	%
Health Management Associates	(12) (13)	First Lien Term Loan	S + 6.50%	11.73	%	3/31/2029	8,307	8,154	8,233	1.10	%
Health Management Associates (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 6.50%	11.73	%	3/31/2029	1,499	444	460	0.06	%

See Notes to Consolidated Financial Statements

34

NUVEEN CHURCHILL DIRECT LENDING CORP.

CONSOLIDATED SCHEDULE OF INVESTMENTS

December 31, 2023

(dollar amounts in thousands, including share data)

Portfolio Company (1) (2)	Footnotes	Investment	Spread Above Reference Rate (3)	Interest Rate (3)		Maturity Date	Par Amount	Amortized Cost	Fair Value (4)	% of Net Assets (5)
Heartland Veterinary Partners LLC (Incremental)	(12)	Subordinated Debt	S + 7.50%	12.96	%	12/10/2027	1,900	1,872	1,875	0.25	%
Heartland Veterinary Partners LLC (Incremental) (Delayed Draw)	(12)	Subordinated Debt	S +7.50%	12.96	%	12/10/2027	9,500	9,500	9,377	1.25	%
HemaSource Inc.	(12)	Subordinated Debt	N/A	8.50% (Cash) 5.00% (PIK)		2/28/2030	5,292	5,153	5,147	0.69	%
InfuCare RX	(6) (12) (13)	First Lien Term Loan	S + 4.50%	9.95	%	1/4/2028	9,248	9,182	9,045	1.21	%
MDC Intermediate Holdings II, LLC	(12)	Subordinated Debt	N/A	10.00% (Cash) 2.25% (PIK)		2/7/2030	1,749	1,711	1,690	0.23	%
MDC Intermediate Holdings II, LLC (Delayed Draw)	(11) (12)	Subordinated Debt	N/A	10.00% (Cash) 2.25% (PIK)		2/7/2030	721	160	143	0.02	%
Midwest Eye Consultants	(6) (13)	First Lien Term Loan	S + 4.50%	10.04	%	8/20/2027	9,021	8,962	8,790	1.18	%
PromptCare	(6) (9) (13)	First Lien Term Loan	S + 6.00%	11.46	%	9/1/2027	8,204	8,121	8,079	1.08	%
PromptCare (Delayed Draw)	(6) (9) (12) (13)	First Lien Term Loan	S + 6.00%	11.46	%	9/1/2027	1,278	1,271	1,258	0.17	%
Quorum Health Resources, LLC	(6) (13)	First Lien Term Loan	S + 5.75%	11.50	%	5/28/2027	7,680	7,627	7,552	1.01	%
Quorum Health Resources, LLC (Delayed Draw) (Incremental)	(6) (10) (12)	First Lien Term Loan	S + 6.25%	11.68	%	5/28/2027	3,248	3,240	3,240	0.43	%
Quorum Health Resources, LLC (Incremental)	(10) (12) (13)	First Lien Term Loan	S + 6.25%	11.68	%	5/28/2027	3,248	3,201	3,240	0.43	%
Sandlot Buyer, LLC (Prime Time Healthcare)	(6) (12) (13)	First Lien Term Loan	S + 6.00%	11.28	%	9/19/2028	8,958	8,729	8,854	1.18	%
Sandlot Buyer, LLC (Prime Time Healthcare) (Incremental)	(12) (13)	First Lien Term Loan	S + 6.00%	11.52	%	9/19/2028	10,122	9,924	10,004	1.34	%
SCP Eye Care Holdco, LLC (DBA EyeSouth Partners)	(6) (13)	First Lien Term Loan	S + 5.75%	11.21	%	10/7/2029	7,474	7,408	7,382	0.99	%
SCP Eye Care Holdco, LLC (DBA EyeSouth Partners) (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 5.75%	11.21	%	10/7/2029	2,443	1,558	1,528	0.21	%
SM Wellness Holdings, Inc	(6) (12) (13)	First Lien Term Loan	S + 4.75%	10.14	%	4/15/2028	14,665	14,573	14,187	1.90	%
Thorne HealthTech	(6) (12) (13)	First Lien Term Loan	S + 5.75%	11.10	%	10/16/2030	10,652	10,549	10,553	1.41	%
TIDI Products	(6) (9) (12) (13)	First Lien Term Loan	S + 5.50%	10.86	%	12/19/2029	15,523	15,368	15,369	2.05	%
TIDI Products (Delayed Draw)	(9) (11) (12)	First Lien Term Loan	S + 5.50%	10.86	%	12/19/2029	4,085	—	(40)	(0.01	%)
US Fertility	(12)	Subordinated Debt	N/A	13.75% (PIK)		6/21/2028	12,391	12,084	12,066	1.61	%
Wellspring Pharmaceutical	(13)	First Lien Term Loan	S + 5.75%	11.03	%	8/22/2028	3,378	3,323	3,298	0.44	%
Wellspring Pharmaceutical (Delayed Draw)	(12)	First Lien Term Loan	S + 5.75%	11.03	%	8/22/2028	1,571	1,561	1,534	0.21	%

See Notes to Consolidated Financial Statements

35

NUVEEN CHURCHILL DIRECT LENDING CORP.

CONSOLIDATED SCHEDULE OF INVESTMENTS

December 31, 2023

(dollar amounts in thousands, including share data)

Portfolio Company (1) (2)	Footnotes	Investment	Spread Above Reference Rate (3)	Interest Rate (3)		Maturity Date	Par Amount	Amortized Cost	Fair Value (4)	% of Net Assets (5)
Wellspring Pharmaceutical (Delayed Draw) (Incremental)	(11) (12)	First Lien Term Loan	S + 6.00%	11.18	%	8/22/2028	3,756	(16)	(55)	(0.01	%)
Wellspring Pharmaceutical (Incremental)	(12) (13)	First Lien Term Loan	S + 6.00%	11.18	%	8/22/2028	1,246	1,223	1,228	0.16	%
Young Innovations (Delayed Draw)	(9) (11) (12)	First Lien Term Loan	S + 5.75%	11.09	%	12/1/2029	3,448	—	(34)	—	%
Young Innovations	(6) (9) (13)	First Lien Term Loan	S + 5.75%	11.09	%	12/1/2029	16,552	16,386	16,391	2.19	%
Total Healthcare & Pharmaceuticals								210,326	207,327	27.72	%
High Tech Industries
Acclaim MidCo, LLC (dba ClaimLogiQ)	(6) (12) (13)	First Lien Term Loan	S + 6.00%	11.35	%	6/13/2029	8,021	7,870	7,951	1.06	%
Acclaim MidCo, LLC (dba ClaimLogiQ) (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 6.00%	11.35	%	6/13/2029	3,225	(15)	(28)	—	%
Argano, LLC	(6)	First Lien Term Loan	S + 5.50%	11.69	%	6/10/2026	5,634	5,602	5,510	0.74	%
Argano, LLC (Delayed Draw)	(6) (13)	First Lien Term Loan	S + 5.50%	11.69	%	6/10/2026	2,494	2,494	2,440	0.33	%
Argano, LLC (Delayed Draw) (Incremental)	(6)	First Lien Term Loan	S + 5.50%	11.69	%	6/10/2026	1,705	1,676	1,667	0.22	%
Diligent Corporation	(6) (9) (12)	First Lien Term Loan	S + 6.25%	11.78	%	7/31/2025	12,469	12,451	12,366	1.65	%
Diligent Corporation	(9) (12) (13)	First Lien Term Loan	S + 5.75%	11.28	%	7/31/2025	3,387	3,372	3,334	0.45	%
Diligent Corporation	(9) (12)	First Lien Term Loan	S + 5.75%	11.28	%	8/4/2025	1,476	1,469	1,453	0.19	%
Diligent Corporation (Delayed Draw)	(9) (12)	First Lien Term Loan	S + 6.25%	11.78	%	7/31/2025	168	168	166	0.02	%
Diligent Corporation (Delayed Draw)	(9) (12)	First Lien Term Loan	S + 6.25%	11.78	%	7/31/2025	106	106	105	0.01	%
Eliassen Group LLC	(6) (9) (12) (13)	First Lien Term Loan	S + 5.50%	10.85	%	4/14/2028	12,069	11,976	12,083	1.62	%
Eliassen Group LLC (Delayed Draw)	(9) (11) (12)	First Lien Term Loan	S + 5.50%	10.85	%	4/14/2028	2,771	864	872	0.11	%
Evergreen Services Group II (Delayed Draw)	(9) (11) (12)	First Lien Term Loan	S + 6.00%	11.35	%	10/4/2030	13,014	8,495	8,342	1.11	%
Evergreen Services Group II	(6) (9) (12) (13)	First Lien Term Loan	S + 6.00%	11.35	%	10/4/2030	16,156	15,917	15,926	2.13	%
Exterro	(6) (9) (12) (13)	First Lien Term Loan	S + 5.50%	11.03	%	6/1/2027	9,474	9,462	9,503	1.27	%
Fineline Merger	(12)	Subordinated Debt	S + 9.26%	14.61	%	8/22/2028	2,453	2,427	2,453	0.33	%
Go Engineer	(6) (9) (13)	First Lien Term Loan	S + 5.38%	10.87	%	12/21/2027	11,572	11,490	11,409	1.53	%
Go Engineer (Delayed Draw)	(9) (12)	First Lien Term Loan	S + 5.38%	10.87	%	12/21/2027	3,152	3,130	3,107	0.42	%
Infinite Electronics (Incremental)	(6) (9) (13)	First Lien Term Loan	S + 6.25%	11.88	%	3/2/2028	6,313	6,152	6,100	0.82	%

See Notes to Consolidated Financial Statements

36

NUVEEN CHURCHILL DIRECT LENDING CORP.

CONSOLIDATED SCHEDULE OF INVESTMENTS

December 31, 2023

(dollar amounts in thousands, including share data)

Portfolio Company (1) (2)	Footnotes	Investment	Spread Above Reference Rate (3)	Interest Rate (3)		Maturity Date	Par Amount	Amortized Cost	Fair Value (4)	% of Net Assets (5)
Infobase Acquisition, Inc.	(6) (13)	First Lien Term Loan	S + 5.50%	10.93	%	6/14/2028	4,331	4,297	4,297	0.57	%
Infobase Acquisition, Inc. (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 5.50%	10.93	%	6/14/2028	721	—	(6)	—	%
ITSavvy LLC	(6) (13)	First Lien Term Loan	S + 5.25%	10.89	%	8/8/2028	7,794	7,730	7,794	1.04	%
ITSavvy LLC (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 5.25%	10.89	%	8/8/2028	1,049	883	891	0.12	%
North Haven CS Acquisition Inc	(6)	First Lien Term Loan	S + 5.25%	10.78	%	1/23/2025	5,787	5,787	5,787	0.77	%
Prosci, Inc.	(6)	First Lien Term Loan	S + 4.50%	9.99	%	10/21/2026	4,733	4,704	4,708	0.63	%
Revalize (Delayed Draw)	(6) (9) (13)	First Lien Term Loan	S + 5.75%	11.21	%	4/15/2027	4,243	4,232	4,064	0.54	%
Revalize (Delayed Draw)	(6) (9) (12)	First Lien Term Loan	S + 5.75%	11.21	%	4/15/2027	1,090	1,083	1,044	0.14	%
Revalize (Delayed Draw)	(9) (12)	First Lien Term Loan	S + 5.75%	11.25	%	4/15/2027	244	243	234	0.03	%
SmartWave	(6) (12)	First Lien Term Loan	S + 6.00%	11.53	%	11/5/2026	9,214	9,145	7,744	1.04	%
Solve Industrial Motion Group	(12)	Subordinated Debt	N/A	5.00% (Cash) 8.00% (PIK)		6/30/2028	1,786	1,760	1,700	0.23	%
Solve Industrial Motion Group	(12)	Subordinated Debt	N/A	5.00% (Cash) 8.00% (PIK)		6/28/2028	763	749	739	0.10	%
Solve Industrial Motion Group (Delayed Draw)	(12)	Subordinated Debt	N/A	5.00% (Cash) 8.00% (PIK)		6/30/2028	2,046	2,046	1,947	0.26	%
Total High Tech Industries								147,765	145,702	19.48	%
Media: Advertising, Printing & Publishing
Tinuiti	(6) (9)	First Lien Term Loan	S + 5.25%	10.70	%	12/10/2026	2,948	2,928	2,823	0.38	%
Tinuiti (Delayed Draw)	(6) (9)	First Lien Term Loan	S + 5.25%	10.70	%	12/10/2026	1,926	1,926	1,845	0.25	%
Tinuiti (Delayed Draw) (Incremental)	(6) (12)	First Lien Term Loan	S + 5.25%	10.70	%	12/10/2026	9,863	9,863	9,445	1.26	%
Wpromote	(13)	First Lien Term Loan	S + 5.75%	11.19	%	10/21/2028	4,379	4,304	4,344	0.58	%
Wpromote (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 5.75%	11.19	%	10/21/2028	588	(4)	(5)	—	%
Total Media: Advertising, Printing & Publishing								19,017	18,452	2.47	%
Media: Diversified & Production
Corporate Visions	(6)	First Lien Term Loan	S + 4.50%	9.96	%	8/12/2027	2,887	2,867	2,752	0.37	%
Corporate Visions	(6)	First Lien Term Loan	S + 4.50%	9.96	%	8/12/2027	2,538	2,509	2,419	0.32	%
Spectrio II	(6) (9) (12) (13)	First Lien Term Loan	S + 6.00%	6.50% (Cash) 5.00% (PIK)		12/9/2026	8,143	8,100	7,556	1.01	%
Spectrio II (Delayed Draw)	(6) (9) (12)	First Lien Term Loan	S + 6.00%	6.50% (Cash) 5.00% (PIK)		12/9/2026	2,893	2,875	2,684	0.36	%

See Notes to Consolidated Financial Statements

37

NUVEEN CHURCHILL DIRECT LENDING CORP.

CONSOLIDATED SCHEDULE OF INVESTMENTS

December 31, 2023

(dollar amounts in thousands, including share data)

Portfolio Company (1) (2)	Footnotes	Investment	Spread Above Reference Rate (3)	Interest Rate (3)		Maturity Date	Par Amount	Amortized Cost	Fair Value (4)	% of Net Assets (5)
Spectrio II (Delayed Draw)	(9) (13)	First Lien Term Loan	S + 6.00%	6.50% (Cash) 5.00% (PIK)		12/9/2026	441	440	407	0.06	%
Total Media: Diversified & Production								16,791	15,818	2.12	%
Retail
Syndigo	(6)	First Lien Term Loan	S + 4.50%	9.97	%	12/14/2027	5,835	5,850	5,747	0.77	%
Total Retail								5,850	5,747	0.77	%
Services: Business
ALKU Intermediate Holdings, LLC	(12) (13)	First Lien Term Loan	S + 6.25%	11.61	%	5/23/2029	4,519	4,434	4,480	0.60	%
Apex Companies Holdings, LLC	(12)	Subordinated Debt	N/A	10.00% (Cash) 2.50% (PIK)		1/31/2029	3,964	3,879	3,953	0.53	%
Apex Companies Holdings, LLC (Delayed Draw)	(11) (12)	Subordinated Debt	N/A	10.00% (Cash) 2.50% (PIK)		1/31/2029	1,197	69	79	0.01	%
ARMstrong (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 6.25%	11.70	%	10/6/2029	3,847	(28)	(55)	(0.01	%)
ARMstrong	(6) (12) (13)	First Lien Term Loan	S + 6.25%	11.70	%	10/6/2029	11,447	11,279	11,284	1.51	%
Big Truck Rental	(12)	Subordinated Debt	S + 8.00%	13.47	%	9/30/2027	10,000	9,858	10,000	1.34	%
Big Truck Rental	(12)	Subordinated Debt	S + 8.00%	13.47	%	9/30/2027	2,500	2,500	2,500	0.33	%
Bounteous	(6) (12) (13)	First Lien Term Loan	S + 5.25%	10.74	%	8/2/2027	5,347	5,310	5,083	0.68	%
Bounteous	(6) (12)	First Lien Term Loan	S + 5.25%	10.74	%	8/2/2027	2,189	2,173	2,080	0.28	%
Bounteous (Delayed Draw)	(6) (12)	First Lien Term Loan	S + 5.25%	10.74	%	8/2/2027	2,768	2,750	2,631	0.35	%
Bounteous (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 5.25%	10.74	%	8/2/2027	4,467	—	(221)	(0.03	%)
BroadcastMed Holdco, LLC	(12)	Subordinated Debt	N/A	10.00% (Cash) 3.75% (PIK)		11/12/2027	3,483	3,424	3,369	0.45	%
Bullhorn Inc	(6) (9) (12) (13)	First Lien Term Loan	S + 5.75%	10.96	%	9/30/2026	13,706	13,609	13,706	1.83	%
BusinesSolver	(6) (9) (12)	First Lien Term Loan	S + 5.50%	10.96	%	12/1/2027	7,741	7,686	7,738	1.03	%
BusinesSolver (Delayed Draw)	(9) (11) (12)	First Lien Term Loan	S + 5.50%	10.96	%	12/1/2027	1,149	176	179	0.02	%
Career Now	(12)	Subordinated Debt	N/A	13.00% (PIK)		3/27/2027	3,277	3,237	2,425	0.32	%
Cornerstone Advisors of Arizona LLC	(6)	First Lien Term Loan	S + 5.50%	11.07	%	9/24/2026	308	306	308	0.04	%
Cornerstone Advisors of Arizona LLC	(6)	First Lien Term Loan	S + 5.50%	11.07	%	9/24/2026	2,295	2,283	2,295	0.31	%
Cornerstone Advisors of Arizona LLC (Delayed Draw)	(6)	First Lien Term Loan	S + 5.50%	11.07	%	9/24/2026	210	210	210	0.03	%
CrossCountry Consulting	(6) (9) (13)	First Lien Term Loan	S + 5.75%	11.21	%	6/1/2029	8,174	8,037	8,217	1.10	%
CrossCountry Consulting (Delayed Draw)	(9) (11) (12)	First Lien Term Loan	S + 5.75%	11.21	%	6/1/2029	3,320	(26)	17	—	%

See Notes to Consolidated Financial Statements

38

NUVEEN CHURCHILL DIRECT LENDING CORP.

CONSOLIDATED SCHEDULE OF INVESTMENTS

December 31, 2023

(dollar amounts in thousands, including share data)

Portfolio Company (1) (2)	Footnotes	Investment	Spread Above Reference Rate (3)	Interest Rate (3)		Maturity Date	Par Amount	Amortized Cost	Fair Value (4)	% of Net Assets (5)
D&H United Fueling Solutions	(6) (13)	First Lien Term Loan	S + 5.50%	11.03	%	9/16/2028	7,491	7,368	7,290	0.97	%
D&H United Fueling Solutions (Delayed Draw)	(6)	First Lien Term Loan	S + 5.50%	11.03	%	9/16/2028	2,384	2,365	2,320	0.31	%
D&H United Fueling Solutions (Delayed Draw) (Incremental)	(11) (12)	First Lien Term Loan	S + 6.00%	11.50	%	9/16/2028	1,567	(7)	(13)	—	%
D&H United Fueling Solutions (Incremental)	(6) (13)	First Lien Term Loan	S + 6.00%	11.50	%	9/16/2028	3,465	3,401	3,436	0.46	%
E78	(6)	First Lien Term Loan	S + 5.75%	11.21	%	12/1/2027	5,600	5,560	5,489	0.74	%
E78	(13)	First Lien Term Loan	S + 5.75%	11.21	%	12/1/2027	1,438	1,426	1,409	0.19	%
E78 (Delayed Draw)	(6) (13)	First Lien Term Loan	S + 5.75%	11.21	%	12/1/2027	4,210	4,180	4,127	0.55	%
E78 (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 5.75%	11.21	%	12/1/2027	3,550	979	909	0.12	%
Evergreen Services Group	(6) (9) (12) (13)	First Lien Term Loan	S + 6.25%	11.70	%	6/15/2029	11,966	11,766	11,733	1.57	%
Evergreen Services Group (Delayed Draw)	(9) (12)	First Lien Term Loan	S + 6.25%	11.70	%	6/15/2029	2,863	2,839	2,807	0.38	%
Gabriel Partners LLC	(6) (9) (13)	First Lien Term Loan	S + 5.75%	11.53	%	9/21/2026	9,192	9,144	9,192	1.23	%
Gabriel Partners LLC (Delayed Draw)	(6) (9) (13)	First Lien Term Loan	S + 5.75%	11.53	%	9/21/2026	1,531	1,531	1,531	0.20	%
Gabriel Partners LLC (Incremental)	(9) (13)	First Lien Term Loan	S + 5.75%	11.53	%	9/21/2026	3,794	3,771	3,794	0.51	%
Keng Acquisition, Inc. (Engage Group Holdings, LLC)	(9) (12) (13)	First Lien Term Loan	S + 6.25%	11.60	%	8/1/2029	9,667	9,526	9,528	1.27	%
Keng Acquisition, Inc. (Engage Group Holdings, LLC) (Delayed Draw)	(9) (11) (12)	First Lien Term Loan	S + 6.25%	11.60	%	8/1/2029	9,314	1,179	1,067	0.14	%
KRIV Acquisition, Inc	(6) (12) (13)	First Lien Term Loan	S + 6.50%	11.85	%	7/6/2029	10,764	10,476	10,453	1.40	%
KRIV Acquisition, Inc (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 6.50%	11.85	%	7/6/2029	1,607	(19)	(46)	(0.01	%)
Lion Merger Sub Inc	(9) (13)	First Lien Term Loan	S + 6.00%	11.45	%	12/17/2025	7,342	7,308	7,259	0.97	%
Lion Merger Sub Inc (Incremental)	(9) (12) (13)	First Lien Term Loan	S + 6.00%	11.45	%	12/17/2025	7,317	7,252	7,234	0.97	%
LSCS Holdings Inc.	(6) (13) (15)	First Lien Term Loan	S + 4.50%	9.86	%	12/16/2028	9,800	9,762	9,675	1.30	%
LYNX FRANCHISING, LLC	(6) (9)	First Lien Term Loan	S + 6.75%	12.47	%	12/23/2026	9,800	9,725	9,699	1.30	%
Micronics	(12)	Subordinated Debt	S + 5.25%	10.00	%	2/17/2027	2,450	2,401	2,401	0.32	%
Output Services Group, Inc.	(10) (12)	First Lien Term Loan	S + 8.00%	13.39	%	5/30/2028	155	155	155	0.02	%
Output Services Group, Inc.	(12)	First Lien Term Loan	S + 6.25%	7.32% (Cash) 4.75% (PIK)		5/30/2028	837	837	837	0.11	%
Phaidon International	(6) (7) (10) (12) (13)	First Lien Term Loan	S + 5.50%	10.96	%	8/22/2029	14,010	13,892	14,010	1.88	%
Plaze	(12)	Subordinated Debt	S + 7.50%	12.97	%	7/7/2028	13,500	13,201	12,465	1.67	%

See Notes to Consolidated Financial Statements

39

NUVEEN CHURCHILL DIRECT LENDING CORP.

CONSOLIDATED SCHEDULE OF INVESTMENTS

December 31, 2023

(dollar amounts in thousands, including share data)

Portfolio Company (1) (2)	Footnotes	Investment	Spread Above Reference Rate (3)	Interest Rate (3)		Maturity Date	Par Amount	Amortized Cost	Fair Value (4)	% of Net Assets (5)
Scaled Agile	(6) (9)	First Lien Term Loan	S +5.50%	10.95	%	12/16/2028	7,936	7,875	7,623	1.02	%
Scaled Agile (Delayed Draw)	(9) (12)	First Lien Term Loan	S + 5.50%	10.95	%	12/16/2028	390	390	375	0.05	%
Smile Brands	(12)	Subordinated Debt	S + 8.50%	14.99% (PIK)		4/12/2028	9,947	9,866	8,665	1.16	%
Soliant Health	(6)	First Lien Term Loan	S + 4.00%	9.47	%	4/1/2028	2,628	2,615	2,628	0.35	%
Technical Safety Services	(6) (13)	First Lien Term Loan	S + 5.50%	11.00	%	6/22/2029	6,772	6,716	6,712	0.90	%
Technical Safety Services (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 5.50%	11.00	%	6/22/2029	6,404	3,903	3,918	0.52	%
Technical Safety Services (Incremental)	(12)	First Lien Term Loan	S + 5.50%	11.00	%	6/22/2029	1,890	1,863	1,873	0.25	%
TouchTunes Interactive	(6) (13) (15)	First Lien Term Loan	S + 5.00%	10.35	%	4/2/2029	9,875	9,793	9,825	1.31	%
Transit Buyer LLC (dba“Propark”)	(6) (13)	First Lien Term Loan	S + 6.25%	11.69	%	1/31/2029	6,823	6,705	6,801	0.91	%
Transit Buyer LLC (dba“Propark”) (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 6.25%	11.69	%	1/31/2029	3,125	1,275	1,318	0.18	%
Trilon Group, LLC	(13)	First Lien Term Loan	S + 6.25%	11.78	%	5/27/2029	2,978	2,958	2,939	0.39	%
Trilon Group, LLC	(6) (13)	First Lien Term Loan	S + 6.25%	11.75	%	5/27/2029	7,406	7,345	7,311	0.98	%
Trilon Group, LLC	(12) (13)	First Lien Term Loan	S + 6.25%	11.78	%	5/27/2029	3,733	3,661	3,685	0.49	%
Trilon Group, LLC (Delayed Draw)	(12)	First Lien Term Loan	S + 6.25%	11.78	%	5/27/2029	7,425	7,425	7,330	0.98	%
Trilon Group, LLC (Delayed Draw)	(12)	First Lien Term Loan	S + 6.25%	11.78	%	5/27/2029	1,985	1,985	1,959	0.26	%
Trilon Group, LLC (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 6.25%	11.78	%	5/27/2029	6,373	1,935	1,884	0.25	%
Vital Records Control	(6) (9)	First Lien Term Loan	S + 5.50%	11.14	%	6/29/2027	4,582	4,544	4,515	0.60	%
Vital Records Control	(9) (13)	First Lien Term Loan	S + 5.75%	11.12	%	6/29/2027	151	149	150	0.02	%
Vital Records Control (Delayed Draw)	(9) (12)	First Lien Term Loan	S + 5.75%	11.12	%	6/29/2027	183	181	182	0.03	%
Total Services: Business								302,368	298,732	39.94	%
Services: Consumer
ADPD Holdings, LLC (a/k/a NearU)	(6) (9) (12) (13)	First Lien Term Loan	S + 6.00%	11.68	%	8/16/2028	8,474	8,474	7,920	1.06	%
ADPD Holdings, LLC (a/k/a NearU) (Delayed Draw)	(9) (11) (12)	First Lien Term Loan	S + 6.00%	11.68	%	8/16/2028	1,577	—	(103)	(0.01	%)
ADPD Holdings, LLC (a/k/a NearU) (Delayed Draw)	(9) (11) (12)	First Lien Term Loan	S + 6.00%	11.68	%	8/16/2028	1,714	—	(112)	(0.01	%)
All My Sons	(6)	First Lien Term Loan	S + 4.75%	10.36	%	10/25/2028	5,261	5,222	5,206	0.69	%
COP Exterminators Acquisition, Inc.	(12)	Subordinated Debt	N/A	9.00% (Cash) 4.00% (PIK)		1/28/2030	838	816	816	0.11	%
COP Exterminators Acquisition, Inc. (Delayed Draw)	(11) (12)	Subordinated Debt	N/A	9.00% (Cash) 4.00% (PIK)		1/28/2030	652	(8)	(17)	0.00	%

See Notes to Consolidated Financial Statements

40

NUVEEN CHURCHILL DIRECT LENDING CORP.

CONSOLIDATED SCHEDULE OF INVESTMENTS

December 31, 2023

(dollar amounts in thousands, including share data)

Portfolio Company (1) (2)	Footnotes	Investment	Spread Above Reference Rate (3)	Interest Rate (3)		Maturity Date	Par Amount	Amortized Cost	Fair Value (4)	% of Net Assets (5)
Excel Fitness	(6) (13)	First Lien Term Loan	S + 5.25%	10.75	%	4/29/2029	9,875	9,778	9,616	1.29	%
Fairway Lawns	(12)	Subordinated Debt	N/A	8.00% (Cash) 5.00% (PIK)		5/17/2029	2,730	2,662	2,659	0.35	%
Fairway Lawns (Delayed Draw)	(11) (12)	Subordinated Debt	N/A	8.00% (Cash) 5.00% (PIK)		5/17/2029	6,287	5,867	5,704	0.76	%
Legacy Service Partners, LLC (“LSP”)	(6) (12) (13)	First Lien Term Loan	S + 6.50%	12.00	%	1/9/2029	10,161	9,983	10,306	1.38	%
Legacy Service Partners, LLC (“LSP”) (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 6.50%	12.00	%	1/9/2029	4,734	3,949	4,037	0.54	%
Liberty Buyer	(9) (13)	First Lien Term Loan	S + 5.50%	11.18	%	6/15/2028	3,929	3,898	3,945	0.53	%
Liberty Buyer (Delayed Draw)	(9) (11) (12)	First Lien Term Loan	S + 5.50%	11.18	%	6/15/2028	744	295	298	0.04	%
NJEye LLC	(6)	First Lien Term Loan	S + 4.75%	10.39	%	3/14/2025	5,340	5,331	5,283	0.71	%
NJEye LLC (Delayed Draw)	(6)	First Lien Term Loan	S + 4.75%	10.39	%	3/14/2025	700	700	692	0.09	%
NJEye LLC (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 4.75%	10.39	%	3/14/2025	1,373	883	870	0.12	%
NJEye LLC (Delayed Draw)	(12)	First Lien Term Loan	S + 4.75%	10.44	%	3/14/2025	890	890	881	0.12	%
North Haven Spartan US Holdco LLC	(6)	First Lien Term Loan	S + 6.25%	11.63	%	6/6/2025	2,503	2,501	2,497	0.33	%
North Haven Spartan US Holdco LLC (Delayed Draw)	(6)	First Lien Term Loan	S + 6.25%	11.63	%	6/6/2025	217	217	217	0.03	%
One World Fitness PFF LLC	(6)	First Lien Term Loan	S + 5.25%	10.70% (Cash) 1.00% (PIK)		11/26/2025	3,872	3,873	3,637	0.48	%
Perennial Services, Group, LLC	(6) (13)	First Lien Term Loan	S + 6.00%	11.49	%	9/8/2029	6,733	6,637	6,634	0.89	%
Perennial Services, Group, LLC (Delayed Draw)	(12)	First Lien Term Loan	S + 6.00%	11.49	%	9/8/2029	6,025	6,011	5,937	0.79	%
Total Services: Consumer								77,979	76,923	10.29	%
Sovereign & Public Finance
LMI Consulting, LLC (LMI)	(13)	First Lien Term Loan	S + 6.50%	11.90	%	7/18/2028	4,351	4,280	4,370	0.59	%
LMI Consulting, LLC (LMI) (Incremental)	(6)	First Lien Term Loan	S + 6.50%	11.89	%	7/18/2028	4,938	4,938	4,959	0.66	%
Total Sovereign & Public Finance								9,218	9,329	1.25	%
Telecommunications
BCM One	(6)	First Lien Term Loan	S + 4.50%	9.96	%	11/17/2027	6,074	6,074	5,966	0.80	%
BCM One (Delayed Draw)	(6)	First Lien Term Loan	S + 4.50%	9.96	%	11/17/2027	1,827	1,827	1,794	0.24	%
MBS Holdings, Inc.	(9) (13)	First Lien Term Loan	S + 6.25%	11.71	%	4/16/2027	1,828	1,797	1,824	0.24	%
Mobile Communications America Inc	(6) (12) (13)	First Lien Term Loan	S + 6.00%	11.35	%	10/16/2029	18,505	18,232	18,241	2.44	%

See Notes to Consolidated Financial Statements

41

NUVEEN CHURCHILL DIRECT LENDING CORP.

CONSOLIDATED SCHEDULE OF INVESTMENTS

December 31, 2023

(dollar amounts in thousands, including share data)

Portfolio Company (1) (2)	Footnotes	Investment	Spread Above Reference Rate (3)	Interest Rate (3)		Maturity Date	Par Amount	Amortized Cost	Fair Value (4)	% of Net Assets (5)
Mobile Communications America Inc (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 6.00%	11.35	%	10/16/2029	5,970	(43)	(85)	(0.01	%)
Momentum Telecom II	(6) (9) (13)	First Lien Term Loan	S + 5.75%	11.21	%	4/16/2027	10,054	9,992	9,891	1.32	%
Momentum Telecom II (Incremental)	(9) (12)	First Lien Term Loan	S + 6.50%	11.96	%	4/16/2027	1,314	1,290	1,320	0.18	%
Sapphire Telecom Inc	(6) (9)	First Lien Term Loan	S + 6.00%	11.53	%	11/20/2025	6,650	6,627	6,650	0.89	%
Tyto Athene, LLC	(6) (12)	First Lien Term Loan	S + 5.50%	11.04	%	4/1/2028	7,157	7,105	6,515	0.87	%
Total Telecommunications								52,901	52,116	6.97	%
Transportation: Cargo
FSK Pallet Holding Corp. (DBA Kamps Pallets)	(6) (13)	First Lien Term Loan	S + 6.00%	11.53	%	12/23/2026	9,875	9,725	9,616	1.29	%
Kenco Group, Inc.	(6) (13)	First Lien Term Loan	S + 5.00%	10.39	%	11/15/2029	8,498	8,349	8,498	1.14	%
Kenco Group, Inc. (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 5.00%	10.39	%	11/15/2029	1,416	(24)	—	—	%
Quantix (f/k/a A&R Logistics Holdings, Inc.) (Incremental)	(6) (9)	First Lien Term Loan	S + 6.50%	12.04	%	5/3/2025	258	257	254	0.03	%
Quantix (f/k/a A&R Logistics Holdings, Inc.) (Incremental)	(6) (9)	First Lien Term Loan	S + 6.00%	11.54	%	5/3/2025	895	891	877	0.12	%
Quantix (f/k/a A&R Logistics Holdings, Inc.) (Incremental)	(6) (9)	First Lien Term Loan	S + 6.50%	12.04	%	5/3/2025	181	180	178	0.02	%
Quantix (f/k/a A&R Logistics Holdings, Inc.) (Incremental)	(6) (9)	First Lien Term Loan	S + 6.50%	12.04	%	5/3/2025	4,367	4,350	4,306	0.57	%
Quantix (f/k/a A&R Logistics Holdings, Inc.) (Incremental)	(9) (13)	First Lien Term Loan	S + 6.50%	11.90	%	5/3/2025	1,359	1,343	1,340	0.18	%
RoadOne (Delayed Draw)	(11) (12)	Subordinated Debt	N/A	8.75% (Cash) 5.00% (PIK)		6/30/2029	1,397	(18)	(28)	—	%
RoadOne	(12)	Subordinated Debt	N/A	8.75% (Cash) 5.00% (PIK)		6/30/2029	4,699	4,579	4,604	0.62	%
SEKO Global Logistics	(12)	Subordinated Debt	S + 9.00%	6.04% (Cash) 4.50% (PIK)		6/30/2027	5,840	5,765	5,676	0.76	%
SEKO Global Logistics	(12)	Subordinated Debt	S + 9.00%	9.86% (Cash) 4.50% (PIK)		6/30/2027	4,053	3,997	3,939	0.53	%
SEKO Global Logistics	(6)	First Lien Term Loan	S + 5.00%	10.72	%	12/30/2026	1,125	1,118	1,115	0.15	%
SEKO Global Logistics (Delayed Draw)	(12)	Subordinated Debt	S + 9.00%	6.04% (Cash) 4.50% (PIK)		6/30/2027	912	912	887	0.12	%
SEKO Global Logistics (Delayed Draw) (Incremental)	(12)	First Lien Term Loan	S + 5.00%	10.72	%	12/30/2026	4,485	4,485	4,444	0.59	%
SEKO Global Logistics (Incremental)	(6) (13)	First Lien Term Loan	S + 5.00%	10.72	%	12/30/2026	1,517	1,506	1,503	0.20	%

See Notes to Consolidated Financial Statements

42

NUVEEN CHURCHILL DIRECT LENDING CORP.

CONSOLIDATED SCHEDULE OF INVESTMENTS

December 31, 2023

(dollar amounts in thousands, including share data)

Portfolio Company (1) (2)	Footnotes	Investment	Spread Above Reference Rate (3)	Interest Rate (3)		Maturity Date	Par Amount	Amortized Cost	Fair Value (4)	% of Net Assets (5)
TI ACQUISITION NC LLC	(6)	First Lien Term Loan	S + 4.75%	10.08	%	3/19/2027	2,780	2,719	2,642	0.35	%
Total Transportation: Cargo								50,134	49,851	6.67	%
Transportation: Consumer
American Student Transportaton Partners, Inc	(12)	Subordinated Debt	N/A	10.00% (Cash) 3.50% (PIK)		9/11/2029	2,081	2,027	2,026	0.27	%
Total Transportation: Consumer								2,027	2,026	0.27	%
Utilities: Electric
DMC HoldCo LLC (DMC Power)	(6) (12) (13)	First Lien Term Loan	S + 6.00%	11.39	%	7/13/2029	5,000	4,927	4,981	0.67	%
DMC HoldCo LLC (DMC Power) (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 6.00%	11.39	%	7/13/2029	1,671	(4)	(7)	—	%
Pinnacle Supply Partners, LLC	(6) (13)	First Lien Term Loan	S + 6.00%	11.47	%	4/3/2030	6,332	6,214	6,287	0.84	%
Pinnacle Supply Partners, LLC (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 6.00%	11.47	%	4/3/2030	3,636	(30)	(26)	—	%
TPC Wire & Cable	(12)	Subordinated Debt	N/A	10.00% (Cash) 1.00% (PIK)		2/16/2028	2,240	2,220	2,215	0.29	%
TPC Wire & Cable (Delayed Draw)	(12)	Subordinated Debt	N/A	11.00% (Cash) 1.50% (PIK)		2/16/2028	913	911	902	0.12	%
Total Utilities: Electric								14,238	14,352	1.92	%
Wholesale
INS Intermediate II, LLC (Ergotech Controls, Inc. – d/b/a INS)	(6) (13)	First Lien Term Loan	S + 6.50%	12.03	%	1/20/2029	7,961	7,822	7,973	1.06	%
INS Intermediate II, LLC (Ergotech Controls, Inc. – d/b/a INS) (Delayed Draw)	(11) (12)	First Lien Term Loan	S + 6.50%	12.03	%	1/20/2029	1,979	(34)	3	—	%
ISG Merger Sub, LLC (dba Industrial Service Group)	(6) (13)	First Lien Term Loan	S + 6.25%	11.60	%	12/7/2028	6,525	6,412	6,569	0.88	%
ISG Merger Sub, LLC (dba Industrial Service Group) (Delayed Draw)	(12)	First Lien Term Loan	S + 6.25%	11.60	%	12/7/2028	3,397	3,383	3,420	0.46	%
Total Wholesale								17,583	17,965	2.40	%
Total Debt Investments								1,640,574	1,610,879	215.39	%

See Notes to Consolidated Financial Statements

43

NUVEEN CHURCHILL DIRECT LENDING CORP.

CONSOLIDATED SCHEDULE OF INVESTMENTS

December 31, 2023

(dollar amounts in thousands, including share data)

Portfolio Company (1) (2)	Footnotes	Investment	Acquisition Date	Shares/Units	Amortized Cost	Fair Value (4)	% of Net Assets (5)
Equity Investments
Aerospace & Defense
BPC Kodiak LLC (Turbine Engine Specialist, Inc)	(8) (12) (14) (16)	Class A-1 Units	9/1/2023	1,530,000	1,530	1,614	0.22	%
Total Aerospace & Defense					1,530	1,614	0.22	%
Automotive
Covercraft	(8) (12) (14)	Covercraft Equity	8/20/2021	768	768	357	0.05	%
High Bar Brands	(8) (10) (12) (14)	Class A Units	12/19/2023	303,000	303	303	0.04	%
S&S Truck Parts	(8) (12) (14)	Partnership Units	3/31/2022	4	378	299	0.04	%
S&S Truck Parts	(8) (12) (14)	Pegasus Units	8/1/2022	78,541	79	62	0.01	%
Total Automotive					1,528	1,021	0.14	%
Beverage, Food & Tobacco
Bardstown PPC Holdings LLC	(8) (10) (12)	Common	7/13/2022	14,777	1,860	2,114	0.28	%
Fresh Edge - Common	(8) (12) (14)	Class B Common Units	10/3/2022	667	—	99	0.01	%
Fresh Edge - Preferred	(8) (12) (14)	Class A Preferred Units	10/3/2022	667	667	745	0.10	%
Tech24	(8) (12) (14)	Company Unit	10/5/2023	954	954	954	0.13	%
Total Beverage, Food & Tobacco					3,481	3,912	0.52	%
Capital Equipment
Crete Mechanical Group	(8) (12) (14)	Equity Co-Investment	5/7/2022	23	230	534	0.07	%
EFC Holdings, LLC	(8) (10) (12) (14)	Class A Common Units	2/28/2023	148	60	113	0.02	%
EFC Holdings, LLC	(8) (10) (12) (14)	Series A Preferred Units	2/28/2023	148	148	158	0.02	%
Precision Surfacing - Common	(8) (10) (12) (14)	Common Units	10/3/2022	3,750,000	3,750	6,513	0.87	%
Repipe Specialists	(8) (12) (14)	Purchased Units	3/18/2022	239	239	6	—	%
Total Capital Equipment					4,427	7,324	0.98	%
Construction & Building
Erie Construction	(8) (12)	Common	7/27/2021	166	166	606	0.08	%
Gannett Fleming	(8) (12) (14)	Series F Units	5/26/2023	569,505	570	830	0.11	%
Gannett Fleming	(8) (12) (14) (16)	Limited Partnership Interests	12/20/2022	424,742	425	619	0.08	%
Total Construction & Building					1,161	2,055	0.27	%
Consumer Goods: Non-durable
FoodScience	(8) (12) (14)	Class B Units	3/1/2021	5,168	5	—	—	%

See Notes to Consolidated Financial Statements

44

NUVEEN CHURCHILL DIRECT LENDING CORP.

CONSOLIDATED SCHEDULE OF INVESTMENTS

December 31, 2023

(dollar amounts in thousands, including share data)

Portfolio Company (1) (2)	Footnotes	Investment	Acquisition Date	Shares/Units	Amortized Cost	Fair Value (4)	% of Net Assets (5)
FoodScience	(8) (12) (14)	Class A Units	3/1/2021	98	98	51	0.01	%
Ultima Health Holdings, LLC	(8) (12) (14)	Preferred Units	9/12/2022	15	170	158	0.02	%
Total Consumer Goods: Non-durable					273	209	0.03	%
Containers, Packaging & Glass
Oliver Packaging	(8) (12) (14)	Class A Common Units	7/6/2022	10,230	1,023	640	0.09	%
Specialized Packaging Group	(7) (8) (10) (12) (14)	Class A Units	12/17/2020	147,708	148	182	0.02	%
Total Containers, Packaging & Glass					1,171	822	0.11	%
Healthcare & Pharmaceuticals
AG MDC Holdings, Inc	(8) (10) (12) (14)	Class A2 Units (Common)	2/7/2023	245	245	177	0.02	%
Anne Arundel	(8) (12) (14)	AA Equity Co-Invest	9/14/2023	12,175	880	2	—	%
Health Management Associates	(8) (12) (14)	Class A Common Units	3/31/2023	399,904,000	400	427	0.06	%
REP HS Topco Holdings (HemaSource Inc.)	(8) (12) (14)	LP Interests	8/31/2023	577,000	577	645	0.09	%
Total Healthcare & Pharmaceuticals					2,102	1,251	0.17	%
High Tech Industries
ITSavvy LLC	(8) (12) (14)	Class A Common Units	8/8/2022	522	522	1,250	0.17	%
Solve Industrial Motion Group	(8) (12) (14)	Solve Industrial Equity	6/30/2021	313	313	210	0.03	%
Total High Tech Industries					835	1,460	0.20	%
Services: Business
Apex Companies Holdings, LLC	(8) (10) (12) (14)	Class A Membership Interests	1/31/2023	1,173	117	127	0.02	%
BroadcastMed Holdco, LLC	(8) (12)	Series A-3 Preferred Units	10/4/2022	56,899	853	888	0.12	%
Career Now	(8) (12) (14)	Series B Limited Partnership Units	10/14/2023	222	22	—	—	%
Career Now	(8) (12) (14)	Common Equity	9/30/2021	624	624	—	—	%
E78	(8) (12) (14)	Class A Common Units	12/1/2021	816	860	835	0.11	%
KRIV Acquisition, Inc	(8) (12) (14)	Class A Units	7/17/2023	790	790	930	0.12	%
Output Services Group, Inc.	(8) (10) (12) (14)	Class A Units	11/30/2023	47,021	833	833	0.11	%
Total Services: Business					4,099	3,613	0.48	%
Services: Consumer
ADPD Holdings, LLC (a/k/a NearU)	(8) (9) (12) (14)	Limited Partnership Interests	8/8/2022	2,432	243	156	0.02	%

See Notes to Consolidated Financial Statements

45

NUVEEN CHURCHILL DIRECT LENDING CORP.

CONSOLIDATED SCHEDULE OF INVESTMENTS

December 31, 2023

(dollar amounts in thousands, including share data)

Portfolio Company (1) (2)	Footnotes	Investment	Acquisition Date	Shares/Units	Amortized Cost	Fair Value (4)	% of Net Assets (5)
COP Exterminators Investment, LLC	(8) (12) (14)	Class A Units	7/31/2023	997,000	1,117	1,163	0.16	%
Legacy Service Partners, LLC (“LSP”)	(8) (12) (14)	Class B Units	1/9/2023	4,907	491	544	0.07	%
Perennial Services Investors LLC	(8) (10) (12) (14)	Class A Units	9/8/2023	7,784	778	1,077	0.14	%
Total Services: Consumer					2,629	2,940	0.39	%
Sovereign & Public Finance
LMI Renaissance	(8) (12) (14)	Limited Partnership Interests	7/18/2022	633,980	634	1,370	0.18	%
Total Sovereign & Public Finance					634	1,370	0.18	%
Transportation: Cargo
RoadOne - Common	(8) (12) (14)	Partnership Units	12/29/2022	1,173,220	939	1,525	0.20	%
SEKO Global Logistics	(8) (12)	Seko Equity Co-Invest	12/30/2020	671,203	332	1,221	0.16	%
Total Transportation: Cargo					1,271	2,746	0.36	%
Transportation: Consumer
ASTP Holdings Co-Investment LP	(8) (12) (14)	Limited Partnership Interest	9/11/2023	173,844	174	189	0.03	%
Total Transportation: Consumer					174	189	0.03	%
Utilities: Electric
Pinnacle Supply Partners, LLC	(8) (12) (14)	Subject Partnership Units	4/3/2023	279,687,000	280	281	0.04	%
Total Utilities: Electric					280	281	0.04	%
Total Equity Investments					25,595	30,807	4.12	%

See Notes to Consolidated Financial Statements

46

NUVEEN CHURCHILL DIRECT LENDING CORP.

CONSOLIDATED SCHEDULE OF INVESTMENTS

December 31, 2023

(dollar amounts in thousands, including share data)

Portfolio Company (1) (2)	Interest Rate (3)	Par Amount	Amortized Cost		Fair Value (4)		% of Net Assets (5)
Cash Equivalents
BlackRock Liquidity Funds Treasury	5.18%	46,784	46,784		46,784		6.26	%
First American Government Obligations Fund	5.19%	32	32		32		—	%
U.S. Bank National Association Money Market Deposit Account	2.05%	17,661	17,661		17,661		2.36	%
Total Cash Equivalents			$	64,477	$	64,477	8.62	%
Total Investments and Cash Equivalents			$	1,730,646	$	1,706,163	228.13	%

_____________

(1)All investments are non-controlled/non-affiliated investments as defined by the Investment Company Act of 1940, as amended (the "1940 Act"). The 1940 Act classifies investments based on the level of control that the Company maintains in a particular portfolio company. As defined in the 1940 Act, a company is generally presumed to be “non-controlled” when the Company owns 25% or less of the portfolio company’s voting securities and “controlled” when the Company owns more than 25% of the portfolio company’s voting securities. The 1940 Act also classifies investments further based on the level of ownership that the Company maintains in a particular portfolio company. As defined in the 1940 Act, a company is generally deemed as “non-affiliated” when the Company owns less than 5% of a portfolio company’s voting securities and “affiliated” when the Company owns 5% or more of a portfolio company’s voting securities.

(2)Unless otherwise indicated, issuers of debt and equity held by the Company are domiciled in the United States.

(3)The majority of the investments bear interest at rates that may be determined by reference to London Interbank Offered Rate (“SOFR” or "S"), which reset monthly or quarterly. For each such investment, the Company has provided the spread over SOFR and the current contractual interest rate in effect at December 31, 2023. As of December 31, 2023, rate for 1M S, 3M S, 6M S, 12M S ("SOFR") are 5.35%, 5.33%, 5.16%, and 4.77% respectively. Certain investments are subject to a SOFR floor. For fixed rate loans, a spread above a reference rate is not applicable.

(4)Investment valued using unobservable inputs (Level 3). See Note 2 “Significant Accounting Policies – Valuation of Portfolio Investments” and Note 4 "Fair Value Measurements" for more information.

(5)Percentage is based on net assets of $747,885 as of December 31, 2023.

(6)Denotes that all or a portion of the assets are owned by CLO-I and/or CLO-II (each as defined in the Note 1 "Organization"), which serve as collateral for the 2022 and 2023 Debt Securitization (as defined in the Notes). See Note 6 "Secured Borrowings".

(7)This portfolio company is not domiciled in the United States. The principal place of business for Specialized Packing Group is Canada. The principal place of business for Phaidon International is the United Kingdom.

(8)Security acquired in transaction exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”), and may be deemed to be a “restricted security” under the Securities Act. As of December 31, 2023, the Company held forty-four restricted securities with an aggregate fair value of 30,807, or 4.12% of the Company’s net assets.

(9)Investment is a unitranche position.

(10)The investment is considered as a non-qualifying asset under Section 55(a) of the 1940 Act. Under the 1940 Act, the Company cannot acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Company's total assets. As of December 31, 2023, total non-qualifying assets at fair value represented 4.24% of the Company's total assets calculated in accordance with the 1940 Act.

(11)Position or portion thereof is an unfunded loan commitment, and no interest is being earned on the unfunded portion. See Note 7 "Commitments and Contingencies". The investment may be subject to unused commitment fees.

(12)Denotes that all or a portion of the assets are owned by the Company or NCDL Equity Holdings (each as defined in Note 1 "Organization"). The Company entered into a senior secured revolving credit agreement (the “Revolving Credit Facility”). The Revolving Credit Facility is guaranteed by NCDL Equity Holdings and will be guaranteed by certain subsidiaries of the Company that are formed or acquired by the Company in the future.

(13)Denotes that all or a portion of the assets are owned by SPV II and/or SPV III (each as defined in Note 1 "Organization"). SPV II has entered into a senior secured revolving credit facility (the “SMBC Financing Facility”). The lenders of the SMBC Financing Facility have a first lien security interest in substantially all of the assets of SPV II. Accordingly, such assets are not available to other creditors of the Company. SPV III has entered into a senior secured revolving credit facility (the “Wells Fargo Financing Facility”). The lenders of the Wells Fargo Financing Facility have a first lien security interest in substantially all of the assets of SPV III. Accordingly, such assets are not available to other creditors of the Company.

(14)Equity investments are non-income producing securities unless otherwise noted.

See Notes to Consolidated Financial Statements

47

NUVEEN CHURCHILL DIRECT LENDING CORP.

CONSOLIDATED SCHEDULE OF INVESTMENTS

December 31, 2023

(dollar amounts in thousands, including share data)

(15)Investments valued using observable inputs (Level 2). See Note 2 “Significant Accounting Policies – Valuation of Portfolio Investments” and Note 4 "Fair Value Measurements" for more information.

(16)Represents an investment held through an aggregator vehicle organized as a pooled investment vehicle.

See Notes to Consolidated Financial Statements

48

NUVEEN CHURCHILL DIRECT LENDING CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

(dollar amounts in thousands, except per share data)

1. ORGANIZATION

Nuveen Churchill Direct Lending Corp., a Maryland corporation (the “Company”), is a closed-end, externally managed, non-diversified management investment company that has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”). In addition, the Company has elected, and intends to qualify annually, to be treated for U.S. federal income tax purposes as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”). Effective June 1, 2020, the Company changed its name from “Nuveen Churchill BDC, Inc.” to “Nuveen Churchill Direct Lending Corp.”

The Company’s investment objective is to generate attractive risk-adjusted returns primarily through current income by investing primarily in senior secured loans to private equity-owned U.S. middle market companies, which the Company defines as companies with approximately $10 million to $250 million of earnings before interest, taxes, depreciation and amortization (“EBITDA”). The Company primarily focuses on investing in U.S. middle market companies with $10 million to $100 million in EBITDA, which it considers the core middle market. The Company's portfolio is comprised primarily of first-lien senior secured debt and unitranche loans. Although it is not the Company's primary strategy, the Company also opportunistically invests in junior capital opportunities, including second-lien loans, subordinated debt, and equity co-investments and similar equity-related securities.

The Company entered into the Advisory Agreement with Churchill DLC Advisor LLC (f/k/a Nuveen Churchill Advisors LLC) (the “Adviser”), under which the Adviser has delegated substantially all of its day-to-day portfolio management obligations through the CAM Sub-Advisory Agreement with Churchill Asset Management LLC (“Churchill"). In addition, the Adviser and Churchill have engaged Nuveen Asset Management, LLC (“Nuveen Asset Management”) pursuant to the NAM Sub-Advisory Agreement, pursuant to which Nuveen Asset Management may manage a portion of the Company's portfolio consisting of cash and cash equivalents, liquid fixed-income securities (including broadly syndicated loans) and other liquid credit instruments, subject to the pace and amount of investment activity in the middle market investment program. Under the Administration Agreement, the Company is provided with certain services by an administrator, Churchill BDC Administration LLC (f/k/a Nuveen Churchill Administration LLC) (the “Administrator”). The Advisers and Administrator are all affiliates and subsidiaries of Nuveen, LLC, a wholly owned subsidiary of Teachers Insurance and Annuity Association of America (“TIAA”). See Note 5, Related Party Transactions.

Churchill NCDLC CLO-I, LLC (“CLO-I”), Churchill NCDLC CLO-II, LLC (“CLO-II”), Churchill NCDLC CLO-III, LLC (“CLO-III”), Nuveen Churchill BDC SPV IV, LLC (“SPV IV”), Nuveen Churchill BDC SPV V, LLC (“SPV V”) and NCDL Equity Holdings LLC ("NCDL Equity Holdings") are wholly owned subsidiaries of the Company and are consolidated in these financial statements commencing from the date of their formation, in accordance with the Company's consolidation policy discussed in Note 2. CLO-I, CLO-II and CLO-III completed term debt securitizations in May 2022, December 2023 and March 2024, respectively. SPV IV and SPV V primarily invest in first-lien senior secured debt and unitranche loans. NCDL Equity Holdings was formed to hold certain equity-related securities.

Beginning with its initial closing in March 2020, the Company conducted private offerings ("Private Offerings") of its shares of common stock to accredited investors in reliance on exemptions from the registration requirements of the Securities Act of 1933, as amended (the "Securities Act"). The Company held its final closing on April 28, 2023.

On January 29, 2024, the Company closed its initial public offering (“IPO”) and the Company’s common stock began trading on the New York Stock Exchange (“NYSE”) under the symbol “NCDL” on January 25, 2024.

49

NUVEEN CHURCHILL DIRECT LENDING CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

(dollar amounts in thousands, except per share data)

2. SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The consolidated financial statements have been prepared on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”). The Company is an investment company for the purposes of accounting and financial reporting in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 946, Financial Services—Investment Companies (“ASC 946”), and pursuant to Regulation S-X. In the opinion of management, all adjustments, which are of a normal recurring nature, considered necessary for the fair statement of the consolidated financial statements for the periods presented, have been included. The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated. Certain prior period amounts have been reclassified to conform to the current period presentation. U.S. GAAP for an investment company requires investments to be recorded at fair value. The carrying value for all other assets and liabilities approximates their fair value, unless otherwise disclosed within.

Use of Estimates

The preparation of consolidated financial statements in conformity with U.S. GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, as well as the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

Cash, Cash Equivalents and Restricted Cash

Cash and restricted cash represent cash deposits held at financial institutions, which at times may exceed U.S. federally insured limits. The Company has restrictions on the uses of the cash held by SPV V based on the terms of the Wells Fargo Financing Facility (as defined in Note 6 below). Cash equivalents include short-term highly liquid investments, such as money market funds, that are readily convertible to cash and have original maturities of three months or less. Cash, restricted cash and cash equivalents are carried at cost, which approximates fair value.

Valuation of Portfolio Investments

Investments are valued in accordance with the fair value principles established by FASB ASC Topic 820, Fair Value Measurement (“ASC Topic 820”) and in accordance with the 1940 Act. ASC Topic 820’s definition of fair value focuses on the amount that would be received to sell the asset or paid to transfer the liability in the principal or most advantageous market, and prioritizes the use of market-based inputs (observable) over entity-specific inputs (unobservable) within a measurement of fair value.

ASC Topic 820 specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. ASC Topic 820 also provides guidance regarding a fair value hierarchy, which prioritizes information used to measure fair value and the effect of fair value measurements on earnings, and provides for enhanced disclosures determined by the level within the hierarchy of information used in the valuation. In accordance with ASC Topic 820, these inputs are summarized in the three levels listed below:

•Level 1 — Valuations are based on unadjusted, quoted prices in active markets for identical assets or liabilities that are accessible at the measurement date.

•Level 2 — Valuations are based on quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly.

•Level 3 — Valuations based on inputs that are unobservable and significant to the overall fair value measurement.

In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, an investment’s level within the fair value hierarchy is based on the lowest level of observable input that is significant to the fair value measurement. The assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the investment.

Active, publicly traded instruments are classified as Level 1 and their values are generally based on quoted market prices, even if both the market’s normal daily trading volume is not sufficient to absorb the quantity held and placing orders to sell the position in a single transaction might affect the quoted price.

50

NUVEEN CHURCHILL DIRECT LENDING CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

(dollar amounts in thousands, except per share data)

Fair value is generally determined as the price that would be received for an investment in a current sale, which assumes an orderly market is available for the market participants at the measurement date. If available, fair value of investments is based on directly observable market prices or on market data derived from comparable assets. The Company’s valuation policy considers the fact that no ready market may exist for many of the securities in which it invests and that fair value for its investments must be determined using unobservable inputs.

Pursuant to Rule 2a-5 under the 1940 Act, the Company's board of directors (the “Board”) has designated the Adviser as the Company's valuation designee (the “Valuation Designee”) to determine the fair value of the Company's investments that do not have readily available market quotations, which became effective beginning with the fiscal quarter ended March 31, 2023. Pursuant to the Company's valuation policy approved by the Board, a valuation committee comprised of employees of the Adviser (the “Valuation Committee”) is responsible for determining the fair value of the Company’s assets for which market quotations are not readily available, subject to the oversight of the Board.

With respect to investments for which market quotations are not readily available (Level 3), the Valuation Designee, subject to the oversight of the Board as described below, defined further below in Note 5, undertakes a multi-step valuation process each quarter, as follows:

i.the quarterly valuation process begins with each portfolio company or investment being initially valued by either the professionals of the applicable investment team that are responsible for the portfolio investment or an independent third-party valuation firm;

ii.to the extent that an independent third-party valuation firm has not been engaged by, or on behalf of, the Company to value 100% of the portfolio, then at a minimum, an independent third-party valuation firm will be engaged by, or on behalf of, the Company will provide positive assurance of the portfolio each quarter (such that each investment is reviewed by a third-party valuation firm at least once on a rolling 12-month basis and each watch-list investment will be reviewed each quarter), including a review of management’s preliminary valuation and recommendation of fair value;

iii.the Valuation Committee then reviews and discusses the valuations with any input, where appropriate, from the independent third-party valuation firm(s), and determine the fair value of each investment in good faith based on the Company’s valuation policy, subject to the oversight of the Board; and

iv.the Valuation Designee provides the Board with the information relating to the fair value determination pursuant to the Company’s valuation policy in connection with each quarterly Board meeting, comply with the periodic board reporting requirements set forth in the Company’s valuation policy, and discuss with the Board its determination of the fair value of each investment in good faith.

The Valuation Designee makes this fair value determination on a quarterly basis and in such other instances when a decision regarding the fair value of the portfolio investments is required. Factors considered by the Valuation Designee as part of the valuation of investments include each portfolio company's credit ratings/risk, current and projected earnings, current and expected leverage, ability to make interest and principal payments, liquidity, compliance with applicable loan covenants, and price to earnings (or other financial) ratios and those of comparable companies, as well as the estimated remaining life of the investment and current market yields and interest rate spreads of similar securities as of the measurement date. Other factors taken into account include changes in the interest rate environment and credit markets that may affect the price at which similar investments would trade. The Valuation Designee may also base its valuation of an investment on recent transactions of investments and securities with similar structure and risk characteristics. The Valuation Designee obtains market data from its ongoing investment purchase efforts, in addition to monitoring transactions that have closed or are discussed in industry publications. External information may include (but is not limited to) observable market data derived from the U.S. loan and equity markets. As part of compiling market data as an indication of current market conditions, management may utilize third-party sources.

The values assigned to investments are based on available information and may fluctuate from period to period. In addition, such values do not necessarily represent the amount that ultimately might be realized upon a portfolio investment's sale. Due to the inherent uncertainty of valuation, the estimated fair value of an investment may differ from the value that would have been used had a ready market for the security existed, and the difference could be material.

51

NUVEEN CHURCHILL DIRECT LENDING CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

(dollar amounts in thousands, except per share data)

The Board is responsible for overseeing the Valuation Designee’s process for determining the fair value of the Company’s assets for which market quotations are not readily available, taking into account the Company’s valuation risks. To facilitate the Board’s oversight of the valuation process, the Valuation Designee provides the Board with quarterly reports, annual reports, and prompt reporting of material matters affecting the Valuation Designee’s determination of fair value. As part of the Board’s oversight role, the Board may request and review additional information to be informed of the Valuation Designee’s process for determining the fair value of the Company's investments.

Investment Transactions and Revenue Recognition

Investment transactions are recorded on the applicable trade date. Any amounts related to purchases, sales and principal paydowns that have traded, but not settled, are reflected as either a receivable for investments sold or payable for investments purchased on the consolidated statements of assets and liabilities. Realized gains or losses are measured by the difference between the net proceeds received and the cost basis of the investment using the specific identification method without regard to unrealized appreciation or depreciation previously recognized and are included as net realized gain (loss) on investments in the consolidated statements of operations. Net change in unrealized appreciation (depreciation) on investments is recognized in the consolidated statements of operations and reflects the period-to-period change in fair value and cost of investments, including the reversal of previously recorded unrealized appreciation or depreciation when gains or losses are realized.

Interest income, including amortization of premium and accretion of discount on loans, and expenses are recorded on the accrual basis. The Company accrues interest income if it expects that ultimately it will be able to collect such income.

The Company may have loans in its portfolio that contain payment-in-kind (“PIK”) income provisions. PIK represents interest that is accrued and recorded as interest income at the contractual rates, increases the loan principal on the respective capitalization dates, and is generally due at maturity. This non-cash source of income is included when determining what must be paid out to shareholders in the form of distributions in order for the Company to maintain its tax treatment as a RIC, even though the Company has not yet collected cash. For the three months ended March 31, 2024 and 2023, the Company earned $1,992 and $321, respectively, in PIK income provisions representing 3.86% and 0.95% of total investment income, respectively.

Dividend income on preferred equity securities is recorded on the accrual basis to the extent that such amounts are payable by the portfolio company and are expected to be collected. Dividend income on common equity securities is recorded on the record date for private portfolio companies or on the ex-dividend date for publicly traded portfolio companies. For the three months ended March 31, 2024 and 2023 the Company earned $308 and $16, respectively, of dividend income on its equity investments.

Other income may include income such as consent, waiver, amendment, unused, and prepayment fees associated with the Company’s investment activities, as well as any fees for managerial assistance services rendered by the Company to its portfolio companies. Such fees are recognized as income when earned or the services are rendered. For the three months ended March 31, 2024 and 2023 the Company earned other income of $217 and $236, respectively, primarily related to prepayment and amendment fees.

Loans are generally placed on non-accrual status when a payment default occurs or if management otherwise believes that the issuer of the loan will not be able to make contractual interest payments or principal payments. The Company will cease recognizing interest income on that loan until all principal and interest is current through payment or until a restructuring occurs, such that the interest income is deemed to be collectible. However, the Company remains contractually entitled to this interest. The Company may make exceptions to this policy if the loan has sufficient collateral value and is in the process of collection. Accrued interest is written-off when it becomes probable that the interest will not be collected and the amount of uncollectible interest can be reasonably estimated. When a PIK investment is placed on non-accrual status, the accrued, uncapitalized interest is generally reversed through PIK income. As of March 31, 2024, the Company had one portfolio company on non-accrual status with a fair value of $2,326 which represents approximately 0.13% of total investments at fair value. As of December 31, 2023, there were no portfolio companies on non-accrual.

Deferred Financing Costs

Deferred financing costs include capitalized expenses related to the closing or amendments of borrowings. Amortization of deferred financing costs is computed on the straight-line basis over the term of the borrowings. The unamortized balance of such costs is included as a direct deduction from the related liability in the accompanying consolidated statements of assets and liabilities. The amortization of such costs is included in interest and debt financing expenses in the accompanying consolidated statements of operations.

52

NUVEEN CHURCHILL DIRECT LENDING CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

(dollar amounts in thousands, except per share data)

Offering Costs

Offering costs associated with the Private Offerings were recognized as a deferred charge on the consolidated statement of assets and liabilities and amortized on a straight-line basis over 12 months. These expenses consist primarily of legal fees and other costs incurred in connection with the Company’s continuous Private Offering of its shares. For the three months ended March 31, 2024 the Company did not incur any offering costs. For the three months ended March 31, 2023 the Company incurred offering costs of $15.

Deferred offering costs include registration expenses related to any shelf registration statement filed by the Company. These expenses consist primarily of SEC registration fees, legal fees and accounting fees incurred related thereto. Upon the completion of an equity offering or a debt offering, the deferred expenses are charged to additional paid-in capital or debt issuance costs, respectively. If there are any deferred offering costs remaining at the expiration of the shelf registration statement, these deferred costs are charged to expense. The Adviser paid the offering costs associated with the IPO on behalf of the Company. The Company is not obligated to repay any such offering costs paid by the Adviser.

Income Taxes

For U.S. federal income tax purposes, the Company has elected, and intends to qualify annually, to be treated as a RIC under the Code. In order to qualify as a RIC, the Company must meet certain minimum distribution, source-of-income and asset diversification requirements. If such requirements are met, then the Company is generally required to pay U.S. federal income taxes only on the portion of its taxable income and capital gains it does not distribute.

The minimum distribution requirements applicable to RICs require the Company to distribute to its shareholders at least 90% of its investment company taxable income (“ICTI”), as defined by the Code, each year. Depending on the level of ICTI earned in a tax year, the Company may choose to carry forward ICTI in excess of current year distributions into the next tax year. Any such carryover ICTI must be distributed before the end of that next tax year through a dividend declared prior to filing the final tax return related to the year which generated such ICTI.

In addition, based on the excise distribution requirements, the Company is subject to a 4% U.S. nondeductible federal excise tax on undistributed income unless the Company distributes in a timely manner an amount at least equal to the sum of (1) 98% of its ordinary income for each calendar year, (2) 98.2% of capital gain net income (both long-term and short-term) for the one-year period ended October 31 in that calendar year and (3) any income realized, but not distributed, in the preceding year. For this purpose, however, any ordinary income or capital gain net income retained by the Company that is subject to U.S. federal income tax at corporate rates is considered to have been distributed. The Company intends to timely distribute to our shareholders substantially all of our annual taxable income for each year, except that the Company may retain certain net capital gains for reinvestment and, depending upon the level of taxable income earned in a year, we may choose to carry forward ICTI for distribution in the following year and pay any applicable U.S. federal excise tax.

The Company evaluates tax positions taken or expected to be taken in the course of preparing its consolidated financial statements to determine whether the tax positions are “more-likely than not” to be sustained by the applicable tax authority. CLO-I, CLO-II, CLO-III, SPV IV and SPV V are disregarded entities for tax purposes and are consolidated with the tax return of the Company. NCDL Equity Holdings has elected to be classified as a corporation for U.S. federal income tax purposes. All penalties and interest associated with income taxes, if any, are included in income tax expense. For the three months ended March 31, 2024 and March 31, 2023, the Company did not incur any excise tax expense.

Dividends and Distributions to Common Shareholders

To the extent that the Company has taxable income, the Company intends to continue to make quarterly distributions to its common shareholders. Dividends and distributions to common shareholders are recorded on the applicable record date. The amount to be distributed to common shareholders is determined by the Board each quarter and is generally based upon the taxable earnings estimated by management and available cash. Net realized capital gains, if any, will generally be distributed at least annually, although the Company may decide to retain such capital gains for investment.

In connection with the IPO, the Board approved an amended and restated dividend reinvestment plan (the "Amended DRIP"), which became effective on January 29, 2024, concurrent with the consummation of the IPO.

The Amended DRIP changed the dividend reinvestment plan from an “opt in” dividend reinvestment plan to an “opt out” dividend reinvestment plan. As a result of the foregoing, if the Board authorizes, and the Company declares, a cash dividend or distribution, shareholders that acquired their shares in the IPO and do not “opt out” of the Amended DRIP will have their cash distributions automatically reinvested in additional shares rather than receiving cash. Notwithstanding the foregoing, a shareholder’s

53

NUVEEN CHURCHILL DIRECT LENDING CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

(dollar amounts in thousands, except per share data)

election (or deemed election) under the dividend reinvestment plan, dated December 19, 2019, will remain in effect for such shareholder and no further action is required by such shareholder with respect to their election under the Amended DRIP.

With respect to each distribution under the Amended DRIP, the Board reserves the right to either issue new shares of common stock or purchase shares of common stock in the open market for the accounts of participants in the Amended DRIP. If newly issued shares are used to implement the Amended DRIP, the number of shares to be issued to a shareholder will be determined by dividing the total dollar amount of the distribution payable to such participant by the market price per share of the Company's common stock at the close of regular trading of the NYSE on the distribution payment date, or if no sale is reported for such day, the average of the reported bid and asked prices. However, if the market price per share on the distribution payment date exceeds the most recently computed net asset value ("NAV") per share, the Company will issue shares at the greater of (i) the most recently computed NAV per share and (ii) 95% of the current market price per share (or such lesser discount to the current market price per share that still exceeds the most recently computed NAV per share). If shares are purchased in the open market to implement the Amended DRIP, the number of shares to be issued to a participant will be determined by dividing the dollar amount of the distribution payable to such participant by the weighted average price per share for all shares of common stock purchased by the plan administrator in the open market in connection with the dividend or distribution. Although each participant may from time to time have an undivided fractional interest in a share, no certificates for a fractional share will be issued. However, dividends and distributions on fractional shares will be credited to each participant’s account.

Functional Currency

The functional currency of the Company is the U.S. Dollar and all transactions were in U.S. Dollars.

3. INVESTMENTS

As of March 31, 2024 and December 31, 2023, our investments consisted of the following (dollar amounts in thousands):

	March 31, 2024						December 31, 2023
	Amortized Cost		Fair Value		% of Fair Value		Amortized Cost		Fair Value		% of Fair Value
First-Lien Term Loans	$	1,610,637	$	1,596,352	88.95	%	$	1,450,120	$	1,427,492	86.95	%
Subordinated Debt1	$	178,330	$	166,502	9.28	%	190,454		183,387		11.17	%
Equity Investments	$	26,018	$	31,705	1.77	%	25,595		30,807		1.88	%
Total	$	1,814,985	$	1,794,559	100.00	%	$	1,666,169	$	1,641,686	100.00	%

_____________________

1As of March 31, 2024, Subordinated Debt is comprised of second lien term loans and/or second lien notes of $84,676, mezzanine debt of $81,113 and $713 of structured debt at fair value and second lien term loans and/or second lien notes of $88,879, mezzanine debt of $86,199 and $3,252 of structured debt at amortized cost.

As of December 31, 2023, Subordinated Debt is comprised of second lien term loans and/or second lien notes of $97,203, mezzanine debt of $83,528 and $2,656 of structured debt at fair value and second lien term loans and/or second lien notes of $100,711, mezzanine debt of $86,495 and $3,247 of structured debt at amortized cost.

The industry composition of our portfolio as a percentage of fair value as of March 31, 2024 and December 31, 2023 was as follows:

54

NUVEEN CHURCHILL DIRECT LENDING CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

(dollar amounts in thousands, except per share data)

Industry	March 31, 2024		December 31, 2023
Aerospace & Defense	3.07	%	3.13	%
Automotive	3.84	%	4.95	%
Banking, Finance, Insurance, Real Estate	3.60	%	3.95	%
Beverage, Food & Tobacco	7.30	%	7.76	%
Capital Equipment	4.62	%	4.21	%
Chemicals, Plastics, & Rubber	1.61	%	2.29	%
Construction & Building	4.50	%	3.90	%
Consumer Goods: Durable	1.05	%	1.51	%
Consumer Goods: Non-durable	3.29	%	3.31	%
Containers, Packaging & Glass	3.89	%	3.97	%
Energy: Electricity	1.61	%	1.75	%
Environmental Industries	3.16	%	2.73	%
Healthcare & Pharmaceuticals	11.91	%	12.72	%
High Tech Industries	10.64	%	8.97	%
Media: Advertising, Printing & Publishing	1.04	%	1.12	%
Media: Diversified & Production	0.87	%	0.96	%
Retail	0.32	%	0.35	%
Services: Business	19.03	%	18.43	%
Services: Consumer	4.98	%	4.86	%
Sovereign & Public Finance	0.76	%	0.65	%
Telecommunications	2.91	%	3.17	%
Transportation: Cargo	3.03	%	3.20	%
Transportation: Consumer	0.70	%	0.13	%
Utilities: Electric	0.81	%	0.89	%
Utilities: Water	0.46	%	—	%
Wholesale	1.00	%	1.09	%
Total	100.00	%	100.00	%

The geographic composition of investments at cost and fair value was as follows:

	March 31, 2024
	Cost	Fair Value	% of Total Investments at Fair Value		Fair Value as % of Net Assets
USA	1,762,869	1,742,508	97.10	%	174.56	%
Canada	38,401	38,391	2.14	%	3.85	%
United Kingdom	13,715	13,660	0.76	%	1.37	%
	1,814,985	1,794,559	100.00	%	179.78	%

	December 31, 2023
	Cost	Fair Value	% of Total Investments at Fair Value		Fair Value as % of Net Assets
USA	1,613,815	1,589,384	96.82	%	212.52	%
Canada	38,462	38,292	2.33	%	5.12	%
United Kingdom	13,892	14,010	0.85	%	1.87	%
	1,666,169	1,641,686	100.00	%	219.51	%

55

NUVEEN CHURCHILL DIRECT LENDING CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

(dollar amounts in thousands, except per share data)

As of March 31, 2024 and December 31, 2023, on a fair value basis, 94.69% and 94.61%, respectively, of the Fund’s debt investments bore interest at a floating rate and 5.31% and 5.39%, respectively, of the Fund’s debt investments bore interest at a fixed rate.

4. FAIR VALUE MEASUREMENTS

Fair Value Disclosures

The following tables present fair value measurements of investments, by major class, and cash equivalents as of March 31, 2024 and December 31, 2023, according to the fair value hierarchy:

As of March 31, 2024	Level 1		Level 2		Level 3		Total
Assets:
First Lien Term Loans	$	—	$	30,955	$	1,565,397	$	1,596,352
Subordinated Debt 1	—		—		166,502		166,502
Equity Investments	—		—		31,705		31,705
Cash Equivalents	52,773		—		—		52,773
Total	$	52,773	$	30,955	$	1,763,604	$	1,847,332

_____________________

1 Subordinated Debt is further comprised of second lien term loans and/or second lien notes of $84,676, mezzanine debt of $81,113 and $713 of structured debt.

As of December 31, 2023	Level 1		Level 2		Level 3		Total
Assets:
First Lien Term Loans	$	—	$	34,481	$	1,393,011	$	1,427,492
Subordinated Debt 1	—		8,691		174,696		183,387
Equity Investments	—		—		30,807		30,807
Cash Equivalents	64,477		—		—		64,477
Total	$	64,477	$	43,172	$	1,598,514	$	1,706,163

_____________________

1 Subordinated Debt is further comprised of second lien term loans and/or second lien notes of $97,203, mezzanine debt of $83,528 and $2,656 of structured debt.

56

NUVEEN CHURCHILL DIRECT LENDING CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

(dollar amounts in thousands, except per share data)

The following tables provide a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the three months ended March 31, 2024 and the year ended December 31, 2023:

	First Lien Term Loans		Subordinated Debt		Equity Investments		Total
Balance as of December 31, 2023	$	1,393,011	$	174,696	$	30,807	$	1,598,514
Purchase of investments	196,582		855		496		197,933
Proceeds from principal repayments and sales of investments	(39,657)		(6,082)		(73)		(45,812)
Payment-in-kind interest	260		1,732		—		1,992
Amortization of premium/accretion of discount, net	833		164		—		997
Net realized gain (loss) on investments	(3,830)		140		—		(3,690)
Net change in unrealized appreciation (depreciation) on investments	8,373		(5,003)		475		3,845
Transfers to Level 3 (1)	9,825		—		—		9,825
Balance as of March 31, 2024	$	1,565,397	$	166,502	$	31,705	$	1,763,604
Net change in unrealized appreciation (depreciation) on non-controlled/non-affiliated company investments still held as of March 31, 2024	$	4,445	$	(5,003)	$	475	$	(83)

_______________

(1)Transfers between levels, if any, are recognized at the beginning of the period in which the transfers occur. For the three months ended March 31, 2024, transfers into Level 3 from Level 2 were a result of changes in the observability of significant inputs for certain portfolio companies.

	First Lien Term Loans		Subordinated Debt		Equity Investments		Total
Balance as of December 31, 2022	$	1,016,856	$	133,243	$	27,313	$	1,177,412
Purchase of investments	513,487		65,296		9,110		587,893
Proceeds from principal repayments and sales of investments	(118,469)		(14,915)		(8,667)		(142,051)
Payment-in-kind interest	221		3,047		—		3,268
Amortization of premium/accretion of discount, net	1,386		426		833		2,645
Net realized gain (loss) on investments	(14,339)		238		6,112		(7,989)
Net change in unrealized appreciation (depreciation) on investments	8,871		(4,191)		(3,894)		786
Transfers out of Level 3 (1)	(23,350)		(8,448)		—		(31,798)
Transfers to Level 3 (1)	8,348		—		—		8,348
Balance as of December 31, 2023	$	1,393,011	$	174,696	$	30,807	$	1,598,514
Net change in unrealized appreciation (depreciation) on non-controlled/non-affiliated company investments still held as of December 31, 2023	$	364	$	(4,167)	$	2,154	$	(1,649)

_______________

(1)Transfers between levels, if any, are recognized at the beginning of the period in which the transfers occur. For the year ended December 31, 2023, transfers into Level 3 from Level 2 were a result of changes in the observability of significant inputs for certain portfolio companies.

57

NUVEEN CHURCHILL DIRECT LENDING CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

(dollar amounts in thousands, except per share data)

Significant Unobservable Inputs

ASC Topic 820 requires disclosure of quantitative information about the significant unobservable inputs used in the valuation of assets and liabilities classified as Level 3 within the fair value hierarchy. The valuation techniques and significant unobservable inputs used in Level 3 fair value measurements of assets as of March 31, 2024 and December 31, 2023 were as follows:

Investment Type	Fair Value at March 31, 2024		Valuation Techniques	Unobservable Inputs	Ranges				Weighted Average
First Lien Term Loans	$	1,400,517	Yield Method	Market Yield Discount Rates	8.58	%	20.85	%	10.80	%
First Lien Term Loans	22,199		Market Approach	EBITDA Multiple	6.50x		13.00x		9.37x
First Lien Term Loans	142,681		Recent Transactions	Transaction Price	99.00		100.69		99.56
Subordinated Debt	151,676		Yield Method	Market Yield Discount Rates	12.18	%	24.91	%	15.30	%
Subordinated Debt	2,326		Black-Scholes	EBITDA Multiple	11.50x		11.50x		11.50x
Subordinated Debt	12,500		Recent Transaction	Transaction Price	100.00		100.00		100.00
Equity	161		Yield Method	Market Yield Discount Rates	8.36	%	8.36	%	8.36	%
Equity	31,066		Market Approach	EBITDA Multiple	5.75x		20.00x		11.32x
Total	$	1,763,126

Equity investments in the amount of $478 at March 31, 2024 have been excluded from the table above as the investments are valued using a recent transaction.

Investment Type	Fair Value at December 31, 2023		Valuation Techniques	Unobservable Inputs	Ranges				Weighted Average
First Lien Term Loans	$	1,192,190	Yield Method	Market Yield Discount Rates	6.13	%	18.73	%	10.63	%
First Lien Term Loans	19,519		Market Approach	EBITDA Multiple	6.50x		9.25x		7.21x
First Lien Term Loans	181,302		Recent Transactions	Transaction Price	59.50		100.00		97.52
Subordinated Debt	162,646		Yield Method	Market Yield Discount Rates	9.70	%	24.91	%	14.44	%
Subordinated Debt	12,050		Recent Transaction	Transaction Price	84.75		98.01		89.53
Equity	158		Yield Method	Market Yield Discount Rates	8.36	%	8.36	%	8.36	%
Equity	29,390		Market Approach	EBITDA Multiple	6.50x		19.50x		10.96x
Equity	2		Market Approach	Blended EBITDA Multiple	13.25x		13.25x		13.25x
				Blended Revenue Multiple	1.40x		1.40x		1.40x
Total	$	1,597,257

Equity investments in the amount of $1,257 at December 31, 2023 have been excluded from the table above as the investments are valued using a recent transaction.

Debt investments are generally valued using a yield analysis. In a yield analysis, a price is ascribed for each investment based upon an assessment of current and expected market yields for similar investments and risk profiles. Additional consideration is given to the expected life, portfolio company performance since close, and other terms and risks associated with an investment. Among other factors, a determinant of risk is the amount of leverage used by the portfolio company relative to its total enterprise value, and the rights and remedies of the Company’s investment within the portfolio company’s capital structure. A recent market trade, if applicable, will also be factored into the valuation.

Equity investments are generally valued using a market approach, which utilizes market value multiples (EBITDA or revenue) of publicly traded comparable companies and available precedent sales transactions of comparable companies. The selected multiple is used to estimate the enterprise value of the underlying investment.

58

NUVEEN CHURCHILL DIRECT LENDING CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

(dollar amounts in thousands, except per share data)

The significant unobservable input used in the yield method is a discount rate based on comparable market yields. Significant increases in discount rates in isolation would result in a significantly lower fair value measurement. The significant unobservable input used in the market approach is the performance multiple, which may include a revenue multiple, EBITDA multiple, or forward-looking metrics. The multiple is used to estimate the enterprise value of the underlying investment. An increase or decrease in the multiple would result in an increase or decrease, respectively, in the fair value. A recent transaction, if applicable, may also be factored into the valuation if the transaction price is believed to be an indicator of value.

Alternative valuation methodologies may be used as deemed appropriate for debt or equity investments, and may include, but are not limited to, a market analysis, income analysis, or liquidation (recovery) analysis.

Weighted average inputs are calculated based on the relative fair value of the investments.

Financial Instruments disclosed but not carried at fair value

The fair value of the Company's credit facilities, which would be categorized as Level 3 within the fair value hierarchy approximates their carrying values. These fair value measurements were based on significant inputs not observable and thus represent Level 3 measurements. The fair value of the 2022 Debt, the 2023 Debt and the 2024 Debt (as defined in Note 6) was based on market quotations(s) received from broker/dealer(s). These fair value measurements were based on quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly and thus represent Level 2 measurements. The carrying value and fair value of the Company’s debt obligations were as follows:

	March 31, 2024				December 31, 2023
	Carrying Value (1)		Fair Value		Carrying Value (1)		Fair Value
Wells Fargo Financing Facility	$	2,500	$	2,500	$	231,000	$	231,000
SMBC Financing Facility	39,000		39,000		37,377		37,377
Revolving Credit Facility	12,000		12,000		126,500		126,500
2022 Debt	342,000		340,307		342,000		338,345
2023 Debt	215,000		217,026		215,000		213,976
2024 Debt	215,000		215,501		—		—
Total	$	825,500	$	826,334	$	951,877	$	947,198

_______________

(1)Carrying value on the consolidated statements of assets and liabilities are net of deferred financing costs.

5. RELATED PARTY TRANSACTIONS

Advisory Agreements

On December 31, 2019, immediately prior to its election to be regulated as a BDC, the Company entered into the investment advisory agreement with the Adviser. The Board, including all of the directors who are not “interested persons” (as defined in the 1940 Act) of the Company (the “Independent Directors”), approved the investment advisory agreement in accordance with, and on the basis of an evaluation satisfactory to such directors as required by, the 1940 Act. On January 29, 2024, the Company entered into an amended and restated investment advisory agreement (the “Advisory Agreement”), which became effective upon the consummation of the IPO on January 29, 2024.

On December 31, 2019, immediately prior to the Company’s election to be regulated as a BDC, the Adviser entered into an investment sub-advisory agreement with Churchill, which was subsequently amended and restated on December 11, 2020, October 7, 2021 and March 8, 2022 (the “CAM Sub-Advisory Agreement”). The Adviser has delegated substantially all of its day-to-day portfolio-management obligations under the Advisory Agreement to Churchill pursuant to the CAM Sub-Advisory Agreement. The Adviser has general oversight over the investment process on behalf of the Company and manages the capital structure of the Company, including, but not limited to, asset and liability management. The Adviser also has ultimate responsibility for the Company’s performance under the terms of the Advisory Agreement. The Adviser retains 32.5% of the management fee and incentive fee payable by the Company. The remaining amount will be paid by the Adviser to Churchill as compensation for services provided by Churchill pursuant to the CAM Sub-Advisory Agreement.

59

NUVEEN CHURCHILL DIRECT LENDING CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

(dollar amounts in thousands, except per share data)

On January 29, 2024, the Adviser and Churchill entered into an investment sub-advisory agreement with Nuveen Asset Management (the “NAM Sub-Advisory Agreement”, and together with the Advisory Agreement and the CAM Sub-Advisory Agreement, the “Advisory Agreements”), pursuant to which Nuveen Asset Management may manage a portion of the Company’s portfolio consisting of cash and cash equivalents, liquid fixed-income securities (including broadly syndicated loans) and other liquid credit instruments (“Liquid Investments”), subject to the pace and amount of investment activity in the middle market investment program. The Company typically refers to an investment as liquid if the investment is, or we expect it to be, actively traded (with a typical settlement period of one month with respect to broadly syndicated loans). The percentage of the Company’s portfolio allocated to the Liquid Investments strategy managed by Nuveen Asset Management will be at the discretion of Churchill. The fees payable to Nuveen Asset Management pursuant to the NAM Sub-Advisory Agreement to manage the Company’s Liquid Investment allocation will be payable by Churchill and will not impact the advisory fees payable by the Company’s shareholders. Churchill will pay Nuveen Asset Management monthly in arrears, 0.375% of the daily weighted average principal amount of the Liquid Investments managed by Nuveen Asset Management pursuant to the NAM Sub-Advisory Agreement. The fees payable to Nuveen Asset Management pursuant to the NAM Sub-Advisory Agreement will not impact the advisory fees payable by the Company's shareholders.

Advisory agreements remain in effect for an initial period of two years and will remain in effect on a year-to-year basis thereafter if approved annually either by the Board or by the affirmative vote of the holders of a majority of our outstanding voting securities and, in each case, a majority of our Independent Directors. On October 27, 2023, the Board, including all of the Independent Directors, approved the Advisory Agreement and the NAM Sub-Advisory Agreement in accordance with, and on the basis of an evaluation satisfactory to such directors as required by, the 1940 Act for an initial two-year term expiring on January 29, 2026. In addition, on October 27, 2023, the Board, including all of the Independent Directors, approved the renewal of the CAM Sub-Advisory Agreement in accordance with, and on the basis of an evaluation satisfactory to such directors as required by, the 1940 Act for an additional one-year term expiring on December 31, 2024. Each Advisory Agreement will automatically terminate in the event of its assignment, as defined in the 1940 Act, by the applicable investment adviser and may be terminated by either the Company or the applicable investment adviser without penalty upon not less than 60 days’ written notice to the other. The holders of a majority of our outstanding voting securities may also terminate any of the Advisory Agreements without penalty.

Compensation of the Adviser - Management Fee

Under the Advisory Agreement, for the first five quarters beginning with the calendar quarter in which the IPO was consummated (i.e., beginning with the calendar quarter ended March 31, 2024 through the calendar quarter ending March 31, 2025), the management fee is calculated at an annual rate of 0.75% of average total assets, excluding cash and cash equivalents and including assets financed using leverage (“Average Total Assets”), at the end of the two most recently completed calendar quarters, and thereafter, the management fee will step up to 1.00% of Average Total Assets. For purposes of this calculation, cash and cash equivalents include any temporary investments in cash-equivalents, U.S. government securities and other high quality investment grade debt investments that mature in 12 months or less from the date of investment. Any management fees will be payable quarterly in arrears.

Compensation of the Adviser - Incentive Fee

Under the Advisory Agreement, the Adviser is waiving the incentive fee on income and incentive fee on capital gains for the first five quarters beginning with the calendar quarter in which the IPO was consummated (i.e., beginning with the calendar quarter ended March 31, 2024 through the calendar quarter ending March 31, 2025). Following the expiration of the fee waiver, the Company will pay an incentive fee to the Adviser that will consist of two parts. The incentive fees will be based on income and capital gains, each as described below. The portion of the incentive fee based on income will be calculated, subject to a cap (the “Incentive Fee Cap”), and payable quarterly in arrears based on pre-incentive fee net investment income in respect of the current calendar quarter and the eleven preceding calendar quarters (or, if fewer, the number of calendar quarters beginning with the calendar quarter in which the IPO was consummated) (such period, the “Trailing Twelve Quarters”) commencing from the beginning of the calendar quarter in which the IPO was consummated, as follows:

•no incentive fee in any calendar quarter in which the aggregate pre-incentive fee net investment income (as defined below) in respect of the Trailing Twelve Quarters does not exceed the hurdle rate of 1.50% (6% annually) for such Trailing Twelve Quarters;

60

NUVEEN CHURCHILL DIRECT LENDING CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

(dollar amounts in thousands, except per share data)

•100% of our aggregate pre-incentive fee net investment income in respect of the Trailing Twelve Quarters with respect to that portion of such pre-incentive fee net investment income, if any, that exceeds the hurdle rate but is less than 1.7647% in any calendar quarter following the consummation of the IPO. The Company refers to this portion of the pre-incentive fee net investment income as the “catch-up” provision. The catch-up is meant to provide the Adviser with 15% of the pre-incentive fee net investment income as if a hurdle rate did not apply if this net investment income exceeds 1.7647% multiplied by our NAV at the beginning of each applicable calendar quarter comprising of the relevant Trailing Twelve Quarters; and

•15% of the aggregate pre-incentive fee net investment income, if any, in respect of the Trailing Twelve Quarters that exceeds 1.7647%.

Under the Advisory Agreement, following the expiration of the fee waiver, the incentive fee on income for a particular quarter will be subject to the Incentive Fee Cap. The Incentive Fee Cap will be equal to the difference between (x) 15% of the Cumulative Pre-Incentive Fee Net Return (as defined below) over the Trailing Twelve Quarters and (y) the aggregate incentive fee on income that was paid to the Adviser by the Company in respect of the first eleven calendar quarters (or, if fewer, the number of calendar quarters beginning with the calendar quarter in which the IPO was consummated) included in the relevant Trailing Twelve Quarters. These calculations will be adjusted for any share issuances or repurchases during the applicable calendar quarter.

“Cumulative Pre-Incentive Fee Net Return” during the relevant Trailing Twelve Quarters, beginning with the calendar quarter in which the IPO was consummated, means (x) the pre-incentive fee net investment income in respect of the relevant Trailing Twelve Quarters less (y) any Net Capital Loss (as defined below), if any, in respect of the relevant Trailing Twelve Quarters. If, in any quarter, the Incentive Fee Cap is zero or a negative value, the Company will pay no incentive fee on income to the Adviser in respect of that quarter. If, in any quarter, the Incentive Fee Cap for such quarter is a positive value but is less than the incentive fee on income that is payable to the Adviser for such quarter calculated as described above, the Company will pay an incentive fee on income to the Adviser equal to the Incentive Fee Cap in respect of such quarter. If, in any quarter, the Incentive Fee Cap for such quarter is equal to or greater than the incentive fee on income that is payable to the Adviser for such quarter calculated as described above, the Company will pay an incentive fee on income to the Adviser equal to the incentive fee calculated as described above for such quarter without regard to the Incentive Fee Cap.

“Net Capital Loss” in respect of a particular period, beginning with the calendar quarter in which the IPO was consummated, means the difference, if positive, between (i) aggregate capital losses, whether realized or unrealized, in respect of such period and (ii) aggregate capital gains, whether realized or unrealized, in respect of such period.

Pre-incentive fee net investment income means interest income, dividend income and any other income (including any other fees such as commitment, origination, structuring, diligence and consulting fees or other fees that the Company receives from portfolio companies but excluding fees for providing managerial assistance) accrued during the relevant calendar quarters, minus operating expenses for the relevant calendar quarters (including the management fee, any expenses payable under the Administration Agreement (as defined below), interest expense and dividends paid on any outstanding preferred shares, but excluding the incentive fee). Pre-incentive fee net investment income will include, in the case of investments with a deferred interest feature such as market discount, debt instruments with PIK interest, preferred shares with PIK dividends and zero-coupon securities, accrued income that the Company has not yet received in cash. The Adviser is not under any obligation to reimburse the Company for any part of the incentive fee it received that was based on accrued interest that the Company never received. Pre-incentive fee net investment income will not include any realized capital gains, realized capital losses or unrealized capital gains or losses. If any distributions from portfolio companies are characterized as a return of capital, such returns of capital would affect the capital gains incentive fee to the extent a gain or loss is realized.

Under the Advisory Agreement, following the expiration of the fee waiver, the second part of the incentive fee will be a capital gains incentive fee that will be determined and payable in arrears as of the end of each fiscal year (or upon termination of the Advisory Agreement, as of the termination date), and equals 15.0% of our realized capital gains as of the end of the fiscal year following the IPO. In no event will the capital gains incentive fee payable pursuant to the Advisory Agreement be in excess of the amount permitted by the Advisers Act, including Section 205 thereof.

61

NUVEEN CHURCHILL DIRECT LENDING CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

(dollar amounts in thousands, except per share data)

In determining the capital gains incentive fee payable to the Adviser, the Company will calculate the cumulative aggregate realized capital gains and cumulative aggregate realized capital losses beginning with the calendar quarter in which the IPO was consummated, and the aggregate unrealized capital depreciation as of the date of the calculation, as applicable, with respect to each of the investments in our portfolio. For this purpose, cumulative aggregate realized capital gains, if any, equals the sum of the differences between the net sales price of each investment, when sold, and the amortized cost of such investment. Cumulative aggregate realized capital losses equals the sum of the amounts by which the net sales price of each investment, when sold, is less than the amortized cost of such investment beginning with the calendar quarter in which this offering is consummated. Aggregate unrealized capital depreciation equals the sum of the difference, if negative, between the valuation of each investment as of the applicable calculation date and the amortized cost of such investment. At the end of the applicable year, the amount of capital gains that will serve as the basis for the calculation of the capital gains incentive fee equals the cumulative aggregate realized capital gains less cumulative aggregate realized capital losses, less aggregate unrealized capital depreciation, with respect to our portfolio of investments.

For the three months ended March 31, 2024 and 2023 base management fees were $3,264 and $2,306, respectively. As of March 31, 2024 and December 31, 2023, $3,264 and $3,006, respectively, of such base management fees, were unpaid and are included in management fees payable in the accompanying consolidated statements of assets and liabilities. As of March 31, 2024, income based incentive fees of $4,459, were waived in accordance with the terms of the Advisory Agreement. As of March 31, 2024, no amounts were payable to the Adviser related to income based incentive fees. As of December 31, 2023, the Adviser was not entitled to any incentive fees under the Advisory Agreement.

Administration Agreement

On December 31, 2019, the Company entered into an administration agreement (the "Administration Agreement"), which was approved by the Board. Pursuant to the Administration Agreement, the Administrator furnishes the Company with office facilities and equipment and provides clerical, bookkeeping and record keeping and other administrative services at such facilities. The Administrator performs, or oversees the performance of, the required administrative services, which include, among other things, assisting the Company with the preparation of the financial records that the Company is required to maintain and with the preparation of reports to shareholders and reports filed with the SEC. At the request of the Adviser or Churchill, the Administrator also may provide significant managerial assistance on the Company’s behalf to those portfolio companies that have accepted the Company’s offer to provide such assistance. U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), provides the Company with certain fund administration and bookkeeping services pursuant to a sub-administration agreement with the Administrator.

For the three months ended March 31, 2024 and 2023 the Company incurred $542 and $309, respectively, in fees under the Administration Agreement, which are included in administration fees in the accompanying consolidated statements of operations. As of March 31, 2024 and December 31, 2023, fees of $961 and $505, respectively, were unpaid and included in accounts payable and accrued expenses in the accompanying consolidated statements of assets and liabilities.

Expense Support Agreement

On December 31, 2019, the Company entered into an expense support and conditional reimbursement agreement (the “Expense Support Agreement”) with the Adviser. The Expense Support Agreement automatically terminated pursuant to its terms upon the consummation of the IPO on January 29, 2024. Under the Expense Support Agreement, the Adviser was able to pay certain expenses of the Company, provided that no portion of the payment was used to pay any interest expense of the Company (each, an “Expense Payment”). Such Expense Payment was made in any combination of cash or other immediately available funds no later than forty-five days after a written commitment from the Adviser to pay such expense, and/or by an offset against amounts due from the Company to the Adviser or its affiliates. The cumulative amount of expense payments by the Adviser under the Expense Support Agreement was $2,979, of which $1,101 was reimbursed by the Company prior to the termination of the Expense Support Agreement.

Directors' Fees

The Board consists of seven members, five of whom are Independent Directors. The Board established an Audit Committee, a Nominating and Corporate Governance Committee, a Compensation Committee, and a Special Transactions Committee, each consisting solely of the Independent Directors, and may establish additional committees in the future. For the three months ended March 31, 2024 and 2023 the Company incurred $128 and $96 respectively, in fees which are included in Directors’ fees in the accompanying consolidated statements of operations. As of March 31, 2024 and December 31, 2023, $128 and $96, respectively, were unpaid and are included in Directors’ fees payable in the accompanying consolidated statements of assets and liabilities.

62

NUVEEN CHURCHILL DIRECT LENDING CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

(dollar amounts in thousands, except per share data)

Other Related Party Transactions

From time to time, Churchill, in its capacity as sub-adviser, and the Administrator may pay amounts owed by the Company to third-party providers of goods or services and the Company will subsequently reimburse Churchill and Administrator for such amounts paid on its behalf. Amounts payable to Churchill and Administrator are settled in the normal course of business without formal payment terms. As of March 31, 2024 and December 31, 2023, the Company owed Churchill and the Administrator $904 and $353 for reimbursements including the Company's allocable portion of overhead, which are included in accounts payable and accrued expenses in the accompanying consolidated statements of assets and liabilities.

6. SECURED BORROWINGS

The Company, CLO-I, CLO-II, CLO-III, SPV IV and SPV V are party to credit facilities or debt obligations as described below. In accordance with the 1940 Act, the Company is currently only allowed to borrow amounts such that its asset coverage, as defined in the 1940 Act, is maintained at a level of at least 150% after such borrowings. As of March 31, 2024 and December 31, 2023, asset coverage was 220.92% and 178.57%, respectively. Proceeds of the credit facilities or debt obligations are used for general corporate purposes, including the funding of portfolio investments. The Company, CLO-I, CLO-II, CLO-III, SPV IV and SPV V were in compliance with all covenants and other requirements of their respective agreements.

Subscription Facility

On September 10, 2020, the Company entered into a revolving credit agreement (the “Subscription Facility Agreement” and the facility thereunder, the “Subscription Facility”) with Sumitomo Mitsui Banking Corporation (“SMBC”), as the administrative agent for certain secured parties, the syndication agent, the lead arranger, the book manager, the letter of credit issuer and the lender. The Subscription Facility had a maximum commitment of $50,000, subject to availability under the "Borrowing Base." The Borrowing Base was calculated based on the unfunded capital commitments of certain investors that had subscribed to purchase shares of the Company, to the extent the capital commitments of such investors also had been approved by SMBC for inclusion in the Borrowing base and met certain additional criteria. The Subscription Facility Agreement expired on September 8, 2023, and the Company fully paid down the outstanding balance including the accrued interest expense.

Wells Fargo Financing Facility

On December 31, 2019, a wholly owned subsidiary of the Company entered into a credit agreement ("the “Wells Fargo Financing Facility” and the agreement relating thereto, as amended from time to time, the “Wells Fargo Financing Facility Agreement”), with Wells Fargo Bank, N.A. as lender (“Wells Fargo”) and administrative agent. The Wells Fargo Financing Facility Agreement was amended on October 28, 2020, March 31, 2022 and March 14, 2024. The most recent amendment on March 14, 2024, among other things: (i) added SPV V as a party to the facility and (ii) decreased the maximum facility amount available from $275,000 to $150,000, which facility amount may be increased, with the consent of the administrative agent and each applicable lender, to up to $250,000 during the reinvestment period.

The Wells Fargo Financing Facility reinvestment period expires on March 31, 2025 and has a maturity date of March 31, 2027. The Wells Fargo Financing Facility Agreement also requires the Company to maintain an asset coverage ratio equal to at least 1.50:1.00. The amount of the borrowings under the Wells Fargo Financing Facility equals the amount of the outstanding advances. Advances under the Wells Fargo Financing Facility may be prepaid and reborrowed at any time during the reinvestment period, but any termination or reduction of the facility amount prior to the first anniversary of the date of the amendment (subject to certain exceptions) is subject to a commitment reduction fee of 1%. Under the Wells Fargo Financing Facility Agreement, the Company pays a fee on daily undrawn amounts under the Wells Fargo Financing Facility of 0.25% per annum during the period ending June 14, 2024, 0.50% per annum for the next six months and thereafter, 0.50% per annum on undrawn amounts of up to 40% of the maximum facility amount and 1.50% per annum on undrawn amounts in excess of 40% of the maximum facility amount.

As of March 31, 2024 and December 31, 2023, the Wells Fargo Financing Facility bore interest at a rate of SOFR, reset daily plus 2.20%, per annum.

SPV V, beginning March 14, 2024, has pledged all of its assets to the collateral agent to secure their obligations under the Wells Fargo Financing Facility. The Company and SPV V have made customary representations and warranties and are required to comply with various financial covenants related to liquidity and other maintenance covenants, reporting requirements and other customary requirements for similar facilities.

63

NUVEEN CHURCHILL DIRECT LENDING CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

(dollar amounts in thousands, except per share data)

SMBC Financing Facility

On November 24, 2020, a wholly owned subsidiary of the Company entered into a senior secured revolving credit facility (the “SMBC Financing Facility” and the agreement relating thereto the “SMBC Financing Facility Agreement”) with SMBC, as the administrative agent, the collateral agent and the lender. On October 19, 2023, SPV IV entered into the borrower joinder agreement (the “SMBC Joinder”) to become party to the SMBC Financing Facility Agreement.

The SMBC Financing Facility Agreement was amended on December 23, 2021, June 29, 2022 and November 21, 2023. The most recent amendment on November 21, 2023 (the "SMBC Financing Facility Amendment"), among other things: (i) extended the reinvestment period from November 24, 2023 to November 24, 2024 and the stated maturity date from November 24, 2025 to November 24, 2026; (ii) changed the interest rate for loans under the SMBC Financing Facility Agreement from (A) either the Base Rate (as defined in the SMBC Financing Facility Agreement) plus 1.15% or the Term SOFR (as defined in the SMBC Financing Facility Agreement) plus 2.15% to (B) either the Base Rate plus 1.65% or Term SOFR plus 2.65%; (iii) reduced the maximum facility amount from $300,000 to $150,000 upon the occurrence of a permitted securitization, subject to a subsequent increase to $250,000, in the sole discretion of the administrative agent, if so requested by the borrowers; and (iv) provide for an unused commitment fee of, from the three month anniversary of the SMBC Financing Facility Amendment date to the six month anniversary of the SMBC Financing Facility Amendment date, 0.50% per annum on the unused commitments and on or after the six month anniversary of the Amendment date, 0.50% per annum on the unused commitments if such unused commitments are less than 50% of the total commitments and 1.00% per annum on the unused commitments if such unused commitments are greater than or equal to 50% of the total commitments. In connection with the SMBC Financing Facility Amendment, the borrowers paid an extension fee of $450 plus an annualized fee of 0.30% multiplied by $150,000 based on the length of time (in years) until the occurrence of a permitted securitization. Advances under the SMBC Financing Facility Agreement may be prepaid and reborrowed at any time during the reinvestment period. As of March 31, 2024 and December 31, 2023, the SMBC Financing Facility bore interest at one-month SOFR plus 2.65% per annum.

Effective December 7, 2023, following the closing of the 2023 Debt Securitization (discussed further below), the maximum facility amount available was reduced to $150,000 from $300,000 and SPV IV began borrowing under the SMBC Financing Facility.

SPV IV, beginning October 19, 2023, has pledged all of its assets to the collateral agent to secure their obligations under the SMBC Financing Facility. The Company, and SPV IV have made customary representations and warranties and are required to comply with various financial covenants related to liquidity and other maintenance covenants, reporting requirements and other customary requirements for similar facilities.

Revolving Credit Facility

On June 23, 2023, the Company entered into a senior secured revolving credit agreement (the “Senior Secured Revolving Credit Agreement" and facility thereunder, the “Revolving Credit Facility”) with SMBC as the lender, administrative agent, and one of the lead arrangers along with Wells Fargo. The Revolving Credit Facility is guaranteed by NCDL Equity Holdings and will be guaranteed by certain subsidiaries of the Company that are formed or acquired by the Company in the future (collectively, the “Guarantors”).

The initial maximum principal amount of the Revolving Credit Facility is $185,000, subject to availability under the borrowing base, which is based on the Company’s portfolio investments and other outstanding indebtedness. Maximum capacity under the Revolving Credit Facility may be increased to $300,000 through the exercise by the Company of an uncommitted accordion feature through which existing and new lenders may, at their option, agree to provide additional financing. The Revolving Credit Facility is secured by a perfected first-priority interest in substantially all of the portfolio investments held by the Company and each Guarantor, subject to certain exceptions, and includes a $25,000 limit for swingline loans.

The availability period under the Revolving Credit Facility will terminate on June 23, 2027 (the “Commitment Termination Date”) and will mature on June 23, 2028 (the “Final Maturity Date”). During the period from the Commitment Termination Date to the Final Maturity Date, the Company will be obligated to make mandatory prepayments out of the proceeds of certain asset sales and other recovery events and equity and debt issuances.

The Company may borrow amounts in U.S. dollars or certain other permitted currencies. Amounts drawn in U.S. dollars will bear interest at either term SOFR plus a margin, or the prime rate plus a margin. The Company may elect either the term SOFR or prime rate at the time of drawdown, and loans denominated in U.S. dollars may be converted from one rate to another at any time at the Company’s option, subject to certain conditions. Amounts drawn in other permitted currencies will bear interest at the relevant rate specified therein plus an applicable margin. The Company also will pay a fee of 0.375% on average daily undrawn amounts. As of March 31, 2024 and December 31, 2023, the Revolving Credit Facility bore interest at one-month SOFR plus 2.25% per annum.

64

NUVEEN CHURCHILL DIRECT LENDING CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

(dollar amounts in thousands, except per share data)

The Senior Secured Revolving Credit Agreement includes customary covenants, including certain limitations on the incurrence by the Company of additional indebtedness and on the Company’s ability to make distributions to its shareholders, or redeem, repurchase or retire shares of stock, upon the occurrence of certain events and certain financial covenants related to asset coverage and minimum shareholders’ equity, as well as customary events of default.

CLO-I

On May 20, 2022 (the “Closing Date”), the Company completed a $448,325 term debt securitization (the “2022 Debt Securitization”). Term debt securitization is also known as a collateralized loan obligation and is a form of secured financing incurred by the Company.

The notes offered in the 2022 Debt Securitization (the “2022 Notes”) were issued by CLO-I, an indirect, wholly owned, consolidated subsidiary of the Company. The 2022 Notes consist of $199,000 of AAA Class A-1 2022 Notes, which bear interest at the three-month Term SOFR plus 1.80%; $34,250 of AAA Class A-1F 2022 Notes, which bear interest at 4.42%; $47,250 of AA Class B 2022 Notes, which bear interest at the three-month Term SOFR plus 2.30%; $31,500 of A Class C 2022 Notes, which bear interest at the three-month Term SOFR plus 3.15%; $27,000 of BBB Class D 2022 Notes, which bear interest at the three-month Term SOFR plus 4.15%; and $79,325 of Subordinated 2022 Notes, which do not bear interest. The Company directly owns all of the BBB Class D 2022 Notes and the Subordinated 2022 Notes and, as such, these notes are eliminated in consolidation.

As part of the 2022 Debt Securitization, CLO-I also entered into a loan agreement (the “CLO-I Loan Agreement”) on the Closing Date, pursuant to which various financial institutions and other persons which are, or may become, parties to the CLO-I Loan Agreement as lenders (the “Lenders”) committed to make $30,000 of AAA Class A-L 2022 Loans to CLO-I (the “2022 Loans” and, together with the 2022 Notes, the “2022 Debt”). The 2022 Loans bear interest at the three-month Term SOFR plus 1.80% and were fully drawn upon the closing of the transactions. Any Lender may elect to convert all of the Class A-L 2022 Loans held by such Lenders into Class A-1 2022 Notes upon written notice to CLO-I in accordance with the CLO-I Loan Agreement.

The 2022 Debt is backed by a diversified portfolio of senior secured and second lien loans. Through April 20, 2026, all principal collections received on the underlying collateral may be used by CLO-I to purchase new collateral under the direction of the Company, in its capacity as collateral manager of CLO-I and in accordance with the Company’s investment strategy, allowing the Company to maintain the initial leverage in the 2022 Debt Securitization. The 2022 Notes are due on April 20, 2034. The 2022 Loans are scheduled to mature, and, unless earlier repaid, the entire unpaid principal balance thereof is due and payable on April 20, 2034.

The 2022 Debt is the secured obligation of CLO-I, and the indenture and the CLO-I Loan Agreement, as applicable, governing the 2022 Debt includes customary covenants and events of default. The 2022 Debt has not been, and will not be, registered under the Securities Act, or any state “blue sky” laws.

The Company serves as collateral manager to CLO-I under a collateral management agreement (the “Collateral Management Agreement”) and has waived the management fee due to it in consideration for providing these services.

CLO-II

On December 7, 2023 (the “Closing Date”), the Company completed a $298,060 term debt securitization (the “2023 Debt Securitization”).

The notes offered in the 2023 Debt Securitization (the “2023 Notes”) were issued by CLO-II, an indirect, wholly owned, consolidated subsidiary of the Company. The 2023 Notes consist of $2,000 of AAA Class X 2023 Notes, which bear interest at the three-month Term SOFR plus 2.00%, $100,500 of AAA Class A-1 2023 Notes, which bear interest at the three-month Term SOFR plus 2.35%; $37,500 of AA Class B 2023 Notes, which bear interest at three-month Term SOFR plus 3.20% and approximately $83,060 of Subordinated 2023 Notes, which do not bear interest. The Company directly owns all of the Subordinated 2023 Notes and as such, these notes are eliminated in consolidation.

As part of the 2023 Debt Securitization, CLO-II also entered into a loan agreement (the “CLO-II Loan Agreement”) on the Closing Date, pursuant to which various financial institutions and other persons which are, or may become, parties to the CLO-II Loan Agreement as lenders (the “Lenders”) committed to make $25,000 of AAA Class A-L-A 2023 Loans and $50,000 AAA Class A-L-B 2023 Loans to CLO-II (the “2023 Loans” and, together with the 2023 Notes, the “2023 Debt”). The 2023 Loans bear interest at the three-month Term SOFR plus 2.35% and were fully drawn upon the closing of the transactions. Any Lender may elect to convert all or a portion of the Class A-L-A 2023 Loans held by such Lenders into Class A-1 2023 Notes upon written notice to CLO-II in accordance with the CLO-II Loan Agreement.

The 2023 Debt is backed by a diversified portfolio of senior secured and second lien loans. Through January 20, 2028, all principal collections received on the underlying collateral may be used by CLO-II to purchase new collateral under the direction of the

65

NUVEEN CHURCHILL DIRECT LENDING CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

(dollar amounts in thousands, except per share data)

Company, in its capacity as collateral manager of CLO-II and in accordance with the Company’s investment strategy, allowing the Company to maintain the initial leverage in the 2023 Debt Securitization. The 2023 Notes are due on January 20, 2036. The 2023 Loans are scheduled to mature, and, unless earlier repaid, the entire unpaid principal balance thereof is due and payable on January 20, 2036.

The 2023 Debt is the secured obligation of CLO-II, and the indenture and the CLO-II Loan Agreement, as applicable, governing the 2023 Debt includes customary covenants and events of default. The 2023 Debt has not been, and will not be, registered under the Securities Act, or any state “blue sky” laws.

The Company serves as collateral manager to CLO-II under a collateral management agreement (the “Collateral Management Agreement”) and has waived the management fee due to it in consideration for providing these services.

CLO-III

On March 14, 2024 (the “Closing Date”), the Company completed a $296,970 term debt securitization (the “2024 Debt Securitization”).

The notes offered in the 2024 Debt Securitization (the “2024 Notes” or “2024 Debt”) were issued by Churchill NCDLC CLO-III, LLC (formerly known as Nuveen Churchill BDC SPV III, LLC) (the “2024 Issuer”), a direct, wholly owned, consolidated subsidiary of the Company, pursuant to an indenture (the “Indenture”) dated as of the Closing Date. The 2024 Notes consist of $2,000 of AAA Class X 2024 Notes, which bear interest at the three-month Term SOFR plus 1.40%; $175,500 of AAA Class A 2024 Notes, which bear interest at the three-month Term SOFR plus 2.00%; $37,500 of AA Class B 2024 Notes, which bear interest at the three-month Term SOFR plus 2.65%; and $81,970 of Subordinated 2024 Notes, which do not bear interest. The Company directly retained all of the Subordinated 2024 Notes and as such, these notes are eliminated in consolidation.

The 2024 Notes are backed by a diversified portfolio of senior secured and second lien loans. The Indenture contains certain

conditions pursuant to which loans can be acquired by the 2024 Issuer, in accordance with rating agency criteria or as otherwise agreed with certain institutional investors who purchased the 2024 Notes. Through April 20, 2028, all principal collections received on the underlying collateral may be used by the 2024 Issuer to purchase new collateral under the direction of the Company, in its capacity as collateral manager of the 2024 Issuer and in accordance with the Company’s investment strategy, allowing the Company to maintain the initial leverage in the 2024 Debt Securitization. The 2024 Notes are due on April 20, 2036.

The 2024 Notes are the secured obligation of the 2024 Issuer, and the Indenture governing the 2024 Notes includes customary covenants and events of default. The 2024 Notes have not been, and will not be, registered under the Securities Act of 1933, as amended, or any state “blue sky” laws and may not be offered or sold in the United States absent registration with the Securities and Exchange Commission or applicable exemption from registration.

The Company serves as collateral manager to the 2024 Issuer under a collateral management agreement (the “Collateral Management Agreement”) and has waived any management fee due to it in consideration for providing these services.

Summary of Secured Borrowings

The Company's debt obligations consisted of the following as of March 31, 2024 and December 31, 2023:

	March 31, 2024
	Wells Fargo Financing Facility		SMBC Financing Facility		CLO-I		CLO-II		CLO-III		Revolving Credit Facility		Total
Total Commitment	$	150,000	$	150,000	$	342,000	$	215,000	$	215,000	$	185,000	$	1,257,000
Amount Outstanding (1)	2,500		39,000		342,000		215,000		215,000		12,000		825,500
Unused Portion (2)	147,500		111,000		—		—		—		173,000		431,500
Amount Available (3)	147,500		111,000		—		—		—		173,000		431,500

_______________

(1)Amount outstanding on the consolidated statements of assets and liabilities is net of deferred financing costs.

(2)The unused portion on the credit facilities is the amount upon which commitment fees are based.

(3)Available for borrowing on the credit facilities based on the computation of collateral to support the borrowings and subject to compliance with applicable covenants and financial ratios.

66

NUVEEN CHURCHILL DIRECT LENDING CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

(dollar amounts in thousands, except per share data)

	December 31, 2023
	Wells Fargo Financing Facility		SMBC Financing Facility		CLO -I		CLO-II		Revolving Credit Facility		Total
Total Commitment	$	275,000	$	150,000	$	342,000	$	215,000	$	185,000	$	1,167,000
Amount Outstanding (1)	231,000		37,377		342,000		215,000		126,500		951,877
Unused Portion (2)	44,000		112,623		—		—		58,500		215,123
Amount Available (3)	43,837		112,623		—		—		58,500		214,960

_______________

(1)Amount outstanding on the consolidated statements of assets and liabilities is net of deferred financing costs.

(2)The unused portion on the credit facilities is the amount upon which commitment fees are based.

(3)Available for borrowing on the credit facilities based on the computation of collateral to support the borrowings and subject to compliance with applicable covenants and financial ratios.

For the three months ended March 31, 2024 and 2023, the components of interest expense and debt financing expenses were as follows:

	Three Months Ended March 31,
	2024			2023
Interest expense	$	15,337		$	12,041
Unused fees	308			267
Amortization of deferred financing costs	1,296			435
Total interest and debt financing expenses	$	16,941		$	12,743
Average interest rate (1)	7.65		%	6.76		%
Average daily borrowings	$	819,927		$	738,069

_______________

(1)Average interest rate includes borrowing interest expense and unused fees.

Contractual Obligations

The following tables show the contractual maturities of the Company's debt obligations as of March 31, 2024 and December 31, 2023:

	Payments Due by Period
As of March 31, 2024	Total		Less than 1 Year		1 to 3 years		3 to 5 years		More than 5 Years
Wells Fargo Financing Facility	$	2,500	$	—	$	2,500	$	—	$	—
SMBC Financing Facility	39,000		—		39,000		—		—
Revolving Credit Facility	12,000		—		—		12,000		—
CLO-I	342,000		—		—		—		342,000
CLO-II	215,000		—		—		—		215,000
CLO-III	215,000		—		—		—		215,000
Total debt obligations	$	825,500	$	—	$	41,500	$	12,000	$	772,000

	Payments Due by Period
As of December 31, 2023	Total		Less than 1 Year		1 to 3 years		3 to 5 years		More than 5 Years
Wells Fargo Financing Facility	$	231,000	$	—	$	—	$	231,000	$	—
SMBC Financing Facility	37,377		—		37,377		—		—
Revolving Credit Facility	126,500		—		—		126,500		—
CLO-I	342,000		—		—		—		342,000
CLO-II	215,000		—		—		—		215,000
Total debt obligations	$	951,877	$	—	$	37,377	$	357,500	$	557,000

67

NUVEEN CHURCHILL DIRECT LENDING CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

(dollar amounts in thousands, except per share data)

7. COMMITMENTS AND CONTINGENCIES

In the ordinary course of its business, the Company enters into contracts or agreements that contain indemnifications or warranties. Future events could occur that might lead to the enforcement of these provisions against the Company. The Company believes that the likelihood of such an event is remote; however, the maximum potential exposure is unknown. No accrual has been made in the consolidated financial statements as of March 31, 2024 and December 31, 2023 for any such exposure.

As of March 31, 2024 and December 31, 2023, the Company had the following unfunded commitments to fund delayed draw loans and equity investments:

Portfolio Company	March 31, 2024		December 31, 2023
360 Training	$	3,094	$	—
Allstar Holdings	7,373		7,373
Alternative Logistics Technologies Buyer, LLC	3,040		—
Anne Arundel	366		366
Apex Companies	1,002		1,115
Aramsco	297		—
ARMstrong	3,847		3,847
ASTP Holdings Co-Investment LP	107		34
Bounteous	—		4,467
BusinesSolver	873		970
Chroma Color	1,379		1,379
ClaimLogiq	3,225		3,225
Classic Collision	16,107		21,867
CMP Ren Partners I-A LP	15		15
Contract Land Staff	3,025		—
Covercraft	4,386		4,386
Crete	148		1,443
CrossCountry Consulting	3,320		3,320
D&H United Fueling Solutions	1,393		1,567
DMC Power	1,671		1,671
E78	2,570		2,570
Elevation Labs	2,188		3,125
Eliassen Group, LLC	1,903		1,903
Engage	8,113		8,113
Ergotech (INS)	1,979		1,979
Evergreen Services Group II	1,122		4,488
EyeSouth	885		885
Fairway Lawns	—		419
Health Management Associates	1,026		1,026
Heartland Veterinary Partners	3,600		—
High Bar Brands	596		596
Image First	143		—
Impact Environmental Group	4,093		7,203
Infobase	—		721
ITSavvy	158		158
Kenco	1,416		1,416
Legacy Service Partners	—		764
Leo Facilities	5,314		6,429
Liberty Group	449		449
Market Performance Group	3,086		—
MEI Buyer LLC	1,814		1,814
MGM Transformer Company	6,388		6,388
Mobile Communications America Inc	5,970		5,970
Mosaic Dental	254		553
National Power	3,051		3,051

68

NUVEEN CHURCHILL DIRECT LENDING CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

(dollar amounts in thousands, except per share data)

Portfolio Company	March 31, 2024		December 31, 2023
NearU	3,291		3,291
NJEye, LLC	489		489
North Haven Spartan US Holdco LLC	3,260		—
Online Labels Group	807		807
Ovation Holdings	343		343
Palmetto Exterminators	109		652
Pinnacle Supply Partners, LLC	3,636		3,636
Precision Aviation Group	4,961		4,961
Propark Mobility	1,797		1,797
Randy's Worldwide Automotive	3,300		3,750
Repipe Specialists	691		691
Rhino Tool House	36		921
Riveron	1,607		1,607
RMA Companies	3,134		3,510
RoadOne	1,397		1,397
RoadOne- Common	—		235
S&S Truck Parts	246		246
Sciens Building Solutions, LLC	1,623		1,623
Sunny Sky Products	1,773		1,773
Tech24	3,550		3,655
Technical Safety Services	2,343		2,429
Tencate	1,540		—
The Facilities Group	4,861		5,028
TIDI Products	4,085		4,085
TPC Wire & Cable Corp	1,715		—
Trilon Group	1,875		4,407
USA Water	3,037		—
Velosio	1,284		—
Watermill Express	2,734		—
Wellspring	3,756		3,756
Wpromote	588		588
WSB / EST	1,307		4,357
Young Innovations	3,448		3,448
Total unfunded commitments	$	179,409	$	180,547

The Company seeks to carefully consider its unfunded portfolio company commitments for the purpose of planning its ongoing financial leverage. Further, the Company considers any outstanding unfunded portfolio company commitments it is required to fund within the 150% asset coverage limitation. As of March 31, 2024, the Company believed it had adequate financial resources to satisfy the unfunded portfolio company commitments.

69

NUVEEN CHURCHILL DIRECT LENDING CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

(dollar amounts in thousands, except per share data)

8. NET ASSETS

The Company has the authority to issue 500,000,000 shares of common stock, par value $0.01 per share.

IPO and Private Offerings

On January 29, 2024, the Company closed its IPO, issuing 5,500,000 shares of its common stock at a public offering price of $18.05 per share. The Company received total cash proceeds of $99,275. The Company's common stock began trading on the NYSE under the symbol “NCDL” on January 25, 2024.

Prior to April 28, 2023, in connection with the Private Offerings, the Company entered into subscription agreements (“Subscription Agreements”) with investors, pursuant to which investors were required to fund drawdowns to purchase the Company's shares of common stock up to the amount of their respective capital commitment each time the Company delivered a drawdown notice. Following the final drawdown notice dated December 21, 2023 and due on January 5, 2024, all capital commitments had been drawn.

The following table summarizes total shares issued and proceeds received in connection with the IPO and the Company's capital drawdowns delivered pursuant to the Subscription Agreements from inception through March 31, 2024:

Date	Shares Issued	Proceeds Received	Issuance Price per Share
January 29, 2024	5,500,000	$99,275	$18.05
January 5, 2024	7,888,094	$142,381	$18.05
November 3, 2023	5,497,609	$100,000	$18.19
July 17, 2023	4,357,515	$78,565	$18.03
April 20, 2023	2,205,038	$40,000	$18.14
December 21, 2022	3,193,195	$60,000	$18.79
August 1, 2022	2,652,775	$50,082	$18.88
April 25, 2022	1,800,426	$34,964	$19.42
January 21, 2022	1,541,568	$30,000	$19.46
December 9, 2021	1,491,676	$29,207	$19.58
November 1, 2021	1,546,427	$30,000	$19.40
August 23, 2021	2,593,357	$50,000	$19.28
July 26, 2021	1,564,928	$30,000	$19.17
June 22, 2021	1,034,668	$20,000	$19.33
April 23, 2021	1,845,984	$35,000	$18.96
March 11, 2021	785,751	$15,000	$19.09
November 6, 2020	1,870,660	$35,000	$18.71
October 16, 2020	1,057,641	$20,000	$18.91
August 6, 2020	1,105,425	$20,000	$18.09
May 7, 2020	1,069,522	$20,000	$18.70
December 31, 2019	3,310,540	$66,211	$20.00
December 19, 2019	50	$1	$20.00

Distributions

The following table summarizes the Company's distributions declared from inception through March 31, 2024:

70

NUVEEN CHURCHILL DIRECT LENDING CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

(dollar amounts in thousands, except per share data)

Date Declared	Record Date	Payment Date	Dividend per Share
January 10, 2024	February 12, 2025	April 28, 2025	$0.10 (3)
January 10, 2024	November 11, 2024	January 28, 2025	$0.10 (3)
January 10, 2024	August 12, 2024	October 28, 2024	$0.10 (3)
January 10, 2024	May 13, 2024	July 29, 2024	$0.10 (3)
January 10, 2024	March 30, 2024	April 29, 2024	$0.45
December 28, 2023	December 29, 2023	January 10, 2024	$0.50
December 28, 2023	December 29, 2023	January 10, 2024	$0.05 (2)
September 28, 2023	September 28, 2023	October 12, 2023	$0.50
September 28, 2023	September 28, 2023	October 12, 2023	$0.05 (2)
June 28, 2023	June 28, 2023	July 12, 2023	$0.50
June 28, 2023	June 28, 2023	July 12, 2023	$0.05 (2)
March 30, 2023	March 30, 2023	April 12, 2023	$0.50
March 30, 2023	March 30, 2023	April 12, 2023	$0.26 (1)
December 29, 2022	December 29, 2022	January 17, 2023	$0.50
September 28, 2022	September 28, 2022	October 11, 2022	$0.47
June 30, 2022	June 30, 2022	July 12, 2022	$0.43
March 30, 2022	March 31, 2022	April 12, 2022	$0.41
December 29, 2021	December 29, 2021	January 18, 2022	$0.40
September 29, 2021	September 29, 2021	October 11, 2021	$0.38
June 29, 2021	June 29, 2021	July 12, 2021	$0.31
March 29, 2021	March 29, 2021	April 19, 2021	$0.30
December 29, 2020	December 29, 2020	January 18, 2021	$0.28
November 4, 2020	November 4, 2020	November 11, 2020	$0.23
August 4, 2020	August 4, 2020	August 11, 2020	$0.28
April 16, 2020	April 16, 2020	April 21, 2020	$0.17

________________

(1)    Represents a special dividend and a supplemental dividend.

(2)    Represents a supplemental dividend.

(3)    Represents a special dividend.

The distributions declared were derived from investment company taxable income and net capital gain, if any. The federal income tax characterization of distributions declared and paid for the fiscal year will be determined at fiscal year-end based upon the Company’s investment company taxable income for the full fiscal year and distributions paid during the full year.

71

NUVEEN CHURCHILL DIRECT LENDING CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

(dollar amounts in thousands, except per share data)

The following table reflects the shares issued pursuant to the dividend reinvestment from inception through March 31, 2024:

Date Declared	Record Date	Payment Date	Shares Issued1
December 28, 2023	December 29, 2023	January 10, 2024	185,541
September 28, 2023	September 28, 2023	October 12, 2023	158,545
June 28, 2023	June 28, 2023	July 12, 2023	128,818
March 30, 2023	March 30, 2023	April 12, 2023	150,703
December 29, 2022	December 29, 2022	January 17, 2023	93,329
September 28, 2022	September 28, 2022	October 11, 2022	68,093
June 30, 2022	June 30, 2022	July 12, 2022	45,341
March 30, 2022	March 31, 2022	April 12, 2022	32,320
December 29, 2021	December 29, 2021	January 18, 2022	23,017
September 29, 2021	September 29, 2021	October 11, 2021	10,639
June 29, 2021	June 29, 2021	July 12, 2021	3,039
March 29, 2021	March 29, 2021	April 19, 2021	1,824
December 29, 2020	December 29, 2020	January 18, 2021	1,550
November 4, 2020	November 4, 2020	November 11, 2020	98
August 4, 2020	August 4, 2020	August 11, 2020	34

________________

(1)    All shares issued to shareholders are newly issued shares.

Share Repurchase Plan

On March 5, 2024, the Company entered into a share repurchase plan (the “Company 10b5-1 Plan”), pursuant to which the Company may purchase up to $99,275 in the aggregate of its outstanding shares of common stock in the open market at prices below its NAV per share over a specified period. Any purchase of the shares pursuant to the Company 10b5-1 Plan will be conducted in accordance with the guidelines and conditions of Rule 10b-18 and Rule 10b5-1 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The Company adopted the Company 10b5-1 Plan because it believes that, if its common stock is trading below its then-current NAV per share, it will be in the best interest of its stockholders for the Company to reinvest in its portfolio.

The Company 10b5-1 Plan is designed to allow the Company to repurchase its shares of common stock at times when the Company otherwise might be prevented from doing so under insider trading laws. The Company 10b5-1 Plan requires BofA Securities, Inc., as agent, to repurchase shares of common stock on the Company's behalf when the market price per share is below the most recently reported NAV per share (including any updates, corrections or adjustments publicly announced by the Company to any previously announced NAV per share). Under the Company 10b5-1 Plan, the agent will increase the volume of purchases made as the price of the shares of the Company's common stock declines, subject to volume restrictions. The timing and amount of any share repurchases will depend on the terms and conditions of the Company 10b5-1 Plan, the market price of the shares of the Company's common stock and trading volumes, and no assurance can be given that any particular amount of shares of the common stock will be repurchased.

The purchase of shares of common stock pursuant to the Company 10b5-1 Plan is intended to satisfy the conditions of Rule 10b5-1 and Rule 10b-18 under the Exchange Act, and will otherwise be subject to applicable law, including Regulation M, which may prohibit purchases under certain circumstances.

The Company 10b5-1 Plan became effective on March 29, 2024 and commenced on April 1, 2024. The 10b5-1 Plan will terminate upon the earliest to occur of (i) 12-months from the effective date (tolled for periods during which the Company 10b5-1 Plan is suspended), (ii) the end of the trading day on which the aggregate purchase price for all shares of common stock purchased under the Company 10b5-1 Plan equals $99,275 and (iii) the occurrence of certain other events described in the Company 10b5-1 Plan.

72

NUVEEN CHURCHILL DIRECT LENDING CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

(dollar amounts in thousands, except per share data)

9. CONSOLIDATED FINANCIAL HIGHLIGHTS

The following is a schedule of financial highlights for the three months ended March 31, 2024 and 2023:

	Three Months Ended March 31,
	2024			2023
Per share data:
Net asset value at beginning of period	$	18.13		$	18.32
Net investment income (1)	0.56			0.60
Net realized gain (loss) (1)	(0.07)			0.23
Total net change in unrealized gain (loss) (1)	0.08			(0.39)
Net increase (decrease) in net assets resulting from operations (1)	0.57			0.44
Shareholder distributions from net investment income (2)	(0.45)			(0.76)
Other (3)	(0.04)			0.01
Net asset value at end of period	$	18.21		$	18.01
Net assets at end of period	$	998,233		$	517,544
Shares outstanding at end of period	54,815,740			28,743,877
Per share market value at end of period	$	18.06		N/A
Total return based on NAV (4)	2.93		%	2.39		%
Total return based on market value (5)	2.55		%	N/A
Ratio/Supplemental data:
Ratio of net expenses to average net assets before expense support and waived fees (6) (7)	12.09		%	12.92		%
Ratio of net expenses to average net assets after expense support and waived fees(6) (7)	10.04		%	12.91		%
Ratio of net investment income to average net assets (6)	13.66		%	13.51		%
Portfolio turnover rate (8)	3.20		%	3.22		%
Asset Coverage Ratio	220.92		%	167.31		%

________________

(1)The per share data was derived by using the weighted average shares outstanding during the period.

(2)The per share data for distributions reflects the actual amount of distributions declared during the period.

(3)Includes the impact of different share amounts used in calculating per share data as a result of calculating certain per share data based on weighted average shares outstanding during the period and certain per share data based on shares outstanding as of a period end or transaction date.

(4)Total return is calculated as the change in NAV per share during the period, plus distributions per share, if any, reinvested in accordance with the Company’s dividend reinvestment plan divided by the beginning NAV per share.

(5)Total return based on market value is calculated as the change in market value per share during the respective periods, taking into account distributions, if any, reinvested in accordance with the Company’s dividend reinvestment plan. The beginning market value per share is based on the initial public offering price of $18.05 per share and is not annualized.

(6)Ratios are annualized. Average net assets is calculated utilizing quarterly net assets. Ratio of net investment income (loss) to average net assets includes the effect of expense support for three months ended March 31, 2023 and waived incentive fees for the three months ended March 31, 2024.

(7)The ratio of interest and debt financing expenses to average net assets for the three months ended March 31, 2024 and 2023 was 7.78% and 9.91%, respectively. Average net assets is calculated utilizing quarterly net assets.

(8)Portfolio turnover rate is calculated using the lesser of year-to-date sales or year-to-date purchases over the average of the invested assets at fair value for the periods reported.

73

NUVEEN CHURCHILL DIRECT LENDING CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

(dollar amounts in thousands, except per share data)

10. SUBSEQUENT EVENTS

The Company’s management evaluated subsequent events through the date of issuance of the consolidated financial statements. There have been no subsequent events that occurred during such period that would require disclosure in, or would be required to be recognized in, the consolidated financial statements as of March 31, 2024, except as discussed below.

On April 9, 2024, the Company entered into Amendment No. 1 (“Amendment No. 1”) to the Senior Secured Revolving Credit Agreement, by and among the Company, as borrower, NCDL Equity Holdings, as subsidiary guarantor, the lenders and issuing banks party thereto, SMBC, as administrative agent for the lenders. Amendment No. 1, among other things: (a) increased the maximum principal amount available under the Revolving Credit Facility from $185,000 to $250,000 pursuant to the accordian feature; and (b) replaced the interest rate benchmark for borrowings denominated in Canadian Dollars from CDOR to CORRA, which includes a credit spread adjustment of 0.29547% for one month tenor borrowings and 0.32138% for three month tenor borrowings.

On May 1, 2024, the Board declared a second quarter regular dividend of $0.45 per share payable on or around July 29, 2024 to shareholders of record as of June 28, 2024.

74

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The discussion and analysis of our financial condition and results of operations should be read in conjunction with our consolidated financial statements and related notes appearing elsewhere in this Quarterly Report on Form 10-Q. The information in this section contains forward-looking statements, which relate to future events, or the future performance or financial condition of Nuveen Churchill Direct Lending Corp., including its wholly owned subsidiaries (collectively, "we", "us", "our", or the "Company"), and involves numerous risks and uncertainties, including, but not limited to, those set forth in “Risk Factors” in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2023 and Part II, Item 1A of and elsewhere in this Quarterly Report on Form 10-Q. This discussion also should be read in conjunction with the “Forward-Looking Statements” in this Quarterly Report on Form 10-Q. Actual results could differ materially from those implied or expressed in any forward-looking statements.

Overview

We were formed on March 13, 2018 as a Delaware limited liability company and converted into a Maryland corporation on June 18, 2019, prior to the commencement of operations. We are a closed-end, externally managed, non-diversified management investment company that has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”). In addition, we have elected, and intend to qualify annually thereafter, to be treated for U.S. federal income tax purposes as a regulated investment company (a “RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”).

Our investment objective is to generate attractive risk-adjusted returns primarily through current income by investing primarily in senior secured loans to private equity-owned U.S. middle market companies, which we define as companies with approximately $10 million to $250 million of annual earnings before interest, taxes, depreciation and amortization (“EBITDA”). We primarily focus on investing in U.S. middle market companies, with $10 million to $100 million in EBITDA, which we consider the core middle market. Our portfolio is comprised primarily of first-lien senior secured debt and unitranche loans. Although it is not our primary strategy, we also opportunistically invest in junior capital opportunities, including second-lien loans, subordinated debt, and equity co-investments and similar equity-related securities.

We have entered into an investment advisory agreement (as amended and restated, the “Advisory Agreement”) with Churchill DLC Advisor LLC (f/k/a Nuveen Churchill Advisors LLC) (the “Adviser”), under which the Adviser has delegated substantially all of its day-to-day portfolio management obligations through a sub-advisory agreement (as amended and restated, the “CAM Sub-Advisory Agreement”) to Churchill Asset Management LLC (“Churchill”). In addition, the Adviser and Churchill have engaged Nuveen Asset Management, LLC (“Nuveen Asset Management” and together with the Adviser and Churchill, the "Advisers") pursuant to a sub-advisory agreement (the "NAM Sub-Advisory Agreement"), pursuant to which Nuveen Asset Management may manage a portion of our portfolio consisting of cash and cash equivalents, liquid fixed-income securities (including broadly syndicated loans) and other liquid credit instruments, subject to the pace and amount of investment activity in the middle market investment program. Under the administration agreement (the “Administration Agreement”), we are provided with certain services by an administrator, Churchill BDC Administration LLC (f/k/a Nuveen Churchill Administration LLC) (the “Administrator”). The Adviser, Churchill, Nuveen Asset Management and Administrator are all affiliates and subsidiaries of Nuveen, LLC (“Nuveen”), a wholly owned subsidiary of Teachers Insurance and Annuity Association of America (“TIAA”).

Churchill NCDLC CLO-I, LLC (“CLO-I”), Churchill NCDLC CLO-II, LLC (“CLO-II”), Churchill NCDLC CLO-III, LLC (“CLO-III”), Nuveen Churchill BDC SPV IV, LLC (“SPV IV”), Nuveen Churchill BDC SPV V, LLC (“SPV V”) and NCDL Equity Holdings LLC ("NCDL Equity Holdings") are wholly owned subsidiaries of the Company and are consolidated in these financial statements commencing from the date of their formation. CLO-I, CLO-II and CLO-III completed term debt securitizations in May 2022, December 2023 and March 2024, respectively. SPV IV and SPV V primarily invest in first-lien senior secured debt and unitranche loans. NCDL Equity Holdings was formed to hold certain equity-related securities.

Beginning with our initial closing in March 2020, we conducted private offerings ("Private Offerings") of our shares of common stock to accredited investors in reliance on exemptions from the registration requirements of the Securities Act of 1933, as amended (the "Securities Act"). We held our final closing on April 28, 2023.

On January 29, 2024, we closed our initial public offering (“IPO”) and our common stock began trading on the New York Stock Exchange (“NYSE”) under the symbol “NCDL” on January 25, 2024.

75

Key Components of Our Results of Operations

Investments

Our level of investment activity varies substantially from period to period depending on many factors, including the amount we have available to invest as well as the amount of debt and equity capital available to middle market companies, the level of merger and acquisition activity in the middle market, the general economic environment and the competitive environment for the types of investments we make.

To qualify as a RIC, we must, among other things, meet certain source-of-income and asset diversification requirements. To the extent we continue to qualify as a RIC, we generally will not be subject to U.S federal income tax on any income we timely distribute to our shareholders.

As a BDC, we are required to comply with certain regulatory requirements. For instance, we are generally required to invest at least 70% of our total assets in “qualifying assets,” including securities of private or thinly traded public U.S. companies, cash, cash equivalents, U.S. government securities and high-quality debt investments that mature in one year or less.

As a BDC, we must not acquire any assets other than “qualifying assets” specified in the 1940 Act unless, at the time the acquisition is made, at least 70% of our total assets are qualifying assets (with certain limited exceptions). Qualifying assets include investments in “eligible portfolio companies.” Under the 1940 Act, the term “eligible portfolio company” includes all private companies, companies whose securities are not listed on a national securities exchange, and certain public companies that have listed their securities on a national securities exchange and have a market capitalization of less than $250.0 million. In addition, we must be organized in the United States to qualify as a BDC.

Revenues

We generate revenue primarily in the form of interest income on debt investments we hold. In addition, we may generate income from dividends on direct equity investments, and capital gains on the sales of loans or debt and equity securities. Our debt investments generally bear interest at a floating rate usually determined on the basis of a benchmark, such as the Secured Overnight Financing Rate (“SOFR”). Interest on these debt investments is generally paid quarterly. In some instances, we receive payments on our debt investments based on scheduled amortization of the outstanding balances. In addition, we may receive repayments of some of our debt investments prior to their scheduled maturity dates. The frequency or volume of these repayments fluctuates significantly from period to period. Our portfolio activity also may reflect the proceeds of sales of securities. In addition, we may generate revenue in the form of commitment, origination, structuring, diligence, consulting or prepayment fees associated with our investment activities as well as any fees for managerial assistance services rendered by us to portfolio companies and other investment related income.

Expenses

The Adviser, Churchill, Nuveen Asset Management and their respective affiliates are responsible for bearing the compensation and routine overhead expenses allocable to personnel providing investment advisory and management services to us. We bear all other out-of-pocket costs and expenses of its operations and transactions, including those costs and expenses incidental to the provision of investment advisory and management services to us (such as items in the third and fourth bullets listed below).

•our organizational costs;

•calculating net asset value (including the cost and expenses of any independent valuation firm);

•expenses, including travel, entertainment, lodging and meal expenses, incurred by the Advisers, or members of their investment teams or payable to third parties, in evaluating, developing, negotiating, structuring and performing due diligence on prospective portfolio companies, including such expenses related to potential investments that were not consummated, and, if necessary, enforcing our rights;

•fees and expenses incurred by the Advisers (and their affiliates) or the Administrator (or its affiliates) payable to third parties, including agents, consultants or other advisors, in monitoring financial and legal affairs for us and in conducting research and due diligence on prospective investments and equity sponsors, analyzing investment opportunities, structuring our investments and monitoring investments and portfolio companies on an ongoing basis;

•costs and expenses incurred in connection with the incurrence of leverage and indebtedness, including borrowings, credit facilities, securitizations, margin financing, and including any principal or interest on our borrowings and indebtedness;

•offerings, sales, and repurchases of our shares and other securities;

76

•fees and expenses payable under any underwriting, dealer manager or placement agent agreements;

•investment advisory fees payable under the Advisory Agreement;

•administration fees and expenses, if any, payable under the Administration Agreement (including payments under the Administration Agreement between us and the Administrator, based upon our allocable portion of the Administrator’s overhead in performing its obligations under the Administration Agreement, including rent and the allocable portion of the cost of our chief financial officer and chief compliance officer, and their respective staffs);

•any applicable administrative agent fees or loan arranging fees incurred with respect to portfolio investments by the Advisers, the Administrator or an affiliate thereof;

•costs and expenses incurred in implementing or maintaining third-party or proprietary software tools, programs or other technology;

•transfer agent, dividend agent and custodial fees and expenses;

•federal and state registration fees;

•all costs of registration and listing our shares on any securities exchange;

•federal, state and local taxes;

•independent directors’ fees and expenses, including reasonable travel, entertainment, lodging and meal expenses, and any legal counsel or other advisors retained by, or at the discretion or for the benefit of, the independent directors;

•costs of preparing and filing reports or other documents required by the SEC or other regulators, and all fees, costs and expenses related to compliance-related matters and regulatory filings related to our activities and/or other regulatory filings, notices or disclosures of the Advisers and their affiliates relating to us and its activities;

•costs of any reports, proxy statements or other notices to shareholders, including printing costs;

•fidelity bond, directors and officers/errors and omissions liability insurance, and any other insurance premiums;

•direct costs and expenses of administration, including printing, mailing, long distance telephone, copying, secretarial and other staff, independent auditors, tax preparers and outside legal costs;

•proxy voting expenses;

•all expenses relating to payments of dividends or interest or distributions in cash or any other form made or caused to be made by our Board to or on account of holders of our securities, including in connection with any dividend reinvestment plan or direct stock purchase plan;

•costs incurred in connection with the formation or maintenance of entities or vehicles to hold our assets for tax or other purposes;

•the allocated costs incurred by the Advisers and/or the Administrator in providing managerial assistance to those portfolio companies that request;

•allocable fees and expenses associated with marketing efforts on our behalf;

•all fees, costs and expenses of any litigation involving us or our portfolio companies and the amount of any judgments or settlements paid in connection therewith, directors and officers, liability or other insurance (including costs of title insurance) and indemnification (including advancement of any fees, costs or expenses to persons entitled to indemnification) or extraordinary expense or liability relating to our affairs;

•fees, costs and expenses of winding up and liquidating our assets; and

•all other expenses incurred by us, the Advisers or the Administrator in connection with administering our business.

77

Portfolio and Investment Activity

Portfolio Composition

Our portfolio and investment activity for the three months ended March 31, 2024 and 2023 is presented below (information presented herein is at amortized cost unless otherwise indicated) (dollar amounts in thousands):

	Three Months Ended March 31,
	2024		2023
Investments:
Total investments, beginning of period	$	1,666,169	$	1,225,573
Purchase of investments	204,329		99,914
Proceeds from principal repayments and sales of investments	(54,896)		(39,602)
Payment-in-kind interest	1,992		321
Amortization of premium/accretion of discount, net	1,016		905
Net realized gain (loss) on investments	(3,625)		6,481
Total investments, end of period	$	1,814,985	$	1,293,592
Portfolio companies at beginning of period	179		145
Number of new portfolio companies funded	23		11
Number of portfolio companies sold or repaid	(7)		(3)
Portfolio companies at end of period	195		153
Count of investments	414		304
Count of industries	26		23

As of March 31, 2024, our debt portfolio reflected the following characteristics, based on fair value:

•Weighted average reported annual EBITDA of $77.4 million.1

•Weighted average of 2.2x interest coverage ratio for our first lien term loans2

•Weighted average of 4.83x net leverage.3

•Approximately 84% of our debt investments have financial covenants.4

________________________________________

1 These calculations include all private debt investments for which fair value is determined by the Adviser in its capacity as the Valuation Designee of the Company's board of directors (the “Board”), and excludes quoted assets. Amounts are weighted based on fair market value of each respective investment as of its most recent quarterly valuation, which are derived from the most recently available portfolio company financial statements.

2 The interest coverage ratio calculation is derived from the most recently available portfolio company financial information received by the Adviser, and is a weighted average based on the fair market value of each respective first lien loan investment as of its most recent reporting to lenders. Such reporting may include assumptions regarding the impact of interest rate hedges established by borrowers to reduce their exposure to floating interest rates (resulting in a reduced hedging rate being used for the total interest expense in respect of such hedges, rather than any higher rates applicable under the documentation for such loans), even if such hedging instruments are not pledged as collateral to lenders in respect of such loans and do not secure the loans themselves. The interest rate coverage ratio excludes junior capital investments and equity co-investments, and applies solely to traditional middle market first lien loans held by us, which also excludes any upper middle market or other first lien loans investments that do not have maintenance financial covenants, and first lien loans that the Adviser has assigned a risk rating of ‘8’ or higher, as well as any portfolio companies with net senior leverage of 15x or greater. As a result of the foregoing exclusions, the interest coverage ratio shown herein applies to 73.48% of our total investments, and 82.61% of our total first lien loan investments, in each case based upon fair value.

3 Net leverage is the ratio of total debt minus cash divided by EBITDA, taking into account only the debt issued through the tranche in which we are a lender. Leverage is derived from the most recently available portfolio company financial statements, and weighted by the fair value of each investment. Net leverage presented excludes equity investments as well as debt instruments to which the Adviser has assigned a risk rating of 8 or higher, and any portfolio companies with net leverage of 15x or greater.

4 Represents the percentage of debt investments with one or more maintenance financial covenants.

78

As of March 31, 2024 and December 31, 2023, our investments consisted of the following (dollar amounts in thousands):

	March 31, 2024						December 31, 2023
	Amortized Cost		Fair Value		% of Fair Value		Amortized Cost		Fair Value		% of Fair Value
First-Lien Term Loans	$	1,610,637	$	1,596,352	88.95	%	$	1,450,120	$	1,427,492	86.95	%
Subordinated Debt 1	$	178,330	$	166,502	9.28	%	190,454		183,387		11.17	%
Equity Investments	$	26,018	$	31,705	1.77	%	25,595		30,807		1.88	%
Total	$	1,814,985	$	1,794,559	100.00	%	$	1,666,169	$	1,641,686	100.00	%
Largest portfolio company investment	$	27,904	$	27,993	1.56	%	$	25,309	$	25,108	1.53	%
Average portfolio company investment	$	9,308	$	9,203	0.51	%	$	9,308	$	9,171	0.56	%

_____________________

1As of March 31, 2024, Subordinated Debt is comprised of second lien term loans and/or second lien notes of $84,676, mezzanine debt of $81,113 and $713 of structured debt at fair value and second lien term loans and/or second lien notes of $88,879, mezzanine debt of $86,199 and $3,252 of structured debt at amortized cost.

As of December 31, 2023, Subordinated Debt is comprised of second lien term loans and/or second lien notes of $97,203 mezzanine debt of $83,528 and $2,656 of structured debt at fair value and second lien term loans and/or second lien notes of $100,711, mezzanine debt of $86,495 and $3,247 of structured debt at amortized cost.

The industry composition of our portfolio as a percentage of fair value as of March 31, 2024 and December 31, 2023 was as follows:

Industry	March 31, 2024		December 31, 2023
Aerospace & Defense	3.07	%	3.13	%
Automotive	3.84	%	4.95	%
Banking, Finance, Insurance, Real Estate	3.60	%	3.95	%
Beverage, Food & Tobacco	7.30	%	7.76	%
Capital Equipment	4.62	%	4.21	%
Chemicals, Plastics, & Rubber	1.61	%	2.29	%
Construction & Building	4.50	%	3.90	%
Consumer Goods: Durable	1.05	%	1.51	%
Consumer Goods: Non-durable	3.29	%	3.31	%
Containers, Packaging & Glass	3.89	%	3.97	%
Energy: Electricity	1.61	%	1.75	%
Environmental Industries	3.16	%	2.73	%
Healthcare & Pharmaceuticals	11.91	%	12.72	%
High Tech Industries	10.64	%	8.97	%
Media: Advertising, Printing & Publishing	1.04	%	1.12	%
Media: Diversified & Production	0.87	%	0.96	%
Retail	0.32	%	0.35	%
Services: Business	19.03	%	18.43	%
Services: Consumer	4.98	%	4.86	%
Sovereign & Public Finance	0.76	%	0.65	%
Telecommunications	2.91	%	3.17	%
Transportation: Cargo	3.03	%	3.20	%
Transportation: Consumer	0.70	%	0.13	%
Utilities: Electric	0.81	%	0.89	%
Utilities: Water	0.46	%	—	%
Wholesale	1.00	%	1.09	%
Total	100.00	%	100.00	%

79

The weighted average yields of our investments as of March 31, 2024 and December 31, 2023 were as follows:

	March 31, 2024		December 31, 2023
Weighted average yield on debt and income producing investments, at cost 1	11.55	%	11.72	%
Weighted average yield on debt and income producing investments, at fair value 2	11.69	%	11.94	%
Percentage of debt investments bearing a floating rate	94.69	%	94.61	%
Percentage of debt investments bearing a fixed rate	5.31	%	5.39	%

_____________________

1 Weighted average yield inclusive of debt and income producing investments on non-accrual status, at cost, as of March 31, 2024 was 11.50%. There were no investments on non-accrual as of December 31, 2023.

2 Weighted average yield inclusive of debt and income producing investments on non-accrual status, at fair value, as of March 31, 2024 was 11.67%. There were no investments on non-accrual as of December 31, 2023.

As of March 31, 2024, 93.50% and 93.60% of our debt and income producing investments at cost and at fair value, respectively, had interest rate floors that govern the minimum applicable interest rates on such loans. As of December 31, 2023, 94.43% and 94.55% of our debt and income producing investments at cost and at fair value, respectively, had interest rate floors that govern the minimum applicable interest rates on such loans.

The weighted average yield of our debt and income producing securities is not the same as a return on investment for our shareholders, but rather relates to our investment portfolio and is calculated before the payment of all of our and our subsidiaries’ fees and expenses. The weighted average yield was computed using the effective interest rates as of each respective date, including accretion of original issue discount, but excluding any investments on non-accrual status, if any. There can be no assurance that the weighted average yield will remain at its current level. Total weighted average yields of our debt and income producing investments, at cost, decreased from 11.72% to 11.55% from December 31, 2023 to March 31, 2024. The decrease in weighted average yields was primarily due to the tightening of spreads in newly originated investments.

While the macro-economic environment continues to present challenges for borrowers, with interest rates remaining at elevated levels, we believe the current environment for private credit remains attractive. Spreads have tightened modestly relative to the fourth quarter of 2023 amidst increased competition in the broadly syndicated loan market and healthy issuance levels of collateralized loan obligations ("CLO"), but remain compelling relative to historical levels.

As markets stabilize and private equity firms become more active in an effort to deploy dry powder and return capital to their investors we are seeing private equity mergers and acquisitions ("M&A") volumes increase, leading to higher levels of demand for middle-market financings. Prepayment activity is also increasing as a result, driven primarily by M&A activity, but also in part by repricing and refinancing while spreads continue to tighten. While prepayments serve as an offset to new transaction activity, we believe that lenders who are well positioned with available liquidity as well as incumbent positions in portfolio companies will benefit from increased levels of activity in the market.

Keeping the macro-economic environment in mind, we are closely monitoring the impacts to our portfolio companies, and we will continue to seek to invest in defensive businesses with low levels of cyclicality and strong levels of free cash flow generation. While we are not seeing signs of a broad-based deterioration in our performance or that of our portfolio companies at this time, there can be no assurance that the performance of certain of our portfolio companies will not be negatively impacted by economic conditions, which could have a negative impact on our future results.

Asset Quality

In addition to various risk management and monitoring tools, we use the Advisers’ investment rating system to characterize and monitor the credit profile and expected level of returns on each investment in our portfolio. Churchill, in its capacity as sub-adviser, utilizes a systematic, consistent approach to credit evaluation, with a particular focus on an acceptable level of debt repayment and deleveraging under a “base case” set of projections (the “Base Case”), which reflects a more conservative estimate than the set of projections provided by a prospective portfolio company (the “Management Case”). The following is a description of the conditions associated with each investment rating:

1.Performing - Superior: Borrower is performing significantly above Management Case.

2.Performing - High: Borrower is performing at or near the Management Case (i.e., in a range slightly below to slightly above).

80

3.Performing - Low Risk: Borrower is operating well ahead of the Base Case to slightly below the Management Case.

4.Performing - Stable Risk: Borrower is operating at or near the Base Case (i.e., in a range slightly below to slightly above). This is the initial rating assigned to all new borrowers.

5.Performing - Management Notice: Borrower is operating below the Base Case. Adverse trends in business conditions and/or industry outlook are viewed as temporary. There is no immediate risk of payment default and only a low to moderate risk of covenant default.

6.Watch List - Low Maintenance: Borrower is operating below the Base Case, with declining margin of protection. Adverse trends in business conditions and/or industry outlook are viewed as probably lasting for more than a year. Payment default is still considered unlikely, but there is a moderate to high risk of covenant default.

7.Watch List - Medium Maintenance: Borrower is operating well below the Base Case, but has adequate liquidity. Adverse trends are more pronounced than in Internal Risk Rating 6 above. There is a high risk of covenant default, or it may have already occurred. Payments are current, although subject to greater uncertainty, and there is a moderate to high risk of payment default.

8.Watch List - High Maintenance: Borrower is operating well below the Base Case. Liquidity may be strained. Covenant default is imminent or may have occurred. Payments are current, but there is a high risk of payment default. Negotiations to restructure or refinance debt on normal terms may have begun. Further significant deterioration appears unlikely and no loss of principal is currently anticipated.

9.Watch List - Possible Loss: At the current level of operations and financial condition, the borrower does not have the ability to service and ultimately repay or refinance all outstanding debt on current terms. Liquidity is strained. Payment default may have occurred or is very likely in the short term unless creditors grant some relief. Loss of principal is possible.

10.Watch List - Probable Loss: At the current level of operations and financial condition, the borrower does not have the ability to service and ultimately repay or refinance all outstanding debt on current terms. Payment default is very likely or may have already occurred. Liquidity is extremely limited. The prospects for improvement in the borrower’s situation are sufficiently negative that loss of some or all principal is probable.

Churchill regularly monitors and, when appropriate, changes the investment rating assigned to each investment in our portfolio. Each investment team will review the investment ratings in connection with monthly or quarterly portfolio reviews.

The following table shows the investment ratings of the investments in our portfolio (dollar amounts in thousands):

	March 31, 2024					December 31, 2023
	Fair Value		% of Portfolio		Number of Portfolio Companies	Fair Value		% of Portfolio		Number of Portfolio Companies
1	$	—	—	%	—	$	—	—	%	—
2	—		—	%	—	—		—	%	—
3	90,541		5.05	%	8	80,342		4.89	%	7
4	1,474,423		82.15	%	153	1,353,243		82.44	%	140
5	152,044		8.47	%	23	138,916		8.46	%	21
6	47,666		2.66	%	6	35,686		2.17	%	6
7	27,559		1.54	%	4	27,653		1.68	%	4
8	2,326		0.13	%	1	5,846		0.36	%	1
9	—		—	%	—	—		—	%	—
10	—		—	%	—	—		—	%	—
Total	$	1,794,559	100.00	%	195	$	1,641,686	100.00	%	179

As of March 31, 2024 and December 31, 2023, the weighted average Internal Risk Rating of our investment portfolio was 4.14 and 4.14, respectively. As of March 31, 2024, there was one portfolio company on non-accrual. As of March 31, 2024, the amortized cost of the portfolio company on non-accrual status was $7.2 million, which represents approximately 0.40% of total investments at amortized cost. As of December 31, 2023, there were no loans on non-accrual.

81

Results of Operations

Operating results for the three months ended March 31, 2024 and 2023 were as follows (dollars amounts in thousands):

	Three Months Ended March 31,
	2024		2023
Investment Income
Interest income	$	49,078	$	33,387
Payment-in-kind interest income	1,992		321
Dividend income	308		16
Other income	217		236
Total investment income	51,595		33,960
Expenses
Interest and debt financing expenses	16,941		12,743
Management fees	3,264		2,306
Incentive fees on net investment income	4,459		—
Professional fees	710		590
Directors' fees	128		96
Administration fees	542		309
Other general and administrative expenses	277		171
Total expenses before expense support and Incentive fees waived	26,321		16,215
Expense support	—		(14)
Incentive fees waived	(4,459)		—
Net Expenses	21,862		16,201
Net investment income	$	29,733	$	17,759
Net Realized and Change in Unrealized Gains (Losses)
Net realized gains (losses)	$	(3,625)	$	6,481
Net change in unrealized gains (losses)	4,057		(11,137)
Income tax (provision) benefit	(141)		(386)
Total net change in unrealized gain (loss)	3,916		(11,523)
Total net realized and change in unrealized gains (losses)	291		(5,042)
Net increase (decrease) in net assets resulting from operations	$	30,024	$	12,717

Net increase (decrease) in net assets resulting from operations can vary from period to period as a result of various factors, including the level of new investment commitments, expenses, the recognition of realized gains and losses, and changes in unrealized appreciation and depreciation on the investment portfolio.

Investment income

Investment income, attributable to interest and fees on our debt investments, increased to $51.6 million for the three months ended March 31, 2024, respectively, from $34.0 million for the three months ended March 31, 2023, primarily due to an increase in interest income from higher weighted average interest rates and increased investment activity driven by an increase in our deployed capital. As of March 31, 2024, the size of our portfolio increased to $1.8 billion from $1.3 billion as of March 31, 2023, at cost. As of March 31, 2024, the weighted average yield of our debt and income producing investments increased to 11.55% from 11.03% as of March 31, 2023 on cost, primarily due to increases in base interest rates. The shifting environment in base interest rates, such as SOFR and any applicable alternate rates, may continue to affect our investment income in the future.

Expenses

Total expenses before expense support and Incentive fees waived increased to $26.3 million for the three months ended March 31, 2024 from $16.2 million for the three months ended March 31, 2023.

Interest and debt financing expenses increased for the three months ended March 31, 2024 compared to the three months ended March 31, 2023 primarily due to higher average daily borrowings, higher average interest rates, the addition of the Revolving Credit Facility (as defined below) in the second quarter of 2023 and the completion of the 2023 Debt Securitization and the 2024 Debt

82

Securitization (each as defined below) on December 7, 2023 and March 14, 2024, respectively. The average daily borrowings for the three months ended March 31, 2024 was $819.9 million compared to $738.1 million for the three months ended March 31, 2023. The average interest rate for the three months ended March 31, 2024 was 7.65% compared to 6.76% for the three months ended March 31, 2023.

The increase in management fees for the three months ended March 31, 2024 from the comparable period in 2023 were driven by our deployment of capital and our increasing invested balance. As of March 31, 2024, incentive fee based on income of $4.5 million were waived in accordance with our Advisory Agreement.

Professional fees include legal, audit, tax, valuation, and other professional fees incurred related to the management of us. Administrative fees represent fees paid to the Administrator for our allocable portion of overhead and other expenses incurred by the Administrator in performing its obligations under the administration agreement, including our allocable portion of the cost of the our chief financial officer and chief compliance officer, and their respective staffs. Other general and administrative expenses include insurance, filing, research, rating agencies, subscriptions and other costs. The increase in professional, administration, and other general and administrative fees for the three months ended March 31, 2024 from the comparable period in 2023 was primarily driven by growing needs of the business given the increase in the Company's size year over year.

The expense support amount represents the amount of expenses paid by the Adviser on our behalf in accordance with the Expense Support Agreement (described further below). These expenses were primarily related to professional fees, specifically ordinary course legal expenses incurred by the Company. The Expense Support Agreement automatically terminated pursuant to its terms upon the consummation of the IPO. Refer to the "Related Party Transactions" section below for further details on the Expense Support Agreement.

Net realized gain (loss) and Net change in unrealized gains (losses) on investments

For the three months ended March 31, 2024, we had a net realized loss on investments of $(3.6) million primarily driven by a final realization of an underperforming debt position which generated a realized loss compared to a net realized gain of $6.5 million for the three months ended March 31, 2023 primarily driven by the realization of two equity investments, which generated realized gains.

We recorded a net change in unrealized gain of $4.1 million for the three months ended March 31, 2024, compared to a net unrealized loss of $(11.1) million for the three months ended March 31, 2023, which reflects the net change in the fair value of our investment portfolio relative to its cost basis over the period. The increase in unrealized gains for the three months ended March 31, 2024 compared to the comparable period in 2023 resulted primarily from the tightening of market spreads and a reversal of unrealized losses on certain of our underperforming debt positions that were ultimately realized.

Liquidity and Capital Resources

Our liquidity and capital resources are generated primarily from cash flows from income earned from our investments and principal repayments, and our net borrowings from our credit facilities and CLO debt issuances (discussed further below). Prior to our IPO on January 29, 2024, we also generated cash flow from the proceeds of capital drawdowns of our privately placed capital commitments. In the future, we may also generate cash flow from future offerings of securities including issuances of debt and/or equity securities through both public registered offerings off of a shelf registration statement and private offerings. Due to the diverse capital sources available to us at this time, we believe we have adequate liquidity to support our near-term capital requirements. Due to an uncertain economic outlook and current market volatility, we regularly evaluate our overall liquidity position and take proactive steps to maintain that position based on such circumstances. The primary uses of our cash are (i) purchases of investments in portfolio companies, (ii) funding the cost of our operations (including fees paid to our Adviser), (iii) debt service, repayment and other financing costs of our borrowings, (iv) cash distributions to the holders of our shares, and (v) share repurchases under the Company 10b5-1 Plan (defined below).

We are generally permitted, under specified conditions, to issue multiple classes of indebtedness and one class of stock senior to our shares if our asset coverage, as defined in the 1940 Act, is at least equal to 150%, if certain requirements are met. In connection with our organization, our Board and TIAA (as our initial shareholder) authorized us to adopt the 150% asset coverage ratio. As of March 31, 2024 and December 31, 2023, our asset coverage ratio was 220.92% and 178.57%, respectively.

Cash and cash equivalents as of March 31, 2024, taken together with cash available under our credit facilities, is expected to be sufficient for our investing activities and to conduct our operations in the near term. As of March 31, 2024, we had $147.5 million available under our Wells Fargo Financing Facility (as defined below), $111.0 million available under our SMBC Financing Facility (as defined below), and $173.0 million available under our SMBC Corporate Revolver (as defined below), subject to asset coverage limitations.

83

For the three months ended March 31, 2024, our cash and cash equivalents balance decreased by $(3.2) million. During that period, $97.6 million was used in operating activities, primarily relating to investment purchases of $204.3 million, offset by $54.9 million in repayments and sales of investments in portfolio companies. During the same period, $94.3 million was used in financing activities, consisting primarily of proceeds from issuance of common shares and secured borrowings of $241.7 million and $323.0 million, respectively, net of shareholder distributions and repayments of secured borrowings of $19.3 million and $449.4 million, respectively.

Equity

Our authorized stock consists of 500,000,000 shares of stock, par value $0.01 per share, all of which are initially designated as common stock.

IPO and Private Offerings

On January 29, 2024, we closed our IPO, issuing 5,500,000 shares of its common stock at a public offering price of $18.05 per share. We received total cash proceeds of $99.3 million. Our common stock began trading on the NYSE under the symbol “NCDL” on January 25, 2024.

Prior to April 28, 2023, in connection with our Private Offerings, we entered into subscription agreements (“Subscription Agreements”) with investors, pursuant to which investors were required to fund drawdowns to purchase our shares of common stock up to the amount of their respective capital commitment each time we delivered a drawdown notice. Following the final drawdown notice dated December 21, 2023 and due on January 5, 2024, all capital commitments had been drawn.

The following table summarizes total shares issued and proceeds received in connection with the IPO and the capital drawdowns delivered pursuant to the Subscription Agreements from inception through March 31, 2024 (dollar amounts in thousands, except per share data):

Date	Shares Issued	Proceeds Received	Issuance Price per Share
January 29, 2024	5,500,000	$99,275	$18.05
January 5, 2024	7,888,094	$142,381	$18.05
November 3, 2023	5,497,609	$100,000	$18.19
July 17, 2023	4,357,515	$78,565	$18.03
April 20, 2023	2,205,038	$40,000	$18.14
December 21, 2022	3,193,195	$60,000	$18.79
August 1, 2022	2,652,775	$50,082	$18.88
April 25, 2022	1,800,426	$34,964	$19.42
January 21, 2022	1,541,568	$30,000	$19.46
December 9, 2021	1,491,676	$29,207	$19.58
November 1, 2021	1,546,427	$30,000	$19.40
August 23, 2021	2,593,357	$50,000	$19.28
July 26, 2021	1,564,928	$30,000	$19.17
June 22, 2021	1,034,668	$20,000	$19.33
April 23, 2021	1,845,984	$35,000	$18.96
March 11, 2021	785,751	$15,000	$19.09
November 6, 2020	1,870,660	$35,000	$18.71
October 16, 2020	1,057,641	$20,000	$18.91
August 6, 2020	1,105,425	$20,000	$18.09
May 7, 2020	1,069,522	$20,000	$18.70
December 31, 2019	3,310,540	$66,211	$20.00
December 19, 2019	50	$1	$20.00

84

Dividends and Distributions

To the extent that we have taxable income, we intend to make quarterly distributions to our common shareholders. Dividends and distributions to common shareholders are recorded on the applicable record date. The amount to be distributed to common shareholders is determined by our Board each quarter and is generally based upon the taxable earnings estimated by management and available cash. Net realized capital gains, if any, will generally be distributed at least annually, although we may decide to retain such capital gains for investment.

In connection with the IPO, our Board approved an amended and restated dividend reinvestment plan (the "Amended DRIP"), which became effective on January 29, 2024, concurrent with the consummation of the IPO.

The Amended DRIP changed the dividend reinvestment plan from an “opt in” dividend reinvestment plan to an “opt out” dividend reinvestment plan. As a result of the foregoing, if our Board authorizes, and we declare, a cash dividend or distribution, shareholders that acquired their shares in the IPO and do not “opt out” of the Amended DRIP will have their cash distributions automatically reinvested in additional shares rather than receiving cash. Notwithstanding the foregoing, a shareholder’s election (or deemed election) under the dividend reinvestment plan, dated December 19, 2019, will remain in effect for such shareholder and no further action is required by such shareholder with respect to their election under the Amended DRIP.

With respect to each distribution under the Amended DRIP, our Board reserves the right to either issue new shares of common stock or purchase shares of common stock in the open market for the accounts of participants in the Amended DRIP. If newly issued shares are used to implement the Amended DRIP, the number of shares to be issued to a shareholder will be determined by dividing the total dollar amount of the distribution payable to such participant by the market price per share of our common stock at the close of regular trading of the NYSE on the distribution payment date, or if no sale is reported for such day, the average of the reported bid and asked prices. However, if the market price per share on the distribution payment date exceeds the most recently computed NAV per share, we will issue shares at the greater of (i) the most recently computed NAV per share and (ii) 95% of the current market price per share (or such lesser discount to the current market price per share that still exceeds the most recently computed NAV per share). If shares are purchased in the open market to implement the Amended DRIP, the number of shares to be issued to a participant will be determined by dividing the dollar amount of the distribution payable to such participant by the weighted average price per share for all shares of common stock purchased by the plan administrator in the open market in connection with the dividend or distribution. Although each participant may from time to time have an undivided fractional interest in a share, no certificates for a fractional share will be issued. However, dividends and distributions on fractional shares will be credited to each participant’s account.

85

The following table summarizes the dividends declared from inception through March 31, 2024:

Date Declared	Record Date	Payment Date	Dividend per Share
January 10, 2024	February 12, 2025	April 28, 2025	$0.10 (3)
January 10, 2024	November 11, 2024	January 28, 2025	$0.10 (3)
January 10, 2024	August 12, 2024	October 28, 2024	$0.10 (3)
January 10, 2024	May 13, 2024	July 29, 2024	$0.10 (3)
January 10, 2024	March 30, 2024	April 29, 2024	$0.45
December 28, 2023	December 29, 2023	January 10, 2024	$0.50
December 28, 2023	December 29, 2023	January 10, 2024	$0.05 (2)
September 28, 2023	September 28, 2023	October 12, 2023	$0.50
September 28, 2023	September 28, 2023	October 12, 2023	$0.05 (2)
June 28, 2023	June 28, 2023	July 12, 2023	$0.50
June 28, 2023	June 28, 2023	July 12, 2023	$0.05 (2)
March 30, 2023	March 30, 2023	April 12, 2023	$0.50
March 30, 2023	March 30, 2023	April 12, 2023	$0.26 (1)
December 29, 2022	December 29, 2022	January 17, 2023	$0.50
September 28, 2022	September 28, 2022	October 11, 2022	$0.47
June 30, 2022	June 30, 2022	July 12, 2022	$0.43
March 30, 2022	March 31, 2022	April 12, 2022	$0.41
December 29, 2021	December 29, 2021	January 18, 2022	$0.40
September 29, 2021	September 29, 2021	October 11, 2021	$0.38
June 29, 2021	June 29, 2021	July 12, 2021	$0.31
March 29, 2021	March 29, 2021	April 19, 2021	$0.30
December 29, 2020	December 29, 2020	January 18, 2021	$0.28
November 4, 2020	November 4, 2020	November 11, 2020	$0.23
August 4, 2020	August 4, 2020	August 11, 2020	$0.28
April 16, 2020	April 16, 2020	April 21, 2020	$0.17

________________
(1) Represents a special dividend and a supplemental dividend.
(2) Represents a supplemental dividend.
(3) Represents a special dividend.

86

The distributions declared were derived from investment company taxable income and net capital gain, if any. The federal income tax characterization of distributions declared and paid for the fiscal year will be determined at fiscal year-end based upon our investment company taxable income for the full fiscal year and distributions paid during the full year.

The following table reflects the shares issued pursuant to the dividend reinvestment plan from inception through March 31, 2024:

Date Declared	Record Date	Payment Date	Shares Issued 1
December 28, 2023	December 29, 2023	January 10, 2024	185,541
September 28, 2023	September 28, 2023	October 12, 2023	158,545
June 28, 2023	June 28, 2023	July 12, 2023	128,818
March 30, 2023	March 30, 2023	April 12, 2023	150,703
December 29, 2022	December 29, 2022	January 17, 2023	93,329
September 28, 2022	September 28, 2022	October 11, 2022	68,093
June 30, 2022	June 30, 2022	July 12, 2022	45,341
March 30, 2022	March 31, 2022	April 12, 2022	32,320
December 29, 2021	December 29, 2021	January 18, 2022	23,017
September 29, 2021	September 29, 2021	October 11, 2021	10,639
June 29, 2021	June 29, 2021	July 12, 2021	3,039
March 29, 2021	March 29, 2021	April 19, 2021	1,824
December 29, 2020	December 29, 2020	January 18, 2021	1,550
November 4, 2020	November 4, 2020	November 11, 2020	98
August 4, 2020	August 4, 2020	August 11, 2020	34

________________

(1)    All shares issued to shareholders are newly issued shares.

Share Repurchase Plan

On March 5, 2024, we entered into a share repurchase plan (the “Company 10b5-1 Plan”), pursuant to which we may purchase up to $99.3 million in the aggregate of its outstanding shares of common stock in the open market at prices below its net asset value (“NAV”) per share over a specified period. Any purchase of the shares pursuant to the Company 10b5-1 Plan will be conducted in accordance with the guidelines and conditions of Rule 10b-18 and Rule 10b5-1 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). We adopted the Company 10b5-1 Plan because we believes that, if our common stock is trading below its then-current NAV per share, it will be in the best interest of its stockholders for us to reinvest in our portfolio.

The Company 10b5-1 Plan is designed to allow us to repurchase our shares of common stock at times when we otherwise might be prevented from doing so under insider trading laws. The Company 10b5-1 Plan requires BofA Securities, Inc., as agent, to repurchase shares of common stock on the Company's behalf when the market price per share is below the most recently reported NAV per share (including any updates, corrections or adjustments publicly announced by us to any previously announced NAV per share). Under the Company 10b5-1 Plan, the agent will increase the volume of purchases made as the price of the shares of the our common stock declines, subject to volume restrictions. The timing and amount of any share repurchases will depend on the terms and conditions of the Company 10b5-1 Plan, the market price of the shares of our common stock and trading volumes, and no assurance can be given that any particular amount of shares of the common stock will be repurchased.

The purchase of shares of common stock pursuant to the Company 10b5-1 Plan is intended to satisfy the conditions of Rule 10b5-1 and Rule 10b-18 under the Exchange Act, and will otherwise be subject to applicable law, including Regulation M, which may prohibit purchases under certain circumstances.

The Company 10b5-1 Plan became effective on March 29, 2024 and commenced on April 1, 2024. The 10b5-1 Plan will terminate upon the earliest to occur of (i) 12-months from the effective date (tolled for periods during which the Company 10b5-1 Plan is suspended), (ii) the end of the trading day on which the aggregate purchase price for all shares of common stock purchased under the Company 10b5-1 Plan equals $99.3 million and (iii) the occurrence of certain other events described in the Company 10b5-1 Plan.

87

Shareholder Transfer Restrictions

With respect to any shares of common stock held by a shareholder prior to the date of the IPO prospectus (January 24, 2024), without the prior written consent of the Board:

•for 365 days following the date of the IPO prospectus (January 24, 2024), a shareholder that is affiliated with the Advisers is not permitted to transfer (whether by sale, gift, merger, by operation of law or otherwise), exchange, assign, pledge, hypothecate or otherwise dispose of or encumber any shares of common stock held by such shareholder prior January 24, 2024;

•for 90 days following the date of the date of the IPO prospectus (January 24, 2024), a shareholder (other than certain individuals and entities affiliated with the Advisers, who are subject to the 365-day restriction above) is not permitted to transfer (whether by sale, gift, merger, by operation of law or otherwise), exchange, assign, pledge, hypothecate or otherwise dispose of or encumber any shares of common stock held by such shareholder prior to January 24, 2024;

•beginning with the 91st day following the date of the IPO prospectus (January 24, 2024) through the 180th day following the date of the IPO prospectus (January 24, 2024), a shareholder (other than certain individuals and entities affiliated with the Advisers, who are subject to the 365-day restriction above) is not permitted to transfer (whether by sale, gift, merger, by operation of law or otherwise), exchange, assign, pledge, hypothecate or otherwise dispose of or encumber 85% of the shares of common stock held by such shareholder prior to January 24, 2024; and

•beginning with the 181st day following the date of the IPO prospectus (January 24, 2024) through the 270th day following the date of the IPO prospectus (January 24, 2024), a shareholder (other than certain individuals and entities affiliated with the Advisers, who are subject to the 365-day restriction above) is not permitted to transfer (whether by sale, gift, merger, by operation of law or otherwise), exchange, assign, pledge, hypothecate or otherwise dispose of or encumber 50% of the shares of common stock held by such shareholder prior to January 24, 2024.

Beginning with the 271st day following the date of the IPO prospectus (January 24, 2024), a shareholder (other than certain individuals and entities affiliated with the Advisers, who are subject to the 365-day restriction above) may transfer (whether by sale, gift, merger, by operation of law or otherwise), exchange, assign, pledge, hypothecate or otherwise dispose of or encumber all of the shares of common stock held by such shareholder prior to the date of the IPO.

This means that, as a result of these transfer restrictions, without the consent of the Board, a shareholder (other than certain individuals and entities affiliated with the Advisers, who are subject to the 365-day restriction above) who owned 100 shares of common stock on January 24, 2024 could not sell any of such shares for 90 days following January 24, 2024; 91 days following January 24, 2024, such shareholder could only sell up to 15 of such shares; 181 days following January 24, 2024, such shareholder could only sell up to 50 of such shares; 271 days following January 24, 2024, such shareholder could sell all of such shares.

Income Taxes

We have elected and intend to qualify annually to be treated as a RIC for U.S. federal income tax purposes under the Code. If we qualify as a RIC, we will not be taxed on our investment company taxable income or realized net capital gains, to the extent that such taxable income or gains are distributed, or deemed to be distributed, to shareholders on a timely basis.

Taxable income generally differs from net income for financial reporting purposes due to temporary and permanent differences in the recognition of income and expenses, and generally excludes net unrealized appreciation or depreciation until realized. Dividends declared and paid by us in a year may differ from taxable income for that year as such dividends may include the distribution of current year taxable income or the distribution of prior year taxable income carried forward into and distributed in the current year. Distributions also may include returns of capital.

To qualify for RIC tax treatment, we must, among other things, distribute, with respect to each taxable year, at least 90% of our investment company net taxable income (i.e., our net ordinary income and our realized net short-term capital gains in excess of realized net long-term capital losses, if any). If we qualify as a RIC, we may also be subject to a U.S. federal excise tax, based on distribution requirements of our taxable income on a calendar year basis. Depending on the level of taxable income earned in a tax year, we may choose to carry forward taxable income in excess of current year distributions into the next year and pay a 4% U.S. federal excise tax on such income. Any such carryover taxable income must be distributed through a dividend declared prior to filing the final tax return related to the year that generated such taxable income.

88

We intend to distribute to our shareholders between 90% and 100% of our annual taxable income (which includes our taxable interest and fee income). We may not be able to achieve operating results that will allow us to make distributions at a specific level or to increase the amount of these distributions from time to time. We cannot assure shareholders that they will receive any distributions or distributions at a particular level.

Secured Borrowings

See Note 6 to the consolidated financial statements in Part I, Item 1 of this Quarterly Report on Form 10-Q for more information on our secured borrowings.

Subscription Facility

On September 10, 2020, we entered into a revolving credit agreement (the “Subscription Facility Agreement” and the facility thereunder, the “Subscription Facility”) with Sumitomo Mitsui Banking Corporation (“SMBC”), as the administrative agent for certain secured parties, the syndication agent, the lead arranger, the book manager, the letter of credit issuer and the lender. The Subscription Facility had a maximum commitment of $50 million, subject to availability under the "Borrowing Base." The Borrowing Base was calculated based on the unfunded capital commitments of certain investors that had subscribed to purchase shares of the Company, to the extent the capital commitments of such investors also had been approved by SMBC for inclusion in the Borrowing base and met certain additional criteria. The Subscription Facility Agreement expired on September 8, 2023, and we fully paid down the outstanding balance including the accrued interest expense.

Wells Fargo Financing Facility

On December 31, 2019, a wholly owned subsidiary of the Company entered into a credit agreement ("the “Wells Fargo Financing Facility” and the agreement relating thereto, as amended from time to time, the “Wells Fargo Financing Facility Agreement”), with Wells Fargo Bank, N.A. as lender (“Wells Fargo”) and administrative agent. The Wells Fargo Financing Facility Agreement was amended on October 28, 2020, March 31, 2022 and March 14, 2024. The most recent amendment on March 14, 2024, among other things: (i) added SPV V as a party to the facility and (ii) decreased the maximum facility amount available from $275 million to $150 million, which facility amount may be increased, with the consent of the administrative agent and each applicable lender, to up to $250 m during the reinvestment period.

The Wells Fargo Financing Facility reinvestment period expires on March 31, 2025 and has a maturity date of March 31, 2027. The Wells Fargo Financing Facility Agreement also requires the Company to maintain an asset coverage ratio equal to at least 1.50:1.00. The amount of the borrowings under the Wells Fargo Financing Facility equals the amount of the outstanding advances. Advances under the Wells Fargo Financing Facility may be prepaid and reborrowed at any time during the reinvestment period, but any termination or reduction of the facility amount prior to the first anniversary of the date of the amendment (subject to certain exceptions) is subject to a commitment reduction fee of 1%. Under the Wells Fargo Financing Facility Agreement, we pay a fee on daily undrawn amounts under the Wells Fargo Financing Facility of 0.25% per annum during the period ending June 14, 2024, 0.50% per annum for the next six months and thereafter, 0.50% per annum on undrawn amounts of up to 40% of the maximum facility amount and 1.50% per annum on undrawn amounts in excess of 40% of the maximum facility amount.

As of March 31, 2024 and December 31, 2023, the Wells Fargo Financing Facility bore interest at a rate of SOFR, reset daily plus 2.20% per annum.

SPV V, beginning March 14, 2024, has pledged all of its assets to the collateral agent to secure their obligations under the Wells Fargo Financing Facility. The Company, and SPV V have made customary representations and warranties and are required to comply with various financial covenants related to liquidity and other maintenance covenants, reporting requirements and other customary requirements for similar facilities.

SMBC Financing Facility

On November 24, 2020, a wholly owned subsidiary of the Company entered into a senior secured revolving credit facility (the “SMBC Financing Facility” and the agreement relating thereto the “SMBC Financing Facility Agreement”) with SMBC, as the administrative agent, the collateral agent and the lender. On October 19, 2023, SPV IV entered into the borrower joinder agreement (the “SMBC Joinder”) to become party to the SMBC Financing Facility Agreement.

89

The SMBC Financing Facility Agreement was amended on December 23, 2021, June 29, 2022 and November 21, 2023. The most recent amendment on November 21, 2023 (the "SMBC Financing Facility Amendment"), among other things: (i) extended the reinvestment period from November 24, 2023 to November 24, 2024 and the stated maturity date from November 24, 2025 to November 24, 2026; (ii) changed the interest rate for loans under the SMBC Financing Facility Agreement from (A) either the Base Rate (as defined in the SMBC Financing Facility Agreement) plus 1.15% or the Term SOFR (as defined in the SMBC Financing Facility Agreement) plus 2.15% to (B) either the Base Rate plus 1.65% or Term SOFR plus 2.65%; (iii) reduced the maximum facility amount from $300 million to $150 million upon the occurrence of a permitted securitization, subject to a subsequent increase to $250 million, in the sole discretion of the administrative agent, if so requested by the borrowers; and (iv) provide for an unused commitment fee of, from the three month anniversary of the SMBC Financing Facility Amendment date to the six month anniversary of the Amendment date, 0.50% per annum on the unused commitments and on or after the six month anniversary of the SMBC Financing Facility Amendment date, 0.50% per annum on the unused commitments if such unused commitments are less than 50% of the total commitments and 1.00% per annum on the unused commitments if such unused commitments are greater than or equal to 50% of the total commitments. In connection with the SMBC Financing Facility Amendment, the borrowers paid an extension fee of $450 thousand plus an annualized fee of 0.30% multiplied by $150 million based on the length of time (in years) until the occurrence of a permitted securitization. Advances under the SMBC Financing Facility Agreement may be prepaid and reborrowed at any time during the reinvestment period. As of March 31, 2024 and December 31, 2023, the SMBC Financing Facility bore interest at one-month SOFR plus 2.65% and one-month SOFR plus 2.65%, respectively, per annum.

Effective December 7, 2023, following the closing of the 2023 Debt Securitization (discussed further below), the maximum facility amount available was reduced to $150 million from $300 million and SPV IV began borrowing under the SMBC Financing Facility.

SPV IV, beginning October 19, 2023, has pledged all of its assets to the collateral agent to secure its obligations under the SMBC Financing Facility. The Company and SPV IV have made customary representations and warranties and are required to comply with various financial covenants related to liquidity and other maintenance covenants, reporting requirements and other customary requirements for similar facilities.

Revolving Credit Facility

On June 23, 2023, we entered into a senior secured revolving credit agreement (the “Senior Secured Revolving Credit Agreement” and facility thereunder, the “Revolving Credit Facility” and together with the Wells Fargo Financing Facility and SMBC Financing Facility, the “Financing Facilities”) with SMBC as the lender, administrative agent, and one of the lead arrangers along with Wells Fargo. The Revolving Credit Facility is guaranteed by NCDL Equity Holdings and will be guaranteed by certain of our subsidiaries that are formed or acquired in the future (collectively, the “Guarantors”).

The initial maximum principal amount of the Revolving Credit Facility is $185 million, subject to availability under the borrowing base, which is based on our portfolio investments and other outstanding indebtedness. Maximum capacity under the Revolving Credit Facility may be increased to $300 million through the exercise by us of an uncommitted accordion feature through which existing and new lenders may, at their option, agree to provide additional financing. The Revolving Credit Facility is secured by a perfected first-priority interest in substantially all of the portfolio investments held by the Company and each Guarantor, subject to certain exceptions, and includes a $25 million limit for swingline loans.

The availability period under the Revolving Credit Facility will terminate on June 23, 2027 (the “Commitment Termination Date”) and will mature on June 23, 2028 (the “Final Maturity Date”). During the period from the Commitment Termination Date to the Final Maturity Date, we will be obligated to make mandatory prepayments out of the proceeds of certain asset sales and other recovery events and equity and debt issuances.

We may borrow amounts in U.S. dollars or certain other permitted currencies. Amounts drawn in U.S. dollars will bear interest at either term SOFR plus a margin, or the prime rate plus a margin. We may elect either the term SOFR or prime rate at the time of drawdown, and loans denominated in U.S. dollars may be converted from one rate to another at any time at our option, subject to certain conditions. Amounts drawn in other permitted currencies will bear interest at the relevant rate specified therein plus an applicable margin. We also will pay a fee of 0.375% on average daily undrawn amounts. As of March 31, 2024, the Revolving Credit Facility bore interest at one-month SOFR plus 2.25% per annum.

The Senior Secured Revolving Credit Agreement includes customary covenants, including certain limitations on the incurrence by the Company of additional indebtedness and on the Company’s ability to make distributions to its shareholders, or redeem, repurchase or retire shares of stock, upon the occurrence of certain events, and certain financial covenants related to asset coverage and minimum shareholders’ equity, as well as customary events of default.

90

CLO-I

On May 20, 2022 (the “Closing Date”), the Company completed a $448.3 million term debt securitization (the “2022 Debt Securitization”). Term debt securitization is also known as a collateralized loan obligation and is a form of secured financing incurred by the Company.

The notes offered in the 2022 Debt Securitization (the “2022 Notes”) were issued by CLO-I, an indirect, wholly owned, consolidated subsidiary of the Company. The 2022 Notes consist of $199.0 million of AAA Class A-1 2022 Notes, which bear interest at the three-month Term SOFR plus 1.80%; $34.3 million of AAA Class A-1F 2022 Notes, which bear interest at 4.42%; $47.3 million of AA Class B 2022 Notes, which bear interest at the three-month Term SOFR plus 2.30%; $31.5 million of A Class C 2022 Notes, which bear interest at the three-month Term SOFR plus 3.15%; $27.0 million of BBB Class D 2022 Notes, which bear interest at the three-month Term SOFR plus 4.15%; and approximately $79.3 million of Subordinated 2022 Notes, which do not bear interest. The Company directly owns all of the BBB Class D 2022 Notes and the Subordinated 2022 Notes and as such, these notes are eliminated in consolidation.

As part of the 2022 Debt Securitization, CLO-I also entered into a loan agreement (the “CLO-I Loan Agreement”) on the Closing Date, pursuant to which various financial institutions and other persons which are, or may become, parties to the CLO-I Loan Agreement as lenders (the “Lenders”) committed to make $30.0 million of AAA Class A-L 2022 Loans to CLO-I (the “2022 Loans” and, together with the 2022 Notes, the “2022 Debt”). The 2022 Loans bear interest at the three-month Term SOFR plus 1.80% and were fully drawn upon the closing of the transactions. Any Lender may elect to convert all of the Class A-L 2022 Loans held by such Lenders into Class A-1 2022 Notes upon written notice to CLO-I in accordance with the CLO-I Loan Agreement.

The 2022 Debt is backed by a diversified portfolio of senior secured and second lien loans. Through April 20, 2026, all principal collections received on the underlying collateral may be used by CLO-I to purchase new collateral under the direction of the Company, in its capacity as collateral manager of CLO-I and in accordance with the Company’s investment strategy, allowing the Company to maintain the initial leverage in the 2022 Debt Securitization. The 2022 Notes are due on April 20, 2034. The 2022 Loans are scheduled to mature, and, unless earlier repaid, the entire unpaid principal balance thereof is due and payable on April 20, 2034.

The 2022 Debt is the secured obligation of CLO-I, and the indenture and the CLO-I Loan Agreement, as applicable, governing the 2022 Debt includes customary covenants and events of default. The 2022 Debt has not been, and will not be, registered under the Securities Act, or any state “blue sky” laws.

The Company serves as collateral manager to CLO-I under a collateral management agreement (the “Collateral Management Agreement”) and has waived the management fee due to it in consideration for providing these services.

CLO-II

On December 7, 2023 (the “Closing Date”), the Company completed a $298.1 million term debt securitization (the “2023 Debt Securitization”).

The notes offered in the 2023 Debt Securitization (the “2023 Notes”) were issued by CLO-II, an indirect, wholly owned, consolidated subsidiary of the Company. The 2023 Notes consist of $2.0 million of AAA Class X 2023 Notes, which bear interest at the three-month Term SOFR plus 2.00%, $100.5 million of AAA Class A-1 2023 Notes, which bear interest at the three-month Term SOFR plus 2.35%; $37.5 million of AA Class B 2023 Notes, which bear interest at three-month Term SOFR plus 3.20% and approximately $83.1 million of Subordinated 2023 Notes, which do not bear interest. The Company directly owns all of the Subordinated 2023 Notes and as such, these notes are eliminated in consolidation.

As part of the 2023 Debt Securitization, CLO-II also entered into a loan agreement (the “CLO-II Loan Agreement”) on the Closing Date, pursuant to which various financial institutions and other persons which are, or may become, parties to the CLO-II Loan Agreement as lenders (the “Lenders”) committed to make $25.0 million of AAA Class A-L-A 2023 Loans and $50.0 million AAA Class A-L-B 2023 Loans to CLO-II (the “2023 Loans” and, together with the 2023 Notes, the “2023 Debt”). The 2023 Loans bear interest at the three-month Term SOFR plus 2.35% and were fully drawn upon the closing of the transactions. Any Lender may elect to convert all or a portion of the Class A-L-A 2023 Loans held by such Lenders into Class A-1 2023 Notes upon written notice to CLO-II in accordance with the CLO-II Loan Agreement.

The 2023 Debt is backed by a diversified portfolio of senior secured and second lien loans. Through January 20, 2028, all principal collections received on the underlying collateral may be used by CLO-II to purchase new collateral under the direction of the Company, in its capacity as collateral manager of CLO-II and in accordance with the Company’s investment strategy, allowing the Company to maintain the initial leverage in the 2023 Debt Securitization. The 2023 Notes are due on January 20, 2036. The 2023 Loans are scheduled to mature, and, unless earlier repaid, the entire unpaid principal balance thereof is due and payable on January 20, 2036.

91

The 2023 Debt is the secured obligation of CLO-II, and the indenture and the CLO-II Loan Agreement, as applicable, governing the 2023 Debt includes customary covenants and events of default. The 2023 Debt has not been, and will not be, registered under the Securities Act, or any state “blue sky” laws.

The Company serves as collateral manager to CLO-II under a collateral management agreement (the “Collateral Management Agreement”) and has waived the management fee due to it in consideration for providing these services.

CLO-III

On March 14, 2024 (the “Closing Date”), the Company completed a $296,970 term debt securitization (the “2024 Debt Securitization”).

The notes offered in the 2024 Debt Securitization (the “2024 Notes” or “2024 Debt”) were issued by Churchill NCDLC CLO-III, LLC (formerly known as Nuveen Churchill BDC SPV III, LLC) (the “2024 Issuer”), a direct, wholly owned, consolidated subsidiary of the Company, pursuant to an indenture (the “Indenture”) dated as of the Closing Date. The 2024 Notes consist of $2,000 of AAA Class X 2024 Notes, which bear interest at the three-month Term SOFR plus 1.40%; $175,500 of AAA Class A 2024 Notes, which bear interest at the three-month Term SOFR plus 2.00%; $37,500 of AA Class B 2024 Notes, which bear interest at the three-month Term SOFR plus 2.65%; and $81,970 of Subordinated 2024 Notes, which do not bear interest. The Company directly retained all of the Subordinated 2024 Notes and as such, these notes are eliminated in consolidation.

The 2024 Notes are backed by a diversified portfolio of senior secured and second lien loans. The Indenture contains certain

conditions pursuant to which loans can be acquired by the 2024 Issuer, in accordance with rating agency criteria or as otherwise agreed with certain institutional investors who purchased the 2024 Notes. Through April 20, 2028, all principal collections received on the underlying collateral may be used by the 2024 Issuer to purchase new collateral under the direction of the Company, in its capacity as collateral manager of the 2024 Issuer and in accordance with the Company’s investment strategy, allowing the Company to maintain the initial leverage in the 2024 Debt Securitization. The 2024 Notes are due on April 20, 2036.

The 2024 Notes are the secured obligation of the 2024 Issuer, and the Indenture governing the 2024 Notes includes customary covenants and events of default. The 2024 Notes have not been, and will not be, registered under the Securities Act of 1933, as amended, or any state “blue sky” laws and may not be offered or sold in the United States absent registration with the Securities and Exchange Commission or applicable exemption from registration.

The Company serves as collateral manager to the 2024 Issuer under a collateral management agreement (the “Collateral Management Agreement”) and has waived any management fee due to it in consideration for providing these services.

Contractual Obligations

The following tables show the contractual maturities of our debt obligations as of March 31, 2024 and December 31, 2023 (dollar amounts in thousands):

	Payments Due by Period
As of March 31, 2024	Total		Less than 1 Year		1 to 3 years		3 to 5 years		More than 5 Years
Wells Fargo Financing Facility	$	2,500	$	—	$	2,500	$	—	$	—
SMBC Financing Facility	39,000		—		39,000		—		—
Revolving Credit Facility	12,000		—		—		12,000		—
CLO-I	342,000		—		—		—		342,000
CLO-II	215,000		—		—		—		215,000
CLO-III	215,000		—		—		—		215,000
Total debt obligations	$	825,500	$	—	$	41,500	$	12,000	$	772,000

92

	Payments Due by Period
As of December 31, 2023	Total		Less than 1 Year		1 to 3 years		3 to 5 years		More than 5 Years
Wells Fargo Financing Facility	$	231,000	$	—	$	—	$	231,000	$	—
SMBC Financing Facility	37,377		—		37,377		—		—
Revolving Credit Facility	126,500		—		—		126,500		—
CLO-I	342,000		—		—		—		342,000
CLO-II	$	215,000	$	—	$	—	$	—	$	215,000
Total debt obligations	$	951,877	$	—	$	37,377	$	357,500	$	557,000

Related-Party Transactions

We have entered into a number of business relationships with affiliated or related parties, including the following:

•the Advisory Agreement;

•the CAM Sub-Advisory Agreement;

•the NAM Sub-Advisory Agreement;

•the Administration Agreement; and

•the Expense Support Agreement.

On June 7, 2019, the SEC granted an exemptive order (the “Order”) that permits us to participate in negotiated co-investment transactions with certain other funds and accounts sponsored or managed by either of the Advisers and/or their affiliates, subject to the conditions of the Order. Pursuant to the Order, the Company is permitted to co-invest with its affiliates if a “required majority” (as defined in Section 57(o) of the 1940 Act) of the Board's independent directors make certain conclusions in connection with a co-investment transaction, including, but not limited to, that (1) the terms of the potential co-investment transaction, including the consideration to be paid, are reasonable and fair to the Company and its stockholders and do not involve overreaching in respect of the Company or its stockholders on the part of any person concerned, and (2) the potential co-investment transaction is consistent with the interests of the Company's stockholders and is consistent with its then-current investment objective and strategies. Neither we nor the affiliated funds are obligated to invest or co-invest when investment opportunities are referred to us or them.

In addition, pursuant to an exemptive order issued by the SEC on April 8, 2020 and applicable to all BDCs through December 31, 2020 (the “Temporary Relief”), the Company was permitted, subject to the satisfaction of certain conditions, to complete follow-on investments in our existing portfolio companies with certain affiliates that are private funds if such private funds did not hold an investment in such existing portfolio company. Without the Temporary Relief, such private funds would not be able to participate in such follow-on investments with us unless the private funds had previously acquired securities of the portfolio company in a co-investment transaction with the Company. Although the Temporary Relief expired on December 31, 2020, the SEC’s Division of Investment Management had indicated that until March 31, 2022, it would not recommend enforcement action, to the extent that any BDC with an existing co-investment order continues to engage in certain transactions described in the Temporary Relief, pursuant to the same terms and conditions described therein. The conditional exemptive order is no longer effective; however, on October 14, 2022, the SEC granted an exemptive order to permit the Company to continue to complete follow-on investments in its existing portfolio companies with certain affiliates that are private funds if such private funds did not hold an investment in such existing portfolio company, subject to certain conditions.

Expense Support Agreement

On December 31, 2019, we entered into the Expense Support Agreement with the Adviser. The Expense Support Agreement automatically terminated pursuant to its terms upon the consummation of the IPO on January 29, 2024. Under the Expense Support Agreement, the Adviser was able to pay certain of our expenses (each, an “Expense Payment”), provided that no portion of the payment was used to pay any of our interest expense. Such Expense Payment was made in any combination of cash or other immediately available funds no later than forty-five days after a written commitment from the Adviser to pay such expense, and/or by an offset against amounts due from us to the Adviser or its affiliates.

93

Following any calendar quarter in which Available Operating Funds (as defined below) exceeded the cumulative distributions accrued to our shareholders based on distributions declared with respect to record dates occurring in such calendar quarter (such amount referred to as the “Excess Operating Funds”), we paid such Excess Operating Funds, or a portion thereof (each, a “Reimbursement Payment”), to the Adviser until such time as all Expense Payments made by the Adviser to us within three years prior to the last business day of such calendar quarter were reimbursed. “Available Operating Fund" means the sum of (i) net investment income (including net realized short-term capital gains reduced by net realized long-term capital losses), (ii) net capital gains (including the excess of net realized long-term capital gains over net realized short-term capital losses) and (iii) dividends and other distributions paid to us on account of investments in portfolio companies (to the extent such amounts listed in clause (iii) are not included under clauses (i) and (ii) above). The amount of the Reimbursement Payment for any calendar quarter was equal the lesser of (i) the Excess Operating Funds in such quarter and (ii) the aggregate amount of all Expense Payments made by the Adviser to us within three years prior to the last business day of such calendar quarter that were not been previously reimbursed by us to the Adviser.

No Reimbursement Payment was made for any quarter if: (1) the annualized rate (based on a 365-day year) of regular cash distributions per share of common stock declared by our Board exclusive of returns of capital, distribution rate reductions due to any fees (including to a transfer agent) payable in connection with distributions, and any declared special dividends or distributions (the “Effective Rate of Distributions Per Share”) declared by us at the time of such Reimbursement Payment, was less than the Effective Rate of Distributions Per Share at the time the Expense Payment was made to which such Reimbursement Payment relates, or (2) our Operating Expense Ratio (as defined below) at the time of such Reimbursement Payment was greater than the Operating Expense Ratio at the time the Expense Payment was made to which such Reimbursement Payment related. The “Operating Expense Ratio” was calculated by dividing Operating Expenses (as defined below), less organizational and offering expenses, base management and incentive fees owed to the Adviser, and interest expense, by our net assets. “Operating Expenses” means all of our operating costs and expenses incurred, as determined in accordance with U.S. GAAP. The Adviser may waive its right to receive all or a portion of any Reimbursement Payment in any particular calendar quarter, in which case such Reimbursement Payment may be reimbursable in a future calendar quarter.

The cumulative amount of expense payments by the Adviser under the Expense Support Agreement was $2,979, of which $1,101 was reimbursed by the Company prior to the termination of the Expense Support Agreement. For the three months ended March 31, 2024, we reimbursed the Adviser for the remaining balance of $632 under the Expense Support Agreement, for previously supported expenses. As of March 31, 2024, there was no unreimbursed expense payments under the Expense Support Agreement.

Off-Balance Sheet Arrangements

In the ordinary course of its business, the Company enters into contracts or agreements that contain indemnifications or warranties. Future events could occur which may give rise to liabilities arising from these provisions against us. We believe that the likelihood of such an event is remote; however, the maximum potential exposure is unknown. No accrual has been made in these consolidated financial statements as of March 31, 2024 and December 31, 2023. We have in the past and may in the future become obligated to fund commitments such as delayed draw commitments.

For more information on our off-balance sheet arrangements, commitments and contingencies see Note 7 to the consolidated financial statements in Part I, Item 1 of this Quarterly Report Form 10-Q.

Critical Accounting Policies and Estimates

The preparation of our consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, and expenses. Changes in the economic environment, financial markets, and any other parameters used in determining such estimates could cause actual results to differ. Our critical accounting policies and estimates, including those relating to the valuation of our portfolio investments, are described below. We consider the most significant accounting policies to be those related to our Valuation of Portfolio Investments, Revenue Recognition, and U.S. Federal Income Taxes, are described below. The valuation of investments is our most significant critical estimate. The critical accounting policies and estimates should be read in connection with our risk factors as disclosed under the heading “Risk Factors” in our Annual Report on Form 10-K for year ended December 31, 2023.

Valuation of Portfolio Investments

At all times, consistent with U.S. GAAP and the 1940 Act, we conduct a valuation of our assets, pursuant to which our net asset value is determined.

94

Our assets are valued on a quarterly basis, or more frequently if required under the 1940 Act. Pursuant to Rule 2a-5 under the 1940 Act, the Board has designated the Adviser as the Company's valuation designee (the “Valuation Designee”) to determine the fair value of the Company's investments that do not have readily available market quotations, which became effective beginning with the fiscal quarter ended March 31, 2023. Pursuant to the Company's valuation policy approved by the Board, a valuation committee comprised of employees of the Adviser (the “Valuation Committee”) is responsible for determining the fair value of the Company's assets for which market quotations are not readily available, subject to the oversight of the Board.

Investments for which market quotations are readily available are typically valued at those market quotations. Market quotations are obtained from independent pricing services, where available. Generally investments marked in this manner will be marked at the mean of the bid and ask of the quotes obtained. To validate market quotations, we utilize a number of factors to determine if the quotations are representative of fair value, including the source and number of the quotations.

With respect to investments for which market quotations are not readily available, we or an independent third-party valuation firm engaged by the Valuation Designee, will take into account relevant factors in determining the fair value of our investments, including and in combination of: comparison to publicly traded securities, including factors such as yield, maturity and measures of credit quality; the enterprise value of a portfolio company; the nature and realizable value of any collateral; the portfolio company's ability to make payments and its earnings and discounted cash flows; and the markets in which the portfolio company does business. Investment performance data utilized are the most recently available financial statements and compliance certificates received from the portfolio companies as of the measurement date which in many cases may reflect a lag in information. The independent third-party valuation firm provides a fair valuation report, a description of the methodology used to determine the fair value and their analysis and calculations to support their conclusion.

When an external event such as a purchase transaction, public offering or subsequent sale or paydown occurs, we use the pricing indicated by the external event to corroborate our valuation.

U.S. GAAP establishes a hierarchical disclosure framework which ranks the level of observability of market price inputs used in measuring investments at fair value. The observability of inputs is impacted by a number of factors, including the type of investment and the characteristics specific to the investment and state of the marketplace, including the existence and transparency of transactions between market participants. Investments with readily available quoted prices or for which fair value can be measured from quoted prices in active markets generally have a higher degree of market price observability and a lesser degree of judgment applied in determining fair value. We review pricing and methodologies in order to determine if observable market information is being used, versus unobservable inputs.

Our accounting policy on the fair value of our investments is critical because the determination of fair value involves subjective judgments and estimates. Accordingly, the notes to our consolidated financial statements express the uncertainty with respect to the possible effect of these valuations, and any change in these valuations, on the consolidated financial statements.

For more information on the fair value hierarchies, our framework for determining fair value and the composition of our portfolio see Note 4 to the consolidated financial statements in Part I, Item 1 of this Quarterly Report Form 10-Q.

Revenue Recognition

Our revenue recognition policies are as follows:

Net realized gains (losses) on investments: Investment transactions are recorded on the trade date. Realized gains or losses are measured by the difference between the net proceeds from the repayment or sale and the amortized cost basis of the investment using the specific identification method.

Investment Income: Interest income, including amortization of premium and accretion of discount on loans are recorded on the accrual basis. We accrue interest income based on the effective yield if we expect that, ultimately, we will be able to collect such income. We may have loans in our portfolio that contain payment-in-kind (“PIK”) income provisions. PIK represents interest that is accrued and recorded as interest income at the contractual rates, increases the loan principal on the respective capitalization dates, and is generally due at maturity.

Other income may include income such as consent, waiver, amendment, unused, and prepayment fees associated with our investment activities as well as any fees for managerial assistance services rendered by us to our portfolio companies. Such fees are recognized as income when earned or the services are rendered.

95

Dividend income on preferred equity securities is recorded on the accrual basis to the extent that such amounts are payable by the portfolio company and are expected to be collected. Dividend income on common equity securities is recorded on the record date for private portfolio companies or on the ex-dividend date for publicly-traded portfolio companies.

Non-accrual: Generally, if a payment default occurs on a loan in the portfolio, or if management otherwise believes that the issuer of the loan will not be able to make contractual interest payments or principal payments, the Sub-Adviser will place the loan on non-accrual status and we will cease recognizing interest income on that loan until all principal and interest is current through payment or until a restructuring occurs, such that the interest income is deemed to be collectible even though we remain contractually entitled to this interest. We may make exceptions to this policy if the loan has sufficient collateral value and is in the process of collection. Accrued interest is written off when it becomes probable that the interest will not be collected and the amount of uncollectible interest can be reasonably estimated.

U.S. Federal Income Taxes

We have elected to be treated as a BDC under the 1940 Act. We have elected, and intend to qualify annually thereafter, to be treated as a RIC under the Code. So long as we maintain our qualification as a RIC, we generally will not be subject to U.S. federal income or excise taxes on any ordinary income or capital gains that we timely distribute at least annually to our stockholders as dividends. As a result, any tax liability related to income earned and distributed by us represents obligations of our stockholders and will not be reflected in our consolidated financial statements.

We evaluate tax positions taken or expected to be taken in the course of preparing our financial statements to determine whether the tax positions are “more-likely-than-not” to be sustained by the applicable tax authority. Tax positions not deemed to meet the “more-likely-than-not” threshold are reversed and recorded as a tax benefit or expense in the current year. All penalties and interest associated with income taxes are included in income tax expense. Conclusions regarding tax positions are subject to review and may be adjusted at a later date based on factors including, but not limited to, on-going analyses of tax laws, regulations and interpretations thereof. As of March 31, 2024, the Company did not have any uncertain tax positions that met the recognition or measurement criteria, nor did the Company have any unrecognized tax benefits.

Our accounting policy on income taxes is critical because if we are unable to maintain our status as a RIC, we would be required to record a provision for U.S. federal income taxes which may be significant to our financial results.

Recent Developments

On April 9, 2024, we entered into Amendment No. 1 (“Amendment No. 1”) to the Senior Secured Revolving Credit Agreement, by and among the Company, as borrower, NCDL Equity Holdings, as subsidiary guarantor, the lenders and issuing banks party thereto, SMBC, as administrative agent for the lenders. Amendment No. 1, among other things: (a) increased the maximum principal amount available under the Revolving Credit Facility from $185,000,000 to $250,000,000 pursuant to the accordian feature; and (b) replaced the interest rate benchmark for borrowings denominated in Canadian Dollars from CDOR to CORRA, which includes a credit spread adjustment of 0.29547% for one month tenor borrowings and 0.32138% for three month tenor borrowings.

On May 1, 2024, our Board declared a second quarter regular dividend of $0.45 per share payable on or around July 29, 2024 to shareholders of record as of June 28, 2024.

From April 1, 2024 through May 3, 2024, BofA Securities, Inc., as agent, has repurchased $2.1 million of shares of the Company’s common stock pursuant to the Company 10b5-1 Plan. As of May 3, 2024, the approximate dollar value of the Company’s common stock remaining to be purchased under the Company 10b5-1 Plan was $97.2 million.

96

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Uncertainty with respect to, among other things, elevated interest rates, inflationary pressures, the ongoing conflict between Russia and Ukraine, the ongoing war in the Middle East, and the failure of major financial institutions introduced significant volatility in the financial markets, and the effects of this volatility has materially impacted and could continue to materially impact our market risks, including those listed below.

Valuation Risk

We have invested, and plan to continue to invest, primarily in illiquid debt and equity securities of private companies. Most of our investments do not have a readily available market price, and we value these investments at fair value as determined in good faith by the Adviser, as the Valuation Designee, in accordance with our valuation policy subject to the oversight of the Board and, based on, among other things, the input of the independent third-party valuation firms engaged by the Valuation Designee. There is no single standard for determining fair value. As a result, determining fair value requires that judgment be applied to the specific facts and circumstances of each portfolio investment while employing a consistently applied valuation process for the types of investments we make. If we were required to liquidate a portfolio investment in a forced or liquidation sale, we may realize amounts that are different from the amounts presented and such differences could be material.

Interest Rate Risk

We are subject to interest rate risk. Interest rate risk is defined as the sensitivity of our current and future earnings to interest rate volatility, variability of spread relationships, the difference in re-pricing internals between our assets and liabilities and the effect that interest rates may have on our cash flows. Because we fund a portion of our investments with borrowings, our net investment income is affected by the difference between the rate at which we invest and the rate at which we borrow. Our net investment income is also affected by fluctuations in various interest rates, including the replacement of LIBOR with alternate rates and prime rates, to the extent our debt investments include floating interest rates. As a result, there can be no assurance that a significant change in market interest rates will not have a material adverse effect on our net investment income.

Since March 2022, the Federal Reserve has been rapidly raising interest rates bringing rates to the 5.25% to 5.50% range. The Federal Reserve left its benchmark rates steady in the first quarter of 2024, and it has indicated that any cuts to benchmark rates in the future will depend on better inflation reports. In a high interest rate environment, our cost of funds would increase, which could reduce our net investment income if there is not a corresponding increase in interest income generated by our investment portfolio. It is possible that the Federal Reserve's tightening cycle could result the United States into a recession, which would likely decrease interest rates. Conversely, a prolonged reduction in interest rates will reduce our gross investment income and could result in a decrease in our net investment income if such decreases in base rates, such as SOFR or other alternate rates, are not offset by corresponding increases in the spread over such base rate that we earn on any portfolio investments, a decrease in our operating expenses, or a decrease in the interest rate associated with our borrowings.

97

As of March 31, 2024, on a fair value basis, approximately 5.31% of our debt investments bear interest at a fixed rate and approximately 94.69% of our debt investments bear interest at a floating rate. As of March 31, 2024, 98.71% of our floating rate debt investments are subject to interest rate floors. Our credit facilities along with our debt issued in our collateralized loan obligations are also subject to floating interest rates and are currently paid based on floating SOFR rates.

The following table estimates the potential changes in net cash flow generated from interest income and expenses, should interest rates increase or decrease by 100, 200 or 300 basis points. Interest income is calculated as revenue from interest generated from our portfolio of investments held on March 31, 2024. Interest expense is calculated based on the terms of the credit facilities and the collateralized loan obligations using the outstanding balance as of March 31, 2024. Interest expense on the credit facilities and the debt issued in our collateralized loan obligations is calculated using the interest rate as of March 31, 2024, adjusted for the impact of hypothetical changes in rates, as shown below. The base interest rate case assumes the rates on our portfolio investments remain unchanged from the actual effective interest rates as of March 31, 2024.

Actual results could differ significantly from those estimated in the table (dollars amounts in thousands).

Changes in Interest Rates	Interest Income		Interest Expense		Net Income
-300 Basis Points	$	(12,738)	$	(6,174)	$	(6,564)
-200 Basis Points	$	(8,492)	$	(4,116)	$	(4,376)
-100 Basis Points	$	(4,246)	$	(2,058)	$	(2,188)
Base Interest Rate	$	—	$	—	$	—
+100 Basis Points	$	4,246	$	2,058	$	2,188
+200 Basis Points	$	8,492	$	4,116	$	4,376
+300 Basis Points	$	12,739	$	6,174	$	6,565

98

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

In accordance with Rules 13a-15(b) and 15d-15(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), we, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, carried out an evaluation of the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) and Rule 15d-15(e) of the Exchange Act) as of the end of the period covered by this Quarterly Report on Form 10-Q.

Based on that evaluation, we, including the Chief Executive Officer and Chief Financial Officer, concluded that our disclosure controls and procedures were effective as of March 31, 2024 and provided reasonable assurance that information required to be disclosed in our periodic SEC filings is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. However, in evaluating the disclosure controls and procedures, we recognize that any controls and procedures, no matter how well designed and operated can provide only reasonable assurance of achieving the desired control objectives, and management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of such possible controls and procedures.

Changes in Internal Controls Over Financial Reporting

There have been no changes in our internal control over financial reporting that occurred during our most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

99

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

We, and our consolidated subsidiaries, the Adviser and the Sub-Adviser are not currently subject to any material legal proceedings, nor, to our knowledge, are any material legal proceedings threatened against us or them. From time to time, we, our consolidated subsidiaries and/or the Adviser and Sub-Adviser may be a party to certain legal proceedings in the ordinary course of business, including proceedings relating to the enforcement of our rights under contracts with our portfolio companies. Our business also is subject to extensive regulation, which may result in regulatory proceedings against us.

ITEM 1A. RISK FACTORS

There have been no material changes to the risk factors previously disclosed under Item 1A in our Annual Report on Form 10-K for the year ended December 31, 2023. For a discussion of our potential risks and uncertainties, see the information under the heading “Risk Factors” in our Annual Report on Form 10-K filed with the SEC on February 27, 2024, which is accessible on the SEC’s website at sec.gov.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Sales of Unregistered Securities

Except as previously reported by us on our Current Reports on Form 8-K, we did not sell any securities during the period covered by this Quarterly Report on Form 10-Q that were not registered under the Securities Act of 1933, as amended.

Issuer Purchases of Equity Securities

On March 5, 2024, the Company entered into a share repurchase plan (the “Company 10b5-1 Plan”), pursuant to which the Company may purchase up to $99,275,000 in the aggregate of its outstanding shares of common stock in the open market at prices below its NAV per share over a specified period. Any purchase of the shares pursuant to the Company 10b5-1 Plan will be conducted in accordance with the guidelines and conditions of Rule 10b-18 and Rule 10b5-1 of the Exchange Act. The Company adopted the Company 10b5-1 Plan because it believes that, if its common stock is trading below its then-current NAV per share, it will be in the best interest of its stockholders for the Company to reinvest in its portfolio.

The Company 10b5-1 Plan is designed to allow the Company to repurchase its shares of common stock at times when the Company otherwise might be prevented from doing so under insider trading laws. The Company 10b5-1 Plan requires BofA Securities, Inc., as agent, to repurchase shares of common stock on the Company's behalf when the market price per share is below the most recently reported NAV per share (including any updates, corrections or adjustments publicly announced by the Company to any previously announced NAV per share). Under the Company 10b5-1 Plan, the agent will increase the volume of purchases made as the price of the shares of the Company's common stock declines, subject to volume restrictions. The timing and amount of any share repurchases will depend on the terms and conditions of the Company 10b5-1 Plan, the market price of the shares of the Company's common stock and trading volumes, and no assurance can be given that any particular amount of shares of the common stock will be repurchased.

The purchase of shares of common stock pursuant to the Company 10b5-1 Plan is intended to satisfy the conditions of Rule 10b5-1 and Rule 10b-18 under the Exchange Act, and will otherwise be subject to applicable law, including Regulation M, which may prohibit purchases under certain circumstances.

The Company 10b5-1 Plan became effective on March 29, 2024 and commenced on April 1, 2024. The 10b5-1 Plan will terminate upon the earliest to occur of (i) 12-months from the effective date (tolled for periods during which the Company 10b5-1 Plan is suspended), (ii) the end of the trading day on which the aggregate purchase price for all shares of common stock purchased under the Company 10b5-1 Plan equals $99,275,000 and (iii) the occurrence of certain other events described in the Company 10b5-1 Plan.

During the three months ended March 31, 2024, the Company did not repurchase any shares under the Company 10b5-1 Plan.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

100

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

(a)None.

(b)None.

(c)For the period covered by this Quarterly Report on Form 10-Q, no director or officer of the Company has entered into any (i) contract, instruction or written plan for the purchase or sale of securities of the Company intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act or (ii) any non-Rule 10b5-1 trading arrangement.

101

ITEM 6. EXHIBITS

3.1	Articles of Amendment and Restatement (1)
3.2	Articles of Amendment (2)
3.3	Bylaws (2)
3.4	Certificate of Merger of Churchill Middle Market CLO V Ltd. (1)
4.1	Form of Subscription Agreement (1)
4.2	Form of Stock Certificate (1)
10.1	Indenture, dated as of March 14, 2024, by and between Churchill NCDLC CLO-III, LLC, as issuer, and U.S. Bank Trust Company, National Association, as trustee (3)
10.2	Collateral Management Agreement, dated as of March 14, 2024, by and between Churchill NCDLC CLO-III, LLC, as issuer, and Nuveen Churchill Direct Lending Corp., as collateral manager (3)
10.3	Third Amendment to Loan and Security Agreement, dated as of March 14, 2024, by and among Nuveen Churchill BDC SPV V, LLC, as borrower, Nuveen Churchill Direct Lending Corp, as the collateral manager and the equity investor, and Wells Fargo Bank National Association, as administrative agent and lender (3)
10.4	Amendment No. 1 to Senior Secured Revolving Credit Agreement, dated as of April 9, 2024, by and among Nuveen Churchill Direct Lending Corp., as borrower, NCDL Equity Holdings LLC, as subsidiary guarantor, the lenders and issuing banks party thereto, Sumitomo Mitsui Banking Corporation, as administrative agent for the lenders (4)
31.1	Certification of Chief Executive Officer pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as amended*
31.2	Certification of Chief Financial Officer pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as amended*
32	Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, as amended*
101.INS	Inline XBRL Instance Document
101.SCH	Inline XBRL Taxonomy Extension Schema Document
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document
104	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

*Filed herewith.

(1)Previously filed on January 29, 2020 with Amendment No. 1 to the Company’s Registration Statement on Form 10 (File No. 000-56133) and incorporated by reference herein.

(2)Previously filed on June 2, 2020 with the Company's Current Report on Form 8-K and incorporated by reference herein.

(3)Previously filed on March 20, 2024 with the Company's Current Report on Form 8-K and incorporated by reference herein.

(4)Previously filed on April 15, 2024 with the Company's Current Report on Form 8-K and incorporated by reference herein.

102

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Nuveen Churchill Direct Lending Corp.
By:	/s/ Kenneth Kencel
	Name: Kenneth Kencel
	Title: President and Chief Executive Officer

By:	/s/ Shai Vichness
	Name: Shai Vichness
	Title: Chief Financial Officer and Treasurer

Date: May 9, 2024

103

EX-31.1

Exhibit 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Kenneth Kencel, Chief Executive Officer of Nuveen Churchill Direct Lending Corp., certify that:

1.I have reviewed this quarterly report on Form 10-Q of Nuveen Churchill Direct Lending Corp.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in the Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a.all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b.any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:	May 9, 2024	By:	/s/ Kenneth Kencel
			Name: Kenneth Kencel
			Title: President and Chief Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Shai Vichness, Chief Financial Officer of Nuveen Churchill Direct Lending Corp., certify that:

1.I have reviewed this quarterly report on Form 10-Q of Nuveen Churchill Direct Lending Corp.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in the Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a.all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b.any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:	May 9, 2024	By:	/s/ Shai Vichness
			Name: Shai Vichness
			Title: Chief Financial Officer and Treasurer

EX-32

Exhibit 32

CERTIFICATION PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (18 U.S.C. 1350)

In connection with the quarterly report of Nuveen Churchill Direct Lending Corp. on Form 10-Q for the period ended March 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), each of the undersigned officers of Nuveen Churchill Direct Lending Corp. does hereby certify, to the best of such officer's knowledge and belief, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1.The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Nuveen Churchill Direct Lending Corp.

Date:	May 9, 2024
	/s/ Kenneth Kencel
	Name: Kenneth Kencel
	Title: President and Chief Executive Officer

Date:	May 9, 2024
	/s/ Shai Vichness
	Name: Shai Vichness
	Title: Chief Financial Officer and Treasurer

XML

Cover - shares	3 Months Ended
	Mar. 31, 2024	May 08, 2024
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2024
Document Transition Report	false
Securities Act File Number	000-56133
Entity Registrant Name	NUVEEN CHURCHILL DIRECT LENDING CORP.
Entity Incorporation, State or Country Code	MD
Entity Tax Identification Number	84-3613224
Entity Address, Address Line One	375 Park Avenue, 9th Floor
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10152
City Area Code	212
Local Phone Number	478-9200
Title of 12(b) Security	Common Stock, par value $0.01
Trading Symbol	NCDL
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		55,037,886
Entity Central Index Key	0001737924
Current Fiscal Year End Date	--12-31
Entity Amendment Flag	false
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q1

XML

CONSOLIDATED STATEMENTS OF ASSETS AND LIABILITIES - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Investments
Non-controlled/non-affiliated company investments, at fair value (amortized cost of $1,814,985 and $1,666,169, respectively)	$ 1,794,559	$ 1,641,686
Cash and cash equivalents	64,146	67,395
Restricted cash	50	50
Interest receivable	16,067	17,674
Receivable for investments sold	422	3,919
Prepaid expenses	118	13
Other assets	125	127
Total assets	1,875,487	1,730,864
Liabilities
Secured borrowings (net of $8,286 and $7,941 deferred financing costs, respectively) (See Note 6)	817,214	943,936
Payable for investments purchased	16,877	0
Interest payable	11,022	9,837
Due to adviser expense support (See Note 5)	0	632
Management fees payable	3,264	3,006
Distributions payable	24,684	22,683
Directors’ fees payable	128	96
Accounts payable and accrued expenses	4,065	2,789
Total liabilities	877,254	982,979
Commitments and contingencies (See Note 7)
Net Assets: (See Note 8)
Common shares, $0.01 par value, 500,000,000 and 500,000,000 shares authorized, 54,815,740 and 41,242,105 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively	548	412
Paid-in-capital in excess of par value	1,021,573	776,719
Total distributable earnings (loss)	(23,888)	(29,246)
Total net assets	998,233	747,885
Total liabilities and net assets	$ 1,875,487	$ 1,730,864
Net asset value per share (in dollars per share)	$ 18.21	$ 18.13
Non-controlled/Non-affiliated
Investments
Non-controlled/non-affiliated company investments, at fair value (amortized cost of $1,814,985 and $1,666,169, respectively)	$ 1,794,559	$ 1,641,686

XML

CONSOLIDATED STATEMENTS OF ASSETS AND LIABILITIES (Parenthetical) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Amortized Cost	$ 1,814,985	$ 1,666,169
Deferred financing costs	$ 8,286	$ 7,941
Common stock, par value per share (in dollars per share)	$ 0.01	$ 0.01
Common shares, shares authorized (in shares)	500,000,000	500,000,000
Common shares, shares issued (in shares)	54,815,740	41,242,105
Common shares, shares outstanding (in shares)	54,815,740	41,242,105
Non-controlled/Non-affiliated
Amortized Cost	$ 1,814,985	$ 1,666,169

XML

CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Investment income:
Payment-in-kind interest income	$ 1,992	$ 321
Dividend income	308	16
Other income	217	236
Expenses:
Interest and debt financing expenses	16,941	12,743
Management fees (See Note 5)	3,264	2,306
Incentive fees on net investment income	4,459	0
Professional fees	710	590
Directors' fees	128	96
Administration fees (See Note 5)	542	309
Other general and administrative expenses	277	171
Total expenses before expense support and Incentive fees waived	26,321	16,215
Expense support (See Note 5)	0	(14)
Incentive fees waived (See Note 5)	(4,459)	0
Net Expenses	21,862	16,201
Net investment income	29,733	17,759
Realized and unrealized gain (loss) on investments:
Net realized gain (loss) on non-controlled/non-affiliated company investments	(3,625)	6,481
Net change in unrealized appreciation (depreciation):
Non-controlled/non-affiliated company investments	4,057	(11,137)
Net increase (decrease) in net assets resulting from operations	$ 30,024	$ 12,717
Per share data:
Net investment income per share - basic (in dollars per share)	$ 0.56	$ 0.62
Net investment income per share - diluted (in dollars per share)	0.56	0.62
Net increase (decrease) in net assets resulting from operations per share - basic and diluted (in dollars per share)	$ 0.57	$ 0.44
Weighted average common shares outstanding - basic (in shares)	52,758,353,000	28,727,285,000
Weighted average common shares outstanding - diluted (in shares)	52,758,353,000	28,727,285,000
Non-controlled/Non-affiliated
Investment income:
Interest income	$ 49,078	$ 33,387
Payment-in-kind interest income	1,992	321
Dividend income	308	16
Other income	217	236
Total investment income	51,595	33,960
Realized and unrealized gain (loss) on investments:
Net realized gain (loss) on non-controlled/non-affiliated company investments	(3,625)	6,481
Net change in unrealized appreciation (depreciation):
Non-controlled/non-affiliated company investments	4,057	(11,137)
Income tax (provision) benefit	(141)	(386)
Total net change in unrealized gain (loss)	3,916	(11,523)
Total net realized and unrealized gain (loss) on investments	$ 291	$ (5,042)

XML

CONSOLIDATED STATEMENTS OF CHANGES IN NET ASSETS (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Increase (decrease) in net assets resulting from operations:
Net investment income	$ 29,733	$ 17,759
Net realized gain (loss) on investments	(3,625)	6,481
Net change in unrealized appreciation (depreciation) on investments	3,916	(11,523)
Net increase (decrease) in net assets resulting from operations	30,024	12,717
Shareholder distributions:
Distributions declared from net investment income	(24,667)	(21,845)
Net increase (decrease) in net assets resulting from shareholder distributions	(24,667)	(21,845)
Capital share transactions:
Issuance of common shares, net	241,657	0
Reinvestment of shareholder distributions, net	3,334	1,715
Net increase (decrease) in net assets resulting from capital share transactions	244,991	1,715
Total increase (decrease) in net assets	250,348	(7,413)
Net assets, at beginning of period	747,885	524,957
Net assets, at end of period	$ 998,233	$ 517,544

XML

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash flows from operating activities:
Net increase (decrease) in net assets resulting from operations	$ 30,024	$ 12,717
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities
Purchase of investments	(204,329)	(99,914)
Proceeds from principal repayments and sales of investments	54,896	39,602
Payment-in-kind interest	(1,992)	(321)
Amortization of premium/accretion of discount, net	(1,016)	(905)
Net realized (gain) loss on investments	3,625	(6,481)
Net change in unrealized (appreciation) depreciation on investments	(4,057)	11,137
Amortization of deferred financing costs	1,296	435
Amortization of offering costs	0	(15)
Changes in operating assets and liabilities:
Due from adviser expense support	0	182
Interest receivable	1,607	(2)
Receivable for investments sold	3,497	98
Prepaid expenses	(105)	(85)
Other assets	2	0
Payable for investments purchased	16,877	0
Interest payable	1,185	1,345
Due to adviser expense support	(632)	(182)
Management fees payable	258	95
Directors’ fees payable	32	0
Accounts payable and accrued expenses	1,276	1,229
Net cash provided by (used in) operating activities	(97,556)	(41,065)
Cash flows from financing activities:
Proceeds from issuance of common shares	241,657	473
Shareholder distributions	(19,332)	(12,610)
Proceeds from secured borrowings	323,000	85,000
Repayments of secured borrowings	(449,377)	(21,500)
Payments of deferred financing costs	(1,641)	0
Net cash provided by (used in) financing activities	94,307	51,363
Net increase (decrease) in Cash and Cash Equivalents and Restricted Cash	(3,249)	10,298
Cash and Cash Equivalents and Restricted Cash, beginning of period	67,445	39,320
Cash and Cash Equivalents and Restricted Cash, end of period	64,196	49,618
Supplemental disclosure of cash flow information:
Cash paid during the period for interest	14,460	10,963
Cash paid during the period for excise taxes	6	0
Supplemental disclosure of non-cash flow Information:
Reinvestment of shareholder distributions	3,334	1,730
Reconciliation of cash and cash equivalents and restricted cash
Cash and cash equivalents	64,146	49,568
Restricted cash	50	50
Total cash and cash equivalents and restricted cash shown on the Consolidated Statements of Cash Flows	$ 64,196	$ 49,618

XML

CONSOLIDATED SCHEDULE OF INVESTMENTS - USD ($) $ in Thousands		Mar. 31, 2024		Dec. 31, 2023
Schedule of Investments [Line Items]
Spread Above Reference Rate	[1],[2],[3],[4]			6.25%
Interest Rate, PIK	[5],[6]	4.00%
Amortized Cost		$ 1,867,758		$ 1,730,646
Fair Value		$ 1,847,332	[7]	$ 1,706,163	[8]
Fair Value as % of Net Assets		185.06%	[9]	228.13%	[10]
Debt Investments
Schedule of Investments [Line Items]
Amortized Cost		$ 1,788,967		$ 1,640,574
Fair Value		$ 1,762,854	[7]	$ 1,610,879	[8]
Fair Value as % of Net Assets		176.60%	[9]	215.39%	[10]
Equity Investments
Schedule of Investments [Line Items]
Amortized Cost		$ 26,018		$ 25,595
Fair Value		$ 31,705	[7]	$ 30,807	[8]
Fair Value as % of Net Assets		3.18%	[9]	4.12%	[10]
Cash Equivalents
Schedule of Investments [Line Items]
Amortized Cost		$ 52,773		$ 64,477
Fair Value		$ 52,773	[7]	$ 64,477	[8]
Fair Value as % of Net Assets		5.28%	[9]	8.62%	[10]
Aerospace & Defense | Debt Investments
Schedule of Investments [Line Items]
Amortized Cost		$ 53,582		$ 50,644
Fair Value		$ 53,265	[7]	$ 49,851	[8]
Fair Value as % of Net Assets		5.34%	[9]	6.67%	[10]
Aerospace & Defense | Equity Investments
Schedule of Investments [Line Items]
Amortized Cost		$ 1,530		$ 1,530
Fair Value		$ 1,859	[7]	$ 1,614	[8]
Fair Value as % of Net Assets		0.19%	[9]	0.22%	[10]
Automotive | Debt Investments
Schedule of Investments [Line Items]
Amortized Cost		$ 70,395		$ 82,339
Fair Value		$ 68,020	[7]	$ 80,284	[8]
Fair Value as % of Net Assets		6.81%	[9]	10.73%	[10]
Automotive | Equity Investments
Schedule of Investments [Line Items]
Amortized Cost		$ 1,528		$ 1,528
Fair Value		$ 972	[7]	$ 1,021	[8]
Fair Value as % of Net Assets		0.10%	[9]	0.14%	[10]
Banking, Finance, Insurance, Real Estate | Debt Investments
Schedule of Investments [Line Items]
Amortized Cost		$ 66,603		$ 66,633
Fair Value		$ 64,593	[7]	$ 64,923	[8]
Fair Value as % of Net Assets		6.47%	[9]	8.68%	[10]
Beverage, Food & Tobacco | Debt Investments
Schedule of Investments [Line Items]
Amortized Cost		$ 127,610		$ 124,399
Fair Value		$ 127,014	[7]	$ 123,423	[8]
Fair Value as % of Net Assets		12.72%	[9]	16.50%	[10]
Beverage, Food & Tobacco | Equity Investments
Schedule of Investments [Line Items]
Amortized Cost		$ 3,499		$ 3,481
Fair Value		$ 4,026	[7]	$ 3,912	[8]
Fair Value as % of Net Assets		0.40%	[9]	0.52%	[10]
Capital Equipment | Debt Investments
Schedule of Investments [Line Items]
Amortized Cost		$ 75,069		$ 62,328
Fair Value		$ 74,940	[7]	$ 61,803	[8]
Fair Value as % of Net Assets		7.51%	[9]	8.26%	[10]
Capital Equipment | Equity Investments
Schedule of Investments [Line Items]
Amortized Cost		$ 4,427		$ 4,427
Fair Value		$ 8,026	[7]	$ 7,324	[8]
Fair Value as % of Net Assets		0.80%	[9]	0.98%	[10]
Chemicals, Plastics, & Rubber | Debt Investments
Schedule of Investments [Line Items]
Amortized Cost		$ 32,481		$ 41,481
Fair Value		$ 28,908	[7]	$ 37,535	[8]
Fair Value as % of Net Assets		2.90%	[9]	5.02%	[10]
Construction & Building | Debt Investments
Schedule of Investments [Line Items]
Amortized Cost		$ 78,713		$ 61,992
Fair Value		$ 78,744	[7]	$ 61,958	[8]
Fair Value as % of Net Assets		7.89%	[9]	8.28%	[10]
Construction & Building | Equity Investments
Schedule of Investments [Line Items]
Amortized Cost		$ 1,161		$ 1,161
Fair Value		$ 1,970	[7]	$ 2,055	[8]
Fair Value as % of Net Assets		0.19%	[9]	0.27%	[10]
Consumer Goods: Durable | Debt Investments
Schedule of Investments [Line Items]
Amortized Cost		$ 20,331		$ 30,122
Fair Value		$ 18,886	[7]	$ 24,814	[8]
Fair Value as % of Net Assets		1.89%	[9]	3.32%	[10]
Consumer Goods: Non-durable | Debt Investments
Schedule of Investments [Line Items]
Amortized Cost		$ 59,439		$ 55,909
Fair Value		$ 58,802	[7]	$ 54,134	[8]
Fair Value as % of Net Assets		5.89%	[9]	7.24%	[10]
Consumer Goods: Non-durable | Equity Investments
Schedule of Investments [Line Items]
Amortized Cost		$ 273		$ 273
Fair Value		$ 262	[7]	$ 209	[8]
Fair Value as % of Net Assets		0.03%	[9]	0.03%	[10]
Containers, Packaging & Glass | Debt Investments
Schedule of Investments [Line Items]
Amortized Cost		$ 69,278		$ 64,852
Fair Value		$ 69,080	[7]	$ 64,328	[8]
Fair Value as % of Net Assets		6.92%	[9]	8.60%	[10]
Containers, Packaging & Glass | Equity Investments
Schedule of Investments [Line Items]
Amortized Cost		$ 1,171		$ 1,171
Fair Value		$ 783	[7]	$ 822	[8]
Fair Value as % of Net Assets		0.08%	[9]	0.11%	[10]
Energy: Electricity | Debt Investments
Schedule of Investments [Line Items]
Amortized Cost		$ 28,773		$ 28,825
Fair Value		$ 28,897	[7]	$ 28,728	[8]
Fair Value as % of Net Assets		2.89%	[9]	3.84%	[10]
Environmental Industries | Debt Investments
Schedule of Investments [Line Items]
Amortized Cost		$ 56,625		$ 44,853
Fair Value		$ 56,676	[7]	$ 44,758	[8]
Fair Value as % of Net Assets		5.68%	[9]	5.98%	[10]
Healthcare & Pharmaceuticals | Debt Investments
Schedule of Investments [Line Items]
Amortized Cost		$ 219,124		$ 210,326
Fair Value		$ 212,164	[7]	$ 207,327	[8]
Fair Value as % of Net Assets		21.26%	[9]	27.72%	[10]
Healthcare & Pharmaceuticals | Equity Investments
Schedule of Investments [Line Items]
Amortized Cost		$ 2,102		$ 2,102
Fair Value		$ 1,345	[7]	$ 1,251	[8]
Fair Value as % of Net Assets		0.13%	[9]	0.17%	[10]
High Tech Industries
Schedule of Investments [Line Items]
Amortized Cost				$ 835
Fair Value	[8]			$ 1,460
Fair Value as % of Net Assets	[10]			0.20%
High Tech Industries | Debt Investments
Schedule of Investments [Line Items]
Amortized Cost		$ 190,718		$ 147,765
Fair Value		$ 189,312	[7]	$ 145,702	[8]
Fair Value as % of Net Assets		18.96%	[9]	19.48%	[10]
High Tech Industries | Equity Investments
Schedule of Investments [Line Items]
Amortized Cost		$ 835
Fair Value	[7]	$ 1,560
Fair Value as % of Net Assets	[9]	0.16%
Media: Advertising, Printing & Publishing | Debt Investments
Schedule of Investments [Line Items]
Amortized Cost		$ 18,975		$ 19,017
Fair Value		$ 18,582	[7]	$ 18,452	[8]
Fair Value as % of Net Assets		1.86%	[9]	2.47%	[10]
Media: Diversified & Production | Debt Investments
Schedule of Investments [Line Items]
Amortized Cost		$ 16,903		$ 16,791
Fair Value		$ 15,672	[7]	$ 15,818	[8]
Fair Value as % of Net Assets		1.57%	[9]	2.12%	[10]
Retail | Debt Investments
Schedule of Investments [Line Items]
Amortized Cost		$ 5,834		$ 5,850
Fair Value		$ 5,789	[7]	$ 5,747	[8]
Fair Value as % of Net Assets		0.59%	[9]	0.77%	[10]
Services: Business | Debt Investments
Schedule of Investments [Line Items]
Amortized Cost		$ 340,283		$ 302,368
Fair Value		$ 337,940	[7]	$ 298,732	[8]
Fair Value as % of Net Assets		33.85%	[9]	39.94%	[10]
Services: Business | Equity Investments
Schedule of Investments [Line Items]
Amortized Cost		$ 4,099		$ 4,099
Fair Value		$ 3,453	[7]	$ 3,613	[8]
Fair Value as % of Net Assets		0.34%	[9]	0.48%	[10]
Services: Consumer | Debt Investments
Schedule of Investments [Line Items]
Amortized Cost		$ 87,189		$ 77,979
Fair Value		$ 86,340	[7]	$ 76,923	[8]
Fair Value as % of Net Assets		8.65%	[9]	10.29%	[10]
Services: Consumer | Equity Investments
Schedule of Investments [Line Items]
Amortized Cost		$ 2,629		$ 2,629
Fair Value		$ 3,052	[7]	$ 2,940	[8]
Fair Value as % of Net Assets		0.31%	[9]	0.39%	[10]
Sovereign & Public Finance | Debt Investments
Schedule of Investments [Line Items]
Amortized Cost		$ 12,125		$ 9,218
Fair Value		$ 12,174	[7]	$ 9,329	[8]
Fair Value as % of Net Assets		1.22%	[9]	1.25%	[10]
Sovereign & Public Finance | Equity Investments
Schedule of Investments [Line Items]
Amortized Cost		$ 634		$ 634
Fair Value		$ 1,421	[7]	$ 1,370	[8]
Fair Value as % of Net Assets		0.14%	[9]	0.18%	[10]
Telecommunications | Debt Investments
Schedule of Investments [Line Items]
Amortized Cost		$ 52,696		$ 52,901
Fair Value		$ 52,240	[7]	$ 52,116	[8]
Fair Value as % of Net Assets		5.23%	[9]	6.97%	[10]
Transportation: Cargo | Debt Investments
Schedule of Investments [Line Items]
Amortized Cost		$ 54,005		$ 50,134
Fair Value		$ 52,281	[7]	$ 49,851	[8]
Fair Value as % of Net Assets		5.24%	[9]	6.67%	[10]
Transportation: Cargo | Equity Investments
Schedule of Investments [Line Items]
Amortized Cost		$ 1,271		$ 1,271
Fair Value		$ 2,152	[7]	$ 2,746	[8]
Fair Value as % of Net Assets		0.22%	[9]	0.36%	[10]
Transportation: Consumer | Debt Investments
Schedule of Investments [Line Items]
Amortized Cost		$ 12,612		$ 2,027
Fair Value		$ 12,542	[7]	$ 2,026	[8]
Fair Value as % of Net Assets		1.26%	[9]	0.27%	[10]
Transportation: Consumer | Equity Investments
Schedule of Investments [Line Items]
Amortized Cost		$ 101		$ 174
Fair Value		$ 82	[7]	$ 189	[8]
Fair Value as % of Net Assets		0.01%	[9]	0.03%	[10]
Utilities: Electric | Debt Investments
Schedule of Investments [Line Items]
Amortized Cost		$ 14,230		$ 14,238
Fair Value		$ 14,286	[7]	$ 14,352	[8]
Fair Value as % of Net Assets		1.43%	[9]	1.92%	[10]
Utilities: Electric | Equity Investments
Schedule of Investments [Line Items]
Amortized Cost		$ 280		$ 280
Fair Value		$ 264	[7]	$ 281	[8]
Fair Value as % of Net Assets		0.03%	[9]	0.04%	[10]
Utilities: Water | Debt Investments
Schedule of Investments [Line Items]
Amortized Cost		$ 7,822
Fair Value	[7]	$ 7,792
Fair Value as % of Net Assets	[9]	0.78%
Utilities: Water | Equity Investments
Schedule of Investments [Line Items]
Amortized Cost		$ 478
Fair Value	[7]	$ 478
Fair Value as % of Net Assets	[9]	0.05%
Wholesale | Debt Investments
Schedule of Investments [Line Items]
Amortized Cost		$ 17,552		$ 17,583
Fair Value		$ 17,915	[7]	$ 17,965	[8]
Fair Value as % of Net Assets		1.79%	[9]	2.40%	[10]
Investment, Identifier [Axis]: 360 Training
Schedule of Investments [Line Items]
Spread Above Reference Rate	[6],[11]	5.00%
Interest Rate	[6],[11]	10.33%
Par Amount	[11]	$ 3,465
Amortized Cost	[11]	3,431
Fair Value	[7],[11]	$ 3,431
Fair Value as % of Net Assets	[9],[11]	0.34%
Investment, Identifier [Axis]: 360 Training (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6],[12]	5.00%
Interest Rate	[5],[6],[12]	10.33%
Par Amount	[5],[12]	$ 3,093
Amortized Cost	[5],[12]	0
Fair Value	[5],[7],[12]	$ (30)
Fair Value as % of Net Assets	[5],[9],[12]	0.00%
Investment, Identifier [Axis]: ADPD Holdings, LLC (a/k/a NearU)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[1],[2],[3],[4],[13]			6.00%
Interest Rate	[1],[2],[3],[4],[13]			11.68%
Par Amount	[1],[2],[3],[13]			$ 8,474
Amortized Cost	[1],[2],[3],[13]			8,474
Fair Value	[1],[2],[3],[8],[13]			$ 7,920
Fair Value as % of Net Assets	[1],[2],[3],[10],[13]			1.06%
Investment, Identifier [Axis]: ADPD Holdings, LLC (a/k/a NearU) (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[2],[4],[13],[14]			6.00%
Interest Rate	[2],[4],[13],[14]			11.68%
Par Amount	[2],[13],[14]			$ 1,577
Amortized Cost	[2],[13],[14]			0
Fair Value	[2],[8],[13],[14]			$ (103)
Fair Value as % of Net Assets	[2],[10],[13],[14]			(0.01%)
Investment, Identifier [Axis]: ADPD Holdings, LLC (a/k/a NearU) (Delayed Draw) 1
Schedule of Investments [Line Items]
Spread Above Reference Rate	[2],[4],[13],[14]			6.00%
Interest Rate	[2],[4],[13],[14]			11.68%
Par Amount	[2],[13],[14]			$ 1,714
Amortized Cost	[2],[13],[14]			0
Fair Value	[2],[8],[13],[14]			$ (112)
Fair Value as % of Net Assets	[2],[10],[13],[14]			(0.01%)
Investment, Identifier [Axis]: ADPD Holdings, LLC (a/k/a NearU) 1
Schedule of Investments [Line Items]
Amortized Cost	[2],[13],[15],[16]			$ 243
Fair Value	[2],[8],[13],[15],[16]			$ 156
Fair Value as % of Net Assets	[2],[10],[13],[15],[16]			0.02%
Shares/Units	[2],[13],[15],[16]			2,432,000
Investment, Identifier [Axis]: AEgis Technologies
Schedule of Investments [Line Items]
Spread Above Reference Rate	[1],[2],[3],[4]			6.50%
Interest Rate	[1],[2],[3],[4]			12.04%
Par Amount	[1],[2],[3]			$ 14,657
Amortized Cost	[1],[2],[3]			14,592
Fair Value	[1],[2],[3],[8]			$ 14,311
Fair Value as % of Net Assets	[1],[2],[3],[10]			1.91%
Investment, Identifier [Axis]: AEgis Technologies 1
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6],[11],[17]	4.75%
Interest Rate	[5],[6],[11],[17]	10.05%
Par Amount	[5],[11],[17]	$ 14,623
Amortized Cost	[5],[11],[17]	14,570
Fair Value	[5],[7],[11],[17]	$ 14,483
Fair Value as % of Net Assets	[5],[9],[11],[17]	1.45%
Investment, Identifier [Axis]: AEgis Technologies 2
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6],[11],[17]	4.75%
Interest Rate	[5],[6],[11],[17]	10.05%
Par Amount	[5],[11],[17]	$ 3,038
Amortized Cost	[5],[11],[17]	3,009
Fair Value	[5],[7],[11],[17]	$ 3,009
Fair Value as % of Net Assets	[5],[9],[11],[17]	0.30%
Investment, Identifier [Axis]: AG MDC Holdings, Inc
Schedule of Investments [Line Items]
Amortized Cost		$ 245	[5],[18],[19]	$ 245	[2],[15],[16],[20]
Fair Value		$ 204	[5],[7],[18],[19]	$ 177	[2],[8],[15],[16],[20]
Fair Value as % of Net Assets		0.02%	[5],[9],[18],[19]	0.02%	[2],[10],[15],[16],[20]
Shares/Units		245	[5],[18],[19]	245,000	[2],[15],[16],[20]
Investment, Identifier [Axis]: AIT Logistics
Schedule of Investments [Line Items]
Spread Above Reference Rate	[6],[17],[21]	4.75%
Interest Rate	[6],[17],[21]	10.17%
Par Amount	[17],[21]	$ 1,281
Amortized Cost	[17],[21]	1,280
Fair Value	[7],[17],[21]	$ 1,286
Fair Value as % of Net Assets	[9],[17],[21]	0.13%
Investment, Identifier [Axis]: ALKU Intermediate Holdings, LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.25%	[5],[6],[11]	6.25%	[1],[2],[4]
Interest Rate		11.58%	[5],[6],[11]	11.61%	[1],[2],[4]
Par Amount		$ 4,508	[5],[11]	$ 4,519	[1],[2]
Amortized Cost		4,428	[5],[11]	4,434	[1],[2]
Fair Value		$ 4,553	[5],[7],[11]	$ 4,480	[1],[2],[8]
Fair Value as % of Net Assets		0.46%	[5],[9],[11]	0.60%	[1],[2],[10]
Investment, Identifier [Axis]: ARMstrong
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6],[11],[17]	6.25%
Interest Rate		11.66%	[5],[6],[11],[17]	11.70%	[1],[2],[3],[4]
Par Amount		$ 11,418	[5],[11],[17]	$ 11,447	[1],[2],[3]
Amortized Cost		11,256	[5],[11],[17]	11,279	[1],[2],[3]
Fair Value		$ 11,371	[5],[7],[11],[17]	$ 11,284	[1],[2],[3],[8]
Fair Value as % of Net Assets		1.13%	[5],[9],[11],[17]	1.51%	[1],[2],[3],[10]
Investment, Identifier [Axis]: ARMstrong (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.25%	[5],[6],[12]	6.25%	[2],[4],[14]
Interest Rate		11.66%	[5],[6],[12]	11.70%	[2],[4],[14]
Par Amount		$ 3,847	[5],[12]	$ 3,847	[2],[14]
Amortized Cost		(27)	[5],[12]	(28)	[2],[14]
Fair Value		$ (16)	[5],[7],[12]	$ (55)	[2],[8],[14]
Fair Value as % of Net Assets		0.00%	[5],[9],[12]	(0.01%)	[2],[10],[14]
Investment, Identifier [Axis]: ASTP Holdings Co-Investment LP
Schedule of Investments [Line Items]
Amortized Cost		$ 101	[5],[19]	$ 174	[2],[15],[16]
Fair Value		$ 82	[5],[7],[19]	$ 189	[2],[8],[15],[16]
Fair Value as % of Net Assets		0.01%	[5],[9],[19]	0.03%	[2],[10],[15],[16]
Shares/Units		101,041,000	[5],[19]	173,844,000	[2],[15],[16]
Investment, Identifier [Axis]: Acclaim MidCo, LLC (dba ClaimLogiQ)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.00%	[5],[6],[17]	6.00%	[1],[2],[3],[4]
Interest Rate		11.31%	[5],[6],[17]	11.35%	[1],[2],[3],[4]
Par Amount		$ 8,001	[5],[17]	$ 8,021	[1],[2],[3]
Amortized Cost		7,856	[5],[17]	7,870	[1],[2],[3]
Fair Value		$ 7,934	[5],[7],[17]	$ 7,951	[1],[2],[3],[8]
Fair Value as % of Net Assets		0.79%	[5],[9],[17]	1.06%	[1],[2],[3],[10]
Investment, Identifier [Axis]: Acclaim MidCo, LLC (dba ClaimLogiQ) (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.00%	[5],[6],[12]	6.00%	[2],[4],[14]
Interest Rate		11.31%	[5],[6],[12]	11.35%	[2],[4],[14]
Par Amount		$ 3,225	[5],[12]	$ 3,225	[2],[14]
Amortized Cost		(14)	[5],[12]	(15)	[2],[14]
Fair Value		$ (27)	[5],[7],[12]	$ (28)	[2],[8],[14]
Fair Value as % of Net Assets		0.00%	[5],[9],[12]	0.00%	[2],[10],[14]
Investment, Identifier [Axis]: Affinity Hospice
Schedule of Investments [Line Items]
Spread Above Reference Rate		4.75%	[5],[6],[17]	4.75%	[2],[3],[4]
Interest Rate		10.15%	[5],[6],[17]	10.20%	[2],[3],[4]
Par Amount		$ 7,852	[5],[17]	$ 7,872	[2],[3]
Amortized Cost		7,800	[5],[17]	7,817	[2],[3]
Fair Value		$ 6,583	[5],[7],[17]	$ 7,048	[2],[3],[8]
Fair Value as % of Net Assets		0.66%	[5],[9],[17]	0.94%	[2],[3],[10]
Investment, Identifier [Axis]: Ahead Data Blue LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[6],[17]	4.25%
Interest Rate	[6],[17]	9.56%
Par Amount	[17]	$ 5,118
Amortized Cost	[17]	5,069
Fair Value	[7],[17]	$ 5,069
Fair Value as % of Net Assets	[9],[17]	0.51%
Investment, Identifier [Axis]: All My Sons
Schedule of Investments [Line Items]
Spread Above Reference Rate		4.75%	[6],[17]	4.75%	[3],[4]
Interest Rate		10.31%	[6],[17]	10.36%	[3],[4]
Par Amount		$ 5,247	[17]	$ 5,261	[3]
Amortized Cost		5,210	[17]	5,222	[3]
Fair Value		$ 5,247	[7],[17]	$ 5,206	[3],[8]
Fair Value as % of Net Assets		0.53%	[9],[17]	0.69%	[3],[10]
Investment, Identifier [Axis]: Allstar Holdings
Schedule of Investments [Line Items]
Interest Rate		10.00%	[5],[6]	10.00%	[2],[4]
Interest Rate, PIK		3.00%	[5],[6]	3.00%	[2],[4]
Par Amount		$ 2,130	[5]	$ 2,114	[2]
Amortized Cost		2,068	[5]	2,053	[2]
Fair Value		$ 2,071	[5],[7]	$ 2,054	[2],[8]
Fair Value as % of Net Assets		0.21%	[5],[9]	0.27%	[2],[10]
Investment, Identifier [Axis]: Allstar Holdings (Delayed Draw)
Schedule of Investments [Line Items]
Interest Rate	[2],[4],[14]			10.00%
Interest Rate, PIK	[2],[4],[14]			3.00%
Par Amount	[2],[14]			$ 4,043
Amortized Cost	[2],[14]			2,803
Fair Value	[2],[8],[14]			$ 2,745
Fair Value as % of Net Assets	[2],[10],[14]			0.37%
Investment, Identifier [Axis]: Allstar Holdings (Delayed Draw) 1
Schedule of Investments [Line Items]
Interest Rate		10.00%	[5],[6],[12]	10.00%	[2],[4],[14]
Interest Rate, PIK		3.00%	[5],[6],[12]	3.00%	[2],[4],[14]
Par Amount		$ 4,065	[5],[12]	$ 6,188	[2],[14]
Amortized Cost		2,826	[5],[12]	(88)	[2],[14]
Fair Value		$ 2,769	[5],[7],[12]	$ (175)	[2],[8],[14]
Fair Value as % of Net Assets		0.28%	[5],[9],[12]	(0.02%)	[2],[10],[14]
Investment, Identifier [Axis]: Allstar Holdings (Delayed Draw) 2
Schedule of Investments [Line Items]
Interest Rate	[5],[6],[12]	10.00%
Interest Rate, PIK	[5],[6],[12]	3.00%
Par Amount	[5],[12]	$ 6,188
Amortized Cost	[5],[12]	(85)
Fair Value	[5],[7],[12]	$ (170)
Fair Value as % of Net Assets	[5],[9],[12]	(0.02%)
Investment, Identifier [Axis]: Alternative Logistics Technologies Buyer, LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6],[11],[17],[22]	5.50%
Interest Rate	[5],[6],[11],[17],[22]	10.83%
Par Amount	[5],[11],[17],[22]	$ 10,640
Amortized Cost	[5],[11],[17],[22]	10,539
Fair Value	[5],[7],[11],[17],[22]	$ 10,538
Fair Value as % of Net Assets	[5],[9],[11],[17],[22]	1.06%
Investment, Identifier [Axis]: Alternative Logistics Technologies Buyer, LLC (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6],[12],[22]	5.50%
Interest Rate	[5],[6],[12],[22]	10.83%
Par Amount	[5],[12],[22]	$ 3,040
Amortized Cost	[5],[12],[22]	0
Fair Value	[5],[7],[12],[22]	$ (29)
Fair Value as % of Net Assets	[5],[9],[12],[22]	0.00%
Investment, Identifier [Axis]: American Auto Auction Group
Schedule of Investments [Line Items]
Spread Above Reference Rate	[2],[3],[4]			5.00%
Interest Rate	[2],[3],[4]			10.50%
Par Amount	[2],[3]			$ 10,520
Amortized Cost	[2],[3]			10,443
Fair Value	[2],[3],[8]			$ 10,266
Fair Value as % of Net Assets	[2],[3],[10]			1.37%
Investment, Identifier [Axis]: American Student Transportaton Partners, Inc
Schedule of Investments [Line Items]
Interest Rate		6.00%	[5],[6]	10.00%	[2],[4]
Interest Rate, PIK		8.50%	[5],[6]	3.50%	[2],[4]
Par Amount		$ 2,125	[5]	$ 2,081	[2]
Amortized Cost		2,073	[5]	2,027	[2]
Fair Value		$ 2,033	[5],[7]	$ 2,026	[2],[8]
Fair Value as % of Net Assets		0.20%	[5],[9]	0.27%	[2],[10]
Investment, Identifier [Axis]: Anne Arundel
Schedule of Investments [Line Items]
Spread Above Reference Rate	[2],[4]
Interest Rate, PIK	[2],[4]			12.75%
Par Amount	[2]			$ 3,282
Amortized Cost		$ 880	[5],[19]	3,247	[2]
Fair Value		$ 0	[5],[7],[19]	$ 2,656	[2],[8]
Fair Value as % of Net Assets		0.00%	[5],[9],[19]	0.36%	[2],[10]
Shares/Units	[5],[19]	12,175
Investment, Identifier [Axis]: Anne Arundel (Delayed Draw)
Schedule of Investments [Line Items]
Interest Rate, PIK		11.00%	[5],[6],[12],[23]	11.00%	[2],[4],[14]
Par Amount		$ 2,396	[5],[12],[23]	$ 2,396	[2],[14]
Amortized Cost		2,023	[5],[12],[23]	2,022	[2],[14]
Fair Value		$ 719	[5],[7],[12],[23]	$ 1,790	[2],[8],[14]
Fair Value as % of Net Assets		0.07%	[5],[9],[12],[23]	0.24%	[2],[10],[14]
Investment, Identifier [Axis]: Anne Arundel 1
Schedule of Investments [Line Items]
Interest Rate, PIK		12.75%	[5],[6],[23]	11.00%	[2],[4]
Par Amount		$ 3,282	[5],[23]	$ 1,972	[2]
Amortized Cost		3,252	[5],[23]	1,957	[2]
Fair Value		$ 713	[5],[7],[23]	$ 1,776	[2],[8]
Fair Value as % of Net Assets		0.07%	[5],[9],[23]	0.24%	[2],[10]
Investment, Identifier [Axis]: Anne Arundel 2
Schedule of Investments [Line Items]
Interest Rate, PIK	[5],[6],[23]	11.00%
Par Amount	[5],[23]	$ 1,972
Amortized Cost		1,959	[5],[23]	$ 880	[2],[15],[16]
Fair Value		$ 894	[5],[7],[23]	$ 2	[2],[8],[15],[16]
Fair Value as % of Net Assets		0.09%	[5],[9],[23]	0.00%	[2],[10],[15],[16]
Shares/Units	[2],[15],[16]			12,175,000
Investment, Identifier [Axis]: Apex Companies Holdings, LLC
Schedule of Investments [Line Items]
Interest Rate	[2],[4]			10.00%
Interest Rate, PIK	[2],[4]			2.50%
Par Amount	[2]			$ 3,964
Amortized Cost	[2]			3,879
Fair Value	[2],[8]			$ 3,953
Fair Value as % of Net Assets	[2],[10]			0.53%
Investment, Identifier [Axis]: Apex Companies Holdings, LLC (Delayed Draw)
Schedule of Investments [Line Items]
Interest Rate		10.00%	[5],[6],[12]	10.00%	[2],[4],[14]
Interest Rate, PIK		2.50%	[5],[6],[12]	2.50%	[2],[4],[14]
Par Amount		$ 1,085	[5],[12]	$ 1,197	[2],[14]
Amortized Cost		71	[5],[12]	69	[2],[14]
Fair Value		$ 80	[5],[7],[12]	$ 79	[2],[8],[14]
Fair Value as % of Net Assets		0.01%	[5],[9],[12]	0.01%	[2],[10],[14]
Investment, Identifier [Axis]: Apex Companies Holdings, LLC 1
Schedule of Investments [Line Items]
Interest Rate	[5],[6]	10.00%
Interest Rate, PIK	[5],[6]	2.50%
Par Amount	[5]	$ 3,989
Amortized Cost		3,908	[5]	$ 117	[2],[15],[16],[20]
Fair Value		$ 3,979	[5],[7]	$ 127	[2],[8],[15],[16],[20]
Fair Value as % of Net Assets		0.40%	[5],[9]	0.02%	[2],[10],[15],[16],[20]
Shares/Units	[2],[15],[16],[20]			1,173,000
Investment, Identifier [Axis]: Apex Companies Holdings, LLC 2
Schedule of Investments [Line Items]
Amortized Cost	[5],[18],[19]	$ 117
Fair Value	[5],[7],[18],[19]	$ 127
Fair Value as % of Net Assets	[5],[9],[18],[19]	0.01%
Shares/Units	[5],[18],[19]	1,173
Investment, Identifier [Axis]: Aramsco
Schedule of Investments [Line Items]
Spread Above Reference Rate	[6],[17],[22]	4.75%
Interest Rate	[6],[17],[22]	10.06%
Par Amount	[17],[22]	$ 1,703
Amortized Cost	[17],[22]	1,703
Fair Value	[7],[17],[22]	$ 1,703
Fair Value as % of Net Assets	[9],[17],[22]	0.17%
Investment, Identifier [Axis]: Aramsco (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6],[12],[22]	4.75%
Interest Rate	[5],[6],[12],[22]	10.06%
Par Amount	[5],[12],[22]	$ 297
Amortized Cost	[5],[12],[22]	0
Fair Value	[5],[7],[12],[22]	$ 0
Fair Value as % of Net Assets	[5],[9],[12],[22]	0.00%
Investment, Identifier [Axis]: Arcadia Consumer Health
Schedule of Investments [Line Items]
Spread Above Reference Rate		4.50%	[6],[11],[17],[22]	4.50%	[1],[3],[4],[13]
Interest Rate		9.91%	[6],[11],[17],[22]	9.98%	[1],[3],[4],[13]
Par Amount		$ 12,572	[11],[17],[22]	$ 12,604	[1],[3],[13]
Amortized Cost		12,496	[11],[17],[22]	12,522	[1],[3],[13]
Fair Value		$ 12,249	[7],[11],[17],[22]	$ 12,192	[1],[3],[8],[13]
Fair Value as % of Net Assets		1.23%	[9],[11],[17],[22]	1.63%	[1],[3],[10],[13]
Investment, Identifier [Axis]: Arcadia Consumer Health (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[6],[17],[22]	5.75%	[1],[2],[4],[13]
Interest Rate		11.16%	[6],[17],[22]	11.23%	[1],[2],[4],[13]
Par Amount		$ 2,160	[17],[22]	$ 2,256	[1],[2],[13]
Amortized Cost		2,124	[17],[22]	2,216	[1],[2],[13]
Fair Value		$ 2,181	[7],[17],[22]	$ 2,251	[1],[2],[8],[13]
Fair Value as % of Net Assets		0.22%	[9],[17],[22]	0.30%	[1],[2],[10],[13]
Investment, Identifier [Axis]: Argano, LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.00%	[6],[17]	5.50%	[3],[4]
Interest Rate		11.68%	[6],[17]	11.69%	[3],[4]
Par Amount		$ 5,619	[17]	$ 5,634	[3]
Amortized Cost		5,591	[17]	5,602	[3]
Fair Value		$ 5,551	[7],[17]	$ 5,510	[3],[8]
Fair Value as % of Net Assets		0.56%	[9],[17]	0.74%	[3],[10]
Investment, Identifier [Axis]: Argano, LLC (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.00%	[6],[11],[17]	5.50%	[1],[3],[4]
Interest Rate		11.68%	[6],[11],[17]	11.69%	[1],[3],[4]
Par Amount		$ 2,488	[11],[17]	$ 2,494	[1],[3]
Amortized Cost		2,489	[11],[17]	2,494	[1],[3]
Fair Value		$ 2,459	[7],[11],[17]	$ 2,440	[1],[3],[8]
Fair Value as % of Net Assets		0.25%	[9],[11],[17]	0.33%	[1],[3],[10]
Investment, Identifier [Axis]: Argano, LLC (Delayed Draw) (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.00%	[6],[17]	5.50%	[3],[4]
Interest Rate		11.68%	[6],[17]	11.69%	[3],[4]
Par Amount		$ 1,700	[17]	$ 1,705	[3]
Amortized Cost		1,674	[17]	1,676	[3]
Fair Value		$ 1,680	[7],[17]	$ 1,667	[3],[8]
Fair Value as % of Net Assets		0.17%	[9],[17]	0.22%	[3],[10]
Investment, Identifier [Axis]: Arotech
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.25%	[5],[6],[17]	6.25%	[2],[3],[4]
Interest Rate		11.66%	[5],[6],[17]	11.70%	[2],[3],[4]
Par Amount		$ 9,178	[5],[17]	$ 9,202	[2],[3]
Amortized Cost		9,109	[5],[17]	9,127	[2],[3]
Fair Value		$ 8,962	[5],[7],[17]	$ 8,945	[2],[3],[8]
Fair Value as % of Net Assets		0.90%	[5],[9],[17]	1.20%	[2],[3],[10]
Investment, Identifier [Axis]: Arotech (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.25%	[5],[6],[17]	6.25%	[1],[2],[3],[4]
Interest Rate		11.66%	[5],[6],[17]	11.70%	[1],[2],[3],[4]
Par Amount		$ 446	[5],[17]	$ 448	[1],[2],[3]
Amortized Cost		445	[5],[17]	446	[1],[2],[3]
Fair Value		$ 436	[5],[7],[17]	$ 435	[1],[2],[3],[8]
Fair Value as % of Net Assets		0.04%	[5],[9],[17]	0.06%	[1],[2],[3],[10]
Investment, Identifier [Axis]: Ascensus
Schedule of Investments [Line Items]
Spread Above Reference Rate	[2],[4],[24]			6.50%
Interest Rate	[2],[4],[24]			12.18%
Par Amount	[2],[24]			$ 9,000
Amortized Cost	[2],[24]			8,935
Fair Value	[2],[8],[24]			$ 8,691
Fair Value as % of Net Assets	[2],[10],[24]			1.16%
Investment, Identifier [Axis]: Ascensus Specialties
Schedule of Investments [Line Items]
Spread Above Reference Rate		4.35%	[6],[11],[17],[22]	4.25%	[1],[3],[4],[13]
Interest Rate		9.68%	[6],[11],[17],[22]	9.71%	[1],[3],[4],[13]
Par Amount		$ 9,706	[11],[17],[22]	$ 9,731	[1],[3],[13]
Amortized Cost		9,573	[11],[17],[22]	9,589	[1],[3],[13]
Fair Value		$ 8,877	[7],[11],[17],[22]	$ 8,776	[1],[3],[8],[13]
Fair Value as % of Net Assets		0.89%	[9],[11],[17],[22]	1.17%	[1],[3],[10],[13]
Investment, Identifier [Axis]: B2B Packaging
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.75%	[6],[11],[17]	6.75%	[1],[3],[4]
Interest Rate		12.21%	[6],[11],[17]	12.28%	[1],[3],[4]
Par Amount		$ 14,659	[11],[17]	$ 14,696	[1],[3]
Amortized Cost		14,630	[11],[17]	14,663	[1],[3]
Fair Value		$ 14,276	[7],[11],[17]	$ 14,398	[1],[3],[8]
Fair Value as % of Net Assets		1.43%	[9],[11],[17]	1.93%	[1],[3],[10]
Investment, Identifier [Axis]: B2B Packaging (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.75%	[6],[17]	6.75%	[3],[4]
Interest Rate		12.24%	[6],[17]	12.29%	[3],[4]
Par Amount		$ 116	[17]	$ 116	[3]
Amortized Cost		114	[17]	114	[3]
Fair Value		$ 113	[7],[17]	$ 114	[3],[8]
Fair Value as % of Net Assets		0.01%	[9],[17]	0.02%	[3],[10]
Investment, Identifier [Axis]: BCM One
Schedule of Investments [Line Items]
Spread Above Reference Rate		4.50%	[6],[17]	4.50%	[3],[4]
Interest Rate		9.92%	[6],[17]	9.96%	[3],[4]
Par Amount		$ 5,942	[17]	$ 6,074	[3]
Amortized Cost		5,942	[17]	6,074	[3]
Fair Value		$ 5,918	[7],[17]	$ 5,966	[3],[8]
Fair Value as % of Net Assets		0.59%	[9],[17]	0.80%	[3],[10]
Investment, Identifier [Axis]: BCM One (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		4.50%	[6],[17]	4.50%	[3],[4]
Interest Rate		9.92%	[6],[17]	9.96%	[3],[4]
Par Amount		$ 1,822	[17]	$ 1,827	[3]
Amortized Cost		1,822	[17]	1,827	[3]
Fair Value		$ 1,815	[7],[17]	$ 1,794	[3],[8]
Fair Value as % of Net Assets		0.18%	[9],[17]	0.24%	[3],[10]
Investment, Identifier [Axis]: BPC Kodiak LLC (Turbine Engine Specialist, Inc)
Schedule of Investments [Line Items]
Amortized Cost		$ 1,530	[5],[19],[25]	$ 1,530	[2],[15],[16],[26]
Fair Value		$ 1,859	[5],[7],[19],[25]	$ 1,614	[2],[8],[15],[16],[26]
Fair Value as % of Net Assets		0.19%	[5],[9],[19],[25]	0.22%	[2],[10],[15],[16],[26]
Shares/Units		1,530,000,000	[5],[19],[25]	1,530,000,000	[2],[15],[16],[26]
Investment, Identifier [Axis]: Badger Sportswear Acquisition Inc
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4]			4.50%
Interest Rate	[3],[4]			10.03%
Par Amount	[3]			$ 3,800
Amortized Cost	[3]			3,800
Fair Value	[3],[8]			$ 3,800
Fair Value as % of Net Assets	[3],[10]			0.51%
Investment, Identifier [Axis]: Bakeovations Intermediate, LLC (d/b/a Commercial Bakeries)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.25%	[5],[6],[11],[17],[18],[27]	6.25%	[1],[2],[3],[4],[20],[28]
Interest Rate		11.31%	[5],[6],[11],[17],[18],[27]	11.60%	[1],[2],[3],[4],[20],[28]
Par Amount		$ 17,239	[5],[11],[17],[18],[27]	$ 17,282	[1],[2],[3],[20],[28]
Amortized Cost		16,927	[5],[11],[17],[18],[27]	16,958	[1],[2],[3],[20],[28]
Fair Value		$ 16,911	[5],[7],[11],[17],[18],[27]	$ 16,940	[1],[2],[3],[8],[20],[28]
Fair Value as % of Net Assets		1.69%	[5],[9],[11],[17],[18],[27]	2.27%	[1],[2],[3],[10],[20],[28]
Investment, Identifier [Axis]: Bardstown PPC Holdings LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[2],[4]			7.75%
Interest Rate	[2],[4]			13.18%
Par Amount	[2]			$ 9,300
Amortized Cost	[2]			9,154
Fair Value	[2],[8]			$ 9,154
Fair Value as % of Net Assets	[2],[10]			1.22%
Investment, Identifier [Axis]: Bardstown PPC Holdings LLC 1
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6]	7.75%
Interest Rate	[5],[6]	13.18%
Par Amount	[5]	$ 9,300
Amortized Cost		9,163	[5]	$ 1,860	[2],[16],[20]
Fair Value		$ 9,234	[5],[7]	$ 2,114	[2],[8],[16],[20]
Fair Value as % of Net Assets		0.93%	[5],[9]	0.28%	[2],[10],[16],[20]
Shares/Units	[2],[16],[20]			14,777,000
Investment, Identifier [Axis]: Bardstown PPC Holdings LLC 2
Schedule of Investments [Line Items]
Amortized Cost	[5],[18],[19]	$ 1,860
Fair Value	[5],[7],[18],[19]	$ 2,207
Fair Value as % of Net Assets	[5],[9],[18],[19]	0.22%
Shares/Units	[5],[18],[19]	14,777
Investment, Identifier [Axis]: Big Truck Rental
Schedule of Investments [Line Items]
Spread Above Reference Rate	[2],[4]			8.00%
Interest Rate	[2],[4]			13.47%
Par Amount	[2]			$ 10,000
Amortized Cost	[2]			9,858
Fair Value	[2],[8]			$ 10,000
Fair Value as % of Net Assets	[2],[10]			1.34%
Investment, Identifier [Axis]: Big Truck Rental 1
Schedule of Investments [Line Items]
Spread Above Reference Rate		8.00%	[5],[6]	8.00%	[2],[4]
Interest Rate		13.44%	[5],[6]	13.47%	[2],[4]
Par Amount		$ 10,000	[5]	$ 2,500	[2]
Amortized Cost		9,869	[5]	2,500	[2]
Fair Value		$ 10,000	[5],[7]	$ 2,500	[2],[8]
Fair Value as % of Net Assets		1.00%	[5],[9]	0.33%	[2],[10]
Investment, Identifier [Axis]: Big Truck Rental 2
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6]	8.00%
Interest Rate	[5],[6]	13.44%
Par Amount	[5]	$ 2,500
Amortized Cost	[5]	2,500
Fair Value	[5],[7]	$ 2,500
Fair Value as % of Net Assets	[5],[9]	0.25%
Investment, Identifier [Axis]: BlackRock Liquidity Funds Treasury
Schedule of Investments [Line Items]
Interest Rate		5.17%		5.18%	[4]
Amortized Cost		$ 52,743		$ 46,784
Fair Value		$ 52,743	[7]	$ 46,784	[8]
Fair Value as % of Net Assets		5.28%	[9]	6.26%	[10]
Shares/Units		52,743,000		46,784,000
Investment, Identifier [Axis]: Boulder Scientific Company LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate		4.50%	[6],[17]	4.50%	[3],[4]
Interest Rate		10.48%	[6],[17]	10.04%	[3],[4]
Par Amount		$ 2,058	[17]	$ 2,064	[3]
Amortized Cost		2,067	[17]	2,073	[3]
Fair Value		$ 1,999	[7],[17]	$ 1,996	[3],[8]
Fair Value as % of Net Assets		0.20%	[9],[17]	0.27%	[3],[10]
Investment, Identifier [Axis]: Bounteous
Schedule of Investments [Line Items]
Spread Above Reference Rate	[1],[2],[3],[4]			5.25%
Interest Rate	[1],[2],[3],[4]			10.74%
Par Amount	[1],[2],[3]			$ 5,347
Amortized Cost	[1],[2],[3]			5,310
Fair Value	[1],[2],[3],[8]			$ 5,083
Fair Value as % of Net Assets	[1],[2],[3],[10]			0.68%
Investment, Identifier [Axis]: Bounteous (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[2],[3],[4]			5.25%
Interest Rate	[2],[3],[4]			10.74%
Par Amount	[2],[3]			$ 2,768
Amortized Cost	[2],[3]			2,750
Fair Value	[2],[3],[8]			$ 2,631
Fair Value as % of Net Assets	[2],[3],[10]			0.35%
Investment, Identifier [Axis]: Bounteous (Delayed Draw) 1
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.25%	[5],[6],[17]	5.25%	[2],[4],[14]
Interest Rate		10.69%	[5],[6],[17]	10.74%	[2],[4],[14]
Par Amount		$ 2,761	[5],[17]	$ 4,467	[2],[14]
Amortized Cost		2,745	[5],[17]	0	[2],[14]
Fair Value		$ 2,746	[5],[7],[17]	$ (221)	[2],[8],[14]
Fair Value as % of Net Assets		0.28%	[5],[9],[17]	(0.03%)	[2],[10],[14]
Investment, Identifier [Axis]: Bounteous (Delayed Draw) 2
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6]	5.25%
Interest Rate	[5],[6]	10.69%
Par Amount	[5]	$ 3,567
Amortized Cost	[5]	3,567
Fair Value	[5],[7]	$ 3,549
Fair Value as % of Net Assets	[5],[9]	0.36%
Investment, Identifier [Axis]: Bounteous 1
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.25%	[5],[6],[11],[17]	5.25%	[2],[3],[4]
Interest Rate		10.69%	[5],[6],[11],[17]	10.74%	[2],[3],[4]
Par Amount		$ 5,334	[5],[11],[17]	$ 2,189	[2],[3]
Amortized Cost		5,299	[5],[11],[17]	2,173	[2],[3]
Fair Value		$ 5,307	[5],[7],[11],[17]	$ 2,080	[2],[3],[8]
Fair Value as % of Net Assets		0.53%	[5],[9],[11],[17]	0.28%	[2],[3],[10]
Investment, Identifier [Axis]: Bounteous 2
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6],[17]	5.25%
Interest Rate	[5],[6],[17]	10.69%
Par Amount	[5],[17]	$ 2,183
Amortized Cost	[5],[17]	2,169
Fair Value	[5],[7],[17]	$ 2,172
Fair Value as % of Net Assets	[5],[9],[17]	0.22%
Investment, Identifier [Axis]: BroadcastMed Holdco, LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6]
Interest Rate	[2],[4]			10.00%
Interest Rate, PIK	[2],[4]			3.75%
Par Amount	[2]			$ 3,483
Amortized Cost	[2]			3,424
Fair Value	[2],[8]			$ 3,369
Fair Value as % of Net Assets	[2],[10]			0.45%
Investment, Identifier [Axis]: BroadcastMed Holdco, LLC 1
Schedule of Investments [Line Items]
Interest Rate	[5],[6]	10.00%
Interest Rate, PIK	[5],[6]	3.75%
Par Amount	[5]	$ 3,615
Amortized Cost		3,560	[5]	$ 853	[2],[16]
Fair Value		$ 3,475	[5],[7]	$ 888	[2],[8],[16]
Fair Value as % of Net Assets		0.35%	[5],[9]	0.12%	[2],[10],[16]
Shares/Units	[2],[16]			56,899,000
Investment, Identifier [Axis]: BroadcastMed Holdco, LLC 2
Schedule of Investments [Line Items]
Amortized Cost	[5],[19]	$ 853
Fair Value	[5],[7],[19]	$ 790
Fair Value as % of Net Assets	[5],[9],[19]	0.08%
Shares/Units	[5],[19]	56,899
Investment, Identifier [Axis]: Bullhorn Inc
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.50%	[5],[6],[11],[17],[22]	5.75%	[1],[2],[3],[4],[13]
Interest Rate		10.93%	[5],[6],[11],[17],[22]	10.96%	[1],[2],[3],[4],[13]
Par Amount		$ 13,671	[5],[11],[17],[22]	$ 13,706	[1],[2],[3],[13]
Amortized Cost		13,585	[5],[11],[17],[22]	13,609	[1],[2],[3],[13]
Fair Value		$ 13,671	[5],[7],[11],[17],[22]	$ 13,706	[1],[2],[3],[8],[13]
Fair Value as % of Net Assets		1.36%	[5],[9],[11],[17],[22]	1.83%	[1],[2],[3],[10],[13]
Investment, Identifier [Axis]: BusinesSolver
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.50%	[6],[17],[22]	5.50%	[2],[3],[4],[13]
Interest Rate		10.91%	[6],[17],[22]	10.96%	[2],[3],[4],[13]
Par Amount		$ 7,721	[17],[22]	$ 7,741	[2],[3],[13]
Amortized Cost		7,671	[17],[22]	7,686	[2],[3],[13]
Fair Value		$ 7,721	[7],[17],[22]	$ 7,738	[2],[3],[8],[13]
Fair Value as % of Net Assets		0.77%	[9],[17],[22]	1.03%	[2],[3],[10],[13]
Investment, Identifier [Axis]: BusinesSolver (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.50%	[5],[6],[12],[22]	5.50%	[2],[4],[13],[14]
Interest Rate		10.91%	[5],[6],[12],[22]	10.96%	[2],[4],[13],[14]
Par Amount		$ 1,149	[5],[12],[22]	$ 1,149	[2],[13],[14]
Amortized Cost		272	[5],[12],[22]	176	[2],[13],[14]
Fair Value		$ 276	[5],[7],[12],[22]	$ 179	[2],[8],[13],[14]
Fair Value as % of Net Assets		0.03%	[5],[9],[12],[22]	0.02%	[2],[10],[13],[14]
Investment, Identifier [Axis]: COP Exterminators Acquisition, Inc.
Schedule of Investments [Line Items]
Interest Rate		9.00%	[5],[6]	9.00%	[2],[4]
Interest Rate, PIK	[2],[4]			4.00%
Par Amount		$ 847	[5]	$ 838	[2]
Amortized Cost		825	[5]	816	[2]
Fair Value		$ 825	[5],[7]	$ 816	[2],[8]
Fair Value as % of Net Assets		0.08%	[5],[9]	0.11%	[2],[10]
Investment, Identifier [Axis]: COP Exterminators Acquisition, Inc. (Delayed Draw)
Schedule of Investments [Line Items]
Interest Rate		9.00%	[5],[6],[12]	9.00%	[2],[4],[14]
Interest Rate, PIK		4.00%	[5],[6],[12]	4.00%	[2],[4],[14]
Par Amount		$ 652	[5],[12]	$ 652	[2],[14]
Amortized Cost		535	[5],[12]	(8)	[2],[14]
Fair Value		$ 526	[5],[7],[12]	$ (17)	[2],[8],[14]
Fair Value as % of Net Assets		0.05%	[5],[9],[12]	0.00%	[2],[10],[14]
Investment, Identifier [Axis]: COP Exterminators Investment, LLC
Schedule of Investments [Line Items]
Amortized Cost		$ 1,117	[5],[19]	$ 1,117	[2],[15],[16]
Fair Value		$ 1,201	[5],[7],[19]	$ 1,163	[2],[8],[15],[16]
Fair Value as % of Net Assets		0.12%	[5],[9],[19]	0.16%	[2],[10],[15],[16]
Shares/Units		997,000	[5],[19]	997,000,000	[2],[15],[16]
Investment, Identifier [Axis]: Career Now
Schedule of Investments [Line Items]
Interest Rate	[2],[4]			13.00%
Interest Rate, PIK	[5],[6]	13.00%
Par Amount		$ 3,393	[5]	$ 3,277	[2]
Amortized Cost		3,355	[5]	3,237	[2]
Fair Value		$ 2,313	[5],[7]	$ 2,425	[2],[8]
Fair Value as % of Net Assets		0.23%	[5],[9]	0.32%	[2],[10]
Investment, Identifier [Axis]: Career Now 1
Schedule of Investments [Line Items]
Amortized Cost		$ 22	[5],[19]	$ 22	[2],[15],[16]
Fair Value		$ 0	[5],[7],[19]	$ 0	[2],[8],[15],[16]
Fair Value as % of Net Assets		0.00%	[5],[9],[19]	0.00%	[2],[10],[15],[16]
Shares/Units		222	[5],[19]	222,000	[2],[15],[16]
Investment, Identifier [Axis]: Career Now 2
Schedule of Investments [Line Items]
Amortized Cost		$ 624	[5],[19]	$ 624	[2],[15],[16]
Fair Value		$ 0	[5],[7],[19]	$ 0	[2],[8],[15],[16]
Fair Value as % of Net Assets		0.00%	[5],[9],[19]	0.00%	[2],[10],[15],[16]
Shares/Units		624	[5],[19]	624,000	[2],[15],[16]
Investment, Identifier [Axis]: Chroma Color Corporation (dba Chroma Color)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.00%	[6],[17]	6.00%	[1],[3],[4]
Interest Rate		11.32%	[6],[17]	11.41%	[1],[3],[4]
Par Amount		$ 6,298	[17]	$ 6,314	[1],[3]
Amortized Cost		6,186	[17]	6,197	[1],[3]
Fair Value		$ 6,188	[7],[17]	$ 6,199	[1],[3],[8]
Fair Value as % of Net Assets		0.62%	[9],[17]	0.83%	[1],[3],[10]
Investment, Identifier [Axis]: Chroma Color Corporation (dba Chroma Color) (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.00%	[5],[6],[12]	6.00%	[2],[4],[14]
Interest Rate		11.32%	[5],[6],[12]	11.41%	[2],[4],[14]
Par Amount		$ 1,379	[5],[12]	$ 1,379	[2],[14]
Amortized Cost		(12)	[5],[12]	(12)	[2],[14]
Fair Value		$ (24)	[5],[7],[12]	$ (25)	[2],[8],[14]
Fair Value as % of Net Assets		0.00%	[5],[9],[12]	0.00%	[2],[10],[14]
Investment, Identifier [Axis]: Classic Collision (Delayed Draw) (Incremental Tranche A-4)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[5],[6],[12]	5.75%	[2],[4],[14]
Interest Rate		10.50%	[5],[6],[12]	11.29%	[2],[4],[14]
Par Amount		$ 25,202	[5],[12]	$ 25,225	[2],[14]
Amortized Cost		9,049	[5],[12]	3,304	[2],[14]
Fair Value		$ 8,766	[5],[7],[12]	$ 3,016	[2],[8],[14]
Fair Value as % of Net Assets		0.88%	[5],[9],[12]	0.40%	[2],[10],[14]
Investment, Identifier [Axis]: Classic Collision (Delayed Draw) (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[5],[6],[11],[17]	5.75%	[1],[2],[3],[4]
Interest Rate		10.50%	[5],[6],[11],[17]	11.29%	[1],[2],[3],[4]
Par Amount		$ 6,923	[5],[11],[17]	$ 6,941	[1],[2],[3]
Amortized Cost		6,923	[5],[11],[17]	6,941	[1],[2],[3]
Fair Value		$ 6,833	[5],[7],[11],[17]	$ 6,847	[1],[2],[3],[8]
Fair Value as % of Net Assets		0.68%	[5],[9],[11],[17]	0.92%	[1],[2],[3],[10]
Investment, Identifier [Axis]: Classic Collision (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[6],[17]	5.75%	[2],[3],[4]
Interest Rate		10.50%	[6],[17]	11.29%	[2],[3],[4]
Par Amount		$ 7,731	[17]	$ 7,751	[2],[3]
Amortized Cost		7,693	[17]	7,707	[2],[3]
Fair Value		$ 7,630	[7],[17]	$ 7,646	[2],[3],[8]
Fair Value as % of Net Assets		0.76%	[9],[17]	1.02%	[2],[3],[10]
Investment, Identifier [Axis]: Coding Solutions Acquisitions
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.50%	[6],[17],[22]	5.75%	[3],[4],[13]
Interest Rate		10.83%	[6],[17],[22]	11.11%	[3],[4],[13]
Par Amount		$ 6,415	[17],[22]	$ 6,432	[3],[13]
Amortized Cost		6,368	[17],[22]	6,380	[3],[13]
Fair Value		$ 6,347	[7],[17],[22]	$ 6,304	[3],[8],[13]
Fair Value as % of Net Assets		0.64%	[9],[17],[22]	0.84%	[3],[10],[13]
Investment, Identifier [Axis]: Coding Solutions Acquisitions (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.50%	[6],[17],[22]	5.75%	[2],[4],[13]
Interest Rate		10.83%	[6],[17],[22]	11.11%	[2],[4],[13]
Par Amount		$ 1,961	[17],[22]	$ 1,966	[2],[13]
Amortized Cost		1,961	[17],[22]	1,966	[2],[13]
Fair Value		$ 1,940	[7],[17],[22]	$ 1,927	[2],[8],[13]
Fair Value as % of Net Assets		0.19%	[9],[17],[22]	0.26%	[2],[10],[13]
Investment, Identifier [Axis]: Collision Right
Schedule of Investments [Line Items]
Spread Above Reference Rate	[1],[2],[3],[4]			5.25%
Interest Rate	[1],[2],[3],[4]			10.50%
Par Amount	[1],[2],[3]			$ 5,294
Amortized Cost	[1],[2],[3]			5,269
Fair Value	[1],[2],[3],[8]			$ 5,282
Fair Value as % of Net Assets	[1],[2],[3],[10]			0.71%
Investment, Identifier [Axis]: Collision Right (Delayed Draw)
Schedule of Investments [Line Items]
Interest Rate	[2],[4]			9.00%
Interest Rate, PIK	[2],[4]			3.75%
Par Amount	[2]			$ 996
Amortized Cost	[2]			985
Fair Value	[2],[8]			$ 968
Fair Value as % of Net Assets	[2],[10]			0.13%
Investment, Identifier [Axis]: Collision Right 1
Schedule of Investments [Line Items]
Interest Rate	[2],[4]			9.00%
Interest Rate, PIK	[2],[4]			3.75%
Par Amount	[2]			$ 1,411
Amortized Cost	[2]			1,380
Fair Value	[2],[8]			$ 1,371
Fair Value as % of Net Assets	[2],[10]			0.18%
Investment, Identifier [Axis]: Contract Land Staff
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6],[11]	5.00%
Interest Rate	[5],[6],[11]	10.31%
Par Amount	[5],[11]	$ 7,564
Amortized Cost	[5],[11]	7,488
Fair Value	[5],[7],[11]	$ 7,488
Fair Value as % of Net Assets	[5],[9],[11]	0.75%
Investment, Identifier [Axis]: Contract Land Staff (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6],[12]	5.00%
Interest Rate	[5],[6],[12]	10.31%
Par Amount	[5],[12]	$ 3,025
Amortized Cost	[5],[12]	(8)
Fair Value	[5],[7],[12]	$ (30)
Fair Value as % of Net Assets	[5],[9],[12]	0.00%
Investment, Identifier [Axis]: Cornerstone Advisors of Arizona LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4]			5.50%
Interest Rate	[3],[4]			11.07%
Par Amount	[3]			$ 308
Amortized Cost	[3]			306
Fair Value	[3],[8]			$ 308
Fair Value as % of Net Assets	[3],[10]			0.04%
Investment, Identifier [Axis]: Cornerstone Advisors of Arizona LLC (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.50%	[6],[17],[18]	5.50%	[3],[4]
Interest Rate		10.83%	[6],[17],[18]	11.07%	[3],[4]
Par Amount		$ 210	[17],[18]	$ 210	[3]
Amortized Cost		209	[17],[18]	210	[3]
Fair Value		$ 210	[7],[17],[18]	$ 210	[3],[8]
Fair Value as % of Net Assets		0.02%	[9],[17],[18]	0.03%	[3],[10]
Investment, Identifier [Axis]: Cornerstone Advisors of Arizona LLC (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[6],[17]	5.50%
Interest Rate	[6],[17]	10.89%
Par Amount	[17]	$ 3,449
Amortized Cost	[17]	3,415
Fair Value	[7],[17]	$ 3,449
Fair Value as % of Net Assets	[9],[17]	0.35%
Investment, Identifier [Axis]: Cornerstone Advisors of Arizona LLC 1
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.50%	[6],[17]	5.50%	[3],[4]
Interest Rate		10.83%	[6],[17]	11.07%	[3],[4]
Par Amount		$ 308	[17]	$ 2,295	[3]
Amortized Cost		306	[17]	2,283	[3]
Fair Value		$ 308	[7],[17]	$ 2,295	[3],[8]
Fair Value as % of Net Assets		0.03%	[9],[17]	0.31%	[3],[10]
Investment, Identifier [Axis]: Cornerstone Advisors of Arizona LLC 2
Schedule of Investments [Line Items]
Spread Above Reference Rate	[6],[17]	5.50%
Interest Rate	[6],[17]	10.83%
Par Amount	[17]	$ 2,289
Amortized Cost	[17]	2,279
Fair Value	[7],[17]	$ 2,289
Fair Value as % of Net Assets	[9],[17]	0.23%
Investment, Identifier [Axis]: Corporate Visions
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4]			4.50%
Interest Rate	[3],[4]			9.96%
Par Amount	[3]			$ 2,887
Amortized Cost	[3]			2,867
Fair Value	[3],[8]			$ 2,752
Fair Value as % of Net Assets	[3],[10]			0.37%
Investment, Identifier [Axis]: Corporate Visions 1
Schedule of Investments [Line Items]
Spread Above Reference Rate		4.50%	[6],[17]	4.50%	[3],[4]
Interest Rate		9.93%	[6],[17]	9.96%	[3],[4]
Par Amount		$ 2,879	[17]	$ 2,538	[3]
Amortized Cost		2,862	[17]	2,509	[3]
Fair Value		$ 2,635	[7],[17]	$ 2,419	[3],[8]
Fair Value as % of Net Assets		0.26%	[9],[17]	0.32%	[3],[10]
Investment, Identifier [Axis]: Corporate Visions 2
Schedule of Investments [Line Items]
Spread Above Reference Rate	[6],[17]	4.50%
Interest Rate	[6],[17]	9.93%
Par Amount	[17]	$ 2,531
Amortized Cost	[17]	2,505
Fair Value	[7],[17]	$ 2,316
Fair Value as % of Net Assets	[9],[17]	0.23%
Investment, Identifier [Axis]: Covercraft
Schedule of Investments [Line Items]
Interest Rate	[2],[4]			10.00%
Interest Rate, PIK	[2],[4]			0.75%
Par Amount	[2]			$ 7,478
Amortized Cost	[2]			7,373
Fair Value	[2],[8]			$ 6,892
Fair Value as % of Net Assets	[2],[10]			0.92%
Investment, Identifier [Axis]: Covercraft (Delayed Draw)
Schedule of Investments [Line Items]
Interest Rate		10.00%	[5],[6],[12]	10.00%	[2],[4],[14]
Interest Rate, PIK		0.75%	[5],[6],[12]	0.75%	[2],[4],[14]
Par Amount		$ 4,386	[5],[12]	$ 4,386	[2],[14]
Amortized Cost		0	[5],[12]	0	[2],[14]
Fair Value		$ (328)	[5],[7],[12]	$ (344)	[2],[8],[14]
Fair Value as % of Net Assets		(0.03%)	[5],[9],[12]	(0.04%)	[2],[10],[14]
Investment, Identifier [Axis]: Covercraft 1
Schedule of Investments [Line Items]
Interest Rate	[5],[6]	10.00%
Interest Rate, PIK	[5],[6]	0.75%
Par Amount	[5]	$ 7,492
Amortized Cost		7,393	[5]	$ 768	[2],[15],[16]
Fair Value		$ 6,932	[5],[7]	$ 357	[2],[8],[15],[16]
Fair Value as % of Net Assets		0.69%	[5],[9]	0.05%	[2],[10],[15],[16]
Shares/Units	[2],[15],[16]			768,000
Investment, Identifier [Axis]: Covercraft 2
Schedule of Investments [Line Items]
Amortized Cost	[5],[19]	$ 768
Fair Value	[5],[7],[19]	$ 330
Fair Value as % of Net Assets	[5],[9],[19]	0.03%
Shares/Units	[5],[19]	768
Investment, Identifier [Axis]: Crete Mechanical Group
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.00%	[6],[17]	5.00%	[3],[4]
Interest Rate	[3],[4]			10.37%
Par Amount	[3]			$ 4,823
Amortized Cost	[3]			4,785
Fair Value	[3],[8]			$ 4,708
Fair Value as % of Net Assets	[3],[10]			0.63%
Investment, Identifier [Axis]: Crete Mechanical Group (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4]			5.00%
Interest Rate	[3],[4]			10.37%
Par Amount	[3]			$ 2,846
Amortized Cost	[3]			2,807
Fair Value	[3],[8]			$ 2,778
Fair Value as % of Net Assets	[3],[10]			0.37%
Investment, Identifier [Axis]: Crete Mechanical Group (Delayed Draw) 1
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.00%	[6],[17]	5.00%	[2],[4],[14]
Interest Rate		10.31%	[6],[17]	10.37%	[2],[4],[14]
Par Amount		$ 2,839	[17]	$ 7,153	[2],[14]
Amortized Cost		2,802	[17]	5,710	[2],[14]
Fair Value		$ 2,827	[7],[17]	$ 5,539	[2],[8],[14]
Fair Value as % of Net Assets		0.28%	[9],[17]	0.74%	[2],[10],[14]
Investment, Identifier [Axis]: Crete Mechanical Group (Delayed Draw) 2
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6],[12]	5.00%
Interest Rate	[5],[6],[12]	10.31%
Par Amount	[5],[12]	$ 7,135
Amortized Cost	[5],[12]	6,987
Fair Value	[5],[7],[12]	$ 6,957
Fair Value as % of Net Assets	[5],[9],[12]	0.70%
Investment, Identifier [Axis]: Crete Mechanical Group 1
Schedule of Investments [Line Items]
Interest Rate	[6],[17]	10.31%
Par Amount	[17]	$ 4,810
Amortized Cost		4,776	[17]	$ 230	[2],[15],[16]
Fair Value		$ 4,790	[7],[17]	$ 534	[2],[8],[15],[16]
Fair Value as % of Net Assets		0.48%	[9],[17]	0.07%	[2],[10],[15],[16]
Shares/Units	[2],[15],[16]			23,000
Investment, Identifier [Axis]: Crete Mechanical Group 2
Schedule of Investments [Line Items]
Amortized Cost	[5],[19]	$ 230
Fair Value	[5],[7],[19]	$ 616
Fair Value as % of Net Assets	[5],[9],[19]	0.06%
Shares/Units	[5],[19]	23
Investment, Identifier [Axis]: CrossCountry Consulting
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[6],[17],[22]	5.75%	[1],[3],[4],[13]
Interest Rate		11.17%	[6],[17],[22]	11.21%	[1],[3],[4],[13]
Par Amount		$ 8,154	[17],[22]	$ 8,174	[1],[3],[13]
Amortized Cost		8,023	[17],[22]	8,037	[1],[3],[13]
Fair Value		$ 8,235	[7],[17],[22]	$ 8,217	[1],[3],[8],[13]
Fair Value as % of Net Assets		0.82%	[9],[17],[22]	1.10%	[1],[3],[10],[13]
Investment, Identifier [Axis]: CrossCountry Consulting (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[5],[6],[12],[22]	5.75%	[2],[4],[13],[14]
Interest Rate		11.17%	[5],[6],[12],[22]	11.21%	[2],[4],[13],[14]
Par Amount		$ 3,320	[5],[12],[22]	$ 3,320	[2],[13],[14]
Amortized Cost		(25)	[5],[12],[22]	(26)	[2],[13],[14]
Fair Value		$ 33	[5],[7],[12],[22]	$ 17	[2],[8],[13],[14]
Fair Value as % of Net Assets		0.00%	[5],[9],[12],[22]	0.00%	[2],[10],[13],[14]
Investment, Identifier [Axis]: D&H United Fueling Solutions
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.00%	[6],[11],[17]	5.50%	[1],[3],[4]
Interest Rate		10.98%	[6],[11],[17]	11.03%	[1],[3],[4]
Par Amount		$ 7,472	[11],[17]	$ 7,491	[1],[3]
Amortized Cost		7,356	[11],[17]	7,368	[1],[3]
Fair Value		$ 7,309	[7],[11],[17]	$ 7,290	[1],[3],[8]
Fair Value as % of Net Assets		0.73%	[9],[11],[17]	0.97%	[1],[3],[10]
Investment, Identifier [Axis]: D&H United Fueling Solutions (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.00%	[6],[17]	5.50%	[3],[4]
Interest Rate		10.98%	[6],[17]	11.03%	[3],[4]
Par Amount		$ 2,378	[17]	$ 2,384	[3]
Amortized Cost		2,360	[17]	2,365	[3]
Fair Value		$ 2,326	[7],[17]	$ 2,320	[3],[8]
Fair Value as % of Net Assets		0.23%	[9],[17]	0.31%	[3],[10]
Investment, Identifier [Axis]: D&H United Fueling Solutions (Delayed Draw) (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.00%	[5],[6],[12]	6.00%	[2],[4],[14]
Interest Rate		11.46%	[5],[6],[12]	11.50%	[2],[4],[14]
Par Amount		$ 1,567	[5],[12]	$ 1,567	[2],[14]
Amortized Cost		167	[5],[12]	(7)	[2],[14]
Fair Value		$ 167	[5],[7],[12]	$ (13)	[2],[8],[14]
Fair Value as % of Net Assets		0.02%	[5],[9],[12]	0.00%	[2],[10],[14]
Investment, Identifier [Axis]: D&H United Fueling Solutions (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.00%	[6],[11],[17]	6.00%	[1],[3],[4]
Interest Rate		11.46%	[6],[11],[17]	11.50%	[1],[3],[4]
Par Amount		$ 3,457	[11],[17]	$ 3,465	[1],[3]
Amortized Cost		3,395	[11],[17]	3,401	[1],[3]
Fair Value		$ 3,441	[7],[11],[17]	$ 3,436	[1],[3],[8]
Fair Value as % of Net Assets		0.34%	[9],[11],[17]	0.46%	[1],[3],[10]
Investment, Identifier [Axis]: DMC HoldCo LLC (DMC Power)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.00%	[6],[17]	6.00%	[1],[2],[3],[4]
Interest Rate		11.31%	[6],[17]	11.39%	[1],[2],[3],[4]
Par Amount		$ 4,988	[17]	$ 5,000	[1],[2],[3]
Amortized Cost		4,918	[17]	4,927	[1],[2],[3]
Fair Value		$ 4,969	[7],[17]	$ 4,981	[1],[2],[3],[8]
Fair Value as % of Net Assets		0.50%	[9],[17]	0.67%	[1],[2],[3],[10]
Investment, Identifier [Axis]: DMC HoldCo LLC (DMC Power) (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.00%	[5],[6],[12]	6.00%	[2],[4],[14]
Interest Rate		11.31%	[5],[6],[12]	11.39%	[2],[4],[14]
Par Amount		$ 1,671	[5],[12]	$ 1,671	[2],[14]
Amortized Cost		(4)	[5],[12]	(4)	[2],[14]
Fair Value		$ (6)	[5],[7],[12]	$ (7)	[2],[8],[14]
Fair Value as % of Net Assets		0.00%	[5],[9],[12]	0.00%	[2],[10],[14]
Investment, Identifier [Axis]: Death Wish Coffee
Schedule of Investments [Line Items]
Spread Above Reference Rate		4.75%	[6],[11],[17],[22]	4.75%	[1],[3],[4],[13]
Interest Rate		10.16%	[6],[11],[17],[22]	10.20%	[1],[3],[4],[13]
Par Amount		$ 9,775	[11],[17],[22]	$ 9,800	[1],[3],[13]
Amortized Cost		9,718	[11],[17],[22]	9,739	[1],[3],[13]
Fair Value		$ 9,775	[7],[11],[17],[22]	$ 9,800	[1],[3],[8],[13]
Fair Value as % of Net Assets		0.98%	[9],[11],[17],[22]	1.31%	[1],[3],[10],[13]
Investment, Identifier [Axis]: Dessert Holdings
Schedule of Investments [Line Items]
Spread Above Reference Rate		7.25%	[5],[6],[17],[22]	7.25%	[4]
Interest Rate		12.69%	[5],[6],[17],[22]	12.72%	[4]
Par Amount		$ 9,000	[5],[17],[22]	$ 9,000
Amortized Cost		8,881	[5],[17],[22]	8,874
Fair Value		$ 7,938	[5],[7],[17],[22]	$ 7,628	[8]
Fair Value as % of Net Assets		0.80%	[5],[9],[17],[22]	1.02%	[10]
Investment, Identifier [Axis]: Diligent Corporation
Schedule of Investments [Line Items]
Spread Above Reference Rate	[2],[3],[4],[13]			6.25%
Interest Rate	[2],[3],[4],[13]			11.78%
Par Amount	[2],[3],[13]			$ 12,469
Amortized Cost	[2],[3],[13]			12,451
Fair Value	[2],[3],[8],[13]			$ 12,366
Fair Value as % of Net Assets	[2],[3],[10],[13]			1.65%
Investment, Identifier [Axis]: Diligent Corporation (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[2],[4],[13]			6.25%
Interest Rate	[2],[4],[13]			11.78%
Par Amount	[2],[13]			$ 168
Amortized Cost	[2],[13]			168
Fair Value	[2],[8],[13]			$ 166
Fair Value as % of Net Assets	[2],[10],[13]			0.02%
Investment, Identifier [Axis]: Diligent Corporation (Delayed Draw) 1
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.25%	[5],[6],[22]	6.25%	[2],[4],[13]
Interest Rate		11.71%	[5],[6],[22]	11.78%	[2],[4],[13]
Par Amount		$ 167	[5],[22]	$ 106	[2],[13]
Amortized Cost		167	[5],[22]	106	[2],[13]
Fair Value		$ 167	[5],[7],[22]	$ 105	[2],[8],[13]
Fair Value as % of Net Assets		0.02%	[5],[9],[22]	0.01%	[2],[10],[13]
Investment, Identifier [Axis]: Diligent Corporation (Delayed Draw) 2
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6],[22]	6.25%
Interest Rate	[5],[6],[22]	11.71%
Par Amount	[5],[22]	$ 106
Amortized Cost	[5],[22]	106
Fair Value	[5],[7],[22]	$ 105
Fair Value as % of Net Assets	[5],[9],[22]	0.01%
Investment, Identifier [Axis]: Diligent Corporation 1
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.25%	[6],[17],[22]	5.75%	[1],[2],[4],[13]
Interest Rate		11.71%	[6],[17],[22]	11.28%	[1],[2],[4],[13]
Par Amount		$ 12,437	[17],[22]	$ 3,387	[1],[2],[13]
Amortized Cost		12,422	[17],[22]	3,372	[1],[2],[13]
Fair Value		$ 12,422	[7],[17],[22]	$ 3,334	[1],[2],[8],[13]
Fair Value as % of Net Assets		1.24%	[9],[17],[22]	0.45%	[1],[2],[10],[13]
Investment, Identifier [Axis]: Diligent Corporation 2
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[5],[6],[11],[17],[22]	5.75%	[2],[4],[13]
Interest Rate		11.21%	[5],[6],[11],[17],[22]	11.28%	[2],[4],[13]
Par Amount		$ 3,378	[5],[11],[17],[22]	$ 1,476	[2],[13]
Amortized Cost		3,366	[5],[11],[17],[22]	1,469	[2],[13]
Fair Value		$ 3,353	[5],[7],[11],[17],[22]	$ 1,453	[2],[8],[13]
Fair Value as % of Net Assets		0.34%	[5],[9],[11],[17],[22]	0.19%	[2],[10],[13]
Investment, Identifier [Axis]: Diligent Corporation 3
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6],[22]	5.75%
Interest Rate	[5],[6],[22]	11.21%
Par Amount	[5],[22]	$ 1,472
Amortized Cost	[5],[22]	1,467
Fair Value	[5],[7],[22]	$ 1,461
Fair Value as % of Net Assets	[5],[9],[22]	0.15%
Investment, Identifier [Axis]: E78
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4]			5.75%
Interest Rate	[3],[4]			11.21%
Par Amount	[3]			$ 5,600
Amortized Cost		$ 860	[5],[19]	5,560	[3]
Fair Value		$ 894	[5],[7],[19]	$ 5,489	[3],[8]
Fair Value as % of Net Assets		0.09%	[5],[9],[19]	0.74%	[3],[10]
Shares/Units	[5],[19]	816
Investment, Identifier [Axis]: E78 (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[1],[3],[4]			5.75%
Interest Rate	[1],[3],[4]			11.21%
Par Amount	[1],[3]			$ 4,210
Amortized Cost	[1],[3]			4,180
Fair Value	[1],[3],[8]			$ 4,127
Fair Value as % of Net Assets	[1],[3],[10]			0.55%
Investment, Identifier [Axis]: E78 (Delayed Draw) 1
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.50%	[6],[11],[17]	5.75%	[2],[4],[14]
Interest Rate		10.93%	[6],[11],[17]	11.21%	[2],[4],[14]
Par Amount		$ 4,200	[11],[17]	$ 3,550	[2],[14]
Amortized Cost		4,172	[11],[17]	979	[2],[14]
Fair Value		$ 4,190	[7],[11],[17]	$ 909	[2],[8],[14]
Fair Value as % of Net Assets		0.42%	[9],[11],[17]	0.12%	[2],[10],[14]
Investment, Identifier [Axis]: E78 (Delayed Draw) 2
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6],[12]	5.75%
Interest Rate	[5],[6],[12]	10.93%
Par Amount	[5],[12]	$ 3,547
Amortized Cost	[5],[12]	977
Fair Value	[5],[7],[12]	$ 969
Fair Value as % of Net Assets	[5],[9],[12]	0.10%
Investment, Identifier [Axis]: E78 1
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.50%	[6],[17]	5.75%	[1],[4]
Interest Rate		10.93%	[6],[17]	11.21%	[1],[4]
Par Amount		$ 5,586	[17]	$ 1,438	[1]
Amortized Cost		5,549	[17]	1,426	[1]
Fair Value		$ 5,573	[7],[17]	$ 1,409	[1],[8]
Fair Value as % of Net Assets		0.56%	[9],[17]	0.19%	[1],[10]
Investment, Identifier [Axis]: E78 2
Schedule of Investments [Line Items]
Spread Above Reference Rate	[6],[11]	5.75%
Interest Rate	[6],[11]	10.93%
Par Amount	[11]	$ 1,434
Amortized Cost		1,424	[11]	$ 860	[2],[15],[16]
Fair Value		$ 1,431	[7],[11]	$ 835	[2],[8],[15],[16]
Fair Value as % of Net Assets		0.14%	[9],[11]	0.11%	[2],[10],[15],[16]
Shares/Units	[2],[15],[16]			816,000
Investment, Identifier [Axis]: EFC Holdings, LLC
Schedule of Investments [Line Items]
Interest Rate	[2],[4]			11.00%
Interest Rate, PIK	[2],[4]			2.50%
Par Amount	[2]			$ 3,167
Amortized Cost	[2]			3,083
Fair Value	[2],[8]			$ 3,137
Fair Value as % of Net Assets	[2],[10]			0.42%
Investment, Identifier [Axis]: EFC Holdings, LLC 1
Schedule of Investments [Line Items]
Interest Rate	[5],[6]	11.00%
Interest Rate, PIK	[5],[6]	2.50%
Par Amount	[5]	$ 3,187
Amortized Cost		3,108	[5]	$ 60	[2],[15],[16],[20]
Fair Value		$ 3,158	[5],[7]	$ 113	[2],[8],[15],[16],[20]
Fair Value as % of Net Assets		0.32%	[5],[9]	0.02%	[2],[10],[15],[16],[20]
Shares/Units	[2],[15],[16],[20]			148,000
Investment, Identifier [Axis]: EFC Holdings, LLC 2
Schedule of Investments [Line Items]
Amortized Cost		$ 60	[5],[18],[19]	$ 148	[2],[15],[16],[20]
Fair Value		$ 120	[5],[7],[18],[19]	$ 158	[2],[8],[15],[16],[20]
Fair Value as % of Net Assets		0.01%	[5],[9],[18],[19]	0.02%	[2],[10],[15],[16],[20]
Shares/Units		148	[5],[18],[19]	148,000	[2],[15],[16],[20]
Investment, Identifier [Axis]: EFC Holdings, LLC 3
Schedule of Investments [Line Items]
Amortized Cost	[5],[18],[19]	$ 148
Fair Value	[5],[7],[18],[19]	$ 161
Fair Value as % of Net Assets	[5],[9],[18],[19]	0.02%
Shares/Units	[5],[18],[19]	148
Investment, Identifier [Axis]: Elevation Labs
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[6],[11],[17]	5.75%	[1],[3],[4]
Interest Rate		11.00%	[6],[11],[17]	11.23%	[1],[3],[4]
Par Amount		$ 6,772	[11],[17]	$ 6,789	[1],[3]
Amortized Cost		6,720	[11],[17]	6,733	[1],[3]
Fair Value		$ 6,675	[7],[11],[17]	$ 6,335	[1],[3],[8]
Fair Value as % of Net Assets		0.67%	[9],[11],[17]	0.85%	[1],[3],[10]
Investment, Identifier [Axis]: Elevation Labs (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[5],[6],[12]	5.75%	[2],[4],[14]
Interest Rate		11.00%	[5],[6],[12]	11.23%	[2],[4],[14]
Par Amount		$ 3,125	[5],[12]	$ 3,125	[2],[14]
Amortized Cost		915	[5],[12]	(24)	[2],[14]
Fair Value		$ 893	[5],[7],[12]	$ (209)	[2],[8],[14]
Fair Value as % of Net Assets		0.09%	[5],[9],[12]	(0.03%)	[2],[10],[14]
Investment, Identifier [Axis]: Eliassen Group LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.50%	[6],[11],[17],[22]	5.50%	[1],[2],[3],[4],[13]
Interest Rate		10.81%	[6],[11],[17],[22]	10.85%	[1],[2],[3],[4],[13]
Par Amount		$ 12,039	[11],[17],[22]	$ 12,069	[1],[2],[3],[13]
Amortized Cost		11,950	[11],[17],[22]	11,976	[1],[2],[3],[13]
Fair Value		$ 12,054	[7],[11],[17],[22]	$ 12,083	[1],[2],[3],[8],[13]
Fair Value as % of Net Assets		1.21%	[9],[11],[17],[22]	1.62%	[1],[2],[3],[10],[13]
Investment, Identifier [Axis]: Eliassen Group LLC (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.50%	[5],[6],[12],[22]	5.50%	[2],[4],[13],[14]
Interest Rate		10.81%	[5],[6],[12],[22]	10.85%	[2],[4],[13],[14]
Par Amount		$ 2,769	[5],[12],[22]	$ 2,771	[2],[13],[14]
Amortized Cost		862	[5],[12],[22]	864	[2],[13],[14]
Fair Value		$ 870	[5],[7],[12],[22]	$ 872	[2],[8],[13],[14]
Fair Value as % of Net Assets		0.09%	[5],[9],[12],[22]	0.11%	[2],[10],[13],[14]
Investment, Identifier [Axis]: Erie Construction
Schedule of Investments [Line Items]
Spread Above Reference Rate	[1],[3],[4]			4.75%
Interest Rate	[1],[3],[4]			10.21%
Par Amount	[1],[3]			$ 10,153
Amortized Cost	[1],[3]			10,083
Fair Value	[1],[3],[8]			$ 10,153
Fair Value as % of Net Assets	[1],[3],[10]			1.36%
Investment, Identifier [Axis]: Erie Construction 1
Schedule of Investments [Line Items]
Spread Above Reference Rate	[6],[11],[17]	4.75%
Interest Rate	[6],[11],[17]	10.15%
Par Amount	[11],[17]	$ 10,016
Amortized Cost		9,951	[11],[17]	$ 166	[2],[16]
Fair Value		$ 9,956	[7],[11],[17]	$ 606	[2],[8],[16]
Fair Value as % of Net Assets		1.00%	[9],[11],[17]	0.08%	[2],[10],[16]
Shares/Units	[2],[16]			166,000
Investment, Identifier [Axis]: Erie Construction 2
Schedule of Investments [Line Items]
Amortized Cost	[5],[19]	$ 166
Fair Value	[5],[7],[19]	$ 521
Fair Value as % of Net Assets	[5],[9],[19]	0.05%
Shares/Units	[5],[19]	166
Investment, Identifier [Axis]: Evergreen Services Group
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.25%	[5],[6],[11],[17],[22]	6.25%	[1],[2],[3],[4],[13]
Interest Rate		11.66%	[5],[6],[11],[17],[22]	11.70%	[1],[2],[3],[4],[13]
Par Amount		$ 11,936	[5],[11],[17],[22]	$ 11,966	[1],[2],[3],[13]
Amortized Cost		11,743	[5],[11],[17],[22]	11,766	[1],[2],[3],[13]
Fair Value		$ 11,773	[5],[7],[11],[17],[22]	$ 11,733	[1],[2],[3],[8],[13]
Fair Value as % of Net Assets		1.17%	[5],[9],[11],[17],[22]	1.57%	[1],[2],[3],[10],[13]
Investment, Identifier [Axis]: Evergreen Services Group (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.25%	[5],[6],[22]	6.25%	[2],[4],[13]
Interest Rate		11.66%	[5],[6],[22]	11.70%	[2],[4],[13]
Par Amount		$ 2,856	[5],[22]	$ 2,863	[2],[13]
Amortized Cost		2,833	[5],[22]	2,839	[2],[13]
Fair Value		$ 2,817	[5],[7],[22]	$ 2,807	[2],[8],[13]
Fair Value as % of Net Assets		0.28%	[5],[9],[22]	0.38%	[2],[10],[13]
Investment, Identifier [Axis]: Evergreen Services Group II
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.25%	[5],[6],[11],[17],[22]	6.00%	[1],[2],[3],[4],[13]
Interest Rate		11.31%	[5],[6],[11],[17],[22]	11.35%	[1],[2],[3],[4],[13]
Par Amount		$ 16,115	[5],[11],[17],[22]	$ 16,156	[1],[2],[3],[13]
Amortized Cost		15,884	[5],[11],[17],[22]	15,917	[1],[2],[3],[13]
Fair Value		$ 16,067	[5],[7],[11],[17],[22]	$ 15,926	[1],[2],[3],[8],[13]
Fair Value as % of Net Assets		1.60%	[5],[9],[11],[17],[22]	2.13%	[1],[2],[3],[10],[13]
Investment, Identifier [Axis]: Evergreen Services Group II (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.25%	[5],[6],[12],[22]	6.00%	[2],[4],[13],[14]
Interest Rate		11.31%	[5],[6],[12],[22]	11.35%	[2],[4],[13],[14]
Par Amount		$ 13,014	[5],[12],[22]	$ 13,014	[2],[13],[14]
Amortized Cost		11,863	[5],[12],[22]	8,495	[2],[13],[14]
Fair Value		$ 11,853	[5],[7],[12],[22]	$ 8,342	[2],[8],[13],[14]
Fair Value as % of Net Assets		1.19%	[5],[9],[12],[22]	1.11%	[2],[10],[13],[14]
Investment, Identifier [Axis]: Excel Fitness
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.25%	[6],[11],[17]	5.25%	[1],[3],[4]
Interest Rate		10.70%	[6],[11],[17]	10.75%	[1],[3],[4]
Par Amount		$ 9,850	[11],[17]	$ 9,875	[1],[3]
Amortized Cost		9,757	[11],[17]	9,778	[1],[3]
Fair Value		$ 9,689	[7],[11],[17]	$ 9,616	[1],[3],[8]
Fair Value as % of Net Assets		0.97%	[9],[11],[17]	1.29%	[1],[3],[10]
Investment, Identifier [Axis]: Exterro
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.50%	[6],[11],[17]	5.50%	[1],[2],[3],[4],[13]
Interest Rate		10.99%	[6],[11],[17]	11.03%	[1],[2],[3],[4],[13]
Par Amount		$ 9,474	[11],[17]	$ 9,474	[1],[2],[3],[13]
Amortized Cost		9,470	[11],[17]	9,462	[1],[2],[3],[13]
Fair Value		$ 9,590	[7],[11],[17]	$ 9,503	[1],[2],[3],[8],[13]
Fair Value as % of Net Assets		0.96%	[9],[11],[17]	1.27%	[1],[2],[3],[10],[13]
Investment, Identifier [Axis]: FSK Pallet Holding Corp. (DBA Kamps Pallets)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.00%	[6],[11],[17]	6.00%	[1],[3],[4]
Interest Rate		11.46%	[6],[11],[17]	11.53%	[1],[3],[4]
Par Amount		$ 9,850	[11],[17]	$ 9,875	[1],[3]
Amortized Cost		9,713	[11],[17]	9,725	[1],[3]
Fair Value		$ 9,500	[7],[11],[17]	$ 9,616	[1],[3],[8]
Fair Value as % of Net Assets		0.94%	[9],[11],[17]	1.29%	[1],[3],[10]
Investment, Identifier [Axis]: Fairway Lawns
Schedule of Investments [Line Items]
Interest Rate		8.00%	[5],[6]	8.00%	[2],[4]
Interest Rate, PIK		5.00%	[5],[6]	5.00%	[2],[4]
Par Amount		$ 2,766	[5]	$ 2,730	[2]
Amortized Cost		2,701	[5]	2,662	[2]
Fair Value		$ 2,695	[5],[7]	$ 2,659	[2],[8]
Fair Value as % of Net Assets		0.27%	[5],[9]	0.35%	[2],[10]
Investment, Identifier [Axis]: Fairway Lawns (Delayed Draw)
Schedule of Investments [Line Items]
Interest Rate		8.00%	[5],[6]	8.00%	[2],[4],[14]
Interest Rate, PIK		5.00%	[5],[6]	5.00%	[2],[4],[14]
Par Amount		$ 5,944	[5]	$ 6,287	[2],[14]
Amortized Cost		5,944	[5]	5,867	[2],[14]
Fair Value		$ 5,794	[5],[7]	$ 5,704	[2],[8],[14]
Fair Value as % of Net Assets		0.58%	[5],[9]	0.76%	[2],[10],[14]
Investment, Identifier [Axis]: Fineline Merger
Schedule of Investments [Line Items]
Spread Above Reference Rate		9.26%	[5],[6]	9.26%	[2],[4]
Interest Rate		14.31%	[5],[6]	14.61%	[2],[4]
Par Amount		$ 2,453	[5]	$ 2,453	[2]
Amortized Cost		2,430	[5]	2,427	[2]
Fair Value		$ 2,453	[5],[7]	$ 2,453	[2],[8]
Fair Value as % of Net Assets		0.25%	[5],[9]	0.33%	[2],[10]
Investment, Identifier [Axis]: First American Government Obligations Fund
Schedule of Investments [Line Items]
Interest Rate		5.17%		5.19%	[4]
Amortized Cost		$ 30		$ 32
Fair Value		$ 30	[7]	$ 32	[8]
Fair Value as % of Net Assets		0.00%	[9]	0.00%	[10]
Shares/Units		30,000		32,000
Investment, Identifier [Axis]: Five Star Packing
Schedule of Investments [Line Items]
Spread Above Reference Rate		4.25%	[6],[11],[17],[21]	4.25%	[1],[3],[4],[24]
Interest Rate		9.57%	[6],[11],[17],[21]	9.63%	[1],[3],[4],[24]
Par Amount		$ 7,557	[11],[17],[21]	$ 7,576	[1],[3],[24]
Amortized Cost		7,467	[11],[17],[21]	7,482	[1],[3],[24]
Fair Value		$ 7,505	[7],[11],[17],[21]	$ 7,482	[1],[3],[8],[24]
Fair Value as % of Net Assets		0.75%	[9],[11],[17],[21]	1.00%	[1],[3],[10],[24]
Investment, Identifier [Axis]: FoodScience
Schedule of Investments [Line Items]
Spread Above Reference Rate	[2],[3],[4]			6.00%
Interest Rate	[2],[3],[4]			11.73%
Par Amount	[2],[3]			$ 7,744
Amortized Cost	[2],[3]			7,696
Fair Value	[2],[3],[8]			$ 7,081
Fair Value as % of Net Assets	[2],[3],[10]			0.95%
Investment, Identifier [Axis]: FoodScience 1
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.00%	[5],[6],[17]	6.00%	[2],[3],[4]
Interest Rate		11.54%	[5],[6],[17]	12.23%	[2],[3],[4]
Par Amount		$ 7,724	[5],[17]	$ 6,880	[2],[3]
Amortized Cost		7,680	[5],[17]	6,831	[2],[3]
Fair Value		$ 7,356	[5],[7],[17]	$ 6,291	[2],[3],[8]
Fair Value as % of Net Assets		0.74%	[5],[9],[17]	0.84%	[2],[3],[10]
Investment, Identifier [Axis]: FoodScience 2
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6],[17]	6.00%
Interest Rate	[5],[6],[17]	11.54%
Par Amount	[5],[17]	$ 6,863
Amortized Cost	[5],[17]	6,815
Fair Value	[5],[7],[17]	$ 6,536
Fair Value as % of Net Assets	[5],[9],[17]	0.65%
Investment, Identifier [Axis]: FoodScience 3
Schedule of Investments [Line Items]
Amortized Cost		$ 5	[5],[19]	$ 5	[2],[15],[16]
Fair Value		$ 0	[5],[7],[19]	$ 0	[2],[8],[15],[16]
Fair Value as % of Net Assets		0.00%	[5],[9],[19]	0.00%	[2],[10],[15],[16]
Shares/Units		5,168	[5],[19]	5,168,000	[2],[15],[16]
Investment, Identifier [Axis]: FoodScience 4
Schedule of Investments [Line Items]
Amortized Cost		$ 98	[5],[19]	$ 98	[2],[15],[16]
Fair Value		$ 80	[5],[7],[19]	$ 51	[2],[8],[15],[16]
Fair Value as % of Net Assets		0.01%	[5],[9],[19]	0.01%	[2],[10],[15],[16]
Shares/Units		98	[5],[19]	98,000	[2],[15],[16]
Investment, Identifier [Axis]: Forefront Dermatology
Schedule of Investments [Line Items]
Spread Above Reference Rate		4.25%	[6],[17],[21],[22]	4.25%	[2],[3],[4],[13],[24]
Interest Rate		9.56%	[6],[17],[21],[22]	9.63%	[2],[3],[4],[13],[24]
Par Amount		$ 3,306	[17],[21],[22]	$ 3,315	[2],[3],[13],[24]
Amortized Cost		3,262	[17],[21],[22]	3,268	[2],[3],[13],[24]
Fair Value		$ 3,236	[7],[17],[21],[22]	$ 3,215	[2],[3],[8],[13],[24]
Fair Value as % of Net Assets		0.32%	[9],[17],[21],[22]	0.43%	[2],[3],[10],[13],[24]
Investment, Identifier [Axis]: Fresh Edge
Schedule of Investments [Line Items]
Spread Above Reference Rate		4.50%	[5],[6]	4.50%	[2],[4]
Interest Rate		10.07%	[5],[6]	10.07%	[2],[4]
Interest Rate, PIK		5.13%	[5],[6]	5.13%	[2],[4]
Par Amount		$ 3,904	[5]	$ 3,853	[2]
Amortized Cost		3,826	[5]	3,772	[2]
Fair Value		$ 3,818	[5],[7]	$ 3,765	[2],[8]
Fair Value as % of Net Assets		0.38%	[5],[9]	0.50%	[2],[10]
Investment, Identifier [Axis]: Fresh Edge (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[2],[4]			4.50%
Interest Rate	[2],[4]			9.98%
Interest Rate, PIK	[2],[4]			5.13%
Par Amount	[2]			$ 914
Amortized Cost	[2]			891
Fair Value	[2],[8]			$ 893
Fair Value as % of Net Assets	[2],[10]			0.12%
Investment, Identifier [Axis]: Fresh Edge (Incremental) 1
Schedule of Investments [Line Items]
Spread Above Reference Rate		4.50%	[5],[6]	4.50%	[2],[4]
Interest Rate		9.76%	[5],[6]	9.76%	[2],[4]
Interest Rate, PIK		5.13%	[5],[6]	5.13%	[2],[4]
Par Amount		$ 922	[5]	$ 769	[2]
Amortized Cost		900	[5]	752	[2]
Fair Value		$ 902	[5],[7]	$ 752	[2],[8]
Fair Value as % of Net Assets		0.09%	[5],[9]	0.10%	[2],[10]
Investment, Identifier [Axis]: Fresh Edge (Incremental) 2
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6]	4.50%
Interest Rate	[5],[6]	9.76%
Interest Rate, PIK	[5],[6]	5.13%
Par Amount	[5]	$ 780
Amortized Cost	[5]	762
Fair Value	[5],[7]	$ 762
Fair Value as % of Net Assets	[5],[9]	0.08%
Investment, Identifier [Axis]: Fresh Edge - Common
Schedule of Investments [Line Items]
Amortized Cost		$ 3	[5],[19]	$ 0	[2],[15],[16]
Fair Value		$ 46	[5],[7],[19]	$ 99	[2],[8],[15],[16]
Fair Value as % of Net Assets		0.00%	[5],[9],[19]	0.01%	[2],[10],[15],[16]
Shares/Units		682	[5],[19]	667,000	[2],[15],[16]
Investment, Identifier [Axis]: Fresh Edge - Preferred
Schedule of Investments [Line Items]
Amortized Cost		$ 682	[5],[19]	$ 667	[2],[15],[16]
Fair Value		$ 790	[5],[7],[19]	$ 745	[2],[8],[15],[16]
Fair Value as % of Net Assets		0.08%	[5],[9],[19]	0.10%	[2],[10],[15],[16]
Shares/Units		682	[5],[19]	667,000	[2],[15],[16]
Investment, Identifier [Axis]: GHR Healthcare
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.00%	[6],[17],[22]	5.00%	[3],[4],[13]
Interest Rate		10.46%	[6],[17],[22]	10.50%	[3],[4],[13]
Par Amount		$ 6,385	[17],[22]	$ 6,401	[3],[13]
Amortized Cost		6,345	[17],[22]	6,359	[3],[13]
Fair Value		$ 6,251	[7],[17],[22]	$ 6,255	[3],[8],[13]
Fair Value as % of Net Assets		0.63%	[9],[17],[22]	0.84%	[3],[10],[13]
Investment, Identifier [Axis]: GHR Healthcare (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.00%	[6],[11],[17],[22]	5.00%	[1],[3],[4],[13]
Interest Rate		10.46%	[6],[11],[17],[22]	10.50%	[1],[3],[4],[13]
Par Amount		$ 1,997	[11],[17],[22]	$ 2,002	[1],[3],[13]
Amortized Cost		1,997	[11],[17],[22]	2,002	[1],[3],[13]
Fair Value		$ 1,955	[7],[11],[17],[22]	$ 1,957	[1],[3],[8],[13]
Fair Value as % of Net Assets		0.20%	[9],[11],[17],[22]	0.26%	[1],[3],[10],[13]
Investment, Identifier [Axis]: GHR Healthcare (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.00%	[6],[11],[17],[22]	5.00%	[1],[4]
Interest Rate		10.46%	[6],[11],[17],[22]	10.50%	[1],[4]
Par Amount		$ 4,970	[11],[17],[22]	$ 4,983	[1]
Amortized Cost		4,896	[11],[17],[22]	4,904	[1]
Fair Value		$ 4,866	[7],[11],[17],[22]	$ 4,869	[1],[8]
Fair Value as % of Net Assets		0.49%	[9],[11],[17],[22]	0.65%	[1],[10]
Investment, Identifier [Axis]: Gabriel Partners LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.25%	[6],[11],[17],[22]	5.75%	[1],[3],[4],[13]
Interest Rate		11.74%	[6],[11],[17],[22]	11.53%	[1],[3],[4],[13]
Par Amount		$ 9,168	[11],[17],[22]	$ 9,192	[1],[3],[13]
Amortized Cost		9,125	[11],[17],[22]	9,144	[1],[3],[13]
Fair Value		$ 9,168	[7],[11],[17],[22]	$ 9,192	[1],[3],[8],[13]
Fair Value as % of Net Assets		0.92%	[9],[11],[17],[22]	1.23%	[1],[3],[10],[13]
Investment, Identifier [Axis]: Gabriel Partners LLC (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.25%	[6],[11],[17],[22]	5.75%	[1],[3],[4],[13]
Interest Rate		11.74%	[6],[11],[17],[22]	11.53%	[1],[3],[4],[13]
Par Amount		$ 1,527	[11],[17],[22]	$ 1,531	[1],[3],[13]
Amortized Cost		1,527	[11],[17],[22]	1,531	[1],[3],[13]
Fair Value		$ 1,527	[7],[11],[17],[22]	$ 1,531	[1],[3],[8],[13]
Fair Value as % of Net Assets		0.15%	[9],[11],[17],[22]	0.20%	[1],[3],[10],[13]
Investment, Identifier [Axis]: Gabriel Partners LLC (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[6],[11],[17],[22]	5.75%	[1],[4],[13]
Interest Rate		11.74%	[6],[11],[17],[22]	11.53%	[1],[4],[13]
Par Amount		$ 3,784	[11],[17],[22]	$ 3,794	[1],[13]
Amortized Cost		3,764	[11],[17],[22]	3,771	[1],[13]
Fair Value		$ 3,784	[7],[11],[17],[22]	$ 3,794	[1],[8],[13]
Fair Value as % of Net Assets		0.38%	[9],[11],[17],[22]	0.51%	[1],[10],[13]
Investment, Identifier [Axis]: Gannett Fleming
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.60%	[6],[11],[17]	6.60%	[1],[3],[4]
Interest Rate		11.90%	[6],[11],[17]	11.95%	[1],[3],[4]
Par Amount		$ 9,875	[11],[17]	$ 9,900	[1],[3]
Amortized Cost		9,712	[11],[17]	9,730	[1],[3]
Fair Value		$ 9,888	[7],[11],[17]	$ 9,913	[1],[3],[8]
Fair Value as % of Net Assets		0.99%	[9],[11],[17]	1.32%	[1],[3],[10]
Investment, Identifier [Axis]: Gannett Fleming 1
Schedule of Investments [Line Items]
Amortized Cost		$ 570	[5],[19]	$ 570	[2],[15],[16]
Fair Value		$ 830	[5],[7],[19]	$ 830	[2],[8],[15],[16]
Fair Value as % of Net Assets		0.08%	[5],[9],[19]	0.11%	[2],[10],[15],[16]
Shares/Units		569,505	[5],[19]	569,505,000	[2],[15],[16]
Investment, Identifier [Axis]: Gannett Fleming 2
Schedule of Investments [Line Items]
Amortized Cost		$ 425	[5],[19],[25]	$ 425	[2],[15],[16],[26]
Fair Value		$ 619	[5],[7],[19],[25]	$ 619	[2],[8],[15],[16],[26]
Fair Value as % of Net Assets		0.06%	[5],[9],[19],[25]	0.08%	[2],[10],[15],[16],[26]
Shares/Units		424,742	[5],[19],[25]	424,742,000	[2],[15],[16],[26]
Investment, Identifier [Axis]: Genesee Scientific
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.50%	[6],[17],[22]	5.50%	[3],[4],[13]
Interest Rate		10.93%	[6],[17],[22]	10.95%	[3],[4],[13]
Par Amount		$ 5,943	[17],[22]	$ 5,959	[3],[13]
Amortized Cost		5,909	[17],[22]	5,922	[3],[13]
Fair Value		$ 5,756	[7],[17],[22]	$ 5,839	[3],[8],[13]
Fair Value as % of Net Assets		0.58%	[9],[17],[22]	0.78%	[3],[10],[13]
Investment, Identifier [Axis]: Genesee Scientific (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.50%	[5],[6],[22]	5.50%	[2],[4],[13]
Interest Rate		10.93%	[5],[6],[22]	10.95%	[2],[4],[13]
Par Amount		$ 1,556	[5],[22]	$ 1,560	[2],[13]
Amortized Cost		1,556	[5],[22]	1,560	[2],[13]
Fair Value		$ 1,507	[5],[7],[22]	$ 1,528	[2],[8],[13]
Fair Value as % of Net Assets		0.15%	[5],[9],[22]	0.20%	[2],[10],[13]
Investment, Identifier [Axis]: Go Engineer
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.38%	[6],[11],[17],[22]	5.38%	[1],[3],[4],[13]
Interest Rate		10.83%	[6],[11],[17],[22]	10.87%	[1],[3],[4],[13]
Par Amount		$ 11,543	[11],[17],[22]	$ 11,572	[1],[3],[13]
Amortized Cost		11,466	[11],[17],[22]	11,490	[1],[3],[13]
Fair Value		$ 11,491	[7],[11],[17],[22]	$ 11,409	[1],[3],[8],[13]
Fair Value as % of Net Assets		1.15%	[9],[11],[17],[22]	1.53%	[1],[3],[10],[13]
Investment, Identifier [Axis]: Go Engineer (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.38%	[6],[17],[22]	5.38%	[2],[4],[13]
Interest Rate		10.83%	[6],[17],[22]	10.87%	[2],[4],[13]
Par Amount		$ 3,144	[17],[22]	$ 3,152	[2],[13]
Amortized Cost		3,123	[17],[22]	3,130	[2],[13]
Fair Value		$ 3,129	[7],[17],[22]	$ 3,107	[2],[8],[13]
Fair Value as % of Net Assets		0.31%	[9],[17],[22]	0.42%	[2],[10],[13]
Investment, Identifier [Axis]: Good2Grow
Schedule of Investments [Line Items]
Spread Above Reference Rate	[1],[2],[4]			5.50%
Interest Rate	[1],[2],[4]			11.04%
Par Amount	[1],[2]			$ 6,362
Amortized Cost	[1],[2]			6,270
Fair Value	[1],[2],[8]			$ 6,362
Fair Value as % of Net Assets	[1],[2],[10]			0.85%
Investment, Identifier [Axis]: Good2Grow 1
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.00%	[5],[6],[11]	4.50%	[1],[3],[4]
Interest Rate		11.04%	[5],[6],[11]	10.04%	[1],[3],[4]
Par Amount		$ 6,346	[5],[11]	$ 9,265	[1],[3]
Amortized Cost		6,260	[5],[11]	9,201	[1],[3]
Fair Value		$ 6,409	[5],[7],[11]	$ 9,137	[1],[3],[8]
Fair Value as % of Net Assets		0.64%	[5],[9],[11]	1.22%	[1],[3],[10]
Investment, Identifier [Axis]: Good2Grow 2
Schedule of Investments [Line Items]
Spread Above Reference Rate	[6],[11],[17]	4.50%
Interest Rate	[6],[11],[17]	9.99%
Par Amount	[11],[17]	$ 9,265
Amortized Cost	[11],[17]	9,205
Fair Value	[7],[11],[17]	$ 9,252
Fair Value as % of Net Assets	[9],[11],[17]	0.93%
Investment, Identifier [Axis]: Halo Buyer Inc
Schedule of Investments [Line Items]
Spread Above Reference Rate		4.50%	[6],[17],[21]	4.50%	[3],[4],[24]
Interest Rate		9.93%	[6],[17],[21]	9.96%	[3],[4],[24]
Par Amount		$ 5,652	[17],[21]	$ 5,668	[3],[24]
Amortized Cost		5,631	[17],[21]	5,641	[3],[24]
Fair Value		$ 4,143	[7],[17],[21]	$ 4,284	[3],[8],[24]
Fair Value as % of Net Assets		0.42%	[9],[17],[21]	0.57%	[3],[10],[24]
Investment, Identifier [Axis]: Handgards
Schedule of Investments [Line Items]
Spread Above Reference Rate		7.00%	[6],[11],[17]	7.00%	[1],[3],[4]
Interest Rate		12.49%	[6],[11],[17]	12.54%	[1],[3],[4]
Par Amount		$ 14,475	[11],[17]	$ 14,513	[1],[3]
Amortized Cost		14,339	[11],[17]	14,364	[1],[3]
Fair Value		$ 14,475	[7],[11],[17]	$ 14,513	[1],[3],[8]
Fair Value as % of Net Assets		1.45%	[9],[11],[17]	1.94%	[1],[3],[10]
Investment, Identifier [Axis]: Harvest Hill Beverage Company
Schedule of Investments [Line Items]
Spread Above Reference Rate	[2],[4]			9.00%
Interest Rate	[2],[4]			14.46%
Par Amount	[2]			$ 3,640
Amortized Cost	[2]			3,540
Fair Value	[2],[8]			$ 3,573
Fair Value as % of Net Assets	[2],[10]			0.48%
Investment, Identifier [Axis]: Health Management Associates
Schedule of Investments [Line Items]
Spread Above Reference Rate	[1],[2],[4]			6.50%
Interest Rate	[1],[2],[4]			11.73%
Par Amount	[1],[2]			$ 8,307
Amortized Cost	[1],[2]			8,154
Fair Value	[1],[2],[8]			$ 8,233
Fair Value as % of Net Assets	[1],[2],[10]			1.10%
Investment, Identifier [Axis]: Health Management Associates (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.25%	[5],[6],[12]	6.50%	[2],[4],[14]
Interest Rate		11.69%	[5],[6],[12]	11.73%	[2],[4],[14]
Par Amount		$ 1,498	[5],[12]	$ 1,499	[2],[14]
Amortized Cost		444	[5],[12]	444	[2],[14]
Fair Value		$ 468	[5],[7],[12]	$ 460	[2],[8],[14]
Fair Value as % of Net Assets		0.05%	[5],[9],[12]	0.06%	[2],[10],[14]
Investment, Identifier [Axis]: Health Management Associates 1
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6],[11],[17]	6.25%
Interest Rate	[5],[6],[11],[17]	11.69%
Par Amount	[5],[11],[17]	$ 8,285
Amortized Cost		8,139	[5],[11],[17]	$ 400	[2],[15],[16]
Fair Value		$ 8,262	[5],[7],[11],[17]	$ 427	[2],[8],[15],[16]
Fair Value as % of Net Assets		0.83%	[5],[9],[11],[17]	0.06%	[2],[10],[15],[16]
Shares/Units	[2],[15],[16]			399,904,000
Investment, Identifier [Axis]: Health Management Associates 2
Schedule of Investments [Line Items]
Amortized Cost	[5],[19]	$ 400
Fair Value	[5],[7],[19]	$ 489
Fair Value as % of Net Assets	[5],[9],[19]	0.05%
Shares/Units	[5],[19]	399,904
Investment, Identifier [Axis]: Heartland Home Services
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.00%	[6],[11],[17],[22]	6.00%	[1],[3],[4],[13]
Interest Rate		11.31%	[6],[11],[17],[22]	11.36%	[1],[3],[4],[13]
Par Amount		$ 6,450	[11],[17],[22]	$ 6,467	[1],[3],[13]
Amortized Cost		6,416	[11],[17],[22]	6,428	[1],[3],[13]
Fair Value		$ 6,312	[7],[11],[17],[22]	$ 6,382	[1],[3],[8],[13]
Fair Value as % of Net Assets		0.63%	[9],[11],[17],[22]	0.85%	[1],[3],[10],[13]
Investment, Identifier [Axis]: Heartland Home Services (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[1],[3],[4],[13]			6.00%
Interest Rate	[1],[3],[4],[13]			11.36%
Par Amount	[1],[3],[13]			$ 5,608
Amortized Cost	[1],[3],[13]			5,589
Fair Value	[1],[3],[8],[13]			$ 5,533
Fair Value as % of Net Assets	[1],[3],[10],[13]			0.74%
Investment, Identifier [Axis]: Heartland Home Services (Delayed Draw) 1
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.00%	[6],[11],[17],[22]	6.00%	[1],[3],[4],[13]
Interest Rate		11.31%	[6],[11],[17],[22]	11.36%	[1],[3],[4],[13]
Par Amount		$ 5,593	[11],[17],[22]	$ 2,571	[1],[3],[13]
Amortized Cost		5,577	[11],[17],[22]	2,571	[1],[3],[13]
Fair Value		$ 5,473	[7],[11],[17],[22]	$ 2,537	[1],[3],[8],[13]
Fair Value as % of Net Assets		0.55%	[9],[11],[17],[22]	0.34%	[1],[3],[10],[13]
Investment, Identifier [Axis]: Heartland Home Services (Delayed Draw) 2
Schedule of Investments [Line Items]
Spread Above Reference Rate	[6],[11],[17],[22]	6.00%
Interest Rate	[6],[11],[17],[22]	11.31%
Par Amount	[11],[17],[22]	$ 2,565
Amortized Cost	[11],[17],[22]	2,565
Fair Value	[7],[11],[17],[22]	$ 2,510
Fair Value as % of Net Assets	[9],[11],[17],[22]	0.25%
Investment, Identifier [Axis]: Heartland Veterinary Partners (Delayed Draw) (Incremental)
Schedule of Investments [Line Items]
Interest Rate	[5],[6],[12]	7.50%
Interest Rate, PIK	[5],[6],[12]	7.00%
Par Amount	[5],[12]	$ 3,600
Amortized Cost	[5],[12]	0
Fair Value	[5],[7],[12]	$ (90)
Fair Value as % of Net Assets	[5],[9],[12]	(0.01%)
Investment, Identifier [Axis]: Heartland Veterinary Partners LLC (Delayed Draw) (Incremental)
Schedule of Investments [Line Items]
Interest Rate	[5],[6]	7.50%
Interest Rate, PIK	[5],[6]	7.00%
Par Amount	[5]	$ 9,500
Amortized Cost	[5]	9,500
Fair Value	[5],[7]	$ 9,263
Fair Value as % of Net Assets	[5],[9]	0.93%
Investment, Identifier [Axis]: Heartland Veterinary Partners LLC (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[2],[4]			7.50%
Interest Rate		7.50%	[5],[6]	12.96%	[2],[4]
Interest Rate, PIK	[5],[6]	7.00%
Par Amount		$ 1,900	[5]	$ 1,900	[2]
Amortized Cost		1,875	[5]	1,872	[2]
Fair Value		$ 1,853	[5],[7]	$ 1,875	[2],[8]
Fair Value as % of Net Assets		0.19%	[5],[9]	0.25%	[2],[10]
Investment, Identifier [Axis]: Heartland Veterinary Partners LLC (Incremental) (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[2],[4]			7.50%
Interest Rate	[2],[4]			12.96%
Par Amount	[2]			$ 9,500
Amortized Cost	[2]			9,500
Fair Value	[2],[8]			$ 9,377
Fair Value as % of Net Assets	[2],[10]			1.25%
Investment, Identifier [Axis]: HemaSource Inc.
Schedule of Investments [Line Items]
Interest Rate		8.50%	[5],[6]	8.50%	[2],[4]
Interest Rate, PIK		5.00%	[5],[6]	5.00%	[2],[4]
Par Amount		$ 5,292	[5]	$ 5,292	[2]
Amortized Cost		5,158	[5]	5,153	[2]
Fair Value		$ 5,154	[5],[7]	$ 5,147	[2],[8]
Fair Value as % of Net Assets		0.52%	[5],[9]	0.69%	[2],[10]
Investment, Identifier [Axis]: High Bar Brands
Schedule of Investments [Line Items]
Interest Rate	[2],[4]			9.00%
Interest Rate, PIK	[2],[4]			4.00%
Par Amount	[2]			$ 2,088
Amortized Cost	[2]			2,035
Fair Value	[2],[8]			$ 2,036
Fair Value as % of Net Assets	[2],[10]			0.27%
Investment, Identifier [Axis]: High Bar Brands (Delayed Draw)
Schedule of Investments [Line Items]
Interest Rate		9.00%	[5],[6],[12]	9.00%	[2],[4],[14]
Interest Rate, PIK		4.00%	[5],[6],[12]	4.00%	[2],[4],[14]
Par Amount		$ 596	[5],[12]	$ 596	[2],[14]
Amortized Cost		(7)	[5],[12]	(7)	[2],[14]
Fair Value		$ (14)	[5],[7],[12]	$ (15)	[2],[8],[14]
Fair Value as % of Net Assets		0.00%	[5],[9],[12]	0.00%	[2],[10],[14]
Investment, Identifier [Axis]: High Bar Brands 1
Schedule of Investments [Line Items]
Interest Rate	[5],[6]	9.00%
Interest Rate, PIK	[5],[6]	4.00%
Par Amount	[5]	$ 2,088
Amortized Cost		2,038	[5]	$ 303	[2],[15],[16],[20]
Fair Value		$ 2,037	[5],[7]	$ 303	[2],[8],[15],[16],[20]
Fair Value as % of Net Assets		0.20%	[5],[9]	0.04%	[2],[10],[15],[16],[20]
Shares/Units	[2],[15],[16],[20]			303,000,000
Investment, Identifier [Axis]: High Bar Brands 2
Schedule of Investments [Line Items]
Amortized Cost	[5],[18],[19]	$ 303
Fair Value	[5],[7],[18],[19]	$ 294
Fair Value as % of Net Assets	[5],[9],[18],[19]	0.03%
Shares/Units	[5],[18],[19]	303,000
Investment, Identifier [Axis]: HireRight
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6],[11]	4.00%
Interest Rate	[5],[6],[11]	9.33%
Par Amount	[5],[11]	$ 6,754
Amortized Cost	[5],[11]	6,686
Fair Value	[5],[7],[11]	$ 6,687
Fair Value as % of Net Assets	[5],[9],[11]	0.67%
Investment, Identifier [Axis]: Hyperion
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6],[11],[21]	4.50%
Interest Rate	[5],[6],[11],[21]	9.94%
Par Amount	[5],[11],[21]	$ 2,647
Amortized Cost	[5],[11],[21]	2,644
Fair Value	[5],[7],[11],[21]	$ 2,650
Fair Value as % of Net Assets	[5],[9],[11],[21]	0.27%
Investment, Identifier [Axis]: ICE USA Infrastructure
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6],[11],[18]	5.75%
Interest Rate	[5],[6],[11],[18]	11.08%
Par Amount	[5],[11],[18]	$ 6,605
Amortized Cost	[5],[11],[18]	6,539
Fair Value	[5],[7],[11],[18]	$ 6,539
Fair Value as % of Net Assets	[5],[9],[11],[18]	0.66%
Investment, Identifier [Axis]: INS Intermediate II, LLC (Ergotech Controls, Inc. – d/b/a INS)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.50%	[6],[11],[17]	6.50%	[1],[3],[4]
Interest Rate		11.96%	[6],[11],[17]	12.03%	[1],[3],[4]
Par Amount		$ 7,941	[11],[17]	$ 7,961	[1],[3]
Amortized Cost		7,809	[11],[17]	7,822	[1],[3]
Fair Value		$ 7,952	[7],[11],[17]	$ 7,973	[1],[3],[8]
Fair Value as % of Net Assets		0.79%	[9],[11],[17]	1.06%	[1],[3],[10]
Investment, Identifier [Axis]: INS Intermediate II, LLC (Ergotech Controls, Inc. – d/b/a INS) (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.50%	[5],[6],[12]	6.50%	[2],[4],[14]
Interest Rate		11.96%	[5],[6],[12]	12.03%	[2],[4],[14]
Par Amount		$ 1,979	[5],[12]	$ 1,979	[2],[14]
Amortized Cost		(32)	[5],[12]	(34)	[2],[14]
Fair Value		$ 3	[5],[7],[12]	$ 3	[2],[8],[14]
Fair Value as % of Net Assets		0.00%	[5],[9],[12]	0.00%	[2],[10],[14]
Investment, Identifier [Axis]: ISG Merger Sub, LLC (dba Industrial Service Group)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[1],[3],[4]			6.25%
Interest Rate	[1],[3],[4]			11.60%
Par Amount	[1],[3]			$ 6,525
Amortized Cost	[1],[3]			6,412
Fair Value	[1],[3],[8]			$ 6,569
Fair Value as % of Net Assets	[1],[3],[10]			0.88%
Investment, Identifier [Axis]: ISG Merger Sub, LLC (dba Industrial Service Group) (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[2],[4]			6.25%
Interest Rate	[2],[4]			11.60%
Par Amount	[2]			$ 3,397
Amortized Cost	[2]			3,383
Fair Value	[2],[8]			$ 3,420
Fair Value as % of Net Assets	[2],[10]			0.46%
Investment, Identifier [Axis]: ITSavvy LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[1],[3],[4]			5.25%
Interest Rate	[1],[3],[4]			10.89%
Par Amount	[1],[3]			$ 7,794
Amortized Cost	[1],[3]			7,730
Fair Value	[1],[3],[8]			$ 7,794
Fair Value as % of Net Assets	[1],[3],[10]			1.04%
Investment, Identifier [Axis]: ITSavvy LLC (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.25%	[5],[6],[12]	5.25%	[2],[4],[14]
Interest Rate		10.89%	[5],[6],[12]	10.89%	[2],[4],[14]
Par Amount		$ 1,049	[5],[12]	$ 1,049	[2],[14]
Amortized Cost		884	[5],[12]	883	[2],[14]
Fair Value		$ 891	[5],[7],[12]	$ 891	[2],[8],[14]
Fair Value as % of Net Assets		0.09%	[5],[9],[12]	0.12%	[2],[10],[14]
Investment, Identifier [Axis]: ITSavvy LLC 1
Schedule of Investments [Line Items]
Spread Above Reference Rate	[6],[17]	5.25%
Interest Rate	[6],[17]	10.89%
Par Amount	[17]	$ 7,774
Amortized Cost		7,715	[17]	$ 522	[2],[15],[16]
Fair Value		$ 7,774	[7],[17]	$ 1,250	[2],[8],[15],[16]
Fair Value as % of Net Assets		0.77%	[9],[17]	0.17%	[2],[10],[15],[16]
Shares/Units	[2],[15],[16]			522,000
Investment, Identifier [Axis]: ITSavvy LLC 2
Schedule of Investments [Line Items]
Amortized Cost	[5],[19]	$ 522
Fair Value	[5],[7],[19]	$ 1,377
Fair Value as % of Net Assets	[5],[9],[19]	0.14%
Shares/Units	[5],[19]	522
Investment, Identifier [Axis]: Image First
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6],[11],[17]	4.25%
Interest Rate	[5],[6],[11],[17]	9.57%
Par Amount	[5],[11],[17]	$ 7,668
Amortized Cost	[5],[11],[17]	7,650
Fair Value	[5],[7],[11],[17]	$ 7,649
Fair Value as % of Net Assets	[5],[9],[11],[17]	0.77%
Investment, Identifier [Axis]: Image First (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6],[12]	4.25%
Interest Rate	[5],[6],[12]	9.57%
Par Amount	[5],[12]	$ 143
Amortized Cost	[5],[12]	0
Fair Value	[5],[7],[12]	$ 0
Fair Value as % of Net Assets	[5],[9],[12]	0.00%
Investment, Identifier [Axis]: Impact Environmental Group
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.00%	[5],[6],[17]	6.00%	[1],[2],[4]
Interest Rate		11.41%	[5],[6],[17]	11.28%	[1],[2],[4]
Par Amount		$ 6,759	[5],[17]	$ 6,776	[1],[2]
Amortized Cost		6,638	[5],[17]	6,650	[1],[2]
Fair Value		$ 6,771	[5],[7],[17]	$ 6,721	[1],[2],[8]
Fair Value as % of Net Assets		0.68%	[5],[9],[17]	0.90%	[1],[2],[10]
Investment, Identifier [Axis]: Impact Environmental Group (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.00%	[5],[6]	6.00%	[2],[4],[14]
Interest Rate		11.41%	[5],[6]	11.28%	[2],[4],[14]
Par Amount		$ 3,158	[5]	$ 3,166	[2],[14]
Amortized Cost		3,143	[5]	2,770	[2],[14]
Fair Value		$ 3,163	[5],[7]	$ 2,759	[2],[8],[14]
Fair Value as % of Net Assets		0.32%	[5],[9]	0.37%	[2],[10],[14]
Investment, Identifier [Axis]: Impact Environmental Group (Delayed Draw) (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.00%	[5],[6],[12]	6.00%	[2],[4],[14]
Interest Rate		11.41%	[5],[6],[12]	11.28%	[2],[4],[14]
Par Amount		$ 6,815	[5],[12]	$ 6,822	[2],[14]
Amortized Cost		2,693	[5],[12]	(32)	[2],[14]
Fair Value		$ 2,734	[5],[7],[12]	$ (55)	[2],[8],[14]
Fair Value as % of Net Assets		0.27%	[5],[9],[12]	(0.01%)	[2],[10],[14]
Investment, Identifier [Axis]: Impact Environmental Group (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.00%	[5],[6]	6.00%	[2],[4]
Interest Rate		11.41%	[5],[6]	11.28%	[2],[4]
Par Amount		$ 1,732	[5]	$ 1,736	[2]
Amortized Cost		1,700	[5]	1,703	[2]
Fair Value		$ 1,735	[5],[7]	$ 1,722	[2],[8]
Fair Value as % of Net Assets		0.17%	[5],[9]	0.23%	[2],[10]
Investment, Identifier [Axis]: Industrial Service Group
Schedule of Investments [Line Items]
Spread Above Reference Rate	[6],[17]	6.25%
Interest Rate	[6],[17]	11.56%
Par Amount	[17]	$ 6,509
Amortized Cost	[17]	6,400
Fair Value	[7],[17]	$ 6,550
Fair Value as % of Net Assets	[9],[17]	0.66%
Investment, Identifier [Axis]: Industrial Service Group (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6],[17]	6.25%
Interest Rate	[5],[6],[17]	11.56%
Par Amount	[5],[17]	$ 3,389
Amortized Cost	[5],[17]	3,375
Fair Value	[5],[7],[17]	$ 3,410
Fair Value as % of Net Assets	[5],[9],[17]	0.34%
Investment, Identifier [Axis]: Infinite Electronics (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.25%	[6],[17],[22]	6.25%	[1],[3],[4],[13]
Interest Rate		11.83%	[6],[17],[22]	11.88%	[1],[3],[4],[13]
Par Amount		$ 6,297	[17],[22]	$ 6,313	[1],[3],[13]
Amortized Cost		6,144	[17],[22]	6,152	[1],[3],[13]
Fair Value		$ 6,096	[7],[17],[22]	$ 6,100	[1],[3],[8],[13]
Fair Value as % of Net Assets		0.61%	[9],[17],[22]	0.82%	[1],[3],[10],[13]
Investment, Identifier [Axis]: Infobase Acquisition, Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.50%	[6],[17]	5.50%	[1],[3],[4]
Interest Rate		10.98%	[6],[17]	10.93%	[1],[3],[4]
Par Amount		$ 4,320	[17]	$ 4,331	[1],[3]
Amortized Cost		4,288	[17]	4,297	[1],[3]
Fair Value		$ 4,310	[7],[17]	$ 4,297	[1],[3],[8]
Fair Value as % of Net Assets		0.43%	[9],[17]	0.57%	[1],[3],[10]
Investment, Identifier [Axis]: Infobase Acquisition, Inc. (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[2],[4],[14]			5.50%
Interest Rate	[2],[4],[14]			10.93%
Par Amount	[2],[14]			$ 721
Amortized Cost	[2],[14]			0
Fair Value	[2],[8],[14]			$ (6)
Fair Value as % of Net Assets	[2],[10],[14]			0.00%
Investment, Identifier [Axis]: InfuCare RX
Schedule of Investments [Line Items]
Spread Above Reference Rate		4.50%	[5],[6],[11],[17]	4.50%	[1],[2],[3],[4]
Interest Rate		9.91%	[5],[6],[11],[17]	9.95%	[1],[2],[3],[4]
Par Amount		$ 9,248	[5],[11],[17]	$ 9,248	[1],[2],[3]
Amortized Cost		9,186	[5],[11],[17]	9,182	[1],[2],[3]
Fair Value		$ 9,226	[5],[7],[11],[17]	$ 9,045	[1],[2],[3],[8]
Fair Value as % of Net Assets		0.92%	[5],[9],[11],[17]	1.21%	[1],[2],[3],[10]
Investment, Identifier [Axis]: JEGS Automotive
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.00%	[6],[17]	6.00%	[3],[4]
Interest Rate		11.47%	[6],[17]	11.46%	[3],[4]
Par Amount		$ 3,978	[17]	$ 3,999	[3]
Amortized Cost		3,951	[17]	3,970	[3]
Fair Value		$ 2,864	[7],[17]	$ 3,381	[3],[8]
Fair Value as % of Net Assets		0.29%	[9],[17]	0.45%	[3],[10]
Investment, Identifier [Axis]: KRIV Acquisition, Inc
Schedule of Investments [Line Items]
Spread Above Reference Rate	[1],[2],[3],[4]			6.50%
Interest Rate	[1],[2],[3],[4]			11.85%
Par Amount	[1],[2],[3]			$ 10,764
Amortized Cost	[1],[2],[3]			10,476
Fair Value	[1],[2],[3],[8]			$ 10,453
Fair Value as % of Net Assets	[1],[2],[3],[10]			1.40%
Investment, Identifier [Axis]: KRIV Acquisition, Inc (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.50%	[5],[6],[12]	6.50%	[2],[4],[14]
Interest Rate		11.80%	[5],[6],[12]	11.85%	[2],[4],[14]
Par Amount		$ 1,607	[5],[12]	$ 1,607	[2],[14]
Amortized Cost		(18)	[5],[12]	(19)	[2],[14]
Fair Value		$ (45)	[5],[7],[12]	$ (46)	[2],[8],[14]
Fair Value as % of Net Assets		0.00%	[5],[9],[12]	(0.01%)	[2],[10],[14]
Investment, Identifier [Axis]: KRIV Acquisition, Inc 1
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6],[11],[17]	6.50%
Interest Rate	[5],[6],[11],[17]	11.80%
Par Amount	[5],[11],[17]	$ 10,737
Amortized Cost		10,459	[5],[11],[17]	$ 790	[2],[15],[16]
Fair Value		$ 10,439	[5],[7],[11],[17]	$ 930	[2],[8],[15],[16]
Fair Value as % of Net Assets		1.05%	[5],[9],[11],[17]	0.12%	[2],[10],[15],[16]
Shares/Units	[2],[15],[16]			790,000
Investment, Identifier [Axis]: KRIV Acquisition, Inc 2
Schedule of Investments [Line Items]
Amortized Cost	[5],[19]	$ 790
Fair Value	[5],[7],[19]	$ 734
Fair Value as % of Net Assets	[5],[9],[19]	0.07%
Shares/Units	[5],[19]	790
Investment, Identifier [Axis]: KSLB Holdings LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate		4.50%	[6],[11]	4.50%	[1],[4]
Interest Rate		9.96%	[6],[11]	10.03%	[1],[4]
Par Amount		$ 2,850	[11]	$ 2,858	[1]
Amortized Cost		2,839	[11]	2,844	[1]
Fair Value		$ 2,736	[7],[11]	$ 2,712	[1],[8]
Fair Value as % of Net Assets		0.27%	[9],[11]	0.36%	[1],[10]
Investment, Identifier [Axis]: Kenco Group, Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.00%	[6],[11],[17]	5.00%	[1],[3],[4]
Interest Rate		10.29%	[6],[11],[17]	10.39%	[1],[3],[4]
Par Amount		$ 8,476	[11],[17]	$ 8,498	[1],[3]
Amortized Cost		8,334	[11],[17]	8,349	[1],[3]
Fair Value		$ 8,476	[7],[11],[17]	$ 8,498	[1],[3],[8]
Fair Value as % of Net Assets		0.85%	[9],[11],[17]	1.14%	[1],[3],[10]
Investment, Identifier [Axis]: Kenco Group, Inc. (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.00%	[5],[6],[12]	5.00%	[2],[4],[14]
Interest Rate		10.29%	[5],[6],[12]	10.39%	[2],[4],[14]
Par Amount		$ 1,416	[5],[12]	$ 1,416	[2],[14]
Amortized Cost		(23)	[5],[12]	(24)	[2],[14]
Fair Value		$ 0	[5],[7],[12]	$ 0	[2],[8],[14]
Fair Value as % of Net Assets		0.00%	[5],[9],[12]	0.00%	[2],[10],[14]
Investment, Identifier [Axis]: Keng Acquisition, Inc. (Engage Group Holdings, LLC)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.25%	[5],[6],[11],[17],[22]	6.25%	[1],[2],[4],[13]
Interest Rate		11.56%	[5],[6],[11],[17],[22]	11.60%	[1],[2],[4],[13]
Par Amount		$ 9,643	[5],[11],[17],[22]	$ 9,667	[1],[2],[13]
Amortized Cost		9,507	[5],[11],[17],[22]	9,526	[1],[2],[13]
Fair Value		$ 9,605	[5],[7],[11],[17],[22]	$ 9,528	[1],[2],[8],[13]
Fair Value as % of Net Assets		0.96%	[5],[9],[11],[17],[22]	1.27%	[1],[2],[10],[13]
Investment, Identifier [Axis]: Keng Acquisition, Inc. (Engage Group Holdings, LLC) (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.25%	[5],[6],[12],[22]	6.25%	[2],[4],[13],[14]
Interest Rate		11.56%	[5],[6],[12],[22]	11.60%	[2],[4],[13],[14]
Par Amount		$ 9,311	[5],[12],[22]	$ 9,314	[2],[13],[14]
Amortized Cost		1,177	[5],[12],[22]	1,179	[2],[13],[14]
Fair Value		$ 1,162	[5],[7],[12],[22]	$ 1,067	[2],[8],[13],[14]
Fair Value as % of Net Assets		0.12%	[5],[9],[12],[22]	0.14%	[2],[10],[13],[14]
Investment, Identifier [Axis]: LMI Consulting, LLC (LMI)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[1],[4]			6.50%
Interest Rate	[1],[4]			11.90%
Par Amount	[1]			$ 4,351
Amortized Cost	[1]			4,280
Fair Value	[1],[8]			$ 4,370
Fair Value as % of Net Assets	[1],[10]			0.59%
Investment, Identifier [Axis]: LMI Consulting, LLC (LMI) (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4]			6.50%
Interest Rate	[3],[4]			11.89%
Par Amount	[3]			$ 4,938
Amortized Cost	[3]			4,938
Fair Value	[3],[8]			$ 4,959
Fair Value as % of Net Assets	[3],[10]			0.66%
Investment, Identifier [Axis]: LMI Renaissance
Schedule of Investments [Line Items]
Amortized Cost	[2],[15],[16]			$ 634
Fair Value	[2],[8],[15],[16]			$ 1,370
Fair Value as % of Net Assets	[2],[10],[15],[16]			0.18%
Shares/Units	[2],[15],[16]			633,980,000
Investment, Identifier [Axis]: LMI Renaissance 1
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6],[11],[17]	5.50%
Interest Rate	[5],[6],[11],[17]	10.84%
Par Amount	[5],[11],[17]	$ 12,224
Amortized Cost	[5],[11],[17]	12,125
Fair Value	[5],[7],[11],[17]	$ 12,174
Fair Value as % of Net Assets	[5],[9],[11],[17]	1.22%
Investment, Identifier [Axis]: LMI Renaissance 2
Schedule of Investments [Line Items]
Amortized Cost	[5],[19]	$ 634
Fair Value	[5],[7],[19]	$ 1,421
Fair Value as % of Net Assets	[5],[9],[19]	0.14%
Shares/Units	[5],[19]	633,980
Investment, Identifier [Axis]: LSCS Holdings Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate		4.50%	[6],[11],[17],[21]	4.50%	[1],[3],[4],[24]
Interest Rate		9.94%	[6],[11],[17],[21]	9.86%	[1],[3],[4],[24]
Par Amount		$ 9,775	[11],[17],[21]	$ 9,800	[1],[3],[24]
Amortized Cost		9,742	[11],[17],[21]	9,762	[1],[3],[24]
Fair Value		$ 9,650	[7],[11],[17],[21]	$ 9,675	[1],[3],[8],[24]
Fair Value as % of Net Assets		0.97%	[9],[11],[17],[21]	1.30%	[1],[3],[10],[24]
Investment, Identifier [Axis]: LYNX FRANCHISING, LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[13]			6.75%
Interest Rate	[3],[4],[13]			12.47%
Par Amount	[3],[13]			$ 9,800
Amortized Cost	[3],[13]			9,725
Fair Value	[3],[8],[13]			$ 9,699
Fair Value as % of Net Assets	[3],[10],[13]			1.30%
Investment, Identifier [Axis]: Legacy Service Partners, LLC (“LSP”)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[1],[2],[3],[4]			6.50%
Interest Rate	[1],[2],[3],[4]			12.00%
Par Amount	[1],[2],[3]			$ 10,161
Amortized Cost	[1],[2],[3]			9,983
Fair Value	[1],[2],[3],[8]			$ 10,306
Fair Value as % of Net Assets	[1],[2],[3],[10]			1.38%
Investment, Identifier [Axis]: Legacy Service Partners, LLC (“LSP”) (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.50%	[5],[6]	6.50%	[2],[4],[14]
Interest Rate		11.96%	[5],[6]	12.00%	[2],[4],[14]
Par Amount		$ 4,724	[5]	$ 4,734	[2],[14]
Amortized Cost		4,704	[5]	3,949	[2],[14]
Fair Value		$ 4,771	[5],[7]	$ 4,037	[2],[8],[14]
Fair Value as % of Net Assets		0.48%	[5],[9]	0.54%	[2],[10],[14]
Investment, Identifier [Axis]: Legacy Service Partners, LLC (“LSP”) 1
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6],[11],[17]	6.50%
Interest Rate	[5],[6],[11],[17]	11.96%
Par Amount	[5],[11],[17]	$ 10,136
Amortized Cost		9,965	[5],[11],[17]	$ 491	[2],[15],[16]
Fair Value		$ 10,237	[5],[7],[11],[17]	$ 544	[2],[8],[15],[16]
Fair Value as % of Net Assets		1.02%	[5],[9],[11],[17]	0.07%	[2],[10],[15],[16]
Shares/Units	[2],[15],[16]			4,907,000
Investment, Identifier [Axis]: Legacy Service Partners, LLC (“LSP”) 2
Schedule of Investments [Line Items]
Amortized Cost	[5],[19]	$ 491
Fair Value	[5],[7],[19]	$ 597
Fair Value as % of Net Assets	[5],[9],[19]	0.06%
Shares/Units	[5],[19]	4,907
Investment, Identifier [Axis]: Liberty Buyer
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[6],[11],[17],[22]	5.50%	[1],[4],[13]
Interest Rate		11.18%	[6],[11],[17],[22]	11.18%	[1],[4],[13]
Par Amount		$ 3,919	[11],[17],[22]	$ 3,929	[1],[13]
Amortized Cost		3,890	[11],[17],[22]	3,898	[1],[13]
Fair Value		$ 3,926	[7],[11],[17],[22]	$ 3,945	[1],[8],[13]
Fair Value as % of Net Assets		0.39%	[9],[11],[17],[22]	0.53%	[1],[10],[13]
Investment, Identifier [Axis]: Liberty Buyer (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[5],[6],[12],[22]	5.50%	[2],[4],[13],[14]
Interest Rate		11.18%	[5],[6],[12],[22]	11.18%	[2],[4],[13],[14]
Par Amount		$ 743	[5],[12],[22]	$ 744	[2],[13],[14]
Amortized Cost		295	[5],[12],[22]	295	[2],[13],[14]
Fair Value		$ 296	[5],[7],[12],[22]	$ 298	[2],[8],[13],[14]
Fair Value as % of Net Assets		0.03%	[5],[9],[12],[22]	0.04%	[2],[10],[13],[14]
Investment, Identifier [Axis]: Lion Merger Sub Inc
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.00%	[6],[11],[22]	6.00%	[1],[4],[13]
Interest Rate		11.41%	[6],[11],[22]	11.45%	[1],[4],[13]
Par Amount		$ 7,323	[11],[22]	$ 7,342	[1],[13]
Amortized Cost		7,293	[11],[22]	7,308	[1],[13]
Fair Value		$ 7,295	[7],[11],[22]	$ 7,259	[1],[8],[13]
Fair Value as % of Net Assets		0.73%	[9],[11],[22]	0.97%	[1],[10],[13]
Investment, Identifier [Axis]: Lion Merger Sub Inc (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.00%	[5],[6],[11],[22]	6.00%	[1],[2],[4],[13]
Interest Rate		11.41%	[5],[6],[11],[22]	11.45%	[1],[2],[4],[13]
Par Amount		$ 7,298	[5],[11],[22]	$ 7,317	[1],[2],[13]
Amortized Cost		7,241	[5],[11],[22]	7,252	[1],[2],[13]
Fair Value		$ 7,270	[5],[7],[11],[22]	$ 7,234	[1],[2],[8],[13]
Fair Value as % of Net Assets		0.73%	[5],[9],[11],[22]	0.97%	[1],[2],[10],[13]
Investment, Identifier [Axis]: Loc Performance Products
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.25%	[6],[17]	5.25%	[2],[3],[4]
Interest Rate		10.68%	[6],[17]	10.71%	[2],[3],[4]
Par Amount		$ 6,539	[17]	$ 6,557	[2],[3]
Amortized Cost		6,489	[17]	6,502	[2],[3]
Fair Value		$ 6,312	[7],[17]	$ 6,270	[2],[3],[8]
Fair Value as % of Net Assets		0.63%	[9],[17]	0.84%	[2],[3],[10]
Investment, Identifier [Axis]: Long Term Care Group
Schedule of Investments [Line Items]
Spread Above Reference Rate		1.26%	[5],[6],[17],[22]	1.00%	[2],[3],[4],[13]
Interest Rate		6.57%	[5],[6],[17],[22]	6.66%	[2],[3],[4],[13]
Interest Rate, PIK		6.00%	[5],[6],[17],[22]	6.00%	[2],[3],[4],[13]
Par Amount		$ 6,963	[5],[17],[22]	$ 6,858	[2],[3],[13]
Amortized Cost		6,920	[5],[17],[22]	6,812	[2],[3],[13]
Fair Value		$ 5,762	[5],[7],[17],[22]	$ 5,916	[2],[3],[8],[13]
Fair Value as % of Net Assets		0.58%	[5],[9],[17],[22]	0.79%	[2],[3],[10],[13]
Investment, Identifier [Axis]: Lynx Franchising, LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[6],[17],[22]	6.75%
Interest Rate	[6],[17],[22]	12.23%
Par Amount	[17],[22]	$ 9,775
Amortized Cost	[17],[22]	9,700
Fair Value	[7],[17],[22]	$ 9,759
Fair Value as % of Net Assets	[9],[17],[22]	0.98%
Investment, Identifier [Axis]: MBS Holdings, Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.25%	[6],[17],[22]	6.25%	[1],[4],[13]
Interest Rate		11.68%	[6],[17],[22]	11.71%	[1],[4],[13]
Par Amount		$ 1,823	[17],[22]	$ 1,828	[1],[13]
Amortized Cost		1,795	[17],[22]	1,797	[1],[13]
Fair Value		$ 1,833	[7],[17],[22]	$ 1,824	[1],[8],[13]
Fair Value as % of Net Assets		0.18%	[9],[17],[22]	0.24%	[1],[10],[13]
Investment, Identifier [Axis]: MDC Intermediate Holdings II, LLC
Schedule of Investments [Line Items]
Interest Rate		10.00%	[5],[6]	10.00%	[2],[4]
Interest Rate, PIK		2.25%	[5],[6]	2.25%	[2],[4]
Par Amount		$ 1,759	[5]	$ 1,749	[2]
Amortized Cost		1,722	[5]	1,711	[2]
Fair Value		$ 1,701	[5],[7]	$ 1,690	[2],[8]
Fair Value as % of Net Assets		0.17%	[5],[9]	0.23%	[2],[10]
Investment, Identifier [Axis]: MDC Intermediate Holdings II, LLC (Delayed Draw)
Schedule of Investments [Line Items]
Interest Rate		10.00%	[5],[6],[12]	10.00%	[2],[4],[14]
Interest Rate, PIK		2.25%	[5],[6],[12]	2.25%	[2],[4],[14]
Par Amount		$ 723	[5],[12]	$ 721	[2],[14]
Amortized Cost		462	[5],[12]	160	[2],[14]
Fair Value		$ 445	[5],[7],[12]	$ 143	[2],[8],[14]
Fair Value as % of Net Assets		0.04%	[5],[9],[12]	0.02%	[2],[10],[14]
Investment, Identifier [Axis]: MEI Rigging & Crating
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.50%	[5],[6],[11],[17]	6.50%	[1],[2],[3],[4]
Interest Rate		11.83%	[5],[6],[11],[17]	11.86%	[1],[2],[3],[4]
Par Amount		$ 11,402	[5],[11],[17]	$ 11,431	[1],[2],[3]
Amortized Cost		11,195	[5],[11],[17]	11,212	[1],[2],[3]
Fair Value		$ 11,305	[5],[7],[11],[17]	$ 11,329	[1],[2],[3],[8]
Fair Value as % of Net Assets		1.12%	[5],[9],[11],[17]	1.51%	[1],[2],[3],[10]
Investment, Identifier [Axis]: MEI Rigging & Crating (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.50%	[5],[6],[12]	6.50%	[2],[4],[14]
Interest Rate		11.83%	[5],[6],[12]	11.86%	[2],[4],[14]
Par Amount		$ 1,814	[5],[12]	$ 1,814	[2],[14]
Amortized Cost		(8)	[5],[12]	(8)	[2],[14]
Fair Value		$ (15)	[5],[7],[12]	$ (16)	[2],[8],[14]
Fair Value as % of Net Assets		0.00%	[5],[9],[12]	0.00%	[2],[10],[14]
Investment, Identifier [Axis]: MGM Transformer Company
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.00%	[5],[6],[11],[17]	6.00%	[1],[2],[3],[4]
Interest Rate		11.33%	[5],[6],[11],[17]	11.38%	[1],[2],[3],[4]
Par Amount		$ 23,553	[5],[11],[17]	$ 23,612	[1],[2],[3]
Amortized Cost		23,217	[5],[11],[17]	23,259	[1],[2],[3]
Fair Value		$ 23,403	[5],[7],[11],[17]	$ 23,271	[1],[2],[3],[8]
Fair Value as % of Net Assets		2.33%	[5],[9],[11],[17]	3.11%	[1],[2],[3],[10]
Investment, Identifier [Axis]: MGM Transformer Company (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.00%	[5],[6],[12]	6.00%	[2],[4],[14]
Interest Rate		11.33%	[5],[6],[12]	11.38%	[2],[4],[14]
Par Amount		$ 6,388	[5],[12]	$ 6,388	[2],[14]
Amortized Cost		(15)	[5],[12]	(16)	[2],[14]
Fair Value		$ (41)	[5],[7],[12]	$ (92)	[2],[8],[14]
Fair Value as % of Net Assets		0.00%	[5],[9],[12]	(0.01%)	[2],[10],[14]
Investment, Identifier [Axis]: MSHC Inc
Schedule of Investments [Line Items]
Spread Above Reference Rate	[6],[17],[22]	4.00%
Interest Rate	[6],[17],[22]	9.57%
Par Amount	[17],[22]	$ 7,979
Amortized Cost	[17],[22]	7,999
Fair Value	[7],[17],[22]	$ 7,999
Fair Value as % of Net Assets	[9],[17],[22]	0.80%
Investment, Identifier [Axis]: Market Performance Group
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.25%	[6],[11],[17]	5.50%	[1],[3],[4]
Interest Rate		10.56%	[6],[11],[17]	11.03%	[1],[3],[4]
Par Amount		$ 12,620	[11],[17]	$ 2,505	[1],[3]
Amortized Cost		12,498	[11],[17]	2,489	[1],[3]
Fair Value		$ 12,503	[7],[11],[17]	$ 2,505	[1],[3],[8]
Fair Value as % of Net Assets		1.25%	[9],[11],[17]	0.33%	[1],[3],[10]
Investment, Identifier [Axis]: Market Performance Group (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6],[12]	5.25%
Interest Rate	[5],[6],[12]	10.56%
Par Amount	[5],[12]	$ 3,086
Amortized Cost	[5],[12]	0
Fair Value	[5],[7],[12]	$ (29)
Fair Value as % of Net Assets	[5],[9],[12]	0.00%
Investment, Identifier [Axis]: Market Performance Group 1
Schedule of Investments [Line Items]
Spread Above Reference Rate	[1],[3],[4]			5.50%
Interest Rate	[1],[3],[4]			11.03%
Par Amount	[1],[3]			$ 7,275
Amortized Cost	[1],[3]			7,256
Fair Value	[1],[3],[8]			$ 7,275
Fair Value as % of Net Assets	[1],[3],[10]			0.97%
Investment, Identifier [Axis]: Micronics
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.25%	[5],[6]	5.25%	[2],[4]
Interest Rate		10.84%	[5],[6]	10.00%	[2],[4]
Par Amount		$ 2,450	[5]	$ 2,450	[2]
Amortized Cost		2,405	[5]	2,401	[2]
Fair Value		$ 2,405	[5],[7]	$ 2,401	[2],[8]
Fair Value as % of Net Assets		0.24%	[5],[9]	0.32%	[2],[10]
Investment, Identifier [Axis]: Midwest Eye Consultants
Schedule of Investments [Line Items]
Spread Above Reference Rate		4.50%	[6],[11],[17]	4.50%	[1],[3],[4]
Interest Rate		9.96%	[6],[11],[17]	10.04%	[1],[3],[4]
Par Amount		$ 8,998	[11],[17]	$ 9,021	[1],[3]
Amortized Cost		8,945	[11],[17]	8,962	[1],[3]
Fair Value		$ 8,936	[7],[11],[17]	$ 8,790	[1],[3],[8]
Fair Value as % of Net Assets		0.90%	[9],[11],[17]	1.18%	[1],[3],[10]
Investment, Identifier [Axis]: Mobile Communications America Inc
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.00%	[5],[6],[11],[17]	6.00%	[1],[2],[3],[4]
Interest Rate		11.31%	[5],[6],[11],[17]	11.35%	[1],[2],[3],[4]
Par Amount		$ 18,459	[5],[11],[17]	$ 18,505	[1],[2],[3]
Amortized Cost		18,196	[5],[11],[17]	18,232	[1],[2],[3]
Fair Value		$ 18,229	[5],[7],[11],[17]	$ 18,241	[1],[2],[3],[8]
Fair Value as % of Net Assets		1.84%	[5],[9],[11],[17]	2.44%	[1],[2],[3],[10]
Investment, Identifier [Axis]: Mobile Communications America Inc (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.00%	[5],[6],[12]	6.00%	[2],[4],[14]
Interest Rate		11.31%	[5],[6],[12]	11.35%	[2],[4],[14]
Par Amount		$ 5,970	[5],[12]	$ 5,970	[2],[14]
Amortized Cost		(42)	[5],[12]	(43)	[2],[14]
Fair Value		$ (74)	[5],[7],[12]	$ (85)	[2],[8],[14]
Fair Value as % of Net Assets		(0.01%)	[5],[9],[12]	(0.01%)	[2],[10],[14]
Investment, Identifier [Axis]: Momentum Telecom II
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[6],[11],[17],[22]	5.75%	[1],[3],[4],[13]
Interest Rate		11.18%	[6],[11],[17],[22]	11.21%	[1],[3],[4],[13]
Par Amount		$ 10,028	[11],[17],[22]	$ 10,054	[1],[3],[13]
Amortized Cost		9,973	[11],[17],[22]	9,992	[1],[3],[13]
Fair Value		$ 9,950	[7],[11],[17],[22]	$ 9,891	[1],[3],[8],[13]
Fair Value as % of Net Assets		1.00%	[9],[11],[17],[22]	1.32%	[1],[3],[10],[13]
Investment, Identifier [Axis]: Momentum Telecom II (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.50%	[6],[17],[22]	6.50%	[2],[4],[13]
Interest Rate		11.93%	[6],[17],[22]	11.96%	[2],[4],[13]
Par Amount		$ 1,311	[17],[22]	$ 1,314	[2],[13]
Amortized Cost		1,289	[17],[22]	1,290	[2],[13]
Fair Value		$ 1,326	[7],[17],[22]	$ 1,320	[2],[8],[13]
Fair Value as % of Net Assets		0.13%	[9],[17],[22]	0.18%	[2],[10],[13]
Investment, Identifier [Axis]: NJEye LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate		4.75%	[6],[17]	4.75%	[3],[4]
Interest Rate		10.17%	[6],[17]	10.39%	[3],[4]
Par Amount		$ 5,326	[17]	$ 5,340	[3]
Amortized Cost		5,321	[17]	5,331	[3]
Fair Value		$ 5,306	[7],[17]	$ 5,283	[3],[8]
Fair Value as % of Net Assets		0.53%	[9],[17]	0.71%	[3],[10]
Investment, Identifier [Axis]: NJEye LLC (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4]			4.75%
Interest Rate	[3],[4]			10.39%
Par Amount	[3]			$ 700
Amortized Cost	[3]			700
Fair Value	[3],[8]			$ 692
Fair Value as % of Net Assets	[3],[10]			0.09%
Investment, Identifier [Axis]: NJEye LLC (Delayed Draw) 1
Schedule of Investments [Line Items]
Spread Above Reference Rate		4.75%	[6],[17]	4.75%	[2],[4],[14]
Interest Rate		10.17%	[6],[17]	10.39%	[2],[4],[14]
Par Amount		$ 698	[17]	$ 1,373	[2],[14]
Amortized Cost		698	[17]	883	[2],[14]
Fair Value		$ 695	[7],[17]	$ 870	[2],[8],[14]
Fair Value as % of Net Assets		0.07%	[9],[17]	0.12%	[2],[10],[14]
Investment, Identifier [Axis]: NJEye LLC (Delayed Draw) 2
Schedule of Investments [Line Items]
Spread Above Reference Rate		4.75%	[5],[6],[12]	4.75%	[2],[4]
Interest Rate		10.17%	[5],[6],[12]	10.44%	[2],[4]
Par Amount		$ 1,373	[5],[12]	$ 890	[2]
Amortized Cost		884	[5],[12]	890	[2]
Fair Value		$ 879	[5],[7],[12]	$ 881	[2],[8]
Fair Value as % of Net Assets		0.09%	[5],[9],[12]	0.12%	[2],[10]
Investment, Identifier [Axis]: NJEye LLC (Delayed Draw) 3
Schedule of Investments [Line Items]
Spread Above Reference Rate	[6],[17]	4.75%
Interest Rate	[6],[17]	10.44%
Par Amount	[17]	$ 888
Amortized Cost	[17]	888
Fair Value	[7],[17]	$ 885
Fair Value as % of Net Assets	[9],[17]	0.09%
Investment, Identifier [Axis]: National Power
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.00%	[5],[6],[17]	6.00%	[1],[2],[4]
Interest Rate		11.34%	[5],[6],[17]	11.36%	[1],[2],[4]
Par Amount		$ 5,660	[5],[17]	$ 5,674	[1],[2]
Amortized Cost		5,578	[5],[17]	5,589	[1],[2]
Fair Value		$ 5,579	[5],[7],[17]	$ 5,593	[1],[2],[8]
Fair Value as % of Net Assets		0.56%	[5],[9],[17]	0.75%	[1],[2],[10]
Investment, Identifier [Axis]: National Power (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.00%	[5],[6],[12]	6.00%	[2],[4],[14]
Interest Rate		11.34%	[5],[6],[12]	11.36%	[2],[4],[14]
Par Amount		$ 3,051	[5],[12]	$ 3,051	[2],[14]
Amortized Cost		(7)	[5],[12]	(7)	[2],[14]
Fair Value		$ (44)	[5],[7],[12]	$ (44)	[2],[8],[14]
Fair Value as % of Net Assets		0.00%	[5],[9],[12]	(0.01%)	[2],[10],[14]
Investment, Identifier [Axis]: NearU (Delayed Draw) 1
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6],[12],[22]	6.00%
Interest Rate	[5],[6],[12],[22]	11.51%
Par Amount	[5],[12],[22]	$ 1,577
Amortized Cost	[5],[12],[22]	0
Fair Value	[5],[7],[12],[22]	$ (104)
Fair Value as % of Net Assets	[5],[9],[12],[22]	(0.01%)
Investment, Identifier [Axis]: NearU (Delayed Draw) 2
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6],[12],[22]	6.00%
Interest Rate	[5],[6],[12],[22]	11.51%
Par Amount	[5],[12],[22]	$ 1,714
Amortized Cost	[5],[12],[22]	0
Fair Value	[5],[7],[12],[22]	$ (113)
Fair Value as % of Net Assets	[5],[9],[12],[22]	(0.01%)
Investment, Identifier [Axis]: NearU 1
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6],[11],[17],[22]	6.00%
Interest Rate	[5],[6],[11],[17],[22]	11.51%
Par Amount	[5],[11],[17],[22]	$ 8,452
Amortized Cost	[5],[11],[17],[22]	8,452
Fair Value	[5],[7],[11],[17],[22]	$ 7,895
Fair Value as % of Net Assets	[5],[9],[11],[17],[22]	0.79%
Investment, Identifier [Axis]: NearU 2
Schedule of Investments [Line Items]
Amortized Cost	[5],[19],[22]	$ 243
Fair Value	[5],[7],[19],[22]	$ 159
Fair Value as % of Net Assets	[5],[9],[19],[22]	0.02%
Shares/Units	[5],[19],[22]	2,432
Investment, Identifier [Axis]: North Haven CS Acquisition Inc
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.50%	[6],[17]	5.25%	[3],[4]
Interest Rate		10.97%	[6],[17]	10.78%	[3],[4]
Par Amount		$ 5,769	[17]	$ 5,787	[3]
Amortized Cost		5,769	[17]	5,787	[3]
Fair Value		$ 5,742	[7],[17]	$ 5,787	[3],[8]
Fair Value as % of Net Assets		0.58%	[9],[17]	0.77%	[3],[10]
Investment, Identifier [Axis]: North Haven CS Acquisition Inc (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6],[11]	5.50%
Interest Rate	[5],[6],[11]	10.97%
Par Amount	[5],[11]	$ 22,355
Amortized Cost	[5],[11]	22,135
Fair Value	[5],[7],[11]	$ 22,251
Fair Value as % of Net Assets	[5],[9],[11]	2.23%
Investment, Identifier [Axis]: North Haven Spartan US Holdco LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.25%	[6],[17]	6.25%	[3],[4]
Interest Rate		11.57%	[6],[17]	11.63%	[3],[4]
Par Amount		$ 2,496	[17]	$ 2,503	[3]
Amortized Cost		2,495	[17]	2,501	[3]
Fair Value		$ 2,466	[7],[17]	$ 2,497	[3],[8]
Fair Value as % of Net Assets		0.25%	[9],[17]	0.33%	[3],[10]
Investment, Identifier [Axis]: North Haven Spartan US Holdco LLC (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.25%	[6],[17]	6.25%	[3],[4]
Interest Rate		11.57%	[6],[17]	11.63%	[3],[4]
Par Amount		$ 216	[17]	$ 217	[3]
Amortized Cost		216	[17]	217	[3]
Fair Value		$ 214	[7],[17]	$ 217	[3],[8]
Fair Value as % of Net Assets		0.02%	[9],[17]	0.03%	[3],[10]
Investment, Identifier [Axis]: North Haven Spartan US Holdco LLC (Delayed Draw) (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[6],[11],[12]	6.25%
Interest Rate	[6],[11],[12]	11.57%
Par Amount	[11],[12]	$ 3,260
Amortized Cost	[11],[12]	(8)
Fair Value	[7],[11],[12]	$ (40)
Fair Value as % of Net Assets	[9],[11],[12]	0.00%
Investment, Identifier [Axis]: Nutrition 101 Buyer LLC (a/k/a 101, Inc.)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.25%	[6],[17]	5.25%	[1],[3],[4]
Interest Rate		10.66%	[6],[17]	10.73%	[1],[3],[4]
Par Amount		$ 6,631	[17]	$ 6,648	[1],[3]
Amortized Cost		6,582	[17]	6,596	[1],[3]
Fair Value		$ 6,386	[7],[17]	$ 6,518	[1],[3],[8]
Fair Value as % of Net Assets		0.64%	[9],[17]	0.87%	[1],[3],[10]
Investment, Identifier [Axis]: OEP Glass Purchaser
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.25%	[6],[11],[17]	5.25%	[1],[2],[3],[4]
Interest Rate		10.45%	[6],[11],[17]	10.55%	[1],[2],[3],[4]
Par Amount		$ 12,563	[11],[17]	$ 12,563	[1],[2],[3]
Amortized Cost		12,472	[11],[17]	12,467	[1],[2],[3]
Fair Value		$ 12,563	[7],[11],[17]	$ 12,508	[1],[2],[3],[8]
Fair Value as % of Net Assets		1.27%	[9],[11],[17]	1.67%	[1],[2],[3],[10]
Investment, Identifier [Axis]: Oliver Packaging
Schedule of Investments [Line Items]
Interest Rate	[2],[4]			1.00%
Interest Rate, PIK	[2],[4]			10.00%
Par Amount	[2]			$ 2,510
Amortized Cost	[2]			2,471
Fair Value	[2],[8]			$ 2,377
Fair Value as % of Net Assets	[2],[10]			0.32%
Investment, Identifier [Axis]: Oliver Packaging 1
Schedule of Investments [Line Items]
Interest Rate	[5],[6]	10.00%
Interest Rate, PIK	[5],[6]	1.00%
Par Amount	[5]	$ 2,510
Amortized Cost		2,473	[5]	$ 1,023	[2],[15],[16]
Fair Value		$ 2,378	[5],[7]	$ 640	[2],[8],[15],[16]
Fair Value as % of Net Assets		0.24%	[5],[9]	0.09%	[2],[10],[15],[16]
Shares/Units	[2],[15],[16]			10,230,000
Investment, Identifier [Axis]: Oliver Packaging 2
Schedule of Investments [Line Items]
Amortized Cost	[5],[19]	$ 1,023
Fair Value	[5],[7],[19]	$ 606
Fair Value as % of Net Assets	[5],[9],[19]	0.06%
Shares/Units	[5],[19]	10,230
Investment, Identifier [Axis]: One World Fitness PFF LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.25%	[6],[17]	5.25%	[3],[4]
Interest Rate		10.66%	[6],[17]	10.70%	[3],[4]
Interest Rate, PIK		1.00%	[6],[17]	1.00%	[3],[4]
Par Amount		$ 3,874	[17]	$ 3,872	[3]
Amortized Cost		3,875	[17]	3,873	[3]
Fair Value		$ 3,686	[7],[17]	$ 3,637	[3],[8]
Fair Value as % of Net Assets		0.37%	[9],[17]	0.48%	[3],[10]
Investment, Identifier [Axis]: Online Labels Group
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.25%	[6],[11]	5.25%	[1],[4]
Interest Rate		10.61%	[6],[11]	10.61%	[1],[4]
Par Amount		$ 3,320	[11]	$ 3,328	[1]
Amortized Cost		3,289	[11]	3,295	[1]
Fair Value		$ 3,303	[7],[11]	$ 3,296	[1],[8]
Fair Value as % of Net Assets		0.33%	[9],[11]	0.44%	[1],[10]
Investment, Identifier [Axis]: Online Labels Group (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[2],[4],[14]			5.25%
Interest Rate	[2],[4],[14]			10.61%
Par Amount	[2],[14]			$ 403
Amortized Cost	[2],[14]			0
Fair Value	[2],[8],[14]			$ (4)
Fair Value as % of Net Assets	[2],[10],[14]			0.00%
Investment, Identifier [Axis]: Online Labels Group (Delayed Draw) 1
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.25%	[5],[6],[12]	5.25%	[2],[4],[14]
Interest Rate		10.61%	[5],[6],[12]	10.61%	[2],[4],[14]
Par Amount		$ 403	[5],[12]	$ 403	[2],[14]
Amortized Cost		0	[5],[12]	0	[2],[14]
Fair Value		$ (2)	[5],[7],[12]	$ (4)	[2],[8],[14]
Fair Value as % of Net Assets		0.00%	[5],[9],[12]	0.00%	[2],[10],[14]
Investment, Identifier [Axis]: Online Labels Group (Delayed Draw) 2
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6],[12]	5.25%
Interest Rate	[5],[6],[12]	10.61%
Par Amount	[5],[12]	$ 403
Amortized Cost	[5],[12]	0
Fair Value	[5],[7],[12]	$ (2)
Fair Value as % of Net Assets	[5],[9],[12]	0.00%
Investment, Identifier [Axis]: Orion Group FM Holdings, LLC (dba Leo Facilities Maintenance)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.25%	[5],[6],[17]	6.25%	[1],[2],[3],[4]
Interest Rate		11.56%	[5],[6],[17]	11.65%	[1],[2],[3],[4]
Par Amount		$ 8,529	[5],[17]	$ 8,550	[1],[2],[3]
Amortized Cost		8,409	[5],[17]	8,426	[1],[2],[3]
Fair Value		$ 8,412	[5],[7],[17]	$ 8,429	[1],[2],[3],[8]
Fair Value as % of Net Assets		0.84%	[5],[9],[17]	1.13%	[1],[2],[3],[10]
Investment, Identifier [Axis]: Orion Group FM Holdings, LLC (dba Leo Facilities Maintenance) (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.25%	[5],[6],[12]	6.25%	[2],[4],[14]
Interest Rate		11.56%	[5],[6],[12]	11.65%	[2],[4],[14]
Par Amount		$ 6,429	[5],[12]	$ 6,429	[2],[14]
Amortized Cost		1,100	[5],[12]	(15)	[2],[14]
Fair Value		$ 1,026	[5],[7],[12]	$ (91)	[2],[8],[14]
Fair Value as % of Net Assets		0.10%	[5],[9],[12]	(0.01%)	[2],[10],[14]
Investment, Identifier [Axis]: Output Services Group, Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate	[2],[4],[20]			8.00%
Interest Rate	[2],[4],[20]			13.39%
Par Amount	[2],[20]			$ 155
Amortized Cost		$ 833	[5],[18],[19]	155	[2],[20]
Fair Value		$ 908	[5],[7],[18],[19]	$ 155	[2],[8],[20]
Fair Value as % of Net Assets		0.09%	[5],[9],[18],[19]	0.02%	[2],[10],[20]
Shares/Units	[5],[18],[19]	47,021
Investment, Identifier [Axis]: Output Services Group, Inc. 1
Schedule of Investments [Line Items]
Spread Above Reference Rate		8.00%	[5],[6],[18]	6.25%	[2],[4]
Interest Rate		13.29%	[5],[6],[18]	7.32%	[2],[4]
Interest Rate, PIK	[2],[4]			4.75%
Par Amount		$ 155	[5],[18]	$ 837	[2]
Amortized Cost		155	[5],[18]	837	[2]
Fair Value		$ 155	[5],[7],[18]	$ 837	[2],[8]
Fair Value as % of Net Assets		0.02%	[5],[9],[18]	0.11%	[2],[10]
Investment, Identifier [Axis]: Output Services Group, Inc. 2
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6]	6.25%
Interest Rate	[5],[6]	7.22%
Interest Rate, PIK	[5],[6]	4.75%
Par Amount	[5]	$ 837
Amortized Cost		837	[5]	$ 833	[2],[15],[16],[20]
Fair Value		$ 837	[5],[7]	$ 833	[2],[8],[15],[16],[20]
Fair Value as % of Net Assets		0.08%	[5],[9]	0.11%	[2],[10],[15],[16],[20]
Shares/Units	[2],[15],[16],[20]			47,021,000
Investment, Identifier [Axis]: Ovation Holdings, Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.25%	[6],[11],[17]	6.25%	[1],[3],[4]
Interest Rate		11.71%	[6],[11],[17]	11.78%	[1],[3],[4]
Par Amount		$ 8,015	[11],[17]	$ 8,035	[1],[3]
Amortized Cost		7,864	[11],[17]	7,876	[1],[3]
Fair Value		$ 8,007	[7],[11],[17]	$ 7,949	[1],[3],[8]
Fair Value as % of Net Assets		0.80%	[9],[11],[17]	1.06%	[1],[3],[10]
Investment, Identifier [Axis]: Ovation Holdings, Inc. (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.25%	[5],[6],[12]	6.25%	[2],[4],[14]
Interest Rate		11.71%	[5],[6],[12]	11.78%	[2],[4],[14]
Par Amount		$ 1,895	[5],[12]	$ 1,899	[2],[14]
Amortized Cost		1,532	[5],[12]	1,535	[2],[14]
Fair Value		$ 1,550	[5],[7],[12]	$ 1,536	[2],[8],[14]
Fair Value as % of Net Assets		0.16%	[5],[9],[12]	0.21%	[2],[10],[14]
Investment, Identifier [Axis]: PT Intermediate Holdings III, LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.98%	[6],[11],[17],[22]	5.98%	[1],[3],[4],[13]
Interest Rate		11.43%	[6],[11],[17],[22]	11.52%	[1],[3],[4],[13]
Par Amount		$ 8,713	[11],[17],[22]	$ 8,735	[1],[3],[13]
Amortized Cost		8,692	[11],[17],[22]	8,711	[1],[3],[13]
Fair Value		$ 8,713	[7],[11],[17],[22]	$ 8,664	[1],[3],[8],[13]
Fair Value as % of Net Assets		0.86%	[9],[11],[17],[22]	1.16%	[1],[3],[10],[13]
Investment, Identifier [Axis]: PT Intermediate Holdings III, LLC (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.98%	[6],[11],[17],[22]	5.98%	[1],[3],[4],[13]
Interest Rate		11.43%	[6],[11],[17],[22]	11.47%	[1],[3],[4],[13]
Par Amount		$ 1,065	[11],[17],[22]	$ 1,068	[1],[3],[13]
Amortized Cost		1,057	[11],[17],[22]	1,059	[1],[3],[13]
Fair Value		$ 1,065	[7],[11],[17],[22]	$ 1,059	[1],[3],[8],[13]
Fair Value as % of Net Assets		0.11%	[9],[11],[17],[22]	0.14%	[1],[3],[10],[13]
Investment, Identifier [Axis]: Palmetto Acquisitionco, Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[5],[6],[11],[17]	5.75%	[1],[2],[3],[4]
Interest Rate		11.06%	[5],[6],[11],[17]	11.10%	[1],[2],[3],[4]
Par Amount		$ 13,281	[5],[11],[17]	$ 13,314	[1],[2],[3]
Amortized Cost		13,066	[5],[11],[17]	13,091	[1],[2],[3]
Fair Value		$ 13,062	[5],[7],[11],[17]	$ 13,085	[1],[2],[3],[8]
Fair Value as % of Net Assets		1.31%	[5],[9],[11],[17]	1.74%	[1],[2],[3],[10]
Investment, Identifier [Axis]: Palmetto Acquisitionco, Inc. (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[5],[6],[12]	5.75%	[2],[4],[14]
Interest Rate		11.06%	[5],[6],[12]	11.10%	[2],[4],[14]
Par Amount		$ 4,839	[5],[12]	$ 4,842	[2],[14]
Amortized Cost		1,271	[5],[12]	1,169	[2],[14]
Fair Value		$ 1,208	[5],[7],[12]	$ 1,103	[2],[8],[14]
Fair Value as % of Net Assets		0.12%	[5],[9],[12]	0.15%	[2],[10],[14]
Investment, Identifier [Axis]: Patriot Growth Insurance Service (Delayed Draw) (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[5],[6],[22]	5.75%	[2],[4],[13]
Interest Rate		11.20%	[5],[6],[22]	11.25%	[2],[4],[13]
Par Amount		$ 7,150	[5],[22]	$ 7,166	[2],[13]
Amortized Cost		7,096	[5],[22]	7,109	[2],[13]
Fair Value		$ 7,022	[5],[7],[22]	$ 7,003	[2],[8],[13]
Fair Value as % of Net Assets		0.70%	[5],[9],[22]	0.94%	[2],[10],[13]
Investment, Identifier [Axis]: Perennial Services Investors LLC
Schedule of Investments [Line Items]
Amortized Cost		$ 778	[5],[18],[19]	$ 778	[2],[15],[16],[20]
Fair Value		$ 1,095	[5],[7],[18],[19]	$ 1,077	[2],[8],[15],[16],[20]
Fair Value as % of Net Assets		0.11%	[5],[9],[18],[19]	0.14%	[2],[10],[15],[16],[20]
Shares/Units		7,784	[5],[18],[19]	7,784,000	[2],[15],[16],[20]
Investment, Identifier [Axis]: Perennial Services, Group, LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.00%	[6],[17]	6.00%	[1],[3],[4]
Interest Rate		11.44%	[6],[17]	11.49%	[1],[3],[4]
Par Amount		$ 6,716	[17]	$ 6,733	[1],[3]
Amortized Cost		6,624	[17]	6,637	[1],[3]
Fair Value		$ 6,688	[7],[17]	$ 6,634	[1],[3],[8]
Fair Value as % of Net Assets		0.67%	[9],[17]	0.89%	[1],[3],[10]
Investment, Identifier [Axis]: Perennial Services, Group, LLC (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.00%	[5],[6],[17]	6.00%	[2],[4]
Interest Rate		11.44%	[5],[6],[17]	11.49%	[2],[4]
Par Amount		$ 6,010	[5],[17]	$ 6,025	[2]
Amortized Cost		5,997	[5],[17]	6,011	[2]
Fair Value		$ 5,985	[5],[7],[17]	$ 5,937	[2],[8]
Fair Value as % of Net Assets		0.60%	[5],[9],[17]	0.79%	[2],[10]
Investment, Identifier [Axis]: Petmate
Schedule of Investments [Line Items]
Spread Above Reference Rate	[2],[3],[4],[13]			5.50%
Interest Rate	[2],[3],[4],[13]			11.23%
Par Amount	[2],[3],[13]			$ 9,825
Amortized Cost	[2],[3],[13]			9,753
Fair Value	[2],[3],[8],[13]			$ 5,846
Fair Value as % of Net Assets	[2],[3],[10],[13]			0.78%
Investment, Identifier [Axis]: Phaidon International
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.50%	[5],[6],[11],[17],[18],[27]	5.50%	[1],[2],[3],[4],[20],[28]
Interest Rate		10.93%	[5],[6],[11],[17],[18],[27]	10.96%	[1],[2],[3],[4],[20],[28]
Par Amount		$ 13,823	[5],[11],[17],[18],[27]	$ 14,010	[1],[2],[3],[20],[28]
Amortized Cost		13,715	[5],[11],[17],[18],[27]	13,892	[1],[2],[3],[20],[28]
Fair Value		$ 13,660	[5],[7],[11],[17],[18],[27]	$ 14,010	[1],[2],[3],[8],[20],[28]
Fair Value as % of Net Assets		1.36%	[5],[9],[11],[17],[18],[27]	1.88%	[1],[2],[3],[10],[20],[28]
Investment, Identifier [Axis]: Pinnacle Supply Partners, LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[1],[3],[4]			6.00%
Interest Rate	[1],[3],[4]			11.47%
Par Amount	[1],[3]			$ 6,332
Amortized Cost	[1],[3]			6,214
Fair Value	[1],[3],[8]			$ 6,287
Fair Value as % of Net Assets	[1],[3],[10]			0.84%
Investment, Identifier [Axis]: Pinnacle Supply Partners, LLC (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.25%	[5],[6],[12]	6.00%	[2],[4],[14]
Interest Rate		11.68%	[5],[6],[12]	11.47%	[2],[4],[14]
Par Amount		$ 3,636	[5],[12]	$ 3,636	[2],[14]
Amortized Cost		(28)	[5],[12]	(30)	[2],[14]
Fair Value		$ (25)	[5],[7],[12]	$ (26)	[2],[8],[14]
Fair Value as % of Net Assets		0.00%	[5],[9],[12]	0.00%	[2],[10],[14]
Investment, Identifier [Axis]: Pinnacle Supply Partners, LLC 1
Schedule of Investments [Line Items]
Spread Above Reference Rate	[6],[17]	6.25%
Interest Rate	[6],[17]	11.68%
Par Amount	[17]	$ 6,316
Amortized Cost		6,203	[17]	$ 280	[2],[15],[16]
Fair Value		$ 6,273	[7],[17]	$ 281	[2],[8],[15],[16]
Fair Value as % of Net Assets		0.62%	[9],[17]	0.04%	[2],[10],[15],[16]
Shares/Units	[2],[15],[16]			279,687,000
Investment, Identifier [Axis]: Pinnacle Supply Partners, LLC 2
Schedule of Investments [Line Items]
Amortized Cost	[5],[19]	$ 280
Fair Value	[5],[7],[19]	$ 264
Fair Value as % of Net Assets	[5],[9],[19]	0.03%
Shares/Units	[5],[19]	279,687
Investment, Identifier [Axis]: Plaze
Schedule of Investments [Line Items]
Spread Above Reference Rate		7.50%	[5],[6]	7.50%	[2],[4]
Interest Rate		12.94%	[5],[6]	12.97%	[2],[4]
Par Amount		$ 13,500	[5]	$ 13,500	[2]
Amortized Cost		13,218	[5]	13,201	[2]
Fair Value		$ 12,574	[5],[7]	$ 12,465	[2],[8]
Fair Value as % of Net Assets		1.26%	[5],[9]	1.67%	[2],[10]
Investment, Identifier [Axis]: Precision Aviation Group
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[5],[6],[11],[17]	5.75%	[1],[2],[3],[4]
Interest Rate		11.06%	[5],[6],[11],[17]	11.12%	[1],[2],[3],[4]
Par Amount		$ 15,002	[5],[11],[17]	$ 15,039	[1],[2],[3]
Amortized Cost		14,714	[5],[11],[17]	14,740	[1],[2],[3]
Fair Value		$ 14,830	[5],[7],[11],[17]	$ 14,740	[1],[2],[3],[8]
Fair Value as % of Net Assets		1.50%	[5],[9],[11],[17]	1.97%	[1],[2],[3],[10]
Investment, Identifier [Axis]: Precision Aviation Group (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[5],[6],[12]	5.75%	[2],[4],[14]
Interest Rate		11.06%	[5],[6],[12]	11.12%	[2],[4],[14]
Par Amount		$ 4,961	[5],[12]	$ 4,961	[2],[14]
Amortized Cost		(47)	[5],[12]	(49)	[2],[14]
Fair Value		$ (57)	[5],[7],[12]	$ (99)	[2],[8],[14]
Fair Value as % of Net Assets		(0.01%)	[5],[9],[12]	(0.01%)	[2],[10],[14]
Investment, Identifier [Axis]: Precision Surfacing
Schedule of Investments [Line Items]
Interest Rate		15.00%	[5],[6]	15.00%	[2],[4]
Par Amount		$ 713	[5]	$ 713	[2]
Amortized Cost		713	[5]	713	[2]
Fair Value		$ 713	[5],[7]	$ 713	[2],[8]
Fair Value as % of Net Assets		0.07%	[5],[9]	0.09%	[2],[10]
Investment, Identifier [Axis]: Precision Surfacing - Common
Schedule of Investments [Line Items]
Amortized Cost		$ 3,750	[5],[18],[19]	$ 3,750	[2],[15],[16],[20]
Fair Value		$ 7,126	[5],[7],[18],[19]	$ 6,513	[2],[8],[15],[16],[20]
Fair Value as % of Net Assets		0.71%	[5],[9],[18],[19]	0.87%	[2],[10],[15],[16],[20]
Shares/Units		3,750,000	[5],[18],[19]	3,750,000,000	[2],[15],[16],[20]
Investment, Identifier [Axis]: Proampac
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6],[11],[22]	4.00%
Interest Rate	[5],[6],[11],[22]	9.30%
Par Amount	[5],[11],[22]	$ 4,514
Amortized Cost	[5],[11],[22]	4,514
Fair Value	[5],[7],[11],[22]	$ 4,545
Fair Value as % of Net Assets	[5],[9],[11],[22]	0.46%
Investment, Identifier [Axis]: PromptCare
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.00%	[6],[17],[22]	6.00%	[1],[3],[4],[13]
Interest Rate		11.45%	[6],[17],[22]	11.46%	[1],[3],[4],[13]
Par Amount		$ 8,183	[17],[22]	$ 8,204	[1],[3],[13]
Amortized Cost		8,110	[17],[22]	8,121	[1],[3],[13]
Fair Value		$ 8,087	[7],[17],[22]	$ 8,079	[1],[3],[8],[13]
Fair Value as % of Net Assets		0.81%	[9],[17],[22]	1.08%	[1],[3],[10],[13]
Investment, Identifier [Axis]: PromptCare (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.00%	[6],[17],[22]	6.00%	[1],[2],[3],[4],[13]
Interest Rate		11.45%	[6],[17],[22]	11.46%	[1],[2],[3],[4],[13]
Par Amount		$ 1,275	[17],[22]	$ 1,278	[1],[2],[3],[13]
Amortized Cost		1,269	[17],[22]	1,271	[1],[2],[3],[13]
Fair Value		$ 1,260	[7],[17],[22]	$ 1,258	[1],[2],[3],[8],[13]
Fair Value as % of Net Assets		0.13%	[9],[17],[22]	0.17%	[1],[2],[3],[10],[13]
Investment, Identifier [Axis]: Propark Mobility
Schedule of Investments [Line Items]
Spread Above Reference Rate	[6],[17]	6.25%
Interest Rate	[6],[17]	11.40%
Par Amount	[17]	$ 6,806
Amortized Cost	[17]	6,694
Fair Value	[7],[17]	$ 6,816
Fair Value as % of Net Assets	[9],[17]	0.68%
Investment, Identifier [Axis]: Propark Mobility (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6],[12]	6.25%
Interest Rate	[5],[6],[12]	11.40%
Par Amount	[5],[12]	$ 3,122
Amortized Cost	[5],[12]	1,274
Fair Value	[5],[7],[12]	$ 1,329
Fair Value as % of Net Assets	[5],[9],[12]	0.13%
Investment, Identifier [Axis]: Prosci, Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate		4.50%	[6],[17]	4.50%	[3],[4]
Interest Rate		9.93%	[6],[17]	9.99%	[3],[4]
Par Amount		$ 4,733	[17]	$ 4,733	[3]
Amortized Cost		4,707	[17]	4,704	[3]
Fair Value		$ 4,733	[7],[17]	$ 4,708	[3],[8]
Fair Value as % of Net Assets		0.47%	[9],[17]	0.63%	[3],[10]
Investment, Identifier [Axis]: Protective Industrial Products (“PIP”)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[1],[2],[3],[4],[13]			5.00%
Interest Rate	[1],[2],[3],[4],[13]			10.47%
Par Amount	[1],[2],[3],[13]			$ 4,860
Amortized Cost	[1],[2],[3],[13]			4,684
Fair Value	[1],[2],[3],[8],[13]			$ 4,909
Fair Value as % of Net Assets	[1],[2],[3],[10],[13]			0.66%
Investment, Identifier [Axis]: Protective Industrial Products (“PIP”) 1
Schedule of Investments [Line Items]
Spread Above Reference Rate	[6],[17]	4.00%
Interest Rate	[6],[17]	9.44%
Par Amount	[17]	$ 3,800
Amortized Cost	[17]	3,796
Fair Value	[7],[17]	$ 3,797
Fair Value as % of Net Assets	[9],[17]	0.38%
Investment, Identifier [Axis]: Protective Industrial Products (“PIP”) 2
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6],[17]	5.00%
Interest Rate	[5],[6],[17]	10.44%
Par Amount	[5],[17]	$ 4,848
Amortized Cost	[5],[17]	4,682
Fair Value	[5],[7],[17]	$ 4,896
Fair Value as % of Net Assets	[5],[9],[17]	0.49%
Investment, Identifier [Axis]: Quantix (Incremental) 1
Schedule of Investments [Line Items]
Spread Above Reference Rate	[6],[17],[22]	6.50%
Interest Rate	[6],[17],[22]	12.23%
Par Amount	[17],[22]	$ 257
Amortized Cost	[17],[22]	256
Fair Value	[7],[17],[22]	$ 251
Fair Value as % of Net Assets	[9],[17],[22]	0.03%
Investment, Identifier [Axis]: Quantix (Incremental) 2
Schedule of Investments [Line Items]
Spread Above Reference Rate	[6],[17],[22]	6.00%
Interest Rate	[6],[17],[22]	11.73%
Par Amount	[17],[22]	$ 892
Amortized Cost	[17],[22]	889
Fair Value	[7],[17],[22]	$ 870
Fair Value as % of Net Assets	[9],[17],[22]	0.09%
Investment, Identifier [Axis]: Quantix (Incremental) 3
Schedule of Investments [Line Items]
Spread Above Reference Rate	[6],[17],[22]	6.50%
Interest Rate	[6],[17],[22]	12.23%
Par Amount	[17],[22]	$ 180
Amortized Cost	[17],[22]	180
Fair Value	[7],[17],[22]	$ 176
Fair Value as % of Net Assets	[9],[17],[22]	0.02%
Investment, Identifier [Axis]: Quantix (Incremental) 4
Schedule of Investments [Line Items]
Spread Above Reference Rate	[6],[17],[22]	6.50%
Interest Rate	[6],[17],[22]	12.23%
Par Amount	[17],[22]	$ 4,356
Amortized Cost	[17],[22]	4,341
Fair Value	[7],[17],[22]	$ 4,247
Fair Value as % of Net Assets	[9],[17],[22]	0.43%
Investment, Identifier [Axis]: Quantix (Incremental) 5
Schedule of Investments [Line Items]
Spread Above Reference Rate	[6],[11],[22]	6.50%
Interest Rate	[6],[11],[22]	11.90%
Par Amount	[11],[22]	$ 1,355
Amortized Cost	[11],[22]	1,342
Fair Value	[7],[11],[22]	$ 1,321
Fair Value as % of Net Assets	[9],[11],[22]	0.13%
Investment, Identifier [Axis]: Quantix (f/k/a A&R Logistics Holdings, Inc.) (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[13]			6.50%
Interest Rate	[3],[4],[13]			12.04%
Par Amount	[3],[13]			$ 258
Amortized Cost	[3],[13]			257
Fair Value	[3],[8],[13]			$ 254
Fair Value as % of Net Assets	[3],[10],[13]			0.03%
Investment, Identifier [Axis]: Quantix (f/k/a A&R Logistics Holdings, Inc.) (Incremental) 1
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[13]			6.00%
Interest Rate	[3],[4],[13]			11.54%
Par Amount	[3],[13]			$ 895
Amortized Cost	[3],[13]			891
Fair Value	[3],[8],[13]			$ 877
Fair Value as % of Net Assets	[3],[10],[13]			0.12%
Investment, Identifier [Axis]: Quantix (f/k/a A&R Logistics Holdings, Inc.) (Incremental) 2
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[13]			6.50%
Interest Rate	[3],[4],[13]			12.04%
Par Amount	[3],[13]			$ 181
Amortized Cost	[3],[13]			180
Fair Value	[3],[8],[13]			$ 178
Fair Value as % of Net Assets	[3],[10],[13]			0.02%
Investment, Identifier [Axis]: Quantix (f/k/a A&R Logistics Holdings, Inc.) (Incremental) 3
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[13]			6.50%
Interest Rate	[3],[4],[13]			12.04%
Par Amount	[3],[13]			$ 4,367
Amortized Cost	[3],[13]			4,350
Fair Value	[3],[8],[13]			$ 4,306
Fair Value as % of Net Assets	[3],[10],[13]			0.57%
Investment, Identifier [Axis]: Quantix (f/k/a A&R Logistics Holdings, Inc.) (Incremental) 4
Schedule of Investments [Line Items]
Spread Above Reference Rate	[1],[4],[13]			6.50%
Interest Rate	[1],[4],[13]			11.90%
Par Amount	[1],[13]			$ 1,359
Amortized Cost	[1],[13]			1,343
Fair Value	[1],[8],[13]			$ 1,340
Fair Value as % of Net Assets	[1],[10],[13]			0.18%
Investment, Identifier [Axis]: Quickbase
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6],[11]	4.00%
Interest Rate	[5],[6],[11]	9.30%
Par Amount	[5],[11]	$ 6,353
Amortized Cost	[5],[11]	6,322
Fair Value	[5],[7],[11]	$ 6,322
Fair Value as % of Net Assets	[5],[9],[11]	0.63%
Investment, Identifier [Axis]: Quorum Health Resources, LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[6],[11],[17]	5.75%	[1],[3],[4]
Interest Rate		11.29%	[6],[11],[17]	11.50%	[1],[3],[4]
Par Amount		$ 7,660	[11],[17]	$ 7,680	[1],[3]
Amortized Cost		7,610	[11],[17]	7,627	[1],[3]
Fair Value		$ 7,500	[7],[11],[17]	$ 7,552	[1],[3],[8]
Fair Value as % of Net Assets		0.75%	[9],[11],[17]	1.01%	[1],[3],[10]
Investment, Identifier [Axis]: Quorum Health Resources, LLC (Delayed Draw) (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.25%	[6],[17],[18]	6.25%	[2],[3],[4],[20]
Interest Rate		11.68%	[6],[17],[18]	11.68%	[2],[3],[4],[20]
Par Amount		$ 3,240	[17],[18]	$ 3,248	[2],[3],[20]
Amortized Cost		3,232	[17],[18]	3,240	[2],[3],[20]
Fair Value		$ 3,215	[7],[17],[18]	$ 3,240	[2],[3],[8],[20]
Fair Value as % of Net Assets		0.32%	[9],[17],[18]	0.43%	[2],[3],[10],[20]
Investment, Identifier [Axis]: Quorum Health Resources, LLC (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.25%	[6],[11],[17],[18]	6.25%	[1],[2],[4],[20]
Interest Rate		11.68%	[6],[11],[17],[18]	11.68%	[1],[2],[4],[20]
Par Amount		$ 3,240	[11],[17],[18]	$ 3,248	[1],[2],[20]
Amortized Cost		3,195	[11],[17],[18]	3,201	[1],[2],[20]
Fair Value		$ 3,215	[7],[11],[17],[18]	$ 3,240	[1],[2],[8],[20]
Fair Value as % of Net Assets		0.32%	[9],[11],[17],[18]	0.43%	[1],[2],[10],[20]
Investment, Identifier [Axis]: REP HS Topco Holdings (HemaSource Inc.)
Schedule of Investments [Line Items]
Amortized Cost		$ 577	[5],[19]	$ 577	[2],[15],[16]
Fair Value		$ 652	[5],[7],[19]	$ 645	[2],[8],[15],[16]
Fair Value as % of Net Assets		0.06%	[5],[9],[19]	0.09%	[2],[10],[15],[16]
Shares/Units		577,000	[5],[19]	577,000,000	[2],[15],[16]
Investment, Identifier [Axis]: RMA Companies (Delayed Draw) 1
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6]	5.75%
Interest Rate	[5],[6]	11.18%
Par Amount	[5]	$ 4,616
Amortized Cost	[5]	4,608
Fair Value	[5],[7]	$ 4,553
Fair Value as % of Net Assets	[5],[9]	0.46%
Investment, Identifier [Axis]: RMA Companies (Delayed Draw) 2
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6],[12]	5.75%
Interest Rate	[5],[6],[12]	11.18%
Par Amount	[5],[12]	$ 3,134
Amortized Cost	[5],[12]	(7)
Fair Value	[5],[7],[12]	$ (43)
Fair Value as % of Net Assets	[5],[9],[12]	0.00%
Investment, Identifier [Axis]: RTH Buyer LLC (dba Rhino Tool House)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[1],[2],[4]			6.25%
Interest Rate	[1],[2],[4]			11.97%
Par Amount	[1],[2]			$ 8,052
Amortized Cost	[1],[2]			7,902
Fair Value	[1],[2],[8]			$ 7,986
Fair Value as % of Net Assets	[1],[2],[10]			1.07%
Investment, Identifier [Axis]: RTH Buyer LLC (dba Rhino Tool House) (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[2],[4],[14]			6.25%
Interest Rate	[2],[4],[14]			11.97%
Par Amount	[2],[14]			$ 1,885
Amortized Cost	[2],[14]			956
Fair Value	[2],[8],[14]			$ 949
Fair Value as % of Net Assets	[2],[10],[14]			0.13%
Investment, Identifier [Axis]: Randys Holdings, Inc
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.50%	[5],[6],[11],[17],[22]	6.50%	[1],[2],[3],[4],[13]
Interest Rate		11.81%	[5],[6],[11],[17],[22]	11.88%	[1],[2],[3],[4],[13]
Par Amount		$ 11,109	[5],[11],[17],[22]	$ 11,138	[1],[2],[3],[13]
Amortized Cost		10,926	[5],[11],[17],[22]	10,943	[1],[2],[3],[13]
Fair Value		$ 10,975	[5],[7],[11],[17],[22]	$ 10,997	[1],[2],[3],[8],[13]
Fair Value as % of Net Assets		1.10%	[5],[9],[11],[17],[22]	1.47%	[1],[2],[3],[10],[13]
Investment, Identifier [Axis]: Randys Holdings, Inc (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.50%	[5],[6],[12],[22]	6.50%	[2],[4],[13],[14]
Interest Rate		11.81%	[5],[6],[12],[22]	11.88%	[2],[4],[13],[14]
Par Amount		$ 3,750	[5],[12],[22]	$ 3,750	[2],[13],[14]
Amortized Cost		450	[5],[12],[22]	0	[2],[13],[14]
Fair Value		$ 405	[5],[7],[12],[22]	$ (47)	[2],[8],[13],[14]
Fair Value as % of Net Assets		0.04%	[5],[9],[12],[22]	(0.01%)	[2],[10],[13],[14]
Investment, Identifier [Axis]: Repipe Specialists
Schedule of Investments [Line Items]
Interest Rate	[2],[4]			10.00%
Interest Rate, PIK	[2],[4]			1.00%
Par Amount	[2]			$ 2,433
Amortized Cost	[2]			2,393
Fair Value	[2],[8]			$ 2,207
Fair Value as % of Net Assets	[2],[10]			0.30%
Investment, Identifier [Axis]: Repipe Specialists (Delayed Draw)
Schedule of Investments [Line Items]
Interest Rate		10.00%	[5],[6],[12]	10.00%	[2],[4],[14]
Interest Rate, PIK		1.00%	[5],[6],[12]	1.00%	[2],[4],[14]
Par Amount		$ 902	[5],[12]	$ 901	[2],[14]
Amortized Cost		211	[5],[12]	210	[2],[14]
Fair Value		$ 123	[5],[7],[12]	$ 126	[2],[8],[14]
Fair Value as % of Net Assets		0.01%	[5],[9],[12]	0.01%	[2],[10],[14]
Investment, Identifier [Axis]: Repipe Specialists 1
Schedule of Investments [Line Items]
Interest Rate	[5],[6]	10.00%
Interest Rate, PIK	[5],[6]	1.00%
Par Amount	[5]	$ 2,439
Amortized Cost		2,401	[5]	$ 239	[2],[15],[16]
Fair Value		$ 2,201	[5],[7]	$ 6	[2],[8],[15],[16]
Fair Value as % of Net Assets		0.22%	[5],[9]	0.00%	[2],[10],[15],[16]
Shares/Units	[2],[15],[16]			239,000
Investment, Identifier [Axis]: Repipe Specialists 2
Schedule of Investments [Line Items]
Amortized Cost	[5],[19]	$ 239
Fair Value	[5],[7],[19]	$ 3
Fair Value as % of Net Assets	[5],[9],[19]	0.00%
Shares/Units	[5],[19]	239
Investment, Identifier [Axis]: Revalize (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[1],[3],[4],[13]			5.75%
Interest Rate	[1],[3],[4],[13]			11.21%
Par Amount	[1],[3],[13]			$ 4,243
Amortized Cost	[1],[3],[13]			4,232
Fair Value	[1],[3],[8],[13]			$ 4,064
Fair Value as % of Net Assets	[1],[3],[10],[13]			0.54%
Investment, Identifier [Axis]: Revalize (Delayed Draw) 1
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[6],[11],[17],[22]	5.75%	[2],[3],[4],[13]
Interest Rate		11.21%	[6],[11],[17],[22]	11.21%	[2],[3],[4],[13]
Par Amount		$ 4,232	[11],[17],[22]	$ 1,090	[2],[3],[13]
Amortized Cost		4,222	[11],[17],[22]	1,083	[2],[3],[13]
Fair Value		$ 4,002	[7],[11],[17],[22]	$ 1,044	[2],[3],[8],[13]
Fair Value as % of Net Assets		0.40%	[9],[11],[17],[22]	0.14%	[2],[3],[10],[13]
Investment, Identifier [Axis]: Revalize (Delayed Draw) 2
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[5],[6],[17],[22]	5.75%	[2],[4],[13]
Interest Rate		11.21%	[5],[6],[17],[22]	11.25%	[2],[4],[13]
Par Amount		$ 1,087	[5],[17],[22]	$ 244	[2],[13]
Amortized Cost		1,080	[5],[17],[22]	243	[2],[13]
Fair Value		$ 1,028	[5],[7],[17],[22]	$ 234	[2],[8],[13]
Fair Value as % of Net Assets		0.10%	[5],[9],[17],[22]	0.03%	[2],[10],[13]
Investment, Identifier [Axis]: Revalize (Delayed Draw) 3
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6],[22]	5.75%
Interest Rate	[5],[6],[22]	11.21%
Par Amount	[5],[22]	$ 244
Amortized Cost	[5],[22]	243
Fair Value	[5],[7],[22]	$ 231
Fair Value as % of Net Assets	[5],[9],[22]	0.02%
Investment, Identifier [Axis]: Rhino Tool House
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6],[11],[17]	6.25%
Interest Rate	[5],[6],[11],[17]	11.73%
Par Amount	[5],[11],[17]	$ 8,031
Amortized Cost	[5],[11],[17]	7,888
Fair Value	[5],[7],[11],[17]	$ 8,044
Fair Value as % of Net Assets	[5],[9],[11],[17]	0.81%
Investment, Identifier [Axis]: Rhino Tool House (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6],[12]	6.25%
Interest Rate	[5],[6],[12]	11.73%
Par Amount	[5],[12]	$ 1,880
Amortized Cost	[5],[12]	1,837
Fair Value	[5],[7],[12]	$ 1,848
Fair Value as % of Net Assets	[5],[9],[12]	0.19%
Investment, Identifier [Axis]: Rise Baking
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.25%	[6],[11],[17],[22]	6.25%	[1],[3],[4],[13]
Interest Rate		11.68%	[6],[11],[17],[22]	11.71%	[1],[3],[4],[13]
Par Amount		$ 14,663	[11],[17],[22]	$ 14,700	[1],[3],[13]
Amortized Cost		14,530	[11],[17],[22]	14,554	[1],[3],[13]
Fair Value		$ 14,875	[7],[11],[17],[22]	$ 14,852	[1],[3],[8],[13]
Fair Value as % of Net Assets		1.49%	[9],[11],[17],[22]	1.99%	[1],[3],[10],[13]
Investment, Identifier [Axis]: Rise Baking (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.25%	[5],[6],[22]	5.50%	[2],[4],[13]
Interest Rate		11.68%	[5],[6],[22]	10.96%	[2],[4],[13]
Par Amount		$ 4,443	[5],[22]	$ 4,454	[2],[13]
Amortized Cost		4,424	[5],[22]	4,432	[2],[13]
Fair Value		$ 4,413	[5],[7],[22]	$ 4,400	[2],[8],[13]
Fair Value as % of Net Assets		0.44%	[5],[9],[22]	0.59%	[2],[10],[13]
Investment, Identifier [Axis]: Risk Strategies (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[5],[6],[17],[22]	5.50%	[2],[4],[13]
Interest Rate		10.96%	[5],[6],[17],[22]	11.00%	[2],[4],[13]
Par Amount		$ 14,831	[5],[17],[22]	$ 14,869	[2],[13]
Amortized Cost		14,831	[5],[17],[22]	14,869	[2],[13]
Fair Value		$ 14,537	[5],[7],[17],[22]	$ 14,606	[2],[8],[13]
Fair Value as % of Net Assets		1.46%	[5],[9],[17],[22]	1.95%	[2],[10],[13]
Investment, Identifier [Axis]: RoadOne
Schedule of Investments [Line Items]
Interest Rate		8.75%	[5],[6]	8.75%	[2],[4]
Interest Rate, PIK		5.00%	[5],[6]	5.00%	[2],[4]
Par Amount		$ 4,759	[5]	$ 4,699	[2]
Amortized Cost		4,642	[5]	4,579	[2]
Fair Value		$ 4,637	[5],[7]	$ 4,604	[2],[8]
Fair Value as % of Net Assets		0.46%	[5],[9]	0.62%	[2],[10]
Investment, Identifier [Axis]: RoadOne (Delayed Draw)
Schedule of Investments [Line Items]
Interest Rate		8.75%	[5],[6],[12]	8.75%	[2],[4],[14]
Interest Rate, PIK		5.00%	[5],[6],[12]	5.00%	[2],[4],[14]
Par Amount		$ 1,397	[5],[12]	$ 1,397	[2],[14]
Amortized Cost		(17)	[5],[12]	(18)	[2],[14]
Fair Value		$ (36)	[5],[7],[12]	$ (28)	[2],[8],[14]
Fair Value as % of Net Assets		0.00%	[5],[9],[12]	0.00%	[2],[10],[14]
Investment, Identifier [Axis]: RoadOne - Common
Schedule of Investments [Line Items]
Amortized Cost		$ 939	[5],[19]	$ 939	[2],[15],[16]
Fair Value		$ 1,471	[5],[7],[19]	$ 1,525	[2],[8],[15],[16]
Fair Value as % of Net Assets		0.15%	[5],[9],[19]	0.20%	[2],[10],[15],[16]
Shares/Units		1,173,220,000	[5],[19]	1,173,220,000	[2],[15],[16]
Investment, Identifier [Axis]: Royal Holdco Corporation (Delayed Draw A)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[2],[4],[14]			5.75%
Interest Rate	[2],[4],[14]			11.21%
Par Amount	[2],[14]			$ 4,690
Amortized Cost	[2],[14]			4,303
Fair Value	[2],[8],[14]			$ 4,246
Fair Value as % of Net Assets	[2],[10],[14]			0.57%
Investment, Identifier [Axis]: Royal Holdco Corporation (Delayed Draw B)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[2],[4],[14]			5.75%
Interest Rate	[2],[4],[14]			11.21%
Par Amount	[2],[14]			$ 3,134
Amortized Cost	[2],[14]			(7)
Fair Value	[2],[8],[14]			$ (45)
Fair Value as % of Net Assets	[2],[10],[14]			(0.01%)
Investment, Identifier [Axis]: Royal Holdco Corporation (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[6],[17],[18]	5.75%	[1],[2],[4],[20]
Interest Rate		11.18%	[6],[17],[18]	11.21%	[1],[2],[4],[20]
Par Amount		$ 3,110	[17],[18]	$ 3,118	[1],[2],[20]
Amortized Cost		3,069	[17],[18]	3,074	[1],[2],[20]
Fair Value		$ 3,068	[7],[17],[18]	$ 3,073	[1],[2],[8],[20]
Fair Value as % of Net Assets		0.31%	[9],[17],[18]	0.41%	[1],[2],[10],[20]
Investment, Identifier [Axis]: S&S Truck Parts
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4]			5.00%
Interest Rate	[3],[4]			10.19%
Par Amount	[3]			$ 6,858
Amortized Cost	[3]			6,803
Fair Value	[3],[8]			$ 6,779
Fair Value as % of Net Assets	[3],[10]			0.91%
Investment, Identifier [Axis]: S&S Truck Parts (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[2],[4],[14]			5.00%
Interest Rate	[2],[4],[14]			10.19%
Par Amount	[2],[14]			$ 98
Amortized Cost	[2],[14]			0
Fair Value	[2],[8],[14]			$ (1)
Fair Value as % of Net Assets	[2],[10],[14]			0.00%
Investment, Identifier [Axis]: S&S Truck Parts (Delayed Draw) 1
Schedule of Investments [Line Items]
Spread Above Reference Rate		4.75%	[5],[6],[12]	5.00%	[2],[4],[14]
Interest Rate		10.22%	[5],[6],[12]	10.19%	[2],[4],[14]
Par Amount		$ 98	[5],[12]	$ 1,724	[2],[14]
Amortized Cost		0	[5],[12]	1,576	[2],[14]
Fair Value		$ (2)	[5],[7],[12]	$ 1,556	[2],[8],[14]
Fair Value as % of Net Assets		0.00%	[5],[9],[12]	0.21%	[2],[10],[14]
Investment, Identifier [Axis]: S&S Truck Parts (Delayed Draw) 2
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6],[12]	4.75%
Interest Rate	[5],[6],[12]	10.22%
Par Amount	[5],[12]	$ 1,720
Amortized Cost	[5],[12]	1,572
Fair Value	[5],[7],[12]	$ 1,535
Fair Value as % of Net Assets	[5],[9],[12]	0.15%
Investment, Identifier [Axis]: S&S Truck Parts 1
Schedule of Investments [Line Items]
Spread Above Reference Rate		4.75%	[6],[17]	5.00%	[1],[4]
Interest Rate		10.22%	[6],[17]	10.19%	[1],[4]
Par Amount		$ 6,841	[17]	$ 1,159	[1]
Amortized Cost		6,788	[17]	1,150	[1]
Fair Value		$ 6,693	[7],[17]	$ 1,146	[1],[8]
Fair Value as % of Net Assets		0.67%	[9],[17]	0.15%	[1],[10]
Investment, Identifier [Axis]: S&S Truck Parts 2
Schedule of Investments [Line Items]
Spread Above Reference Rate	[6],[17]	4.75%
Interest Rate	[6],[17]	10.22%
Par Amount	[17]	$ 1,156
Amortized Cost		1,147	[17]	$ 378	[2],[15],[16]
Fair Value		$ 1,131	[7],[17]	$ 299	[2],[8],[15],[16]
Fair Value as % of Net Assets		0.11%	[9],[17]	0.04%	[2],[10],[15],[16]
Shares/Units	[2],[15],[16]			4,000
Investment, Identifier [Axis]: S&S Truck Parts 3
Schedule of Investments [Line Items]
Amortized Cost		$ 378	[5],[19]	$ 79	[2],[15],[16]
Fair Value		$ 288	[5],[7],[19]	$ 62	[2],[8],[15],[16]
Fair Value as % of Net Assets		0.03%	[5],[9],[19]	0.01%	[2],[10],[15],[16]
Shares/Units		4	[5],[19]	78,541,000	[2],[15],[16]
Investment, Identifier [Axis]: S&S Truck Parts 4
Schedule of Investments [Line Items]
Amortized Cost	[5],[19]	$ 79
Fair Value	[5],[7],[19]	$ 60
Fair Value as % of Net Assets	[5],[9],[19]	0.01%
Shares/Units	[5],[19]	78,541
Investment, Identifier [Axis]: SCP Eye Care Holdco, LLC (DBA EyeSouth Partners)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[6],[11],[17]	5.75%	[1],[3],[4]
Interest Rate		11.18%	[6],[11],[17]	11.21%	[1],[3],[4]
Par Amount		$ 7,455	[11],[17]	$ 7,474	[1],[3]
Amortized Cost		7,392	[11],[17]	7,408	[1],[3]
Fair Value		$ 7,367	[7],[11],[17]	$ 7,382	[1],[3],[8]
Fair Value as % of Net Assets		0.74%	[9],[11],[17]	0.99%	[1],[3],[10]
Investment, Identifier [Axis]: SCP Eye Care Holdco, LLC (DBA EyeSouth Partners) (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[5],[6],[12]	5.75%	[2],[4],[14]
Interest Rate		11.18%	[5],[6],[12]	11.21%	[2],[4],[14]
Par Amount		$ 2,439	[5],[12]	$ 2,443	[2],[14]
Amortized Cost		1,554	[5],[12]	1,558	[2],[14]
Fair Value		$ 1,525	[5],[7],[12]	$ 1,528	[2],[8],[14]
Fair Value as % of Net Assets		0.15%	[5],[9],[12]	0.21%	[2],[10],[14]
Investment, Identifier [Axis]: SEKO Global Logistics
Schedule of Investments [Line Items]
Spread Above Reference Rate	[2],[4]			9.00%
Interest Rate	[2],[4]			6.04%
Interest Rate, PIK	[2],[4]			4.50%
Par Amount	[2]			$ 5,840
Amortized Cost		$ 332	[5],[19]	5,765	[2]
Fair Value		$ 681	[5],[7],[19]	$ 5,676	[2],[8]
Fair Value as % of Net Assets		0.07%	[5],[9],[19]	0.76%	[2],[10]
Shares/Units	[5],[19]	671,203,000
Investment, Identifier [Axis]: SEKO Global Logistics (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.00%	[5],[6]	9.00%	[2],[4]
Interest Rate		10.50%	[5],[6]	6.04%	[2],[4]
Interest Rate, PIK		4.50%	[5],[6]	4.50%	[2],[4]
Par Amount		$ 923	[5]	$ 912	[2]
Amortized Cost		923	[5]	912	[2]
Fair Value		$ 826	[5],[7]	$ 887	[2],[8]
Fair Value as % of Net Assets		0.08%	[5],[9]	0.12%	[2],[10]
Investment, Identifier [Axis]: SEKO Global Logistics (Delayed Draw) (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.00%	[5],[6],[17]	5.00%	[2],[4]
Interest Rate		10.46%	[5],[6],[17]	10.72%	[2],[4]
Par Amount		$ 4,473	[5],[17]	$ 4,485	[2]
Amortized Cost		4,473	[5],[17]	4,485	[2]
Fair Value		$ 4,164	[5],[7],[17]	$ 4,444	[2],[8]
Fair Value as % of Net Assets		0.42%	[5],[9],[17]	0.59%	[2],[10]
Investment, Identifier [Axis]: SEKO Global Logistics (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.00%	[6],[17]	5.00%	[1],[3],[4]
Interest Rate		10.46%	[6],[17]	10.72%	[1],[3],[4]
Par Amount		$ 1,513	[17]	$ 1,517	[1],[3]
Amortized Cost		1,503	[17]	1,506	[1],[3]
Fair Value		$ 1,409	[7],[17]	$ 1,503	[1],[3],[8]
Fair Value as % of Net Assets		0.14%	[9],[17]	0.20%	[1],[3],[10]
Investment, Identifier [Axis]: SEKO Global Logistics 1
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.00%	[5],[6]	9.00%	[2],[4]
Interest Rate		10.50%	[5],[6]	9.86%	[2],[4]
Interest Rate, PIK		4.50%	[5],[6]	4.50%	[2],[4]
Par Amount		$ 5,905	[5]	$ 4,053	[2]
Amortized Cost		5,835	[5]	3,997	[2]
Fair Value		$ 5,288	[5],[7]	$ 3,939	[2],[8]
Fair Value as % of Net Assets		0.53%	[5],[9]	0.53%	[2],[10]
Investment, Identifier [Axis]: SEKO Global Logistics 2
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.00%	[5],[6]	5.00%	[3],[4]
Interest Rate		10.50%	[5],[6]	10.72%	[3],[4]
Interest Rate, PIK	[5],[6]	4.50%
Par Amount		$ 4,098	[5]	$ 1,125	[3]
Amortized Cost		4,046	[5]	1,118	[3]
Fair Value		$ 3,670	[5],[7]	$ 1,115	[3],[8]
Fair Value as % of Net Assets		0.37%	[5],[9]	0.15%	[3],[10]
Investment, Identifier [Axis]: SEKO Global Logistics 3
Schedule of Investments [Line Items]
Spread Above Reference Rate	[6],[17]	5.00%
Interest Rate	[6],[17]	10.46%
Par Amount	[17]	$ 1,122
Amortized Cost		1,116	[17]	$ 332	[2],[16]
Fair Value		$ 1,045	[7],[17]	$ 1,221	[2],[8],[16]
Fair Value as % of Net Assets		0.10%	[9],[17]	0.16%	[2],[10],[16]
Shares/Units	[2],[16]			671,203,000
Investment, Identifier [Axis]: SM Wellness Holdings, Inc
Schedule of Investments [Line Items]
Spread Above Reference Rate		4.50%	[5],[6],[11],[17]	4.75%	[1],[2],[3],[4]
Interest Rate		10.07%	[5],[6],[11],[17]	10.14%	[1],[2],[3],[4]
Par Amount		$ 14,627	[5],[11],[17]	$ 14,665	[1],[2],[3]
Amortized Cost		14,542	[5],[11],[17]	14,573	[1],[2],[3]
Fair Value		$ 14,149	[5],[7],[11],[17]	$ 14,187	[1],[2],[3],[8]
Fair Value as % of Net Assets		1.42%	[5],[9],[11],[17]	1.90%	[1],[2],[3],[10]
Investment, Identifier [Axis]: Sandlot Buyer, LLC (Prime Time Healthcare)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.00%	[5],[6],[11],[17]	6.00%	[1],[2],[3],[4]
Interest Rate		11.28%	[5],[6],[11],[17]	11.28%	[1],[2],[3],[4]
Par Amount		$ 8,625	[5],[11],[17]	$ 8,958	[1],[2],[3]
Amortized Cost		8,414	[5],[11],[17]	8,729	[1],[2],[3]
Fair Value		$ 8,543	[5],[7],[11],[17]	$ 8,854	[1],[2],[3],[8]
Fair Value as % of Net Assets		0.86%	[5],[9],[11],[17]	1.18%	[1],[2],[3],[10]
Investment, Identifier [Axis]: Sandlot Buyer, LLC (Prime Time Healthcare) (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[1],[2],[4]			6.00%
Interest Rate	[1],[2],[4]			11.52%
Par Amount	[1],[2]			$ 10,122
Amortized Cost	[1],[2]			9,924
Fair Value	[1],[2],[8]			$ 10,004
Fair Value as % of Net Assets	[1],[2],[10]			1.34%
Investment, Identifier [Axis]: Sandlot Buyer, LLC (Prime Time Healthcare) (Incremental))
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6],[11]	6.00%
Interest Rate	[5],[6],[11]	11.27%
Par Amount	[5],[11]	$ 9,994
Amortized Cost	[5],[11]	9,806
Fair Value	[5],[7],[11]	$ 9,899
Fair Value as % of Net Assets	[5],[9],[11]	0.99%
Investment, Identifier [Axis]: Sapphire Telecom Inc
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.00%	[6],[17],[22]	6.00%	[3],[4],[13]
Interest Rate		11.47%	[6],[17],[22]	11.53%	[3],[4],[13]
Par Amount		$ 6,633	[17],[22]	$ 6,650	[3],[13]
Amortized Cost		6,613	[17],[22]	6,627	[3],[13]
Fair Value		$ 6,633	[7],[17],[22]	$ 6,650	[3],[8],[13]
Fair Value as % of Net Assets		0.66%	[9],[17],[22]	0.89%	[3],[10],[13]
Investment, Identifier [Axis]: Scaled Agile
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.50%	[6],[17],[22]	5.50%	[3],[4],[13]
Interest Rate		10.91%	[6],[17],[22]	10.95%	[3],[4],[13]
Par Amount		$ 7,915	[17],[22]	$ 7,936	[3],[13]
Amortized Cost		7,858	[17],[22]	7,875	[3],[13]
Fair Value		$ 7,461	[7],[17],[22]	$ 7,623	[3],[8],[13]
Fair Value as % of Net Assets		0.75%	[9],[17],[22]	1.02%	[3],[10],[13]
Investment, Identifier [Axis]: Scaled Agile (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.50%	[5],[6],[22]	5.50%	[2],[4],[13]
Interest Rate		10.91%	[5],[6],[22]	10.95%	[2],[4],[13]
Par Amount		$ 389	[5],[22]	$ 390	[2],[13]
Amortized Cost		389	[5],[22]	390	[2],[13]
Fair Value		$ 367	[5],[7],[22]	$ 375	[2],[8],[13]
Fair Value as % of Net Assets		0.04%	[5],[9],[22]	0.05%	[2],[10],[13]
Investment, Identifier [Axis]: Sciens Building Solutions, LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[6],[17],[22]	5.75%	[1],[3],[4],[13]
Interest Rate		11.18%	[6],[17],[22]	11.23%	[1],[3],[4],[13]
Par Amount		$ 9,291	[17],[22]	$ 9,315	[1],[3],[13]
Amortized Cost		9,167	[17],[22]	9,183	[1],[3],[13]
Fair Value		$ 9,200	[7],[17],[22]	$ 9,128	[1],[3],[8],[13]
Fair Value as % of Net Assets		0.92%	[9],[17],[22]	1.22%	[1],[3],[10],[13]
Investment, Identifier [Axis]: Sciens Building Solutions, LLC (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[5],[6],[11],[12],[17],[22]	5.75%	[1],[2],[3],[4],[13],[14]
Interest Rate		11.18%	[5],[6],[11],[12],[17],[22]	11.23%	[1],[2],[3],[4],[13],[14]
Par Amount		$ 4,907	[5],[11],[12],[17],[22]	$ 4,915	[1],[2],[3],[13],[14]
Amortized Cost		3,253	[5],[11],[12],[17],[22]	3,259	[1],[2],[3],[13],[14]
Fair Value		$ 3,236	[5],[7],[11],[12],[17],[22]	$ 3,193	[1],[2],[3],[8],[13],[14]
Fair Value as % of Net Assets		0.32%	[5],[9],[11],[12],[17],[22]	0.43%	[1],[2],[3],[10],[13],[14]
Investment, Identifier [Axis]: SmartSign 1
Schedule of Investments [Line Items]
Spread Above Reference Rate	[6],[11],[17]	5.50%
Interest Rate	[6],[11],[17]	10.93%
Par Amount	[11],[17]	$ 9,850
Amortized Cost	[11],[17]	9,776
Fair Value	[7],[11],[17]	$ 9,742
Fair Value as % of Net Assets	[9],[11],[17]	0.97%
Investment, Identifier [Axis]: SmartSign 2
Schedule of Investments [Line Items]
Spread Above Reference Rate	[6],[17]	5.75%
Interest Rate	[6],[17]	11.17%
Par Amount	[17]	$ 5,012
Amortized Cost	[17]	4,924
Fair Value	[7],[17]	$ 5,001
Fair Value as % of Net Assets	[9],[17]	0.50%
Investment, Identifier [Axis]: SmartWave
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.00%	[5],[6],[17]	6.00%	[2],[3],[4]
Interest Rate		11.46%	[5],[6],[17]	11.53%	[2],[3],[4]
Par Amount		$ 9,190	[5],[17]	$ 9,214	[2],[3]
Amortized Cost		9,128	[5],[17]	9,145	[2],[3]
Fair Value		$ 7,599	[5],[7],[17]	$ 7,744	[2],[3],[8]
Fair Value as % of Net Assets		0.76%	[5],[9],[17]	1.04%	[2],[3],[10]
Investment, Identifier [Axis]: Smile Brands
Schedule of Investments [Line Items]
Spread Above Reference Rate		8.50%	[5],[6]	8.50%	[2],[4]
Interest Rate, PIK		14.95%	[5],[6]	14.99%	[2],[4]
Par Amount		$ 10,325	[5]	$ 9,947	[2]
Amortized Cost		10,255	[5]	9,866	[2]
Fair Value		$ 8,763	[5],[7]	$ 8,665	[2],[8]
Fair Value as % of Net Assets		0.88%	[5],[9]	1.16%	[2],[10]
Investment, Identifier [Axis]: Soliant Health
Schedule of Investments [Line Items]
Spread Above Reference Rate		4.00%	[6],[17]	4.00%	[3],[4]
Interest Rate		9.44%	[6],[17]	9.47%	[3],[4]
Par Amount		$ 5,353	[17]	$ 2,628	[3]
Amortized Cost		5,350	[17]	2,615	[3]
Fair Value		$ 5,370	[7],[17]	$ 2,628	[3],[8]
Fair Value as % of Net Assets		0.54%	[9],[17]	0.35%	[3],[10]
Investment, Identifier [Axis]: Solve Industrial Motion Group
Schedule of Investments [Line Items]
Interest Rate	[2],[4]			5.00%
Interest Rate, PIK	[2],[4]			8.00%
Par Amount	[2]			$ 1,786
Amortized Cost		$ 313	[5],[19]	1,760	[2]
Fair Value		$ 183	[5],[7],[19]	$ 1,700	[2],[8]
Fair Value as % of Net Assets		0.02%	[5],[9],[19]	0.23%	[2],[10]
Shares/Units	[5],[19]	313
Investment, Identifier [Axis]: Solve Industrial Motion Group (Delayed Draw)
Schedule of Investments [Line Items]
Interest Rate		5.00%	[5],[6]	5.00%	[2],[4]
Interest Rate, PIK		8.00%	[5],[6]	8.00%	[2],[4]
Par Amount		$ 2,088	[5]	$ 2,046	[2]
Amortized Cost		2,088	[5]	2,046	[2]
Fair Value		$ 1,987	[5],[7]	$ 1,947	[2],[8]
Fair Value as % of Net Assets		0.20%	[5],[9]	0.26%	[2],[10]
Investment, Identifier [Axis]: Solve Industrial Motion Group 1
Schedule of Investments [Line Items]
Interest Rate		5.00%	[5],[6]	5.00%	[2],[4]
Interest Rate, PIK		8.00%	[5],[6]	8.00%	[2],[4]
Par Amount		$ 1,823	[5]	$ 763	[2]
Amortized Cost		1,798	[5]	749	[2]
Fair Value		$ 1,735	[5],[7]	$ 739	[2],[8]
Fair Value as % of Net Assets		0.17%	[5],[9]	0.10%	[2],[10]
Investment, Identifier [Axis]: Solve Industrial Motion Group 2
Schedule of Investments [Line Items]
Interest Rate	[5],[6]	5.00%
Interest Rate, PIK	[5],[6]	8.00%
Par Amount	[5]	$ 779
Amortized Cost		767	[5]	$ 313	[2],[15],[16]
Fair Value		$ 755	[5],[7]	$ 210	[2],[8],[15],[16]
Fair Value as % of Net Assets		0.08%	[5],[9]	0.03%	[2],[10],[15],[16]
Shares/Units	[2],[15],[16]			313,000
Investment, Identifier [Axis]: Southern Veterinary Partners
Schedule of Investments [Line Items]
Spread Above Reference Rate	[6],[22]	4.00%
Interest Rate	[6],[22]	9.44%
Par Amount	[22]	$ 2,118
Amortized Cost	[22]	2,113
Fair Value	[7],[22]	$ 2,113
Fair Value as % of Net Assets	[9],[22]	0.21%
Investment, Identifier [Axis]: Spartech
Schedule of Investments [Line Items]
Spread Above Reference Rate		4.75%	[5],[6],[11],[17],[22]	4.75%	[1],[2],[3],[4],[13]
Interest Rate		10.07%	[5],[6],[11],[17],[22]	10.16%	[1],[2],[3],[4],[13]
Par Amount		$ 14,731	[5],[11],[17],[22]	$ 14,768	[1],[2],[3],[13]
Amortized Cost		14,667	[5],[11],[17],[22]	14,699	[1],[2],[3],[13]
Fair Value		$ 11,868	[5],[7],[11],[17],[22]	$ 11,898	[1],[2],[3],[8],[13]
Fair Value as % of Net Assets		1.19%	[5],[9],[11],[17],[22]	1.59%	[1],[2],[3],[10],[13]
Investment, Identifier [Axis]: Specialized Packaging Group
Schedule of Investments [Line Items]
Spread Above Reference Rate	[1],[3],[4],[20],[28]			5.50%
Interest Rate	[1],[3],[4],[20],[28]			11.23%
Par Amount	[1],[3],[20],[28]			$ 2,983
Amortized Cost		$ 148	[5],[18],[19],[27]	2,968	[1],[3],[20],[28]
Fair Value		$ 177	[5],[7],[18],[19],[27]	$ 2,921	[1],[3],[8],[20],[28]
Fair Value as % of Net Assets		0.02%	[5],[9],[18],[19],[27]	0.39%	[1],[3],[10],[20],[28]
Shares/Units	[5],[18],[19],[27]	147,708
Investment, Identifier [Axis]: Specialized Packaging Group (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[1],[4],[20],[28]			6.25%
Interest Rate	[1],[4],[20],[28]			11.98%
Par Amount	[1],[20],[28]			$ 4,409
Amortized Cost	[1],[20],[28]			4,354
Fair Value	[1],[8],[20],[28]			$ 4,375
Fair Value as % of Net Assets	[1],[10],[20],[28]			0.58%
Investment, Identifier [Axis]: Specialized Packaging Group (Incremental) 1
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.25%	[6],[11],[18],[27]	6.25%	[1],[2],[4],[20],[28]
Interest Rate		11.79%	[6],[11],[18],[27]	11.78%	[1],[2],[4],[20],[28]
Par Amount		$ 4,398	[11],[18],[27]	$ 6,894	[1],[2],[20],[28]
Amortized Cost		4,350	[11],[18],[27]	6,798	[1],[2],[20],[28]
Fair Value		$ 4,381	[7],[11],[18],[27]	$ 6,751	[1],[2],[8],[20],[28]
Fair Value as % of Net Assets		0.44%	[9],[11],[18],[27]	0.90%	[1],[2],[10],[20],[28]
Investment, Identifier [Axis]: Specialized Packaging Group (Incremental) 2
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6],[11],[17],[18],[27]	6.25%
Interest Rate	[5],[6],[11],[17],[18],[27]	11.79%
Par Amount	[5],[11],[17],[18],[27]	$ 6,877
Amortized Cost	[5],[11],[17],[18],[27]	6,793
Fair Value	[5],[7],[11],[17],[18],[27]	$ 6,850
Fair Value as % of Net Assets	[5],[9],[11],[17],[18],[27]	0.69%
Investment, Identifier [Axis]: Specialized Packaging Group 1
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.50%	[6],[11],[17],[18],[27]	5.50%	[1],[3],[4],[20],[28]
Interest Rate		11.04%	[6],[11],[17],[18],[27]	11.23%	[1],[3],[4],[20],[28]
Par Amount		$ 2,975	[11],[17],[18],[27]	$ 7,275	[1],[3],[20],[28]
Amortized Cost		2,962	[11],[17],[18],[27]	7,236	[1],[3],[20],[28]
Fair Value		$ 2,929	[7],[11],[17],[18],[27]	$ 7,123	[1],[3],[8],[20],[28]
Fair Value as % of Net Assets		0.29%	[9],[11],[17],[18],[27]	0.95%	[1],[3],[10],[20],[28]
Investment, Identifier [Axis]: Specialized Packaging Group 2
Schedule of Investments [Line Items]
Spread Above Reference Rate	[6],[11],[17],[18],[27]	5.50%
Interest Rate	[6],[11],[17],[18],[27]	11.04%
Par Amount	[11],[17],[18],[27]	$ 7,256
Amortized Cost		7,221	[11],[17],[18],[27]	$ 148	[2],[15],[16],[20],[28]
Fair Value		$ 7,143	[7],[11],[17],[18],[27]	$ 182	[2],[8],[15],[16],[20],[28]
Fair Value as % of Net Assets		0.71%	[9],[11],[17],[18],[27]	0.02%	[2],[10],[15],[16],[20],[28]
Shares/Units	[2],[15],[16],[20],[28]			147,708,000
Investment, Identifier [Axis]: Spectrio II
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.00%	[5],[6],[11],[17],[22]	6.00%	[1],[2],[3],[4],[13]
Interest Rate		6.50%	[5],[6],[11],[17],[22]	6.50%	[1],[2],[3],[4],[13]
Interest Rate, PIK		5.00%	[5],[6],[11],[17],[22]	5.00%	[1],[2],[3],[4],[13]
Par Amount		$ 8,225	[5],[11],[17],[22]	$ 8,143	[1],[2],[3],[13]
Amortized Cost		8,187	[5],[11],[17],[22]	8,100	[1],[2],[3],[13]
Fair Value		$ 7,608	[5],[7],[11],[17],[22]	$ 7,556	[1],[2],[3],[8],[13]
Fair Value as % of Net Assets		0.77%	[5],[9],[11],[17],[22]	1.01%	[1],[2],[3],[10],[13]
Investment, Identifier [Axis]: Spectrio II (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[2],[3],[4],[13]			6.00%
Interest Rate	[2],[3],[4],[13]			6.50%
Interest Rate, PIK	[2],[3],[4],[13]			5.00%
Par Amount	[2],[3],[13]			$ 2,893
Amortized Cost	[2],[3],[13]			2,875
Fair Value	[2],[3],[8],[13]			$ 2,684
Fair Value as % of Net Assets	[2],[3],[10],[13]			0.36%
Investment, Identifier [Axis]: Spectrio II (Delayed Draw) 1
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.00%	[5],[6],[17],[22]	6.00%	[1],[4],[13]
Interest Rate		6.33%	[5],[6],[17],[22]	6.50%	[1],[4],[13]
Interest Rate, PIK		5.00%	[5],[6],[17],[22]	5.00%	[1],[4],[13]
Par Amount		$ 2,922	[5],[17],[22]	$ 441	[1],[13]
Amortized Cost		2,905	[5],[17],[22]	440	[1],[13]
Fair Value		$ 2,703	[5],[7],[17],[22]	$ 407	[1],[8],[13]
Fair Value as % of Net Assets		0.27%	[5],[9],[17],[22]	0.06%	[1],[10],[13]
Investment, Identifier [Axis]: Spectrio II (Delayed Draw) 2
Schedule of Investments [Line Items]
Spread Above Reference Rate	[6],[11],[22]	6.00%
Interest Rate	[6],[11],[22]	6.33%
Interest Rate, PIK	[6],[11],[22]	5.00%
Par Amount	[11],[22]	$ 446
Amortized Cost	[11],[22]	444
Fair Value	[7],[11],[22]	$ 410
Fair Value as % of Net Assets	[9],[11],[22]	0.04%
Investment, Identifier [Axis]: Summit Hill Foods
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.00%	[6],[17]	6.00%	[3],[4]
Interest Rate		11.34%	[6],[17]	11.39%	[3],[4]
Par Amount		$ 9,811	[17]	$ 9,835	[3]
Amortized Cost		9,669	[17]	9,689	[3]
Fair Value		$ 9,669	[7],[17]	$ 9,690	[3],[8]
Fair Value as % of Net Assets		0.97%	[9],[17]	1.30%	[3],[10]
Investment, Identifier [Axis]: Sunny Sky Products
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.25%	[5],[6],[11],[17]	5.25%	[1],[2],[4]
Interest Rate		10.55%	[5],[6],[11],[17]	10.60%	[1],[2],[4]
Par Amount		$ 7,076	[5],[11],[17]	$ 7,093	[1],[2]
Amortized Cost		7,010	[5],[11],[17]	7,025	[1],[2]
Fair Value		$ 7,009	[5],[7],[11],[17]	$ 7,026	[1],[2],[8]
Fair Value as % of Net Assets		0.70%	[5],[9],[11],[17]	0.94%	[1],[2],[10]
Investment, Identifier [Axis]: Sunny Sky Products (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.25%	[5],[6],[12]	5.25%	[2],[4],[14]
Interest Rate		10.55%	[5],[6],[12]	10.60%	[2],[4],[14]
Par Amount		$ 1,773	[5],[12]	$ 1,773	[2],[14]
Amortized Cost		0	[5],[12]	0	[2],[14]
Fair Value		$ (17)	[5],[7],[12]	$ (17)	[2],[8],[14]
Fair Value as % of Net Assets		0.00%	[5],[9],[12]	0.00%	[2],[10],[14]
Investment, Identifier [Axis]: Syndigo
Schedule of Investments [Line Items]
Spread Above Reference Rate		4.50%	[6],[17]	4.50%	[3],[4]
Interest Rate		9.94%	[6],[17]	9.97%	[3],[4]
Par Amount		$ 5,820	[17]	$ 5,835	[3]
Amortized Cost		5,834	[17]	5,850	[3]
Fair Value		$ 5,789	[7],[17]	$ 5,747	[3],[8]
Fair Value as % of Net Assets		0.59%	[9],[17]	0.77%	[3],[10]
Investment, Identifier [Axis]: System One
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6],[17],[22]	4.00%
Interest Rate	[5],[6],[17],[22]	9.46%
Par Amount	[5],[17],[22]	$ 2,253
Amortized Cost	[5],[17],[22]	2,250
Fair Value	[5],[7],[17],[22]	$ 2,249
Fair Value as % of Net Assets	[5],[9],[17],[22]	0.23%
Investment, Identifier [Axis]: TI ACQUISITION NC LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate		4.75%	[6],[17]	4.75%	[3],[4]
Interest Rate		10.04%	[6],[17]	10.08%	[3],[4]
Par Amount		$ 2,773	[17]	$ 2,780	[3]
Amortized Cost		2,715	[17]	2,719	[3]
Fair Value		$ 2,666	[7],[17]	$ 2,642	[3],[8]
Fair Value as % of Net Assets		0.27%	[9],[17]	0.35%	[3],[10]
Investment, Identifier [Axis]: TIDI Products
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.50%	[5],[6],[11],[17],[22]	5.50%	[1],[2],[3],[4],[13]
Interest Rate		10.83%	[5],[6],[11],[17],[22]	10.86%	[1],[2],[3],[4],[13]
Par Amount		$ 15,484	[5],[11],[17],[22]	$ 15,523	[1],[2],[3],[13]
Amortized Cost		15,337	[5],[11],[17],[22]	15,368	[1],[2],[3],[13]
Fair Value		$ 15,427	[5],[7],[11],[17],[22]	$ 15,369	[1],[2],[3],[8],[13]
Fair Value as % of Net Assets		1.55%	[5],[9],[11],[17],[22]	2.05%	[1],[2],[3],[10],[13]
Investment, Identifier [Axis]: TIDI Products (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.50%	[5],[6],[12],[22]	5.50%	[2],[4],[13],[14]
Interest Rate		10.83%	[5],[6],[12],[22]	10.86%	[2],[4],[13],[14]
Par Amount		$ 4,085	[5],[12],[22]	$ 4,085	[2],[13],[14]
Amortized Cost		0	[5],[12],[22]	0	[2],[13],[14]
Fair Value		$ (15)	[5],[7],[12],[22]	$ (40)	[2],[8],[13],[14]
Fair Value as % of Net Assets		0.00%	[5],[9],[12],[22]	(0.01%)	[2],[10],[13],[14]
Investment, Identifier [Axis]: TPC Wire & Cable
Schedule of Investments [Line Items]
Interest Rate		11.00%	[5],[6]	10.00%	[2],[4]
Interest Rate, PIK		1.50%	[5],[6]	1.00%	[2],[4]
Par Amount		$ 2,244	[5]	$ 2,240	[2]
Amortized Cost		2,225	[5]	2,220	[2]
Fair Value		$ 2,204	[5],[7]	$ 2,215	[2],[8]
Fair Value as % of Net Assets		0.22%	[5],[9]	0.29%	[2],[10]
Investment, Identifier [Axis]: TPC Wire & Cable (Delayed Draw)
Schedule of Investments [Line Items]
Interest Rate		11.00%	[5],[6],[12]	11.00%	[2],[4]
Interest Rate, PIK		1.50%	[5],[6],[12]	1.50%	[2],[4]
Par Amount		$ 918	[5],[12]	$ 913	[2]
Amortized Cost		916	[5],[12]	911	[2]
Fair Value		$ 901	[5],[7],[12]	$ 902	[2],[8]
Fair Value as % of Net Assets		0.09%	[5],[9],[12]	0.12%	[2],[10]
Investment, Identifier [Axis]: TPC Wire & Cable Corp (Delayed Draw) (Incremental)
Schedule of Investments [Line Items]
Interest Rate	[5],[6],[12]	11.00%
Interest Rate, PIK	[5],[6],[12]	1.50%
Par Amount	[5],[12]	$ 1,714
Amortized Cost	[5],[12]	0
Fair Value	[5],[7],[12]	$ (30)
Fair Value as % of Net Assets	[5],[9],[12]	0.00%
Investment, Identifier [Axis]: Team Services Group
Schedule of Investments [Line Items]
Spread Above Reference Rate	[6],[17]	5.00%
Interest Rate	[6],[17]	10.58%
Par Amount	[17]	$ 6,650
Amortized Cost	[17]	6,617
Fair Value	[7],[17]	$ 6,620
Fair Value as % of Net Assets	[9],[17]	0.66%
Investment, Identifier [Axis]: Tech24
Schedule of Investments [Line Items]
Amortized Cost		$ 954	[5],[19]	$ 954	[2],[15],[16]
Fair Value		$ 983	[5],[7],[19]	$ 954	[2],[8],[15],[16]
Fair Value as % of Net Assets		0.10%	[5],[9],[19]	0.13%	[2],[10],[15],[16]
Shares/Units		954	[5],[19]	954,000	[2],[15],[16]
Investment, Identifier [Axis]: Technical Safety Services
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.50%	[6],[17]	5.50%	[1],[3],[4]
Interest Rate		10.95%	[6],[17]	11.00%	[1],[3],[4]
Par Amount		$ 6,755	[17]	$ 6,772	[1],[3]
Amortized Cost		6,701	[17]	6,716	[1],[3]
Fair Value		$ 6,755	[7],[17]	$ 6,712	[1],[3],[8]
Fair Value as % of Net Assets		0.68%	[9],[17]	0.90%	[1],[3],[10]
Investment, Identifier [Axis]: Technical Safety Services (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.50%	[5],[6],[12]	5.50%	[2],[4],[14]
Interest Rate		10.95%	[5],[6],[12]	11.00%	[2],[4],[14]
Par Amount		$ 6,394	[5],[12]	$ 6,404	[2],[14]
Amortized Cost		3,982	[5],[12]	3,903	[2],[14]
Fair Value		$ 4,051	[5],[7],[12]	$ 3,918	[2],[8],[14]
Fair Value as % of Net Assets		0.41%	[5],[9],[12]	0.52%	[2],[10],[14]
Investment, Identifier [Axis]: Technical Safety Services (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.50%	[5],[6],[17]	5.50%	[2],[4]
Interest Rate		10.95%	[5],[6],[17]	11.00%	[2],[4]
Par Amount		$ 1,885	[5],[17]	$ 1,890	[2]
Amortized Cost		1,859	[5],[17]	1,863	[2]
Fair Value		$ 1,885	[5],[7],[17]	$ 1,873	[2],[8]
Fair Value as % of Net Assets		0.19%	[5],[9],[17]	0.25%	[2],[10]
Investment, Identifier [Axis]: Tencate
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6],[11],[17],[22]	4.00%
Interest Rate	[5],[6],[11],[17],[22]	9.31%
Par Amount	[5],[11],[17],[22]	$ 7,034
Amortized Cost	[5],[11],[17],[22]	6,999
Fair Value	[5],[7],[11],[17],[22]	$ 7,001
Fair Value as % of Net Assets	[5],[9],[11],[17],[22]	0.70%
Investment, Identifier [Axis]: Tencate (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6],[12],[22]	4.00%
Interest Rate	[5],[6],[12],[22]	9.31%
Par Amount	[5],[12],[22]	$ 1,540
Amortized Cost	[5],[12],[22]	0
Fair Value	[5],[7],[12],[22]	$ (7)
Fair Value as % of Net Assets	[5],[9],[12],[22]	0.00%
Investment, Identifier [Axis]: The Facilities Group
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[13]			5.75%
Interest Rate	[3],[4],[13]			11.23%
Par Amount	[3],[13]			$ 4,872
Amortized Cost	[3],[13]			4,840
Fair Value	[3],[8],[13]			$ 4,847
Fair Value as % of Net Assets	[3],[10],[13]			0.64%
Investment, Identifier [Axis]: The Facilities Group (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[2],[4],[13],[14]			5.75%
Interest Rate	[2],[4],[13],[14]			11.22%
Par Amount	[2],[13],[14]			$ 5,028
Amortized Cost	[2],[13],[14]			0
Fair Value	[2],[8],[13],[14]			$ (25)
Fair Value as % of Net Assets	[2],[10],[13],[14]			0.00%
Investment, Identifier [Axis]: The Facilities Group (Delayed Draw) 1
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[5],[6],[12],[22]	5.75%	[2],[3],[4],[13]
Interest Rate		11.15%	[5],[6],[12],[22]	11.22%	[2],[3],[4],[13]
Par Amount		$ 5,028	[5],[12],[22]	$ 4,952	[2],[3],[13]
Amortized Cost		167	[5],[12],[22]	4,952	[2],[3],[13]
Fair Value		$ 167	[5],[7],[12],[22]	$ 4,927	[2],[3],[8],[13]
Fair Value as % of Net Assets		0.02%	[5],[9],[12],[22]	0.66%	[2],[3],[10],[13]
Investment, Identifier [Axis]: The Facilities Group (Delayed Draw) 2
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6],[17],[22]	5.75%
Interest Rate	[5],[6],[17],[22]	11.16%
Par Amount	[5],[17],[22]	$ 4,939
Amortized Cost	[5],[17],[22]	4,939
Fair Value	[5],[7],[17],[22]	$ 4,939
Fair Value as % of Net Assets	[5],[9],[17],[22]	0.49%
Investment, Identifier [Axis]: The Facilities Group 1
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[6],[17],[22]	5.75%	[1],[4],[13]
Interest Rate		11.16%	[6],[17],[22]	11.22%	[1],[4],[13]
Par Amount		$ 4,859	[17],[22]	$ 9,051	[1],[13]
Amortized Cost		4,830	[17],[22]	8,963	[1],[13]
Fair Value		$ 4,859	[7],[17],[22]	$ 9,006	[1],[8],[13]
Fair Value as % of Net Assets		0.49%	[9],[17],[22]	1.20%	[1],[10],[13]
Investment, Identifier [Axis]: The Facilities Group 2
Schedule of Investments [Line Items]
Spread Above Reference Rate	[6],[11],[17],[22]	5.75%
Interest Rate	[6],[11],[17],[22]	11.15%
Par Amount	[11],[17],[22]	$ 9,026
Amortized Cost	[11],[17],[22]	8,944
Fair Value	[7],[11],[17],[22]	$ 9,026
Fair Value as % of Net Assets	[9],[11],[17],[22]	0.91%
Investment, Identifier [Axis]: Thorne HealthTech
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.00%	[5],[6],[11],[17]	5.75%	[1],[2],[3],[4]
Interest Rate		11.06%	[5],[6],[11],[17]	11.10%	[1],[2],[3],[4]
Par Amount		$ 10,625	[5],[11],[17]	$ 10,652	[1],[2],[3]
Amortized Cost		10,525	[5],[11],[17]	10,549	[1],[2],[3]
Fair Value		$ 10,522	[5],[7],[11],[17]	$ 10,553	[1],[2],[3],[8]
Fair Value as % of Net Assets		1.05%	[5],[9],[11],[17]	1.41%	[1],[2],[3],[10]
Investment, Identifier [Axis]: Tinuiti
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.25%	[6],[17],[22]	5.25%	[3],[4],[13]
Interest Rate		10.65%	[6],[17],[22]	10.70%	[3],[4],[13]
Par Amount		$ 2,940	[17],[22]	$ 2,948	[3],[13]
Amortized Cost		2,922	[17],[22]	2,928	[3],[13]
Fair Value		$ 2,842	[7],[17],[22]	$ 2,823	[3],[8],[13]
Fair Value as % of Net Assets		0.28%	[9],[17],[22]	0.38%	[3],[10],[13]
Investment, Identifier [Axis]: Tinuiti (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.25%	[6],[17],[22]	5.25%	[3],[4],[13]
Interest Rate		10.65%	[6],[17],[22]	10.70%	[3],[4],[13]
Par Amount		$ 1,922	[17],[22]	$ 1,926	[3],[13]
Amortized Cost		1,921	[17],[22]	1,926	[3],[13]
Fair Value		$ 1,857	[7],[17],[22]	$ 1,845	[3],[8],[13]
Fair Value as % of Net Assets		0.19%	[9],[17],[22]	0.25%	[3],[10],[13]
Investment, Identifier [Axis]: Tinuiti (Delayed Draw) (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.25%	[5],[6],[17],[22]	5.25%	[2],[3],[4]
Interest Rate		10.65%	[5],[6],[17],[22]	10.70%	[2],[3],[4]
Par Amount		$ 9,838	[5],[17],[22]	$ 9,863	[2],[3]
Amortized Cost		9,838	[5],[17],[22]	9,863	[2],[3]
Fair Value		$ 9,509	[5],[7],[17],[22]	$ 9,445	[2],[3],[8]
Fair Value as % of Net Assets		0.95%	[5],[9],[17],[22]	1.26%	[2],[3],[10]
Investment, Identifier [Axis]: TouchTunes Interactive
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.00%	[6],[11],[17]	5.00%	[1],[3],[4],[24]
Interest Rate		10.30%	[6],[11],[17]	10.35%	[1],[3],[4],[24]
Par Amount		$ 9,850	[11],[17]	$ 9,875	[1],[3],[24]
Amortized Cost		9,772	[11],[17]	9,793	[1],[3],[24]
Fair Value		$ 9,899	[7],[11],[17]	$ 9,825	[1],[3],[8],[24]
Fair Value as % of Net Assets		0.99%	[9],[11],[17]	1.31%	[1],[3],[10],[24]
Investment, Identifier [Axis]: Transit Buyer LLC (dba“Propark”)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[1],[3],[4]			6.25%
Interest Rate	[1],[3],[4]			11.69%
Par Amount	[1],[3]			$ 6,823
Amortized Cost	[1],[3]			6,705
Fair Value	[1],[3],[8]			$ 6,801
Fair Value as % of Net Assets	[1],[3],[10]			0.91%
Investment, Identifier [Axis]: Transit Buyer LLC (dba“Propark”) (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[2],[4],[14]			6.25%
Interest Rate	[2],[4],[14]			11.69%
Par Amount	[2],[14]			$ 3,125
Amortized Cost	[2],[14]			1,275
Fair Value	[2],[8],[14]			$ 1,318
Fair Value as % of Net Assets	[2],[10],[14]			0.18%
Investment, Identifier [Axis]: Trilon Group, LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[1],[4]			6.25%
Interest Rate	[1],[4]			11.78%
Par Amount	[1]			$ 2,978
Amortized Cost	[1]			2,958
Fair Value	[1],[8]			$ 2,939
Fair Value as % of Net Assets	[1],[10]			0.39%
Investment, Identifier [Axis]: Trilon Group, LLC (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[2],[4]			6.25%
Interest Rate	[2],[4]			11.78%
Par Amount	[2]			$ 7,425
Amortized Cost	[2]			7,425
Fair Value	[2],[8]			$ 7,330
Fair Value as % of Net Assets	[2],[10]			0.98%
Investment, Identifier [Axis]: Trilon Group, LLC (Delayed Draw) 1
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.00%	[5],[6]	6.25%	[2],[4]
Interest Rate		11.71%	[5],[6]	11.78%	[2],[4]
Par Amount		$ 7,406	[5]	$ 1,985	[2]
Amortized Cost		7,406	[5]	1,985	[2]
Fair Value		$ 7,333	[5],[7]	$ 1,959	[2],[8]
Fair Value as % of Net Assets		0.73%	[5],[9]	0.26%	[2],[10]
Investment, Identifier [Axis]: Trilon Group, LLC (Delayed Draw) 2
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.25%	[5],[6]	6.25%	[2],[4],[14]
Interest Rate		11.71%	[5],[6]	11.78%	[2],[4],[14]
Par Amount		$ 1,980	[5]	$ 6,373	[2],[14]
Amortized Cost		1,980	[5]	1,935	[2],[14]
Fair Value		$ 1,960	[5],[7]	$ 1,884	[2],[8],[14]
Fair Value as % of Net Assets		0.20%	[5],[9]	0.25%	[2],[10],[14]
Investment, Identifier [Axis]: Trilon Group, LLC (Delayed Draw) 3
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6],[12]	6.25%
Interest Rate	[5],[6],[12]	11.72%
Par Amount	[5],[12]	$ 6,373
Amortized Cost	[5],[12]	4,469
Fair Value	[5],[7],[12]	$ 4,436
Fair Value as % of Net Assets	[5],[9],[12]	0.44%
Investment, Identifier [Axis]: Trilon Group, LLC 1
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.25%	[6],[11]	6.25%	[1],[3],[4]
Interest Rate		11.71%	[6],[11]	11.75%	[1],[3],[4]
Par Amount		$ 2,970	[11]	$ 7,406	[1],[3]
Amortized Cost		2,951	[11]	7,345	[1],[3]
Fair Value		$ 2,941	[7],[11]	$ 7,311	[1],[3],[8]
Fair Value as % of Net Assets		0.29%	[9],[11]	0.98%	[1],[3],[10]
Investment, Identifier [Axis]: Trilon Group, LLC 2
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.00%	[6],[11],[17]	6.25%	[1],[2],[4]
Interest Rate		11.71%	[6],[11],[17]	11.78%	[1],[2],[4]
Par Amount		$ 7,388	[11],[17]	$ 3,733	[1],[2]
Amortized Cost		7,328	[11],[17]	3,661	[1],[2]
Fair Value		$ 7,315	[7],[11],[17]	$ 3,685	[1],[2],[8]
Fair Value as % of Net Assets		0.73%	[9],[11],[17]	0.49%	[1],[2],[10]
Investment, Identifier [Axis]: Trilon Group, LLC 3
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6],[11]	6.25%
Interest Rate	[5],[6],[11]	11.72%
Par Amount	[5],[11]	$ 3,724
Amortized Cost	[5],[11]	3,654
Fair Value	[5],[7],[11]	$ 3,687
Fair Value as % of Net Assets	[5],[9],[11]	0.37%
Investment, Identifier [Axis]: Turbine Engine Specialist, Inc
Schedule of Investments [Line Items]
Spread Above Reference Rate		9.50%	[5],[6]	9.50%	[2],[4]
Interest Rate		14.93%	[5],[6]	14.96%	[2],[4]
Par Amount		$ 2,550	[5]	$ 2,556	[2]
Amortized Cost		2,491	[5]	2,494	[2]
Fair Value		$ 2,517	[5],[7]	$ 2,509	[2],[8]
Fair Value as % of Net Assets		0.25%	[5],[9]	0.33%	[2],[10]
Investment, Identifier [Axis]: Tyto Athene, LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.50%	[5],[6],[17]	5.50%	[2],[3],[4]
Interest Rate		10.98%	[5],[6],[17]	11.04%	[2],[3],[4]
Par Amount		$ 7,157	[5],[17]	$ 7,157	[2],[3]
Amortized Cost		7,108	[5],[17]	7,105	[2],[3]
Fair Value		$ 6,610	[5],[7],[17]	$ 6,515	[2],[3],[8]
Fair Value as % of Net Assets		0.66%	[5],[9],[17]	0.87%	[2],[3],[10]
Investment, Identifier [Axis]: U.S. Bank National Association Money Market Deposit Account
Schedule of Investments [Line Items]
Interest Rate	[4]			2.05%
Amortized Cost				$ 17,661
Fair Value	[8]			$ 17,661
Fair Value as % of Net Assets	[10]			2.36%
Shares/Units				17,661,000
Investment, Identifier [Axis]: US Fertility
Schedule of Investments [Line Items]
Spread Above Reference Rate	[2],[4]
Interest Rate, PIK		13.75%	[5],[6]	13.75%	[2],[4]
Par Amount		$ 12,831	[5]	$ 12,391	[2]
Amortized Cost		12,543	[5]	12,084	[2]
Fair Value		$ 12,652	[5],[7]	$ 12,066	[2],[8]
Fair Value as % of Net Assets		1.27%	[5],[9]	1.61%	[2],[10]
Investment, Identifier [Axis]: USA Water (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6],[12]	4.75%
Interest Rate	[5],[6],[12]	10.06%
Par Amount	[5],[12]	$ 3,037
Amortized Cost	[5],[12]	0
Fair Value	[5],[7],[12]	$ (29)
Fair Value as % of Net Assets	[5],[9],[12]	0.00%
Investment, Identifier [Axis]: USA Water 1
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6],[17]	4.75%
Interest Rate	[5],[6],[17]	10.06%
Par Amount	[5],[17]	$ 7,897
Amortized Cost	[5],[17]	7,822
Fair Value	[5],[7],[17]	$ 7,821
Fair Value as % of Net Assets	[5],[9],[17]	0.78%
Investment, Identifier [Axis]: USA Water 2
Schedule of Investments [Line Items]
Amortized Cost	[5],[18],[19]	$ 478
Fair Value	[5],[7],[18],[19]	$ 478
Fair Value as % of Net Assets	[5],[9],[18],[19]	0.05%
Shares/Units	[5],[18],[19]	4,781,000
Investment, Identifier [Axis]: Ultima Health Holdings, LLC
Schedule of Investments [Line Items]
Interest Rate	[2],[4]			11.00%
Interest Rate, PIK	[2],[4]			1.50%
Par Amount	[2]			$ 1,734
Amortized Cost	[2]			1,706
Fair Value	[2],[8]			$ 1,704
Fair Value as % of Net Assets	[2],[10]			0.23%
Investment, Identifier [Axis]: Ultima Health Holdings, LLC 1
Schedule of Investments [Line Items]
Interest Rate	[5],[6]	11.00%
Interest Rate, PIK	[5],[6]	1.50%
Par Amount	[5]	$ 1,740
Amortized Cost		1,713	[5]	$ 170	[2],[15],[16]
Fair Value		$ 1,745	[5],[7]	$ 158	[2],[8],[15],[16]
Fair Value as % of Net Assets		0.17%	[5],[9]	0.02%	[2],[10],[15],[16]
Shares/Units	[2],[15],[16]			15,000
Investment, Identifier [Axis]: Ultima Health Holdings, LLC 2
Schedule of Investments [Line Items]
Amortized Cost	[5],[19]	$ 170
Fair Value	[5],[7],[19]	$ 182
Fair Value as % of Net Assets	[5],[9],[19]	0.02%
Shares/Units	[5],[19]	15
Investment, Identifier [Axis]: Valkyrie
Schedule of Investments [Line Items]
Interest Rate		10.50%	[5],[6]	10.50%	[2],[4]
Interest Rate, PIK		1.00%	[5],[6]	1.00%	[2],[4]
Par Amount		$ 2,843	[5]	$ 2,836	[2]
Amortized Cost		2,802	[5]	2,792	[2]
Fair Value		$ 2,773	[5],[7]	$ 2,740	[2],[8]
Fair Value as % of Net Assets		0.28%	[5],[9]	0.37%	[2],[10]
Investment, Identifier [Axis]: Velosio
Schedule of Investments [Line Items]
Spread Above Reference Rate	[6],[11],[17],[22]	5.25%
Interest Rate	[6],[11],[17],[22]	10.58%
Par Amount	[11],[17],[22]	$ 6,248
Amortized Cost	[11],[17],[22]	6,187
Fair Value	[7],[11],[17],[22]	$ 6,187
Fair Value as % of Net Assets	[9],[11],[17],[22]	0.62%
Investment, Identifier [Axis]: Velosio (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6],[12],[22]	5.25%
Interest Rate	[5],[6],[12],[22]	10.58%
Par Amount	[5],[12],[22]	$ 1,284
Amortized Cost	[5],[12],[22]	0
Fair Value	[5],[7],[12],[22]	$ (12)
Fair Value as % of Net Assets	[5],[9],[12],[22]	0.00%
Investment, Identifier [Axis]: Vensure Employer Services
Schedule of Investments [Line Items]
Spread Above Reference Rate		4.75%	[6],[11],[17]	4.75%	[1],[3],[4]
Interest Rate		10.08%	[6],[11],[17]	10.12%	[1],[3],[4]
Par Amount		$ 14,619	[11],[17]	$ 14,656	[1],[3]
Amortized Cost		14,595	[11],[17]	14,628	[1],[3]
Fair Value		$ 14,399	[7],[11],[17]	$ 14,326	[1],[3],[8]
Fair Value as % of Net Assets		1.44%	[9],[11],[17]	1.92%	[1],[3],[10]
Investment, Identifier [Axis]: Vistage
Schedule of Investments [Line Items]
Spread Above Reference Rate	[6],[17],[22]	4.75%
Interest Rate	[6],[17],[22]	10.05%
Par Amount	[17],[22]	$ 6,982
Amortized Cost	[17],[22]	6,948
Fair Value	[7],[17],[22]	$ 6,947
Fair Value as % of Net Assets	[9],[17],[22]	0.70%
Investment, Identifier [Axis]: Vital Records Control
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4],[13]			5.50%
Interest Rate	[3],[4],[13]			11.14%
Par Amount	[3],[13]			$ 4,582
Amortized Cost	[3],[13]			4,544
Fair Value	[3],[8],[13]			$ 4,515
Fair Value as % of Net Assets	[3],[10],[13]			0.60%
Investment, Identifier [Axis]: Vital Records Control (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[2],[4],[13]			5.75%
Interest Rate	[2],[4],[13]			11.12%
Par Amount	[2],[13]			$ 183
Amortized Cost	[2],[13]			181
Fair Value	[2],[8],[13]			$ 182
Fair Value as % of Net Assets	[2],[10],[13]			0.03%
Investment, Identifier [Axis]: Vital Records Control 1
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.50%	[6],[17],[22]	5.75%	[1],[4],[13]
Interest Rate		11.07%	[6],[17],[22]	11.12%	[1],[4],[13]
Par Amount		$ 4,571	[17],[22]	$ 151	[1],[13]
Amortized Cost		4,536	[17],[22]	149	[1],[13]
Fair Value		$ 4,542	[7],[17],[22]	$ 150	[1],[8],[13]
Fair Value as % of Net Assets		0.46%	[9],[17],[22]	0.02%	[1],[10],[13]
Investment, Identifier [Axis]: Vital Records Control 2
Schedule of Investments [Line Items]
Spread Above Reference Rate	[6],[17],[22]	5.75%
Interest Rate	[6],[17],[22]	11.07%
Par Amount	[17],[22]	$ 333
Amortized Cost	[17],[22]	330
Fair Value	[7],[17],[22]	$ 333
Fair Value as % of Net Assets	[9],[17],[22]	0.03%
Investment, Identifier [Axis]: WSB Engineering Holdings Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.00%	[5],[6],[17]	6.00%	[1],[2],[4]
Interest Rate		11.34%	[5],[6],[17]	11.39%	[1],[2],[4]
Par Amount		$ 6,503	[5],[17]	$ 6,519	[1],[2]
Amortized Cost		6,413	[5],[17]	6,426	[1],[2]
Fair Value		$ 6,412	[5],[7],[17]	$ 6,424	[1],[2],[8]
Fair Value as % of Net Assets		0.64%	[5],[9],[17]	0.86%	[1],[2],[10]
Investment, Identifier [Axis]: WSB Engineering Holdings Inc. (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.00%	[5],[6],[12]	6.00%	[2],[4],[14]
Interest Rate		11.34%	[5],[6],[12]	11.39%	[2],[4],[14]
Par Amount		$ 4,350	[5],[12]	$ 4,357	[2],[14]
Amortized Cost		3,013	[5],[12]	(31)	[2],[14]
Fair Value		$ 2,981	[5],[7],[12]	$ (64)	[2],[8],[14]
Fair Value as % of Net Assets		0.30%	[5],[9],[12]	(0.01%)	[2],[10],[14]
Investment, Identifier [Axis]: Watermill Express (Delayed Draw) (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6],[12],[22]	5.75%
Interest Rate	[5],[6],[12],[22]	11.21%
Par Amount	[5],[12],[22]	$ 3,179
Amortized Cost	[5],[12],[22]	445
Fair Value	[5],[7],[12],[22]	$ 416
Fair Value as % of Net Assets	[5],[9],[12],[22]	0.04%
Investment, Identifier [Axis]: Watermill Express (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[6],[11],[17],[22]	5.75%
Interest Rate	[6],[11],[17],[22]	11.21%
Par Amount	[11],[17],[22]	$ 6,359
Amortized Cost	[11],[17],[22]	6,298
Fair Value	[7],[11],[17],[22]	$ 6,300
Fair Value as % of Net Assets	[9],[11],[17],[22]	0.63%
Investment, Identifier [Axis]: Watermill Express, LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[6],[17],[18],[22]	5.00%	[3],[4],[13]
Interest Rate		11.21%	[6],[17],[18],[22]	10.50%	[3],[4],[13]
Par Amount		$ 3,247	[17],[18],[22]	$ 3,256	[3],[13]
Amortized Cost		3,228	[17],[18],[22]	3,236	[3],[13]
Fair Value		$ 3,217	[7],[17],[18],[22]	$ 3,241	[3],[8],[13]
Fair Value as % of Net Assets		0.32%	[9],[17],[18],[22]	0.43%	[3],[10],[13]
Investment, Identifier [Axis]: Watermill Express, LLC (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[6],[17],[22]	5.00%	[2],[4],[13]
Interest Rate		11.21%	[6],[17],[22]	10.50%	[2],[4],[13]
Par Amount		$ 314	[17],[22]	$ 314	[2],[13]
Amortized Cost		314	[17],[22]	315	[2],[13]
Fair Value		$ 311	[7],[17],[22]	$ 313	[2],[8],[13]
Fair Value as % of Net Assets		0.03%	[9],[17],[22]	0.04%	[2],[10],[13]
Investment, Identifier [Axis]: Wellspring Pharmaceutical
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[6],[17]	5.75%	[1],[4]
Interest Rate		11.03%	[6],[17]	11.03%	[1],[4]
Par Amount		$ 3,370	[17]	$ 3,378	[1]
Amortized Cost		3,317	[17]	3,323	[1]
Fair Value		$ 3,317	[7],[17]	$ 3,298	[1],[8]
Fair Value as % of Net Assets		0.33%	[9],[17]	0.44%	[1],[10]
Investment, Identifier [Axis]: Wellspring Pharmaceutical (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[5],[6]	5.75%	[2],[4]
Interest Rate		11.03%	[5],[6]	11.03%	[2],[4]
Par Amount		$ 1,567	[5]	$ 1,571	[2]
Amortized Cost		1,558	[5]	1,561	[2]
Fair Value		$ 1,543	[5],[7]	$ 1,534	[2],[8]
Fair Value as % of Net Assets		0.15%	[5],[9]	0.21%	[2],[10]
Investment, Identifier [Axis]: Wellspring Pharmaceutical (Delayed Draw) (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.00%	[5],[6],[12]	6.00%	[2],[4],[14]
Interest Rate		11.33%	[5],[6],[12]	11.18%	[2],[4],[14]
Par Amount		$ 3,756	[5],[12]	$ 3,756	[2],[14]
Amortized Cost		(15)	[5],[12]	(16)	[2],[14]
Fair Value		$ (26)	[5],[7],[12]	$ (55)	[2],[8],[14]
Fair Value as % of Net Assets		0.00%	[5],[9],[12]	(0.01%)	[2],[10],[14]
Investment, Identifier [Axis]: Wellspring Pharmaceutical (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.00%	[5],[6],[11],[17]	6.00%	[1],[2],[4]
Interest Rate		11.33%	[5],[6],[11],[17]	11.18%	[1],[2],[4]
Par Amount		$ 1,243	[5],[11],[17]	$ 1,246	[1],[2]
Amortized Cost		1,221	[5],[11],[17]	1,223	[1],[2]
Fair Value		$ 1,234	[5],[7],[11],[17]	$ 1,228	[1],[2],[8]
Fair Value as % of Net Assets		0.12%	[5],[9],[11],[17]	0.16%	[1],[2],[10]
Investment, Identifier [Axis]: World Insurance Associates
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6],[17],[22]	6.00%
Interest Rate	[5],[6],[17],[22]	11.31%
Par Amount	[5],[17],[22]	$ 14,843
Amortized Cost	[5],[17],[22]	14,832
Fair Value	[5],[7],[17],[22]	$ 14,586
Fair Value as % of Net Assets	[5],[9],[17],[22]	1.46%
Investment, Identifier [Axis]: World Insurance Associates (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[2],[3],[4],[13]			6.00%
Interest Rate	[2],[3],[4],[13]			11.35%
Par Amount	[2],[3],[13]			$ 14,881
Amortized Cost	[2],[3],[13]			14,869
Fair Value	[2],[3],[8],[13]			$ 14,841
Fair Value as % of Net Assets	[2],[3],[10],[13]			1.98%
Investment, Identifier [Axis]: Worldwide Express
Schedule of Investments [Line Items]
Spread Above Reference Rate	[6],[17],[21]	4.00%
Interest Rate	[6],[17],[21]	9.57%
Par Amount	[17],[21]	$ 2,494
Amortized Cost	[17],[21]	2,457
Fair Value	[7],[17],[21]	$ 2,485
Fair Value as % of Net Assets	[9],[17],[21]	0.25%
Investment, Identifier [Axis]: Wpromote
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[6],[11],[17]	5.75%	[1],[4]
Interest Rate		11.18%	[6],[11],[17]	11.19%	[1],[4]
Par Amount		$ 4,368	[11],[17]	$ 4,379	[1]
Amortized Cost		4,297	[11],[17]	4,304	[1]
Fair Value		$ 4,373	[7],[11],[17]	$ 4,344	[1],[8]
Fair Value as % of Net Assets		0.44%	[9],[11],[17]	0.58%	[1],[10]
Investment, Identifier [Axis]: Wpromote (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[5],[6],[12]	5.75%	[2],[4],[14]
Interest Rate		11.18%	[5],[6],[12]	11.19%	[2],[4],[14]
Par Amount		$ 588	[5],[12]	$ 588	[2],[14]
Amortized Cost		(3)	[5],[12]	(4)	[2],[14]
Fair Value		$ 1	[5],[7],[12]	$ (5)	[2],[8],[14]
Fair Value as % of Net Assets		0.00%	[5],[9],[12]	0.00%	[2],[10],[14]
Investment, Identifier [Axis]: Wrench Group
Schedule of Investments [Line Items]
Spread Above Reference Rate	[6],[11],[22]	4.00%
Interest Rate	[6],[11],[22]	9.57%
Par Amount	[11],[22]	$ 4,500
Amortized Cost	[11],[22]	4,490
Fair Value	[7],[11],[22]	$ 4,491
Fair Value as % of Net Assets	[9],[11],[22]	0.45%
Investment, Identifier [Axis]: Xpressmyself.com LLC (a/k/a SmartSign)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[1],[3],[4]			5.50%
Interest Rate	[1],[3],[4]			10.98%
Par Amount	[1],[3]			$ 9,875
Amortized Cost	[1],[3]			9,796
Fair Value	[1],[3],[8]			$ 9,701
Fair Value as % of Net Assets	[1],[3],[10]			1.30%
Investment, Identifier [Axis]: Xpressmyself.com LLC (a/k/a SmartSign) 1
Schedule of Investments [Line Items]
Spread Above Reference Rate	[3],[4]			5.75%
Interest Rate	[3],[4]			11.22%
Par Amount	[3]			$ 5,025
Amortized Cost	[3]			4,932
Fair Value	[3],[8]			$ 4,983
Fair Value as % of Net Assets	[3],[10]			0.67%
Investment, Identifier [Axis]: Young Innovations
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[6],[11],[17],[22]	5.75%	[1],[3],[4],[13]
Interest Rate		11.07%	[6],[11],[17],[22]	11.09%	[1],[3],[4],[13]
Par Amount		$ 16,510	[11],[17],[22]	$ 16,552	[1],[3],[13]
Amortized Cost		16,354	[11],[17],[22]	16,386	[1],[3],[13]
Fair Value		$ 16,352	[7],[11],[17],[22]	$ 16,391	[1],[3],[8],[13]
Fair Value as % of Net Assets		1.63%	[9],[11],[17],[22]	2.19%	[1],[3],[10],[13]
Investment, Identifier [Axis]: Young Innovations (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[5],[6],[12],[22]	5.75%	[2],[4],[13],[14]
Interest Rate		11.07%	[5],[6],[12],[22]	11.09%	[2],[4],[13],[14]
Par Amount		$ 3,448	[5],[12],[22]	$ 3,448	[2],[13],[14]
Amortized Cost		0	[5],[12],[22]	0	[2],[13],[14]
Fair Value		$ (33)	[5],[7],[12],[22]	$ (34)	[2],[8],[13],[14]
Fair Value as % of Net Assets		0.00%	[5],[9],[12],[22]	0.00%	[2],[10],[13],[14]

[1] Denotes that all or a portion of the assets are owned by SPV II and/or SPV III (each as defined in Note 1 "Organization"). SPV II has entered into a senior secured revolving credit facility (the “SMBC Financing Facility”). The lenders of the SMBC Financing Facility have a first lien security interest in substantially all of the assets of SPV II. Accordingly, such assets are not available to other creditors of the Company. SPV III has entered into a senior secured revolving credit facility (the “Wells Fargo Financing Facility”). The lenders of the Wells Fargo Financing Facility have a first lien security interest in substantially all of the assets of SPV III. Accordingly, such assets are not available to other creditors of the Company.

[2] Denotes that all or a portion of the assets are owned by the Company or NCDL Equity Holdings (each as defined in Note 1 "Organization"). The Company entered into a senior secured revolving credit agreement (the “Revolving Credit Facility”). The Revolving Credit Facility is guaranteed by NCDL Equity Holdings and will be guaranteed by certain subsidiaries of the Company that are formed or acquired by the Company in the future.

[3] Denotes that all or a portion of the assets are owned by CLO-I and/or CLO-II (each as defined in the Note 1 "Organization"), which serve as collateral for the 2022 and 2023 Debt Securitization (as defined in the Notes). See Note 6 "Secured Borrowings".

[4] The majority of the investments bear interest at rates that may be determined by reference to London Interbank Offered Rate (“SOFR” or "S"), which reset monthly or quarterly. For each such investment, the Company has provided the spread over SOFR and the current contractual interest rate in effect at December 31, 2023. As of December 31, 2023, rate for 1M S, 3M S, 6M S, 12M S ("SOFR") are 5.35%, 5.33%, 5.16%, and 4.77% respectively. Certain investments are subject to a SOFR floor. For fixed rate loans, a spread above a reference rate is not applicable.

[5] Denotes that all or a portion of the assets are owned by the Company or NCDL Equity Holdings (each as defined in Note 1 "Organization"). The Company entered into a senior secured revolving credit agreement (the “Revolving Credit Facility”). The Revolving Credit Facility is guaranteed by NCDL Equity Holdings and will be guaranteed by certain subsidiaries of the Company that are formed or acquired by the Company in the future.

[6] The majority of the investments bear interest at rates that may be determined by reference to Secured Overnight Financing Rate ("SOFR" or "S"), which reset monthly or quarterly. For each such investment, the Company has provided the spread over SOFR and the current contractual interest rate in effect at March 31, 2024. As of March 31, 2024, rates for 1M S, 3M S, 6M S, 12M S ("SOFR") are 5.33%, 5.30%, 5.22%, and 5.00% respectively. Certain investments are subject to a SOFR floor. For fixed rate loans, a spread above a reference rate is not applicable.

[7] Investment valued using unobservable inputs (Level 3). See Note 2 “Significant Accounting Policies – Valuation of Portfolio Investments” and Note 4 "Fair Value Measurements" for more information.

[8] Investment valued using unobservable inputs (Level 3). See Note 2 “Significant Accounting Policies – Valuation of Portfolio Investments” and Note 4 "Fair Value Measurements" for more information.

[9] Percentage is based on net assets of $998,233 as of March 31, 2024.

[10] Percentage is based on net assets of $747,885 as of December 31, 2023.

[11] Denotes that all or a portion of the assets are owned by SPV IV and/or SPV V (each as defined in Note 1 "Organization"). SPV IV has entered into a senior secured revolving credit facility (the “SMBC Financing Facility”). The lenders of the SMBC Financing Facility have a first lien security interest in substantially all of the assets of SPV IV. Accordingly, such assets are not available to other creditors of the Company. SPV V has entered into a senior secured revolving credit facility (the “Wells Fargo Financing Facility”). The lenders of the Wells Fargo Financing Facility have a first lien security interest in substantially all of the assets of SPV V. Accordingly, such assets are not available to other creditors of the Company.

[12] Position or portion thereof is an unfunded loan commitment, and no interest is being earned on the unfunded portion. See Note 7 "Commitments and Contingencies". The investment may be subject to unused commitment fees.

[13] Investment is a unitranche position.

[14] Position or portion thereof is an unfunded loan commitment, and no interest is being earned on the unfunded portion. See Note 7 "Commitments and Contingencies". The investment may be subject to unused commitment fees.

[15] Equity investments are non-income producing securities unless otherwise noted.

[16] Security acquired in transaction exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”), and may be deemed to be a “restricted security” under the Securities Act. As of December 31, 2023, the Company held forty-four restricted securities with an aggregate fair value of 30,807, or 4.12% of the Company’s net assets.

[17] Denotes that all or a portion of the assets are owned by CLO-I, CLO-II and/or CLO-III (each as defined in Note 1 "Organization"), which serve as collateral for the 2022 Debt Securitization, the 2023 Debt Securitization, and 2024 Debt Securitization (each as defined in the Notes). See Note 6 "Secured Borrowings".

[18] The investment is considered a non-qualifying asset under Section 55(a) of the 1940 Act. Under the 1940 Act, the Company cannot acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Company's total assets. As of March 31, 2024, total non-qualifying assets at fair value represented 4.50% of the Company's total assets calculated in accordance with the 1940 Act.

[19] Security acquired in transaction exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”), and may be deemed to be a “restricted security” under the Securities Act. As of March 31, 2024, the Company held forty-four restricted securities with an aggregate fair value of $31,705, or 3.18% of the Company’s net assets.

[20] The investment is considered as a non-qualifying asset under Section 55(a) of the 1940 Act. Under the 1940 Act, the Company cannot acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Company's total assets. As of December 31, 2023, total non-qualifying assets at fair value represented 4.24% of the Company's total assets calculated in accordance with the 1940 Act.

[21] Investments valued using observable inputs (Level 2). See Note 2 “Significant Accounting Policies – Valuation of Portfolio Investments” and Note 4 "Fair Value Measurements" for more information.

[22] Investment is a unitranche position.

[23] Loan was on non-accrual status as of March 31, 2024.

[24] Investments valued using observable inputs (Level 2). See Note 2 “Significant Accounting Policies – Valuation of Portfolio Investments” and Note 4 "Fair Value Measurements" for more information.

[25] Represents an investment held through an aggregator vehicle organized as a pooled investment vehicle.

[26] Represents an investment held through an aggregator vehicle organized as a pooled investment vehicle.

[27] This portfolio company is not domiciled in the United States. The principal place of business for Specialized Packing Group and Bakeovations Intermediate is Canada and the principal place of business for Phaidon International is the United Kingdom.

[28] This portfolio company is not domiciled in the United States. The principal place of business for Specialized Packing Group is Canada. The principal place of business for Phaidon International is the United Kingdom.

XML

CONSOLIDATED SCHEDULE OF INVESTMENTS (Parenthetical) $ in Thousands		Mar. 31, 2024 USD ($) restricted_security		Dec. 31, 2023 USD ($) investment
Schedule of Investments [Line Items]
Effective interest rate	[1],[2],[3],[4]			6.25%
Net assets		$ 998,233		$ 747,885
Fair Value		$ 1,847,332	[5]	$ 1,706,163	[6]
Percent of net assets		185.06%	[7]	228.13%	[8]
Restricted Security
Schedule of Investments [Line Items]
Number of restricted securities held		44		44
Fair Value		$ 31,705		$ 30,807
Percent of net assets		3.18%		4.12%
Non Qualifying Assets
Schedule of Investments [Line Items]
Percent of net assets		4.50%		4.24%
Qualifying Assets
Schedule of Investments [Line Items]
Percent of net assets		70.00%		70.00%
One Month SOFR
Schedule of Investments [Line Items]
Effective interest rate		5.33%		5.35%
Three Month SOFR
Schedule of Investments [Line Items]
Effective interest rate		5.30%		5.33%
Six Month SOFR
Schedule of Investments [Line Items]
Effective interest rate		5.22%		5.16%
Twelve Month SOFR
Schedule of Investments [Line Items]
Effective interest rate		5.00%		4.77%

[1] Denotes that all or a portion of the assets are owned by SPV II and/or SPV III (each as defined in Note 1 "Organization"). SPV II has entered into a senior secured revolving credit facility (the “SMBC Financing Facility”). The lenders of the SMBC Financing Facility have a first lien security interest in substantially all of the assets of SPV II. Accordingly, such assets are not available to other creditors of the Company. SPV III has entered into a senior secured revolving credit facility (the “Wells Fargo Financing Facility”). The lenders of the Wells Fargo Financing Facility have a first lien security interest in substantially all of the assets of SPV III. Accordingly, such assets are not available to other creditors of the Company.

[2] Denotes that all or a portion of the assets are owned by the Company or NCDL Equity Holdings (each as defined in Note 1 "Organization"). The Company entered into a senior secured revolving credit agreement (the “Revolving Credit Facility”). The Revolving Credit Facility is guaranteed by NCDL Equity Holdings and will be guaranteed by certain subsidiaries of the Company that are formed or acquired by the Company in the future.

[3] Denotes that all or a portion of the assets are owned by CLO-I and/or CLO-II (each as defined in the Note 1 "Organization"), which serve as collateral for the 2022 and 2023 Debt Securitization (as defined in the Notes). See Note 6 "Secured Borrowings".

[4] The majority of the investments bear interest at rates that may be determined by reference to London Interbank Offered Rate (“SOFR” or "S"), which reset monthly or quarterly. For each such investment, the Company has provided the spread over SOFR and the current contractual interest rate in effect at December 31, 2023. As of December 31, 2023, rate for 1M S, 3M S, 6M S, 12M S ("SOFR") are 5.35%, 5.33%, 5.16%, and 4.77% respectively. Certain investments are subject to a SOFR floor. For fixed rate loans, a spread above a reference rate is not applicable.

[5] Investment valued using unobservable inputs (Level 3). See Note 2 “Significant Accounting Policies – Valuation of Portfolio Investments” and Note 4 "Fair Value Measurements" for more information.

[6] Investment valued using unobservable inputs (Level 3). See Note 2 “Significant Accounting Policies – Valuation of Portfolio Investments” and Note 4 "Fair Value Measurements" for more information.

[7] Percentage is based on net assets of $998,233 as of March 31, 2024.

[8] Percentage is based on net assets of $747,885 as of December 31, 2023.

XML

ORGANIZATION

3 Months Ended

Mar. 31, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]

ORGANIZATION

ORGANIZATION

Nuveen Churchill Direct Lending Corp., a Maryland corporation (the “Company”), is a closed-end, externally managed, non-diversified management investment company that has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”). In addition, the Company has elected, and intends to qualify annually, to be treated for U.S. federal income tax purposes as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”). Effective June 1, 2020, the Company changed its name from “Nuveen Churchill BDC, Inc.” to “Nuveen Churchill Direct Lending Corp.”

The Company’s investment objective is to generate attractive risk-adjusted returns primarily through current income by investing primarily in senior secured loans to private equity-owned U.S. middle market companies, which the Company defines as companies with approximately $10 million to $250 million of earnings before interest, taxes, depreciation and amortization (“EBITDA”). The Company primarily focuses on investing in U.S. middle market companies with $10 million to $100 million in EBITDA, which it considers the core middle market. The Company's portfolio is comprised primarily of first-lien senior secured debt and unitranche loans. Although it is not the Company's primary strategy, the Company also opportunistically invests in junior capital opportunities, including second-lien loans, subordinated debt, and equity co-investments and similar equity-related securities.

The Company entered into the Advisory Agreement with Churchill DLC Advisor LLC (f/k/a Nuveen Churchill Advisors LLC) (the “Adviser”), under which the Adviser has delegated substantially all of its day-to-day portfolio management obligations through the CAM Sub-Advisory Agreement with Churchill Asset Management LLC (“Churchill"). In addition, the Adviser and Churchill have engaged Nuveen Asset Management, LLC (“Nuveen Asset Management”) pursuant to the NAM Sub-Advisory Agreement, pursuant to which Nuveen Asset Management may manage a portion of the Company's portfolio consisting of cash and cash equivalents, liquid fixed-income securities (including broadly syndicated loans) and other liquid credit instruments, subject to the pace and amount of investment activity in the middle market investment program. Under the Administration Agreement, the Company is provided with certain services by an administrator, Churchill BDC Administration LLC (f/k/a Nuveen Churchill Administration LLC) (the “Administrator”). The Advisers and Administrator are all affiliates and subsidiaries of Nuveen, LLC, a wholly owned subsidiary of Teachers Insurance and Annuity Association of America (“TIAA”). See Note 5, Related Party Transactions.

Churchill NCDLC CLO-I, LLC (“CLO-I”), Churchill NCDLC CLO-II, LLC (“CLO-II”), Churchill NCDLC CLO-III, LLC (“CLO-III”), Nuveen Churchill BDC SPV IV, LLC (“SPV IV”), Nuveen Churchill BDC SPV V, LLC (“SPV V”) and NCDL Equity Holdings LLC ("NCDL Equity Holdings") are wholly owned subsidiaries of the Company and are consolidated in these financial statements commencing from the date of their formation, in accordance with the Company's consolidation policy discussed in Note 2. CLO-I, CLO-II and CLO-III completed term debt securitizations in May 2022, December 2023 and March 2024, respectively. SPV IV and SPV V primarily invest in first-lien senior secured debt and unitranche loans. NCDL Equity Holdings was formed to hold certain equity-related securities.

Beginning with its initial closing in March 2020, the Company conducted private offerings ("Private Offerings") of its shares of common stock to accredited investors in reliance on exemptions from the registration requirements of the Securities Act of 1933, as amended (the "Securities Act"). The Company held its final closing on April 28, 2023.

On January 29, 2024, the Company closed its initial public offering (“IPO”) and the Company’s common stock began trading on the New York Stock Exchange (“NYSE”) under the symbol “NCDL” on January 25, 2024.

XML

SIGNIFICANT ACCOUNTING POLICIES

3 Months Ended

Mar. 31, 2024

Accounting Policies [Abstract]

SIGNIFICANT ACCOUNTING POLICIES

SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The consolidated financial statements have been prepared on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”). The Company is an investment company for the purposes of accounting and financial reporting in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 946, Financial Services—Investment Companies (“ASC 946”), and pursuant to Regulation S-X. In the opinion of management, all adjustments, which are of a normal recurring nature, considered necessary for the fair statement of the consolidated financial statements for the periods presented, have been included. The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated. Certain prior period amounts have been reclassified to conform to the current period presentation. U.S. GAAP for an investment company requires investments to be recorded at fair value. The carrying value for all other assets and liabilities approximates their fair value, unless otherwise disclosed within.

Use of Estimates

The preparation of consolidated financial statements in conformity with U.S. GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, as well as the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

Cash, Cash Equivalents and Restricted Cash

Cash and restricted cash represent cash deposits held at financial institutions, which at times may exceed U.S. federally insured limits. The Company has restrictions on the uses of the cash held by SPV V based on the terms of the Wells Fargo Financing Facility (as defined in Note 6 below). Cash equivalents include short-term highly liquid investments, such as money market funds, that are readily convertible to cash and have original maturities of three months or less. Cash, restricted cash and cash equivalents are carried at cost, which approximates fair value.

Valuation of Portfolio Investments

Investments are valued in accordance with the fair value principles established by FASB ASC Topic 820, Fair Value Measurement (“ASC Topic 820”) and in accordance with the 1940 Act. ASC Topic 820’s definition of fair value focuses on the amount that would be received to sell the asset or paid to transfer the liability in the principal or most advantageous market, and prioritizes the use of market-based inputs (observable) over entity-specific inputs (unobservable) within a measurement of fair value.

ASC Topic 820 specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. ASC Topic 820 also provides guidance regarding a fair value hierarchy, which prioritizes information used to measure fair value and the effect of fair value measurements on earnings, and provides for enhanced disclosures determined by the level within the hierarchy of information used in the valuation. In accordance with ASC Topic 820, these inputs are summarized in the three levels listed below:

•Level 1 — Valuations are based on unadjusted, quoted prices in active markets for identical assets or liabilities that are accessible at the measurement date.

•Level 2 — Valuations are based on quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly.

•Level 3 — Valuations based on inputs that are unobservable and significant to the overall fair value measurement.

In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, an investment’s level within the fair value hierarchy is based on the lowest level of observable input that is significant to the fair value measurement. The assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the investment.

Active, publicly traded instruments are classified as Level 1 and their values are generally based on quoted market prices, even if both the market’s normal daily trading volume is not sufficient to absorb the quantity held and placing orders to sell the position in a single transaction might affect the quoted price.

Fair value is generally determined as the price that would be received for an investment in a current sale, which assumes an orderly market is available for the market participants at the measurement date. If available, fair value of investments is based on directly observable market prices or on market data derived from comparable assets. The Company’s valuation policy considers the fact that no ready market may exist for many of the securities in which it invests and that fair value for its investments must be determined using unobservable inputs.

Pursuant to Rule 2a-5 under the 1940 Act, the Company's board of directors (the “Board”) has designated the Adviser as the Company's valuation designee (the “Valuation Designee”) to determine the fair value of the Company's investments that do not have readily available market quotations, which became effective beginning with the fiscal quarter ended March 31, 2023. Pursuant to the Company's valuation policy approved by the Board, a valuation committee comprised of employees of the Adviser (the “Valuation Committee”) is responsible for determining the fair value of the Company’s assets for which market quotations are not readily available, subject to the oversight of the Board.

With respect to investments for which market quotations are not readily available (Level 3), the Valuation Designee, subject to the oversight of the Board as described below, defined further below in Note 5, undertakes a multi-step valuation process each quarter, as follows:

i.the quarterly valuation process begins with each portfolio company or investment being initially valued by either the professionals of the applicable investment team that are responsible for the portfolio investment or an independent third-party valuation firm;

ii.to the extent that an independent third-party valuation firm has not been engaged by, or on behalf of, the Company to value 100% of the portfolio, then at a minimum, an independent third-party valuation firm will be engaged by, or on behalf of, the Company will provide positive assurance of the portfolio each quarter (such that each investment is reviewed by a third-party valuation firm at least once on a rolling 12-month basis and each watch-list investment will be reviewed each quarter), including a review of management’s preliminary valuation and recommendation of fair value;

iii.the Valuation Committee then reviews and discusses the valuations with any input, where appropriate, from the independent third-party valuation firm(s), and determine the fair value of each investment in good faith based on the Company’s valuation policy, subject to the oversight of the Board; and

iv.the Valuation Designee provides the Board with the information relating to the fair value determination pursuant to the Company’s valuation policy in connection with each quarterly Board meeting, comply with the periodic board reporting requirements set forth in the Company’s valuation policy, and discuss with the Board its determination of the fair value of each investment in good faith.

The Valuation Designee makes this fair value determination on a quarterly basis and in such other instances when a decision regarding the fair value of the portfolio investments is required. Factors considered by the Valuation Designee as part of the valuation of investments include each portfolio company's credit ratings/risk, current and projected earnings, current and expected leverage, ability to make interest and principal payments, liquidity, compliance with applicable loan covenants, and price to earnings (or other financial) ratios and those of comparable companies, as well as the estimated remaining life of the investment and current market yields and interest rate spreads of similar securities as of the measurement date. Other factors taken into account include changes in the interest rate environment and credit markets that may affect the price at which similar investments would trade. The Valuation Designee may also base its valuation of an investment on recent transactions of investments and securities with similar structure and risk characteristics. The Valuation Designee obtains market data from its ongoing investment purchase efforts, in addition to monitoring transactions that have closed or are discussed in industry publications. External information may include (but is not limited to) observable market data derived from the U.S. loan and equity markets. As part of compiling market data as an indication of current market conditions, management may utilize third-party sources.

The values assigned to investments are based on available information and may fluctuate from period to period. In addition, such values do not necessarily represent the amount that ultimately might be realized upon a portfolio investment's sale. Due to the inherent uncertainty of valuation, the estimated fair value of an investment may differ from the value that would have been used had a ready market for the security existed, and the difference could be material.

The Board is responsible for overseeing the Valuation Designee’s process for determining the fair value of the Company’s assets for which market quotations are not readily available, taking into account the Company’s valuation risks. To facilitate the Board’s oversight of the valuation process, the Valuation Designee provides the Board with quarterly reports, annual reports, and prompt reporting of material matters affecting the Valuation Designee’s determination of fair value. As part of the Board’s oversight role, the Board may request and review additional information to be informed of the Valuation Designee’s process for determining the fair value of the Company's investments.

Investment Transactions and Revenue Recognition

Investment transactions are recorded on the applicable trade date. Any amounts related to purchases, sales and principal paydowns that have traded, but not settled, are reflected as either a receivable for investments sold or payable for investments purchased on the consolidated statements of assets and liabilities. Realized gains or losses are measured by the difference between the net proceeds received and the cost basis of the investment using the specific identification method without regard to unrealized appreciation or depreciation previously recognized and are included as net realized gain (loss) on investments in the consolidated statements of operations. Net change in unrealized appreciation (depreciation) on investments is recognized in the consolidated statements of operations and reflects the period-to-period change in fair value and cost of investments, including the reversal of previously recorded unrealized appreciation or depreciation when gains or losses are realized.

Interest income, including amortization of premium and accretion of discount on loans, and expenses are recorded on the accrual basis. The Company accrues interest income if it expects that ultimately it will be able to collect such income.

The Company may have loans in its portfolio that contain payment-in-kind (“PIK”) income provisions. PIK represents interest that is accrued and recorded as interest income at the contractual rates, increases the loan principal on the respective capitalization dates, and is generally due at maturity. This non-cash source of income is included when determining what must be paid out to shareholders in the form of distributions in order for the Company to maintain its tax treatment as a RIC, even though the Company has not yet collected cash. For the three months ended March 31, 2024 and 2023, the Company earned $1,992 and $321, respectively, in PIK income provisions representing 3.86% and 0.95% of total investment income, respectively.

Dividend income on preferred equity securities is recorded on the accrual basis to the extent that such amounts are payable by the portfolio company and are expected to be collected. Dividend income on common equity securities is recorded on the record date for private portfolio companies or on the ex-dividend date for publicly traded portfolio companies. For the three months ended March 31, 2024 and 2023 the Company earned $308 and $16, respectively, of dividend income on its equity investments.

Other income may include income such as consent, waiver, amendment, unused, and prepayment fees associated with the Company’s investment activities, as well as any fees for managerial assistance services rendered by the Company to its portfolio companies. Such fees are recognized as income when earned or the services are rendered. For the three months ended March 31, 2024 and 2023 the Company earned other income of $217 and $236, respectively, primarily related to prepayment and amendment fees.

Loans are generally placed on non-accrual status when a payment default occurs or if management otherwise believes that the issuer of the loan will not be able to make contractual interest payments or principal payments. The Company will cease recognizing interest income on that loan until all principal and interest is current through payment or until a restructuring occurs, such that the interest income is deemed to be collectible. However, the Company remains contractually entitled to this interest. The Company may make exceptions to this policy if the loan has sufficient collateral value and is in the process of collection. Accrued interest is written-off when it becomes probable that the interest will not be collected and the amount of uncollectible interest can be reasonably estimated. When a PIK investment is placed on non-accrual status, the accrued, uncapitalized interest is generally reversed through PIK income. As of March 31, 2024, the Company had one portfolio company on non-accrual status with a fair value of $2,326 which represents approximately 0.13% of total investments at fair value. As of December 31, 2023, there were no portfolio companies on non-accrual.

Deferred Financing Costs

Deferred financing costs include capitalized expenses related to the closing or amendments of borrowings. Amortization of deferred financing costs is computed on the straight-line basis over the term of the borrowings. The unamortized balance of such costs is included as a direct deduction from the related liability in the accompanying consolidated statements of assets and liabilities. The amortization of such costs is included in interest and debt financing expenses in the accompanying consolidated statements of operations.

Offering Costs

Offering costs associated with the Private Offerings were recognized as a deferred charge on the consolidated statement of assets and liabilities and amortized on a straight-line basis over 12 months. These expenses consist primarily of legal fees and other costs incurred in connection with the Company’s continuous Private Offering of its shares. For the three months ended March 31, 2024 the Company did not incur any offering costs. For the three months ended March 31, 2023 the Company incurred offering costs of $15.

Deferred offering costs include registration expenses related to any shelf registration statement filed by the Company. These expenses consist primarily of SEC registration fees, legal fees and accounting fees incurred related thereto. Upon the completion of an equity offering or a debt offering, the deferred expenses are charged to additional paid-in capital or debt issuance costs, respectively. If there are any deferred offering costs remaining at the expiration of the shelf registration statement, these deferred costs are charged to expense. The Adviser paid the offering costs associated with the IPO on behalf of the Company. The Company is not obligated to repay any such offering costs paid by the Adviser.

Income Taxes

For U.S. federal income tax purposes, the Company has elected, and intends to qualify annually, to be treated as a RIC under the Code. In order to qualify as a RIC, the Company must meet certain minimum distribution, source-of-income and asset diversification requirements. If such requirements are met, then the Company is generally required to pay U.S. federal income taxes only on the portion of its taxable income and capital gains it does not distribute.

The minimum distribution requirements applicable to RICs require the Company to distribute to its shareholders at least 90% of its investment company taxable income (“ICTI”), as defined by the Code, each year. Depending on the level of ICTI earned in a tax year, the Company may choose to carry forward ICTI in excess of current year distributions into the next tax year. Any such carryover ICTI must be distributed before the end of that next tax year through a dividend declared prior to filing the final tax return related to the year which generated such ICTI.

In addition, based on the excise distribution requirements, the Company is subject to a 4% U.S. nondeductible federal excise tax on undistributed income unless the Company distributes in a timely manner an amount at least equal to the sum of (1) 98% of its ordinary income for each calendar year, (2) 98.2% of capital gain net income (both long-term and short-term) for the one-year period ended October 31 in that calendar year and (3) any income realized, but not distributed, in the preceding year. For this purpose, however, any ordinary income or capital gain net income retained by the Company that is subject to U.S. federal income tax at corporate rates is considered to have been distributed. The Company intends to timely distribute to our shareholders substantially all of our annual taxable income for each year, except that the Company may retain certain net capital gains for reinvestment and, depending upon the level of taxable income earned in a year, we may choose to carry forward ICTI for distribution in the following year and pay any applicable U.S. federal excise tax.

The Company evaluates tax positions taken or expected to be taken in the course of preparing its consolidated financial statements to determine whether the tax positions are “more-likely than not” to be sustained by the applicable tax authority. CLO-I, CLO-II, CLO-III, SPV IV and SPV V are disregarded entities for tax purposes and are consolidated with the tax return of the Company. NCDL Equity Holdings has elected to be classified as a corporation for U.S. federal income tax purposes. All penalties and interest associated with income taxes, if any, are included in income tax expense. For the three months ended March 31, 2024 and March 31, 2023, the Company did not incur any excise tax expense.

Dividends and Distributions to Common Shareholders

To the extent that the Company has taxable income, the Company intends to continue to make quarterly distributions to its common shareholders. Dividends and distributions to common shareholders are recorded on the applicable record date. The amount to be distributed to common shareholders is determined by the Board each quarter and is generally based upon the taxable earnings estimated by management and available cash. Net realized capital gains, if any, will generally be distributed at least annually, although the Company may decide to retain such capital gains for investment.

In connection with the IPO, the Board approved an amended and restated dividend reinvestment plan (the "Amended DRIP"), which became effective on January 29, 2024, concurrent with the consummation of the IPO.

The Amended DRIP changed the dividend reinvestment plan from an “opt in” dividend reinvestment plan to an “opt out” dividend reinvestment plan. As a result of the foregoing, if the Board authorizes, and the Company declares, a cash dividend or distribution, shareholders that acquired their shares in the IPO and do not “opt out” of the Amended DRIP will have their cash distributions automatically reinvested in additional shares rather than receiving cash. Notwithstanding the foregoing, a shareholder’s

election (or deemed election) under the dividend reinvestment plan, dated December 19, 2019, will remain in effect for such shareholder and no further action is required by such shareholder with respect to their election under the Amended DRIP.

With respect to each distribution under the Amended DRIP, the Board reserves the right to either issue new shares of common stock or purchase shares of common stock in the open market for the accounts of participants in the Amended DRIP. If newly issued shares are used to implement the Amended DRIP, the number of shares to be issued to a shareholder will be determined by dividing the total dollar amount of the distribution payable to such participant by the market price per share of the Company's common stock at the close of regular trading of the NYSE on the distribution payment date, or if no sale is reported for such day, the average of the reported bid and asked prices. However, if the market price per share on the distribution payment date exceeds the most recently computed net asset value ("NAV") per share, the Company will issue shares at the greater of (i) the most recently computed NAV per share and (ii) 95% of the current market price per share (or such lesser discount to the current market price per share that still exceeds the most recently computed NAV per share). If shares are purchased in the open market to implement the Amended DRIP, the number of shares to be issued to a participant will be determined by dividing the dollar amount of the distribution payable to such participant by the weighted average price per share for all shares of common stock purchased by the plan administrator in the open market in connection with the dividend or distribution. Although each participant may from time to time have an undivided fractional interest in a share, no certificates for a fractional share will be issued. However, dividends and distributions on fractional shares will be credited to each participant’s account.

Functional Currency

The functional currency of the Company is the U.S. Dollar and all transactions were in U.S. Dollars.

XML

INVESTMENTS

3 Months Ended

Mar. 31, 2024

Investments, Debt and Equity Securities [Abstract]

INVESTMENTS

INVESTMENTS

As of March 31, 2024 and December 31, 2023, our investments consisted of the following (dollar amounts in thousands):

	March 31, 2024						December 31, 2023
	Amortized Cost		Fair Value		% of Fair Value		Amortized Cost		Fair Value		% of Fair Value
First-Lien Term Loans	$	1,610,637	$	1,596,352	88.95	%	$	1,450,120	$	1,427,492	86.95	%
Subordinated Debt1	$	178,330	$	166,502	9.28	%	190,454		183,387		11.17	%
Equity Investments	$	26,018	$	31,705	1.77	%	25,595		30,807		1.88	%
Total	$	1,814,985	$	1,794,559	100.00	%	$	1,666,169	$	1,641,686	100.00	%

_____________________

1As of March 31, 2024, Subordinated Debt is comprised of second lien term loans and/or second lien notes of $84,676, mezzanine debt of $81,113 and $713 of structured debt at fair value and second lien term loans and/or second lien notes of $88,879, mezzanine debt of $86,199 and $3,252 of structured debt at amortized cost.

As of December 31, 2023, Subordinated Debt is comprised of second lien term loans and/or second lien notes of $97,203, mezzanine debt of $83,528 and $2,656 of structured debt at fair value and second lien term loans and/or second lien notes of $100,711, mezzanine debt of $86,495 and $3,247 of structured debt at amortized cost.

The industry composition of our portfolio as a percentage of fair value as of March 31, 2024 and December 31, 2023 was as follows:

Industry	March 31, 2024		December 31, 2023
Aerospace & Defense	3.07	%	3.13	%
Automotive	3.84	%	4.95	%
Banking, Finance, Insurance, Real Estate	3.60	%	3.95	%
Beverage, Food & Tobacco	7.30	%	7.76	%
Capital Equipment	4.62	%	4.21	%
Chemicals, Plastics, & Rubber	1.61	%	2.29	%
Construction & Building	4.50	%	3.90	%
Consumer Goods: Durable	1.05	%	1.51	%
Consumer Goods: Non-durable	3.29	%	3.31	%
Containers, Packaging & Glass	3.89	%	3.97	%
Energy: Electricity	1.61	%	1.75	%
Environmental Industries	3.16	%	2.73	%
Healthcare & Pharmaceuticals	11.91	%	12.72	%
High Tech Industries	10.64	%	8.97	%
Media: Advertising, Printing & Publishing	1.04	%	1.12	%
Media: Diversified & Production	0.87	%	0.96	%
Retail	0.32	%	0.35	%
Services: Business	19.03	%	18.43	%
Services: Consumer	4.98	%	4.86	%
Sovereign & Public Finance	0.76	%	0.65	%
Telecommunications	2.91	%	3.17	%
Transportation: Cargo	3.03	%	3.20	%
Transportation: Consumer	0.70	%	0.13	%
Utilities: Electric	0.81	%	0.89	%
Utilities: Water	0.46	%	—	%
Wholesale	1.00	%	1.09	%
Total	100.00	%	100.00	%

The geographic composition of investments at cost and fair value was as follows:

	March 31, 2024
	Cost	Fair Value	% of Total Investments at Fair Value		Fair Value as % of Net Assets
USA	1,762,869	1,742,508	97.10	%	174.56	%
Canada	38,401	38,391	2.14	%	3.85	%
United Kingdom	13,715	13,660	0.76	%	1.37	%
	1,814,985	1,794,559	100.00	%	179.78	%

	December 31, 2023
	Cost	Fair Value	% of Total Investments at Fair Value		Fair Value as % of Net Assets
USA	1,613,815	1,589,384	96.82	%	212.52	%
Canada	38,462	38,292	2.33	%	5.12	%
United Kingdom	13,892	14,010	0.85	%	1.87	%
	1,666,169	1,641,686	100.00	%	219.51	%

As of March 31, 2024 and December 31, 2023, on a fair value basis, 94.69% and 94.61%, respectively, of the Fund’s debt investments bore interest at a floating rate and 5.31% and 5.39%, respectively, of the Fund’s debt investments bore interest at a fixed rate.

XML

FAIR VALUE MEASUREMENTS

3 Months Ended

Mar. 31, 2024

Fair Value Disclosures [Abstract]

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS

Fair Value Disclosures

The following tables present fair value measurements of investments, by major class, and cash equivalents as of March 31, 2024 and December 31, 2023, according to the fair value hierarchy:

As of March 31, 2024	Level 1		Level 2		Level 3		Total
Assets:
First Lien Term Loans	$	—	$	30,955	$	1,565,397	$	1,596,352
Subordinated Debt 1	—		—		166,502		166,502
Equity Investments	—		—		31,705		31,705
Cash Equivalents	52,773		—		—		52,773
Total	$	52,773	$	30,955	$	1,763,604	$	1,847,332

_____________________

1 Subordinated Debt is further comprised of second lien term loans and/or second lien notes of $84,676, mezzanine debt of $81,113 and $713 of structured debt.

As of December 31, 2023	Level 1		Level 2		Level 3		Total
Assets:
First Lien Term Loans	$	—	$	34,481	$	1,393,011	$	1,427,492
Subordinated Debt 1	—		8,691		174,696		183,387
Equity Investments	—		—		30,807		30,807
Cash Equivalents	64,477		—		—		64,477
Total	$	64,477	$	43,172	$	1,598,514	$	1,706,163

_____________________

1 Subordinated Debt is further comprised of second lien term loans and/or second lien notes of $97,203, mezzanine debt of $83,528 and $2,656 of structured debt.

The following tables provide a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the three months ended March 31, 2024 and the year ended December 31, 2023:

	First Lien Term Loans		Subordinated Debt		Equity Investments		Total
Balance as of December 31, 2023	$	1,393,011	$	174,696	$	30,807	$	1,598,514
Purchase of investments	196,582		855		496		197,933
Proceeds from principal repayments and sales of investments	(39,657)		(6,082)		(73)		(45,812)
Payment-in-kind interest	260		1,732		—		1,992
Amortization of premium/accretion of discount, net	833		164		—		997
Net realized gain (loss) on investments	(3,830)		140		—		(3,690)
Net change in unrealized appreciation (depreciation) on investments	8,373		(5,003)		475		3,845
Transfers to Level 3 (1)	9,825		—		—		9,825
Balance as of March 31, 2024	$	1,565,397	$	166,502	$	31,705	$	1,763,604
Net change in unrealized appreciation (depreciation) on non-controlled/non-affiliated company investments still held as of March 31, 2024	$	4,445	$	(5,003)	$	475	$	(83)

_______________

(1)Transfers between levels, if any, are recognized at the beginning of the period in which the transfers occur. For the three months ended March 31, 2024, transfers into Level 3 from Level 2 were a result of changes in the observability of significant inputs for certain portfolio companies.

	First Lien Term Loans		Subordinated Debt		Equity Investments		Total
Balance as of December 31, 2022	$	1,016,856	$	133,243	$	27,313	$	1,177,412
Purchase of investments	513,487		65,296		9,110		587,893
Proceeds from principal repayments and sales of investments	(118,469)		(14,915)		(8,667)		(142,051)
Payment-in-kind interest	221		3,047		—		3,268
Amortization of premium/accretion of discount, net	1,386		426		833		2,645
Net realized gain (loss) on investments	(14,339)		238		6,112		(7,989)
Net change in unrealized appreciation (depreciation) on investments	8,871		(4,191)		(3,894)		786
Transfers out of Level 3 (1)	(23,350)		(8,448)		—		(31,798)
Transfers to Level 3 (1)	8,348		—		—		8,348
Balance as of December 31, 2023	$	1,393,011	$	174,696	$	30,807	$	1,598,514
Net change in unrealized appreciation (depreciation) on non-controlled/non-affiliated company investments still held as of December 31, 2023	$	364	$	(4,167)	$	2,154	$	(1,649)

_______________

(1)Transfers between levels, if any, are recognized at the beginning of the period in which the transfers occur. For the year ended December 31, 2023, transfers into Level 3 from Level 2 were a result of changes in the observability of significant inputs for certain portfolio companies.

Significant Unobservable Inputs

ASC Topic 820 requires disclosure of quantitative information about the significant unobservable inputs used in the valuation of assets and liabilities classified as Level 3 within the fair value hierarchy. The valuation techniques and significant unobservable inputs used in Level 3 fair value measurements of assets as of March 31, 2024 and December 31, 2023 were as follows:

Investment Type	Fair Value at March 31, 2024		Valuation Techniques	Unobservable Inputs	Ranges				Weighted Average
First Lien Term Loans	$	1,400,517	Yield Method	Market Yield Discount Rates	8.58	%	20.85	%	10.80	%
First Lien Term Loans	22,199		Market Approach	EBITDA Multiple	6.50x		13.00x		9.37x
First Lien Term Loans	142,681		Recent Transactions	Transaction Price	99.00		100.69		99.56
Subordinated Debt	151,676		Yield Method	Market Yield Discount Rates	12.18	%	24.91	%	15.30	%
Subordinated Debt	2,326		Black-Scholes	EBITDA Multiple	11.50x		11.50x		11.50x
Subordinated Debt	12,500		Recent Transaction	Transaction Price	100.00		100.00		100.00
Equity	161		Yield Method	Market Yield Discount Rates	8.36	%	8.36	%	8.36	%
Equity	31,066		Market Approach	EBITDA Multiple	5.75x		20.00x		11.32x
Total	$	1,763,126

Equity investments in the amount of $478 at March 31, 2024 have been excluded from the table above as the investments are valued using a recent transaction.

Investment Type	Fair Value at December 31, 2023		Valuation Techniques	Unobservable Inputs	Ranges				Weighted Average
First Lien Term Loans	$	1,192,190	Yield Method	Market Yield Discount Rates	6.13	%	18.73	%	10.63	%
First Lien Term Loans	19,519		Market Approach	EBITDA Multiple	6.50x		9.25x		7.21x
First Lien Term Loans	181,302		Recent Transactions	Transaction Price	59.50		100.00		97.52
Subordinated Debt	162,646		Yield Method	Market Yield Discount Rates	9.70	%	24.91	%	14.44	%
Subordinated Debt	12,050		Recent Transaction	Transaction Price	84.75		98.01		89.53
Equity	158		Yield Method	Market Yield Discount Rates	8.36	%	8.36	%	8.36	%
Equity	29,390		Market Approach	EBITDA Multiple	6.50x		19.50x		10.96x
Equity	2		Market Approach	Blended EBITDA Multiple	13.25x		13.25x		13.25x
				Blended Revenue Multiple	1.40x		1.40x		1.40x
Total	$	1,597,257

Equity investments in the amount of $1,257 at December 31, 2023 have been excluded from the table above as the investments are valued using a recent transaction.

Debt investments are generally valued using a yield analysis. In a yield analysis, a price is ascribed for each investment based upon an assessment of current and expected market yields for similar investments and risk profiles. Additional consideration is given to the expected life, portfolio company performance since close, and other terms and risks associated with an investment. Among other factors, a determinant of risk is the amount of leverage used by the portfolio company relative to its total enterprise value, and the rights and remedies of the Company’s investment within the portfolio company’s capital structure. A recent market trade, if applicable, will also be factored into the valuation.

Equity investments are generally valued using a market approach, which utilizes market value multiples (EBITDA or revenue) of publicly traded comparable companies and available precedent sales transactions of comparable companies. The selected multiple is used to estimate the enterprise value of the underlying investment.

The significant unobservable input used in the yield method is a discount rate based on comparable market yields. Significant increases in discount rates in isolation would result in a significantly lower fair value measurement. The significant unobservable input used in the market approach is the performance multiple, which may include a revenue multiple, EBITDA multiple, or forward-looking metrics. The multiple is used to estimate the enterprise value of the underlying investment. An increase or decrease in the multiple would result in an increase or decrease, respectively, in the fair value. A recent transaction, if applicable, may also be factored into the valuation if the transaction price is believed to be an indicator of value.

Alternative valuation methodologies may be used as deemed appropriate for debt or equity investments, and may include, but are not limited to, a market analysis, income analysis, or liquidation (recovery) analysis.

Weighted average inputs are calculated based on the relative fair value of the investments.

Financial Instruments disclosed but not carried at fair value

The fair value of the Company's credit facilities, which would be categorized as Level 3 within the fair value hierarchy approximates their carrying values. These fair value measurements were based on significant inputs not observable and thus represent Level 3 measurements. The fair value of the 2022 Debt, the 2023 Debt and the 2024 Debt (as defined in Note 6) was based on market quotations(s) received from broker/dealer(s). These fair value measurements were based on quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly and thus represent Level 2 measurements. The carrying value and fair value of the Company’s debt obligations were as follows:

	March 31, 2024				December 31, 2023
	Carrying Value (1)		Fair Value		Carrying Value (1)		Fair Value
Wells Fargo Financing Facility	$	2,500	$	2,500	$	231,000	$	231,000
SMBC Financing Facility	39,000		39,000		37,377		37,377
Revolving Credit Facility	12,000		12,000		126,500		126,500
2022 Debt	342,000		340,307		342,000		338,345
2023 Debt	215,000		217,026		215,000		213,976
2024 Debt	215,000		215,501		—		—
Total	$	825,500	$	826,334	$	951,877	$	947,198

_______________

(1)Carrying value on the consolidated statements of assets and liabilities are net of deferred financing costs.

XML

RELATED PARTY TRANSACTIONS

3 Months Ended

Mar. 31, 2024

Related Party Transactions [Abstract]

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS

Advisory Agreements

On December 31, 2019, immediately prior to its election to be regulated as a BDC, the Company entered into the investment advisory agreement with the Adviser. The Board, including all of the directors who are not “interested persons” (as defined in the 1940 Act) of the Company (the “Independent Directors”), approved the investment advisory agreement in accordance with, and on the basis of an evaluation satisfactory to such directors as required by, the 1940 Act. On January 29, 2024, the Company entered into an amended and restated investment advisory agreement (the “Advisory Agreement”), which became effective upon the consummation of the IPO on January 29, 2024.

On December 31, 2019, immediately prior to the Company’s election to be regulated as a BDC, the Adviser entered into an investment sub-advisory agreement with Churchill, which was subsequently amended and restated on December 11, 2020, October 7, 2021 and March 8, 2022 (the “CAM Sub-Advisory Agreement”). The Adviser has delegated substantially all of its day-to-day portfolio-management obligations under the Advisory Agreement to Churchill pursuant to the CAM Sub-Advisory Agreement. The Adviser has general oversight over the investment process on behalf of the Company and manages the capital structure of the Company, including, but not limited to, asset and liability management. The Adviser also has ultimate responsibility for the Company’s performance under the terms of the Advisory Agreement. The Adviser retains 32.5% of the management fee and incentive fee payable by the Company. The remaining amount will be paid by the Adviser to Churchill as compensation for services provided by Churchill pursuant to the CAM Sub-Advisory Agreement.

On January 29, 2024, the Adviser and Churchill entered into an investment sub-advisory agreement with Nuveen Asset Management (the “NAM Sub-Advisory Agreement”, and together with the Advisory Agreement and the CAM Sub-Advisory Agreement, the “Advisory Agreements”), pursuant to which Nuveen Asset Management may manage a portion of the Company’s portfolio consisting of cash and cash equivalents, liquid fixed-income securities (including broadly syndicated loans) and other liquid credit instruments (“Liquid Investments”), subject to the pace and amount of investment activity in the middle market investment program. The Company typically refers to an investment as liquid if the investment is, or we expect it to be, actively traded (with a typical settlement period of one month with respect to broadly syndicated loans). The percentage of the Company’s portfolio allocated to the Liquid Investments strategy managed by Nuveen Asset Management will be at the discretion of Churchill. The fees payable to Nuveen Asset Management pursuant to the NAM Sub-Advisory Agreement to manage the Company’s Liquid Investment allocation will be payable by Churchill and will not impact the advisory fees payable by the Company’s shareholders. Churchill will pay Nuveen Asset Management monthly in arrears, 0.375% of the daily weighted average principal amount of the Liquid Investments managed by Nuveen Asset Management pursuant to the NAM Sub-Advisory Agreement. The fees payable to Nuveen Asset Management pursuant to the NAM Sub-Advisory Agreement will not impact the advisory fees payable by the Company's shareholders.

Advisory agreements remain in effect for an initial period of two years and will remain in effect on a year-to-year basis thereafter if approved annually either by the Board or by the affirmative vote of the holders of a majority of our outstanding voting securities and, in each case, a majority of our Independent Directors. On October 27, 2023, the Board, including all of the Independent Directors, approved the Advisory Agreement and the NAM Sub-Advisory Agreement in accordance with, and on the basis of an evaluation satisfactory to such directors as required by, the 1940 Act for an initial two-year term expiring on January 29, 2026. In addition, on October 27, 2023, the Board, including all of the Independent Directors, approved the renewal of the CAM Sub-Advisory Agreement in accordance with, and on the basis of an evaluation satisfactory to such directors as required by, the 1940 Act for an additional one-year term expiring on December 31, 2024. Each Advisory Agreement will automatically terminate in the event of its assignment, as defined in the 1940 Act, by the applicable investment adviser and may be terminated by either the Company or the applicable investment adviser without penalty upon not less than 60 days’ written notice to the other. The holders of a majority of our outstanding voting securities may also terminate any of the Advisory Agreements without penalty.

Compensation of the Adviser - Management Fee

Under the Advisory Agreement, for the first five quarters beginning with the calendar quarter in which the IPO was consummated (i.e., beginning with the calendar quarter ended March 31, 2024 through the calendar quarter ending March 31, 2025), the management fee is calculated at an annual rate of 0.75% of average total assets, excluding cash and cash equivalents and including assets financed using leverage (“Average Total Assets”), at the end of the two most recently completed calendar quarters, and thereafter, the management fee will step up to 1.00% of Average Total Assets. For purposes of this calculation, cash and cash equivalents include any temporary investments in cash-equivalents, U.S. government securities and other high quality investment grade debt investments that mature in 12 months or less from the date of investment. Any management fees will be payable quarterly in arrears.

Compensation of the Adviser - Incentive Fee

Under the Advisory Agreement, the Adviser is waiving the incentive fee on income and incentive fee on capital gains for the first five quarters beginning with the calendar quarter in which the IPO was consummated (i.e., beginning with the calendar quarter ended March 31, 2024 through the calendar quarter ending March 31, 2025). Following the expiration of the fee waiver, the Company will pay an incentive fee to the Adviser that will consist of two parts. The incentive fees will be based on income and capital gains, each as described below. The portion of the incentive fee based on income will be calculated, subject to a cap (the “Incentive Fee Cap”), and payable quarterly in arrears based on pre-incentive fee net investment income in respect of the current calendar quarter and the eleven preceding calendar quarters (or, if fewer, the number of calendar quarters beginning with the calendar quarter in which the IPO was consummated) (such period, the “Trailing Twelve Quarters”) commencing from the beginning of the calendar quarter in which the IPO was consummated, as follows:

•no incentive fee in any calendar quarter in which the aggregate pre-incentive fee net investment income (as defined below) in respect of the Trailing Twelve Quarters does not exceed the hurdle rate of 1.50% (6% annually) for such Trailing Twelve Quarters;

•100% of our aggregate pre-incentive fee net investment income in respect of the Trailing Twelve Quarters with respect to that portion of such pre-incentive fee net investment income, if any, that exceeds the hurdle rate but is less than 1.7647% in any calendar quarter following the consummation of the IPO. The Company refers to this portion of the pre-incentive fee net investment income as the “catch-up” provision. The catch-up is meant to provide the Adviser with 15% of the pre-incentive fee net investment income as if a hurdle rate did not apply if this net investment income exceeds 1.7647% multiplied by our NAV at the beginning of each applicable calendar quarter comprising of the relevant Trailing Twelve Quarters; and

•15% of the aggregate pre-incentive fee net investment income, if any, in respect of the Trailing Twelve Quarters that exceeds 1.7647%.

Under the Advisory Agreement, following the expiration of the fee waiver, the incentive fee on income for a particular quarter will be subject to the Incentive Fee Cap. The Incentive Fee Cap will be equal to the difference between (x) 15% of the Cumulative Pre-Incentive Fee Net Return (as defined below) over the Trailing Twelve Quarters and (y) the aggregate incentive fee on income that was paid to the Adviser by the Company in respect of the first eleven calendar quarters (or, if fewer, the number of calendar quarters beginning with the calendar quarter in which the IPO was consummated) included in the relevant Trailing Twelve Quarters. These calculations will be adjusted for any share issuances or repurchases during the applicable calendar quarter.

“Cumulative Pre-Incentive Fee Net Return” during the relevant Trailing Twelve Quarters, beginning with the calendar quarter in which the IPO was consummated, means (x) the pre-incentive fee net investment income in respect of the relevant Trailing Twelve Quarters less (y) any Net Capital Loss (as defined below), if any, in respect of the relevant Trailing Twelve Quarters. If, in any quarter, the Incentive Fee Cap is zero or a negative value, the Company will pay no incentive fee on income to the Adviser in respect of that quarter. If, in any quarter, the Incentive Fee Cap for such quarter is a positive value but is less than the incentive fee on income that is payable to the Adviser for such quarter calculated as described above, the Company will pay an incentive fee on income to the Adviser equal to the Incentive Fee Cap in respect of such quarter. If, in any quarter, the Incentive Fee Cap for such quarter is equal to or greater than the incentive fee on income that is payable to the Adviser for such quarter calculated as described above, the Company will pay an incentive fee on income to the Adviser equal to the incentive fee calculated as described above for such quarter without regard to the Incentive Fee Cap.

“Net Capital Loss” in respect of a particular period, beginning with the calendar quarter in which the IPO was consummated, means the difference, if positive, between (i) aggregate capital losses, whether realized or unrealized, in respect of such period and (ii) aggregate capital gains, whether realized or unrealized, in respect of such period.

Pre-incentive fee net investment income means interest income, dividend income and any other income (including any other fees such as commitment, origination, structuring, diligence and consulting fees or other fees that the Company receives from portfolio companies but excluding fees for providing managerial assistance) accrued during the relevant calendar quarters, minus operating expenses for the relevant calendar quarters (including the management fee, any expenses payable under the Administration Agreement (as defined below), interest expense and dividends paid on any outstanding preferred shares, but excluding the incentive fee). Pre-incentive fee net investment income will include, in the case of investments with a deferred interest feature such as market discount, debt instruments with PIK interest, preferred shares with PIK dividends and zero-coupon securities, accrued income that the Company has not yet received in cash. The Adviser is not under any obligation to reimburse the Company for any part of the incentive fee it received that was based on accrued interest that the Company never received. Pre-incentive fee net investment income will not include any realized capital gains, realized capital losses or unrealized capital gains or losses. If any distributions from portfolio companies are characterized as a return of capital, such returns of capital would affect the capital gains incentive fee to the extent a gain or loss is realized.

Under the Advisory Agreement, following the expiration of the fee waiver, the second part of the incentive fee will be a capital gains incentive fee that will be determined and payable in arrears as of the end of each fiscal year (or upon termination of the Advisory Agreement, as of the termination date), and equals 15.0% of our realized capital gains as of the end of the fiscal year following the IPO. In no event will the capital gains incentive fee payable pursuant to the Advisory Agreement be in excess of the amount permitted by the Advisers Act, including Section 205 thereof.

In determining the capital gains incentive fee payable to the Adviser, the Company will calculate the cumulative aggregate realized capital gains and cumulative aggregate realized capital losses beginning with the calendar quarter in which the IPO was consummated, and the aggregate unrealized capital depreciation as of the date of the calculation, as applicable, with respect to each of the investments in our portfolio. For this purpose, cumulative aggregate realized capital gains, if any, equals the sum of the differences between the net sales price of each investment, when sold, and the amortized cost of such investment. Cumulative aggregate realized capital losses equals the sum of the amounts by which the net sales price of each investment, when sold, is less than the amortized cost of such investment beginning with the calendar quarter in which this offering is consummated. Aggregate unrealized capital depreciation equals the sum of the difference, if negative, between the valuation of each investment as of the applicable calculation date and the amortized cost of such investment. At the end of the applicable year, the amount of capital gains that will serve as the basis for the calculation of the capital gains incentive fee equals the cumulative aggregate realized capital gains less cumulative aggregate realized capital losses, less aggregate unrealized capital depreciation, with respect to our portfolio of investments.

For the three months ended March 31, 2024 and 2023 base management fees were $3,264 and $2,306, respectively. As of March 31, 2024 and December 31, 2023, $3,264 and $3,006, respectively, of such base management fees, were unpaid and are included in management fees payable in the accompanying consolidated statements of assets and liabilities. As of March 31, 2024, income based incentive fees of $4,459, were waived in accordance with the terms of the Advisory Agreement. As of March 31, 2024, no amounts were payable to the Adviser related to income based incentive fees. As of December 31, 2023, the Adviser was not entitled to any incentive fees under the Advisory Agreement.

Administration Agreement

On December 31, 2019, the Company entered into an administration agreement (the "Administration Agreement"), which was approved by the Board. Pursuant to the Administration Agreement, the Administrator furnishes the Company with office facilities and equipment and provides clerical, bookkeeping and record keeping and other administrative services at such facilities. The Administrator performs, or oversees the performance of, the required administrative services, which include, among other things, assisting the Company with the preparation of the financial records that the Company is required to maintain and with the preparation of reports to shareholders and reports filed with the SEC. At the request of the Adviser or Churchill, the Administrator also may provide significant managerial assistance on the Company’s behalf to those portfolio companies that have accepted the Company’s offer to provide such assistance. U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), provides the Company with certain fund administration and bookkeeping services pursuant to a sub-administration agreement with the Administrator.

For the three months ended March 31, 2024 and 2023 the Company incurred $542 and $309, respectively, in fees under the Administration Agreement, which are included in administration fees in the accompanying consolidated statements of operations. As of March 31, 2024 and December 31, 2023, fees of $961 and $505, respectively, were unpaid and included in accounts payable and accrued expenses in the accompanying consolidated statements of assets and liabilities.

Expense Support Agreement

On December 31, 2019, the Company entered into an expense support and conditional reimbursement agreement (the “Expense Support Agreement”) with the Adviser. The Expense Support Agreement automatically terminated pursuant to its terms upon the consummation of the IPO on January 29, 2024. Under the Expense Support Agreement, the Adviser was able to pay certain expenses of the Company, provided that no portion of the payment was used to pay any interest expense of the Company (each, an “Expense Payment”). Such Expense Payment was made in any combination of cash or other immediately available funds no later than forty-five days after a written commitment from the Adviser to pay such expense, and/or by an offset against amounts due from the Company to the Adviser or its affiliates. The cumulative amount of expense payments by the Adviser under the Expense Support Agreement was $2,979, of which $1,101 was reimbursed by the Company prior to the termination of the Expense Support Agreement.

Directors' Fees

The Board consists of seven members, five of whom are Independent Directors. The Board established an Audit Committee, a Nominating and Corporate Governance Committee, a Compensation Committee, and a Special Transactions Committee, each consisting solely of the Independent Directors, and may establish additional committees in the future. For the three months ended March 31, 2024 and 2023 the Company incurred $128 and $96 respectively, in fees which are included in Directors’ fees in the accompanying consolidated statements of operations. As of March 31, 2024 and December 31, 2023, $128 and $96, respectively, were unpaid and are included in Directors’ fees payable in the accompanying consolidated statements of assets and liabilities.

Other Related Party Transactions

From time to time, Churchill, in its capacity as sub-adviser, and the Administrator may pay amounts owed by the Company to third-party providers of goods or services and the Company will subsequently reimburse Churchill and Administrator for such amounts paid on its behalf. Amounts payable to Churchill and Administrator are settled in the normal course of business without formal payment terms. As of March 31, 2024 and December 31, 2023, the Company owed Churchill and the Administrator $904 and $353 for reimbursements including the Company's allocable portion of overhead, which are included in accounts payable and accrued expenses in the accompanying consolidated statements of assets and liabilities.

XML

SECURED BORROWINGS

3 Months Ended

Mar. 31, 2024

Debt Disclosure [Abstract]

SECURED BORROWINGS

SECURED BORROWINGS

The Company, CLO-I, CLO-II, CLO-III, SPV IV and SPV V are party to credit facilities or debt obligations as described below. In accordance with the 1940 Act, the Company is currently only allowed to borrow amounts such that its asset coverage, as defined in the 1940 Act, is maintained at a level of at least 150% after such borrowings. As of March 31, 2024 and December 31, 2023, asset coverage was 220.92% and 178.57%, respectively. Proceeds of the credit facilities or debt obligations are used for general corporate purposes, including the funding of portfolio investments. The Company, CLO-I, CLO-II, CLO-III, SPV IV and SPV V were in compliance with all covenants and other requirements of their respective agreements.

Subscription Facility

On September 10, 2020, the Company entered into a revolving credit agreement (the “Subscription Facility Agreement” and the facility thereunder, the “Subscription Facility”) with Sumitomo Mitsui Banking Corporation (“SMBC”), as the administrative agent for certain secured parties, the syndication agent, the lead arranger, the book manager, the letter of credit issuer and the lender. The Subscription Facility had a maximum commitment of $50,000, subject to availability under the "Borrowing Base." The Borrowing Base was calculated based on the unfunded capital commitments of certain investors that had subscribed to purchase shares of the Company, to the extent the capital commitments of such investors also had been approved by SMBC for inclusion in the Borrowing base and met certain additional criteria. The Subscription Facility Agreement expired on September 8, 2023, and the Company fully paid down the outstanding balance including the accrued interest expense.

Wells Fargo Financing Facility

On December 31, 2019, a wholly owned subsidiary of the Company entered into a credit agreement ("the “Wells Fargo Financing Facility” and the agreement relating thereto, as amended from time to time, the “Wells Fargo Financing Facility Agreement”), with Wells Fargo Bank, N.A. as lender (“Wells Fargo”) and administrative agent. The Wells Fargo Financing Facility Agreement was amended on October 28, 2020, March 31, 2022 and March 14, 2024. The most recent amendment on March 14, 2024, among other things: (i) added SPV V as a party to the facility and (ii) decreased the maximum facility amount available from $275,000 to $150,000, which facility amount may be increased, with the consent of the administrative agent and each applicable lender, to up to $250,000 during the reinvestment period.

The Wells Fargo Financing Facility reinvestment period expires on March 31, 2025 and has a maturity date of March 31, 2027. The Wells Fargo Financing Facility Agreement also requires the Company to maintain an asset coverage ratio equal to at least 1.50:1.00. The amount of the borrowings under the Wells Fargo Financing Facility equals the amount of the outstanding advances. Advances under the Wells Fargo Financing Facility may be prepaid and reborrowed at any time during the reinvestment period, but any termination or reduction of the facility amount prior to the first anniversary of the date of the amendment (subject to certain exceptions) is subject to a commitment reduction fee of 1%. Under the Wells Fargo Financing Facility Agreement, the Company pays a fee on daily undrawn amounts under the Wells Fargo Financing Facility of 0.25% per annum during the period ending June 14, 2024, 0.50% per annum for the next six months and thereafter, 0.50% per annum on undrawn amounts of up to 40% of the maximum facility amount and 1.50% per annum on undrawn amounts in excess of 40% of the maximum facility amount.

As of March 31, 2024 and December 31, 2023, the Wells Fargo Financing Facility bore interest at a rate of SOFR, reset daily plus 2.20%, per annum.

SPV V, beginning March 14, 2024, has pledged all of its assets to the collateral agent to secure their obligations under the Wells Fargo Financing Facility. The Company and SPV V have made customary representations and warranties and are required to comply with various financial covenants related to liquidity and other maintenance covenants, reporting requirements and other customary requirements for similar facilities.

SMBC Financing Facility

On November 24, 2020, a wholly owned subsidiary of the Company entered into a senior secured revolving credit facility (the “SMBC Financing Facility” and the agreement relating thereto the “SMBC Financing Facility Agreement”) with SMBC, as the administrative agent, the collateral agent and the lender. On October 19, 2023, SPV IV entered into the borrower joinder agreement (the “SMBC Joinder”) to become party to the SMBC Financing Facility Agreement.

The SMBC Financing Facility Agreement was amended on December 23, 2021, June 29, 2022 and November 21, 2023. The most recent amendment on November 21, 2023 (the "SMBC Financing Facility Amendment"), among other things: (i) extended the reinvestment period from November 24, 2023 to November 24, 2024 and the stated maturity date from November 24, 2025 to November 24, 2026; (ii) changed the interest rate for loans under the SMBC Financing Facility Agreement from (A) either the Base Rate (as defined in the SMBC Financing Facility Agreement) plus 1.15% or the Term SOFR (as defined in the SMBC Financing Facility Agreement) plus 2.15% to (B) either the Base Rate plus 1.65% or Term SOFR plus 2.65%; (iii) reduced the maximum facility amount from $300,000 to $150,000 upon the occurrence of a permitted securitization, subject to a subsequent increase to $250,000, in the sole discretion of the administrative agent, if so requested by the borrowers; and (iv) provide for an unused commitment fee of, from the three month anniversary of the SMBC Financing Facility Amendment date to the six month anniversary of the SMBC Financing Facility Amendment date, 0.50% per annum on the unused commitments and on or after the six month anniversary of the Amendment date, 0.50% per annum on the unused commitments if such unused commitments are less than 50% of the total commitments and 1.00% per annum on the unused commitments if such unused commitments are greater than or equal to 50% of the total commitments. In connection with the SMBC Financing Facility Amendment, the borrowers paid an extension fee of $450 plus an annualized fee of 0.30% multiplied by $150,000 based on the length of time (in years) until the occurrence of a permitted securitization. Advances under the SMBC Financing Facility Agreement may be prepaid and reborrowed at any time during the reinvestment period. As of March 31, 2024 and December 31, 2023, the SMBC Financing Facility bore interest at one-month SOFR plus 2.65% per annum.

Effective December 7, 2023, following the closing of the 2023 Debt Securitization (discussed further below), the maximum facility amount available was reduced to $150,000 from $300,000 and SPV IV began borrowing under the SMBC Financing Facility.

SPV IV, beginning October 19, 2023, has pledged all of its assets to the collateral agent to secure their obligations under the SMBC Financing Facility. The Company, and SPV IV have made customary representations and warranties and are required to comply with various financial covenants related to liquidity and other maintenance covenants, reporting requirements and other customary requirements for similar facilities.

Revolving Credit Facility

On June 23, 2023, the Company entered into a senior secured revolving credit agreement (the “Senior Secured Revolving Credit Agreement" and facility thereunder, the “Revolving Credit Facility”) with SMBC as the lender, administrative agent, and one of the lead arrangers along with Wells Fargo. The Revolving Credit Facility is guaranteed by NCDL Equity Holdings and will be guaranteed by certain subsidiaries of the Company that are formed or acquired by the Company in the future (collectively, the “Guarantors”).

The initial maximum principal amount of the Revolving Credit Facility is $185,000, subject to availability under the borrowing base, which is based on the Company’s portfolio investments and other outstanding indebtedness. Maximum capacity under the Revolving Credit Facility may be increased to $300,000 through the exercise by the Company of an uncommitted accordion feature through which existing and new lenders may, at their option, agree to provide additional financing. The Revolving Credit Facility is secured by a perfected first-priority interest in substantially all of the portfolio investments held by the Company and each Guarantor, subject to certain exceptions, and includes a $25,000 limit for swingline loans.

The availability period under the Revolving Credit Facility will terminate on June 23, 2027 (the “Commitment Termination Date”) and will mature on June 23, 2028 (the “Final Maturity Date”). During the period from the Commitment Termination Date to the Final Maturity Date, the Company will be obligated to make mandatory prepayments out of the proceeds of certain asset sales and other recovery events and equity and debt issuances.

The Company may borrow amounts in U.S. dollars or certain other permitted currencies. Amounts drawn in U.S. dollars will bear interest at either term SOFR plus a margin, or the prime rate plus a margin. The Company may elect either the term SOFR or prime rate at the time of drawdown, and loans denominated in U.S. dollars may be converted from one rate to another at any time at the Company’s option, subject to certain conditions. Amounts drawn in other permitted currencies will bear interest at the relevant rate specified therein plus an applicable margin. The Company also will pay a fee of 0.375% on average daily undrawn amounts. As of March 31, 2024 and December 31, 2023, the Revolving Credit Facility bore interest at one-month SOFR plus 2.25% per annum.

The Senior Secured Revolving Credit Agreement includes customary covenants, including certain limitations on the incurrence by the Company of additional indebtedness and on the Company’s ability to make distributions to its shareholders, or redeem, repurchase or retire shares of stock, upon the occurrence of certain events and certain financial covenants related to asset coverage and minimum shareholders’ equity, as well as customary events of default.

CLO-I

On May 20, 2022 (the “Closing Date”), the Company completed a $448,325 term debt securitization (the “2022 Debt Securitization”). Term debt securitization is also known as a collateralized loan obligation and is a form of secured financing incurred by the Company.

The notes offered in the 2022 Debt Securitization (the “2022 Notes”) were issued by CLO-I, an indirect, wholly owned, consolidated subsidiary of the Company. The 2022 Notes consist of $199,000 of AAA Class A-1 2022 Notes, which bear interest at the three-month Term SOFR plus 1.80%; $34,250 of AAA Class A-1F 2022 Notes, which bear interest at 4.42%; $47,250 of AA Class B 2022 Notes, which bear interest at the three-month Term SOFR plus 2.30%; $31,500 of A Class C 2022 Notes, which bear interest at the three-month Term SOFR plus 3.15%; $27,000 of BBB Class D 2022 Notes, which bear interest at the three-month Term SOFR plus 4.15%; and $79,325 of Subordinated 2022 Notes, which do not bear interest. The Company directly owns all of the BBB Class D 2022 Notes and the Subordinated 2022 Notes and, as such, these notes are eliminated in consolidation.

As part of the 2022 Debt Securitization, CLO-I also entered into a loan agreement (the “CLO-I Loan Agreement”) on the Closing Date, pursuant to which various financial institutions and other persons which are, or may become, parties to the CLO-I Loan Agreement as lenders (the “Lenders”) committed to make $30,000 of AAA Class A-L 2022 Loans to CLO-I (the “2022 Loans” and, together with the 2022 Notes, the “2022 Debt”). The 2022 Loans bear interest at the three-month Term SOFR plus 1.80% and were fully drawn upon the closing of the transactions. Any Lender may elect to convert all of the Class A-L 2022 Loans held by such Lenders into Class A-1 2022 Notes upon written notice to CLO-I in accordance with the CLO-I Loan Agreement.

The 2022 Debt is backed by a diversified portfolio of senior secured and second lien loans. Through April 20, 2026, all principal collections received on the underlying collateral may be used by CLO-I to purchase new collateral under the direction of the Company, in its capacity as collateral manager of CLO-I and in accordance with the Company’s investment strategy, allowing the Company to maintain the initial leverage in the 2022 Debt Securitization. The 2022 Notes are due on April 20, 2034. The 2022 Loans are scheduled to mature, and, unless earlier repaid, the entire unpaid principal balance thereof is due and payable on April 20, 2034.

The 2022 Debt is the secured obligation of CLO-I, and the indenture and the CLO-I Loan Agreement, as applicable, governing the 2022 Debt includes customary covenants and events of default. The 2022 Debt has not been, and will not be, registered under the Securities Act, or any state “blue sky” laws.

The Company serves as collateral manager to CLO-I under a collateral management agreement (the “Collateral Management Agreement”) and has waived the management fee due to it in consideration for providing these services.

CLO-II

On December 7, 2023 (the “Closing Date”), the Company completed a $298,060 term debt securitization (the “2023 Debt Securitization”).

The notes offered in the 2023 Debt Securitization (the “2023 Notes”) were issued by CLO-II, an indirect, wholly owned, consolidated subsidiary of the Company. The 2023 Notes consist of $2,000 of AAA Class X 2023 Notes, which bear interest at the three-month Term SOFR plus 2.00%, $100,500 of AAA Class A-1 2023 Notes, which bear interest at the three-month Term SOFR plus 2.35%; $37,500 of AA Class B 2023 Notes, which bear interest at three-month Term SOFR plus 3.20% and approximately $83,060 of Subordinated 2023 Notes, which do not bear interest. The Company directly owns all of the Subordinated 2023 Notes and as such, these notes are eliminated in consolidation.

As part of the 2023 Debt Securitization, CLO-II also entered into a loan agreement (the “CLO-II Loan Agreement”) on the Closing Date, pursuant to which various financial institutions and other persons which are, or may become, parties to the CLO-II Loan Agreement as lenders (the “Lenders”) committed to make $25,000 of AAA Class A-L-A 2023 Loans and $50,000 AAA Class A-L-B 2023 Loans to CLO-II (the “2023 Loans” and, together with the 2023 Notes, the “2023 Debt”). The 2023 Loans bear interest at the three-month Term SOFR plus 2.35% and were fully drawn upon the closing of the transactions. Any Lender may elect to convert all or a portion of the Class A-L-A 2023 Loans held by such Lenders into Class A-1 2023 Notes upon written notice to CLO-II in accordance with the CLO-II Loan Agreement.

The 2023 Debt is backed by a diversified portfolio of senior secured and second lien loans. Through January 20, 2028, all principal collections received on the underlying collateral may be used by CLO-II to purchase new collateral under the direction of the

Company, in its capacity as collateral manager of CLO-II and in accordance with the Company’s investment strategy, allowing the Company to maintain the initial leverage in the 2023 Debt Securitization. The 2023 Notes are due on January 20, 2036. The 2023 Loans are scheduled to mature, and, unless earlier repaid, the entire unpaid principal balance thereof is due and payable on January 20, 2036.

The 2023 Debt is the secured obligation of CLO-II, and the indenture and the CLO-II Loan Agreement, as applicable, governing the 2023 Debt includes customary covenants and events of default. The 2023 Debt has not been, and will not be, registered under the Securities Act, or any state “blue sky” laws.

The Company serves as collateral manager to CLO-II under a collateral management agreement (the “Collateral Management Agreement”) and has waived the management fee due to it in consideration for providing these services.

CLO-III

On March 14, 2024 (the “Closing Date”), the Company completed a $296,970 term debt securitization (the “2024 Debt Securitization”).

The notes offered in the 2024 Debt Securitization (the “2024 Notes” or “2024 Debt”) were issued by Churchill NCDLC CLO-III, LLC (formerly known as Nuveen Churchill BDC SPV III, LLC) (the “2024 Issuer”), a direct, wholly owned, consolidated subsidiary of the Company, pursuant to an indenture (the “Indenture”) dated as of the Closing Date. The 2024 Notes consist of $2,000 of AAA Class X 2024 Notes, which bear interest at the three-month Term SOFR plus 1.40%; $175,500 of AAA Class A 2024 Notes, which bear interest at the three-month Term SOFR plus 2.00%; $37,500 of AA Class B 2024 Notes, which bear interest at the three-month Term SOFR plus 2.65%; and $81,970 of Subordinated 2024 Notes, which do not bear interest. The Company directly retained all of the Subordinated 2024 Notes and as such, these notes are eliminated in consolidation.

The 2024 Notes are backed by a diversified portfolio of senior secured and second lien loans. The Indenture contains certain

conditions pursuant to which loans can be acquired by the 2024 Issuer, in accordance with rating agency criteria or as otherwise agreed with certain institutional investors who purchased the 2024 Notes. Through April 20, 2028, all principal collections received on the underlying collateral may be used by the 2024 Issuer to purchase new collateral under the direction of the Company, in its capacity as collateral manager of the 2024 Issuer and in accordance with the Company’s investment strategy, allowing the Company to maintain the initial leverage in the 2024 Debt Securitization. The 2024 Notes are due on April 20, 2036.

The 2024 Notes are the secured obligation of the 2024 Issuer, and the Indenture governing the 2024 Notes includes customary covenants and events of default. The 2024 Notes have not been, and will not be, registered under the Securities Act of 1933, as amended, or any state “blue sky” laws and may not be offered or sold in the United States absent registration with the Securities and Exchange Commission or applicable exemption from registration.

The Company serves as collateral manager to the 2024 Issuer under a collateral management agreement (the “Collateral Management Agreement”) and has waived any management fee due to it in consideration for providing these services.

Summary of Secured Borrowings

The Company's debt obligations consisted of the following as of March 31, 2024 and December 31, 2023:

	March 31, 2024
	Wells Fargo Financing Facility		SMBC Financing Facility		CLO-I		CLO-II		CLO-III		Revolving Credit Facility		Total
Total Commitment	$	150,000	$	150,000	$	342,000	$	215,000	$	215,000	$	185,000	$	1,257,000
Amount Outstanding (1)	2,500		39,000		342,000		215,000		215,000		12,000		825,500
Unused Portion (2)	147,500		111,000		—		—		—		173,000		431,500
Amount Available (3)	147,500		111,000		—		—		—		173,000		431,500

_______________

(1)Amount outstanding on the consolidated statements of assets and liabilities is net of deferred financing costs.

(2)The unused portion on the credit facilities is the amount upon which commitment fees are based.

(3)Available for borrowing on the credit facilities based on the computation of collateral to support the borrowings and subject to compliance with applicable covenants and financial ratios.

	December 31, 2023
	Wells Fargo Financing Facility		SMBC Financing Facility		CLO -I		CLO-II		Revolving Credit Facility		Total
Total Commitment	$	275,000	$	150,000	$	342,000	$	215,000	$	185,000	$	1,167,000
Amount Outstanding (1)	231,000		37,377		342,000		215,000		126,500		951,877
Unused Portion (2)	44,000		112,623		—		—		58,500		215,123
Amount Available (3)	43,837		112,623		—		—		58,500		214,960

_______________

(1)Amount outstanding on the consolidated statements of assets and liabilities is net of deferred financing costs.

(2)The unused portion on the credit facilities is the amount upon which commitment fees are based.

(3)Available for borrowing on the credit facilities based on the computation of collateral to support the borrowings and subject to compliance with applicable covenants and financial ratios.

For the three months ended March 31, 2024 and 2023, the components of interest expense and debt financing expenses were as follows:

	Three Months Ended March 31,
	2024			2023
Interest expense	$	15,337		$	12,041
Unused fees	308			267
Amortization of deferred financing costs	1,296			435
Total interest and debt financing expenses	$	16,941		$	12,743
Average interest rate (1)	7.65		%	6.76		%
Average daily borrowings	$	819,927		$	738,069

_______________

(1)Average interest rate includes borrowing interest expense and unused fees.

Contractual Obligations

The following tables show the contractual maturities of the Company's debt obligations as of March 31, 2024 and December 31, 2023:

	Payments Due by Period
As of March 31, 2024	Total		Less than 1 Year		1 to 3 years		3 to 5 years		More than 5 Years
Wells Fargo Financing Facility	$	2,500	$	—	$	2,500	$	—	$	—
SMBC Financing Facility	39,000		—		39,000		—		—
Revolving Credit Facility	12,000		—		—		12,000		—
CLO-I	342,000		—		—		—		342,000
CLO-II	215,000		—		—		—		215,000
CLO-III	215,000		—		—		—		215,000
Total debt obligations	$	825,500	$	—	$	41,500	$	12,000	$	772,000

	Payments Due by Period
As of December 31, 2023	Total		Less than 1 Year		1 to 3 years		3 to 5 years		More than 5 Years
Wells Fargo Financing Facility	$	231,000	$	—	$	—	$	231,000	$	—
SMBC Financing Facility	37,377		—		37,377		—		—
Revolving Credit Facility	126,500		—		—		126,500		—
CLO-I	342,000		—		—		—		342,000
CLO-II	215,000		—		—		—		215,000
Total debt obligations	$	951,877	$	—	$	37,377	$	357,500	$	557,000

XML

COMMITMENTS AND CONTINGENCIES

3 Months Ended

Mar. 31, 2024

Commitments and Contingencies Disclosure [Abstract]

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES

In the ordinary course of its business, the Company enters into contracts or agreements that contain indemnifications or warranties. Future events could occur that might lead to the enforcement of these provisions against the Company. The Company believes that the likelihood of such an event is remote; however, the maximum potential exposure is unknown. No accrual has been made in the consolidated financial statements as of March 31, 2024 and December 31, 2023 for any such exposure.

As of March 31, 2024 and December 31, 2023, the Company had the following unfunded commitments to fund delayed draw loans and equity investments:

Portfolio Company	March 31, 2024		December 31, 2023
360 Training	$	3,094	$	—
Allstar Holdings	7,373		7,373
Alternative Logistics Technologies Buyer, LLC	3,040		—
Anne Arundel	366		366
Apex Companies	1,002		1,115
Aramsco	297		—
ARMstrong	3,847		3,847
ASTP Holdings Co-Investment LP	107		34
Bounteous	—		4,467
BusinesSolver	873		970
Chroma Color	1,379		1,379
ClaimLogiq	3,225		3,225
Classic Collision	16,107		21,867
CMP Ren Partners I-A LP	15		15
Contract Land Staff	3,025		—
Covercraft	4,386		4,386
Crete	148		1,443
CrossCountry Consulting	3,320		3,320
D&H United Fueling Solutions	1,393		1,567
DMC Power	1,671		1,671
E78	2,570		2,570
Elevation Labs	2,188		3,125
Eliassen Group, LLC	1,903		1,903
Engage	8,113		8,113
Ergotech (INS)	1,979		1,979
Evergreen Services Group II	1,122		4,488
EyeSouth	885		885
Fairway Lawns	—		419
Health Management Associates	1,026		1,026
Heartland Veterinary Partners	3,600		—
High Bar Brands	596		596
Image First	143		—
Impact Environmental Group	4,093		7,203
Infobase	—		721
ITSavvy	158		158
Kenco	1,416		1,416
Legacy Service Partners	—		764
Leo Facilities	5,314		6,429
Liberty Group	449		449
Market Performance Group	3,086		—
MEI Buyer LLC	1,814		1,814
MGM Transformer Company	6,388		6,388
Mobile Communications America Inc	5,970		5,970
Mosaic Dental	254		553
National Power	3,051		3,051

Portfolio Company	March 31, 2024		December 31, 2023
NearU	3,291		3,291
NJEye, LLC	489		489
North Haven Spartan US Holdco LLC	3,260		—
Online Labels Group	807		807
Ovation Holdings	343		343
Palmetto Exterminators	109		652
Pinnacle Supply Partners, LLC	3,636		3,636
Precision Aviation Group	4,961		4,961
Propark Mobility	1,797		1,797
Randy's Worldwide Automotive	3,300		3,750
Repipe Specialists	691		691
Rhino Tool House	36		921
Riveron	1,607		1,607
RMA Companies	3,134		3,510
RoadOne	1,397		1,397
RoadOne- Common	—		235
S&S Truck Parts	246		246
Sciens Building Solutions, LLC	1,623		1,623
Sunny Sky Products	1,773		1,773
Tech24	3,550		3,655
Technical Safety Services	2,343		2,429
Tencate	1,540		—
The Facilities Group	4,861		5,028
TIDI Products	4,085		4,085
TPC Wire & Cable Corp	1,715		—
Trilon Group	1,875		4,407
USA Water	3,037		—
Velosio	1,284		—
Watermill Express	2,734		—
Wellspring	3,756		3,756
Wpromote	588		588
WSB / EST	1,307		4,357
Young Innovations	3,448		3,448
Total unfunded commitments	$	179,409	$	180,547

The Company seeks to carefully consider its unfunded portfolio company commitments for the purpose of planning its ongoing financial leverage. Further, the Company considers any outstanding unfunded portfolio company commitments it is required to fund within the 150% asset coverage limitation. As of March 31, 2024, the Company believed it had adequate financial resources to satisfy the unfunded portfolio company commitments.

XML

NET ASSETS

3 Months Ended

Mar. 31, 2024

Stockholders' Equity Note [Abstract]

NET ASSETS

NET ASSETS

The Company has the authority to issue 500,000,000 shares of common stock, par value $0.01 per share.

IPO and Private Offerings

On January 29, 2024, the Company closed its IPO, issuing 5,500,000 shares of its common stock at a public offering price of $18.05 per share. The Company received total cash proceeds of $99,275. The Company's common stock began trading on the NYSE under the symbol “NCDL” on January 25, 2024.

Prior to April 28, 2023, in connection with the Private Offerings, the Company entered into subscription agreements (“Subscription Agreements”) with investors, pursuant to which investors were required to fund drawdowns to purchase the Company's shares of common stock up to the amount of their respective capital commitment each time the Company delivered a drawdown notice. Following the final drawdown notice dated December 21, 2023 and due on January 5, 2024, all capital commitments had been drawn.

The following table summarizes total shares issued and proceeds received in connection with the IPO and the Company's capital drawdowns delivered pursuant to the Subscription Agreements from inception through March 31, 2024:

Date	Shares Issued	Proceeds Received	Issuance Price per Share
January 29, 2024	5,500,000	$99,275	$18.05
January 5, 2024	7,888,094	$142,381	$18.05
November 3, 2023	5,497,609	$100,000	$18.19
July 17, 2023	4,357,515	$78,565	$18.03
April 20, 2023	2,205,038	$40,000	$18.14
December 21, 2022	3,193,195	$60,000	$18.79
August 1, 2022	2,652,775	$50,082	$18.88
April 25, 2022	1,800,426	$34,964	$19.42
January 21, 2022	1,541,568	$30,000	$19.46
December 9, 2021	1,491,676	$29,207	$19.58
November 1, 2021	1,546,427	$30,000	$19.40
August 23, 2021	2,593,357	$50,000	$19.28
July 26, 2021	1,564,928	$30,000	$19.17
June 22, 2021	1,034,668	$20,000	$19.33
April 23, 2021	1,845,984	$35,000	$18.96
March 11, 2021	785,751	$15,000	$19.09
November 6, 2020	1,870,660	$35,000	$18.71
October 16, 2020	1,057,641	$20,000	$18.91
August 6, 2020	1,105,425	$20,000	$18.09
May 7, 2020	1,069,522	$20,000	$18.70
December 31, 2019	3,310,540	$66,211	$20.00
December 19, 2019	50	$1	$20.00

Distributions

The following table summarizes the Company's distributions declared from inception through March 31, 2024:

Date Declared	Record Date	Payment Date	Dividend per Share
January 10, 2024	February 12, 2025	April 28, 2025	$0.10 (3)
January 10, 2024	November 11, 2024	January 28, 2025	$0.10 (3)
January 10, 2024	August 12, 2024	October 28, 2024	$0.10 (3)
January 10, 2024	May 13, 2024	July 29, 2024	$0.10 (3)
January 10, 2024	March 30, 2024	April 29, 2024	$0.45
December 28, 2023	December 29, 2023	January 10, 2024	$0.50
December 28, 2023	December 29, 2023	January 10, 2024	$0.05 (2)
September 28, 2023	September 28, 2023	October 12, 2023	$0.50
September 28, 2023	September 28, 2023	October 12, 2023	$0.05 (2)
June 28, 2023	June 28, 2023	July 12, 2023	$0.50
June 28, 2023	June 28, 2023	July 12, 2023	$0.05 (2)
March 30, 2023	March 30, 2023	April 12, 2023	$0.50
March 30, 2023	March 30, 2023	April 12, 2023	$0.26 (1)
December 29, 2022	December 29, 2022	January 17, 2023	$0.50
September 28, 2022	September 28, 2022	October 11, 2022	$0.47
June 30, 2022	June 30, 2022	July 12, 2022	$0.43
March 30, 2022	March 31, 2022	April 12, 2022	$0.41
December 29, 2021	December 29, 2021	January 18, 2022	$0.40
September 29, 2021	September 29, 2021	October 11, 2021	$0.38
June 29, 2021	June 29, 2021	July 12, 2021	$0.31
March 29, 2021	March 29, 2021	April 19, 2021	$0.30
December 29, 2020	December 29, 2020	January 18, 2021	$0.28
November 4, 2020	November 4, 2020	November 11, 2020	$0.23
August 4, 2020	August 4, 2020	August 11, 2020	$0.28
April 16, 2020	April 16, 2020	April 21, 2020	$0.17

________________

(1)    Represents a special dividend and a supplemental dividend.

(2)    Represents a supplemental dividend.

(3)    Represents a special dividend.

The distributions declared were derived from investment company taxable income and net capital gain, if any. The federal income tax characterization of distributions declared and paid for the fiscal year will be determined at fiscal year-end based upon the Company’s investment company taxable income for the full fiscal year and distributions paid during the full year.

The following table reflects the shares issued pursuant to the dividend reinvestment from inception through March 31, 2024:

Date Declared	Record Date	Payment Date	Shares Issued1
December 28, 2023	December 29, 2023	January 10, 2024	185,541
September 28, 2023	September 28, 2023	October 12, 2023	158,545
June 28, 2023	June 28, 2023	July 12, 2023	128,818
March 30, 2023	March 30, 2023	April 12, 2023	150,703
December 29, 2022	December 29, 2022	January 17, 2023	93,329
September 28, 2022	September 28, 2022	October 11, 2022	68,093
June 30, 2022	June 30, 2022	July 12, 2022	45,341
March 30, 2022	March 31, 2022	April 12, 2022	32,320
December 29, 2021	December 29, 2021	January 18, 2022	23,017
September 29, 2021	September 29, 2021	October 11, 2021	10,639
June 29, 2021	June 29, 2021	July 12, 2021	3,039
March 29, 2021	March 29, 2021	April 19, 2021	1,824
December 29, 2020	December 29, 2020	January 18, 2021	1,550
November 4, 2020	November 4, 2020	November 11, 2020	98
August 4, 2020	August 4, 2020	August 11, 2020	34

________________

(1)    All shares issued to shareholders are newly issued shares.

Share Repurchase Plan

On March 5, 2024, the Company entered into a share repurchase plan (the “Company 10b5-1 Plan”), pursuant to which the Company may purchase up to $99,275 in the aggregate of its outstanding shares of common stock in the open market at prices below its NAV per share over a specified period. Any purchase of the shares pursuant to the Company 10b5-1 Plan will be conducted in accordance with the guidelines and conditions of Rule 10b-18 and Rule 10b5-1 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The Company adopted the Company 10b5-1 Plan because it believes that, if its common stock is trading below its then-current NAV per share, it will be in the best interest of its stockholders for the Company to reinvest in its portfolio.

The Company 10b5-1 Plan is designed to allow the Company to repurchase its shares of common stock at times when the Company otherwise might be prevented from doing so under insider trading laws. The Company 10b5-1 Plan requires BofA Securities, Inc., as agent, to repurchase shares of common stock on the Company's behalf when the market price per share is below the most recently reported NAV per share (including any updates, corrections or adjustments publicly announced by the Company to any previously announced NAV per share). Under the Company 10b5-1 Plan, the agent will increase the volume of purchases made as the price of the shares of the Company's common stock declines, subject to volume restrictions. The timing and amount of any share repurchases will depend on the terms and conditions of the Company 10b5-1 Plan, the market price of the shares of the Company's common stock and trading volumes, and no assurance can be given that any particular amount of shares of the common stock will be repurchased.

The purchase of shares of common stock pursuant to the Company 10b5-1 Plan is intended to satisfy the conditions of Rule 10b5-1 and Rule 10b-18 under the Exchange Act, and will otherwise be subject to applicable law, including Regulation M, which may prohibit purchases under certain circumstances.

The Company 10b5-1 Plan became effective on March 29, 2024 and commenced on April 1, 2024. The 10b5-1 Plan will terminate upon the earliest to occur of (i) 12-months from the effective date (tolled for periods during which the Company 10b5-1 Plan is suspended), (ii) the end of the trading day on which the aggregate purchase price for all shares of common stock purchased under the Company 10b5-1 Plan equals $99,275 and (iii) the occurrence of certain other events described in the Company 10b5-1 Plan.

XML

CONSOLIDATED FINANCIAL HIGHLIGHTS

3 Months Ended

Mar. 31, 2024

Investment Company [Abstract]

CONSOLIDATED FINANCIAL HIGHLIGHTS

CONSOLIDATED FINANCIAL HIGHLIGHTS

The following is a schedule of financial highlights for the three months ended March 31, 2024 and 2023:

	Three Months Ended March 31,
	2024			2023
Per share data:
Net asset value at beginning of period	$	18.13		$	18.32
Net investment income (1)	0.56			0.60
Net realized gain (loss) (1)	(0.07)			0.23
Total net change in unrealized gain (loss) (1)	0.08			(0.39)
Net increase (decrease) in net assets resulting from operations (1)	0.57			0.44
Shareholder distributions from net investment income (2)	(0.45)			(0.76)
Other (3)	(0.04)			0.01
Net asset value at end of period	$	18.21		$	18.01
Net assets at end of period	$	998,233		$	517,544
Shares outstanding at end of period	54,815,740			28,743,877
Per share market value at end of period	$	18.06		N/A
Total return based on NAV (4)	2.93		%	2.39		%
Total return based on market value (5)	2.55		%	N/A
Ratio/Supplemental data:
Ratio of net expenses to average net assets before expense support and waived fees (6) (7)	12.09		%	12.92		%
Ratio of net expenses to average net assets after expense support and waived fees(6) (7)	10.04		%	12.91		%
Ratio of net investment income to average net assets (6)	13.66		%	13.51		%
Portfolio turnover rate (8)	3.20		%	3.22		%
Asset Coverage Ratio	220.92		%	167.31		%

________________

(1)The per share data was derived by using the weighted average shares outstanding during the period.

(2)The per share data for distributions reflects the actual amount of distributions declared during the period.

(3)Includes the impact of different share amounts used in calculating per share data as a result of calculating certain per share data based on weighted average shares outstanding during the period and certain per share data based on shares outstanding as of a period end or transaction date.

(4)Total return is calculated as the change in NAV per share during the period, plus distributions per share, if any, reinvested in accordance with the Company’s dividend reinvestment plan divided by the beginning NAV per share.

(5)Total return based on market value is calculated as the change in market value per share during the respective periods, taking into account distributions, if any, reinvested in accordance with the Company’s dividend reinvestment plan. The beginning market value per share is based on the initial public offering price of $18.05 per share and is not annualized.

(6)Ratios are annualized. Average net assets is calculated utilizing quarterly net assets. Ratio of net investment income (loss) to average net assets includes the effect of expense support for three months ended March 31, 2023 and waived incentive fees for the three months ended March 31, 2024.

(7)The ratio of interest and debt financing expenses to average net assets for the three months ended March 31, 2024 and 2023 was 7.78% and 9.91%, respectively. Average net assets is calculated utilizing quarterly net assets.

(8)Portfolio turnover rate is calculated using the lesser of year-to-date sales or year-to-date purchases over the average of the invested assets at fair value for the periods reported.

XML

SUBSEQUENT EVENTS

3 Months Ended

Mar. 31, 2024

Subsequent Events [Abstract]

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS

The Company’s management evaluated subsequent events through the date of issuance of the consolidated financial statements. There have been no subsequent events that occurred during such period that would require disclosure in, or would be required to be recognized in, the consolidated financial statements as of March 31, 2024, except as discussed below.

On April 9, 2024, the Company entered into Amendment No. 1 (“Amendment No. 1”) to the Senior Secured Revolving Credit Agreement, by and among the Company, as borrower, NCDL Equity Holdings, as subsidiary guarantor, the lenders and issuing banks party thereto, SMBC, as administrative agent for the lenders. Amendment No. 1, among other things: (a) increased the maximum principal amount available under the Revolving Credit Facility from $185,000 to $250,000 pursuant to the accordian feature; and (b) replaced the interest rate benchmark for borrowings denominated in Canadian Dollars from CDOR to CORRA, which includes a credit spread adjustment of 0.29547% for one month tenor borrowings and 0.32138% for three month tenor borrowings.

On May 1, 2024, the Board declared a second quarter regular dividend of $0.45 per share payable on or around July 29, 2024 to shareholders of record as of June 28, 2024.

XML

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ 30,024	$ 12,717

XML

Insider Trading Arrangements	3 Months Ended
	Mar. 31, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

XML

SIGNIFICANT ACCOUNTING POLICIES (Policies)

3 Months Ended

Mar. 31, 2024

Accounting Policies [Abstract]

Basis of Presentation

Basis of Presentation

The consolidated financial statements have been prepared on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”). The Company is an investment company for the purposes of accounting and financial reporting in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 946, Financial Services—Investment Companies (“ASC 946”), and pursuant to Regulation S-X. In the opinion of management, all adjustments, which are of a normal recurring nature, considered necessary for the fair statement of the consolidated financial statements for the periods presented, have been included.

Consolidation

The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated. Certain prior period amounts have been reclassified to conform to the current period presentation. U.S. GAAP for an investment company requires investments to be recorded at fair value. The carrying value for all other assets and liabilities approximates their fair value, unless otherwise disclosed within.

Use of Estimates

Use of Estimates

The preparation of consolidated financial statements in conformity with U.S. GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, as well as the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

Cash, Cash Equivalents and Restricted Cash

Cash, Cash Equivalents and Restricted Cash

Cash and restricted cash represent cash deposits held at financial institutions, which at times may exceed U.S. federally insured limits. The Company has restrictions on the uses of the cash held by SPV V based on the terms of the Wells Fargo Financing Facility (as defined in Note 6 below). Cash equivalents include short-term highly liquid investments, such as money market funds, that are readily convertible to cash and have original maturities of three months or less. Cash, restricted cash and cash equivalents are carried at cost, which approximates fair value.

Valuation of Portfolio Investments

Valuation of Portfolio Investments

Investments are valued in accordance with the fair value principles established by FASB ASC Topic 820, Fair Value Measurement (“ASC Topic 820”) and in accordance with the 1940 Act. ASC Topic 820’s definition of fair value focuses on the amount that would be received to sell the asset or paid to transfer the liability in the principal or most advantageous market, and prioritizes the use of market-based inputs (observable) over entity-specific inputs (unobservable) within a measurement of fair value.

ASC Topic 820 specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. ASC Topic 820 also provides guidance regarding a fair value hierarchy, which prioritizes information used to measure fair value and the effect of fair value measurements on earnings, and provides for enhanced disclosures determined by the level within the hierarchy of information used in the valuation. In accordance with ASC Topic 820, these inputs are summarized in the three levels listed below:

•Level 1 — Valuations are based on unadjusted, quoted prices in active markets for identical assets or liabilities that are accessible at the measurement date.

•Level 2 — Valuations are based on quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly.

•Level 3 — Valuations based on inputs that are unobservable and significant to the overall fair value measurement.

In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, an investment’s level within the fair value hierarchy is based on the lowest level of observable input that is significant to the fair value measurement. The assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the investment.

Active, publicly traded instruments are classified as Level 1 and their values are generally based on quoted market prices, even if both the market’s normal daily trading volume is not sufficient to absorb the quantity held and placing orders to sell the position in a single transaction might affect the quoted price.

Fair value is generally determined as the price that would be received for an investment in a current sale, which assumes an orderly market is available for the market participants at the measurement date. If available, fair value of investments is based on directly observable market prices or on market data derived from comparable assets. The Company’s valuation policy considers the fact that no ready market may exist for many of the securities in which it invests and that fair value for its investments must be determined using unobservable inputs.

Pursuant to Rule 2a-5 under the 1940 Act, the Company's board of directors (the “Board”) has designated the Adviser as the Company's valuation designee (the “Valuation Designee”) to determine the fair value of the Company's investments that do not have readily available market quotations, which became effective beginning with the fiscal quarter ended March 31, 2023. Pursuant to the Company's valuation policy approved by the Board, a valuation committee comprised of employees of the Adviser (the “Valuation Committee”) is responsible for determining the fair value of the Company’s assets for which market quotations are not readily available, subject to the oversight of the Board.

With respect to investments for which market quotations are not readily available (Level 3), the Valuation Designee, subject to the oversight of the Board as described below, defined further below in Note 5, undertakes a multi-step valuation process each quarter, as follows:

i.the quarterly valuation process begins with each portfolio company or investment being initially valued by either the professionals of the applicable investment team that are responsible for the portfolio investment or an independent third-party valuation firm;

ii.to the extent that an independent third-party valuation firm has not been engaged by, or on behalf of, the Company to value 100% of the portfolio, then at a minimum, an independent third-party valuation firm will be engaged by, or on behalf of, the Company will provide positive assurance of the portfolio each quarter (such that each investment is reviewed by a third-party valuation firm at least once on a rolling 12-month basis and each watch-list investment will be reviewed each quarter), including a review of management’s preliminary valuation and recommendation of fair value;

iii.the Valuation Committee then reviews and discusses the valuations with any input, where appropriate, from the independent third-party valuation firm(s), and determine the fair value of each investment in good faith based on the Company’s valuation policy, subject to the oversight of the Board; and

iv.the Valuation Designee provides the Board with the information relating to the fair value determination pursuant to the Company’s valuation policy in connection with each quarterly Board meeting, comply with the periodic board reporting requirements set forth in the Company’s valuation policy, and discuss with the Board its determination of the fair value of each investment in good faith.

The Valuation Designee makes this fair value determination on a quarterly basis and in such other instances when a decision regarding the fair value of the portfolio investments is required. Factors considered by the Valuation Designee as part of the valuation of investments include each portfolio company's credit ratings/risk, current and projected earnings, current and expected leverage, ability to make interest and principal payments, liquidity, compliance with applicable loan covenants, and price to earnings (or other financial) ratios and those of comparable companies, as well as the estimated remaining life of the investment and current market yields and interest rate spreads of similar securities as of the measurement date. Other factors taken into account include changes in the interest rate environment and credit markets that may affect the price at which similar investments would trade. The Valuation Designee may also base its valuation of an investment on recent transactions of investments and securities with similar structure and risk characteristics. The Valuation Designee obtains market data from its ongoing investment purchase efforts, in addition to monitoring transactions that have closed or are discussed in industry publications. External information may include (but is not limited to) observable market data derived from the U.S. loan and equity markets. As part of compiling market data as an indication of current market conditions, management may utilize third-party sources.

The values assigned to investments are based on available information and may fluctuate from period to period. In addition, such values do not necessarily represent the amount that ultimately might be realized upon a portfolio investment's sale. Due to the inherent uncertainty of valuation, the estimated fair value of an investment may differ from the value that would have been used had a ready market for the security existed, and the difference could be material.

The Board is responsible for overseeing the Valuation Designee’s process for determining the fair value of the Company’s assets for which market quotations are not readily available, taking into account the Company’s valuation risks. To facilitate the Board’s oversight of the valuation process, the Valuation Designee provides the Board with quarterly reports, annual reports, and prompt reporting of material matters affecting the Valuation Designee’s determination of fair value. As part of the Board’s oversight role, the Board may request and review additional information to be informed of the Valuation Designee’s process for determining the fair value of the Company's investments.

Investment Transactions

Investment transactions are recorded on the applicable trade date. Any amounts related to purchases, sales and principal paydowns that have traded, but not settled, are reflected as either a receivable for investments sold or payable for investments purchased on the consolidated statements of assets and liabilities. Realized gains or losses are measured by the difference between the net proceeds received and the cost basis of the investment using the specific identification method without regard to unrealized appreciation or depreciation previously recognized and are included as net realized gain (loss) on investments in the consolidated statements of operations. Net change in unrealized appreciation (depreciation) on investments is recognized in the consolidated statements of operations and reflects the period-to-period change in fair value and cost of investments, including the reversal of previously recorded unrealized appreciation or depreciation when gains or losses are realized.

Revenue Recognition

Interest income, including amortization of premium and accretion of discount on loans, and expenses are recorded on the accrual basis. The Company accrues interest income if it expects that ultimately it will be able to collect such income.

The Company may have loans in its portfolio that contain payment-in-kind (“PIK”) income provisions. PIK represents interest that is accrued and recorded as interest income at the contractual rates, increases the loan principal on the respective capitalization dates, and is generally due at maturity. This non-cash source of income is included when determining what must be paid out to shareholders in the form of distributions in order for the Company to maintain its tax treatment as a RIC, even though the Company has not yet collected cash. For the three months ended March 31, 2024 and 2023, the Company earned $1,992 and $321, respectively, in PIK income provisions representing 3.86% and 0.95% of total investment income, respectively.

Dividend income on preferred equity securities is recorded on the accrual basis to the extent that such amounts are payable by the portfolio company and are expected to be collected. Dividend income on common equity securities is recorded on the record date for private portfolio companies or on the ex-dividend date for publicly traded portfolio companies. For the three months ended March 31, 2024 and 2023 the Company earned $308 and $16, respectively, of dividend income on its equity investments.

Other income may include income such as consent, waiver, amendment, unused, and prepayment fees associated with the Company’s investment activities, as well as any fees for managerial assistance services rendered by the Company to its portfolio companies. Such fees are recognized as income when earned or the services are rendered. For the three months ended March 31, 2024 and 2023 the Company earned other income of $217 and $236, respectively, primarily related to prepayment and amendment fees.

Loans are generally placed on non-accrual status when a payment default occurs or if management otherwise believes that the issuer of the loan will not be able to make contractual interest payments or principal payments. The Company will cease recognizing interest income on that loan until all principal and interest is current through payment or until a restructuring occurs, such that the interest income is deemed to be collectible. However, the Company remains contractually entitled to this interest. The Company may make exceptions to this policy if the loan has sufficient collateral value and is in the process of collection. Accrued interest is written-off when it becomes probable that the interest will not be collected and the amount of uncollectible interest can be reasonably estimated. When a PIK investment is placed on non-accrual status, the accrued, uncapitalized interest is generally reversed through PIK income. As of March 31, 2024, the Company had one portfolio company on non-accrual status with a fair value of $2,326 which represents approximately 0.13% of total investments at fair value. As of December 31, 2023, there were no portfolio companies on non-accrual.

Deferred Financing Costs

Deferred Financing Costs

Deferred financing costs include capitalized expenses related to the closing or amendments of borrowings. Amortization of deferred financing costs is computed on the straight-line basis over the term of the borrowings. The unamortized balance of such costs is included as a direct deduction from the related liability in the accompanying consolidated statements of assets and liabilities. The amortization of such costs is included in interest and debt financing expenses in the accompanying consolidated statements of operations.

Offering Costs

Offering Costs

Offering costs associated with the Private Offerings were recognized as a deferred charge on the consolidated statement of assets and liabilities and amortized on a straight-line basis over 12 months. These expenses consist primarily of legal fees and other costs incurred in connection with the Company’s continuous Private Offering of its shares. For the three months ended March 31, 2024 the Company did not incur any offering costs. For the three months ended March 31, 2023 the Company incurred offering costs of $15.

Deferred offering costs include registration expenses related to any shelf registration statement filed by the Company. These expenses consist primarily of SEC registration fees, legal fees and accounting fees incurred related thereto. Upon the completion of an equity offering or a debt offering, the deferred expenses are charged to additional paid-in capital or debt issuance costs, respectively. If there are any deferred offering costs remaining at the expiration of the shelf registration statement, these deferred costs are charged to expense. The Adviser paid the offering costs associated with the IPO on behalf of the Company. The Company is not obligated to repay any such offering costs paid by the Adviser.

Income Taxes

Income Taxes

For U.S. federal income tax purposes, the Company has elected, and intends to qualify annually, to be treated as a RIC under the Code. In order to qualify as a RIC, the Company must meet certain minimum distribution, source-of-income and asset diversification requirements. If such requirements are met, then the Company is generally required to pay U.S. federal income taxes only on the portion of its taxable income and capital gains it does not distribute.

The minimum distribution requirements applicable to RICs require the Company to distribute to its shareholders at least 90% of its investment company taxable income (“ICTI”), as defined by the Code, each year. Depending on the level of ICTI earned in a tax year, the Company may choose to carry forward ICTI in excess of current year distributions into the next tax year. Any such carryover ICTI must be distributed before the end of that next tax year through a dividend declared prior to filing the final tax return related to the year which generated such ICTI.

In addition, based on the excise distribution requirements, the Company is subject to a 4% U.S. nondeductible federal excise tax on undistributed income unless the Company distributes in a timely manner an amount at least equal to the sum of (1) 98% of its ordinary income for each calendar year, (2) 98.2% of capital gain net income (both long-term and short-term) for the one-year period ended October 31 in that calendar year and (3) any income realized, but not distributed, in the preceding year. For this purpose, however, any ordinary income or capital gain net income retained by the Company that is subject to U.S. federal income tax at corporate rates is considered to have been distributed. The Company intends to timely distribute to our shareholders substantially all of our annual taxable income for each year, except that the Company may retain certain net capital gains for reinvestment and, depending upon the level of taxable income earned in a year, we may choose to carry forward ICTI for distribution in the following year and pay any applicable U.S. federal excise tax.

The Company evaluates tax positions taken or expected to be taken in the course of preparing its consolidated financial statements to determine whether the tax positions are “more-likely than not” to be sustained by the applicable tax authority. CLO-I, CLO-II, CLO-III, SPV IV and SPV V are disregarded entities for tax purposes and are consolidated with the tax return of the Company. NCDL Equity Holdings has elected to be classified as a corporation for U.S. federal income tax purposes. All penalties and interest associated with income taxes, if any, are included in income tax expense. For the three months ended March 31, 2024 and March 31, 2023, the Company did not incur any excise tax expense.

Dividends and Distributions to Common Shareholders

Dividends and Distributions to Common Shareholders

To the extent that the Company has taxable income, the Company intends to continue to make quarterly distributions to its common shareholders. Dividends and distributions to common shareholders are recorded on the applicable record date. The amount to be distributed to common shareholders is determined by the Board each quarter and is generally based upon the taxable earnings estimated by management and available cash. Net realized capital gains, if any, will generally be distributed at least annually, although the Company may decide to retain such capital gains for investment.

In connection with the IPO, the Board approved an amended and restated dividend reinvestment plan (the "Amended DRIP"), which became effective on January 29, 2024, concurrent with the consummation of the IPO.

The Amended DRIP changed the dividend reinvestment plan from an “opt in” dividend reinvestment plan to an “opt out” dividend reinvestment plan. As a result of the foregoing, if the Board authorizes, and the Company declares, a cash dividend or distribution, shareholders that acquired their shares in the IPO and do not “opt out” of the Amended DRIP will have their cash distributions automatically reinvested in additional shares rather than receiving cash. Notwithstanding the foregoing, a shareholder’s

election (or deemed election) under the dividend reinvestment plan, dated December 19, 2019, will remain in effect for such shareholder and no further action is required by such shareholder with respect to their election under the Amended DRIP.

With respect to each distribution under the Amended DRIP, the Board reserves the right to either issue new shares of common stock or purchase shares of common stock in the open market for the accounts of participants in the Amended DRIP. If newly issued shares are used to implement the Amended DRIP, the number of shares to be issued to a shareholder will be determined by dividing the total dollar amount of the distribution payable to such participant by the market price per share of the Company's common stock at the close of regular trading of the NYSE on the distribution payment date, or if no sale is reported for such day, the average of the reported bid and asked prices. However, if the market price per share on the distribution payment date exceeds the most recently computed net asset value ("NAV") per share, the Company will issue shares at the greater of (i) the most recently computed NAV per share and (ii) 95% of the current market price per share (or such lesser discount to the current market price per share that still exceeds the most recently computed NAV per share). If shares are purchased in the open market to implement the Amended DRIP, the number of shares to be issued to a participant will be determined by dividing the dollar amount of the distribution payable to such participant by the weighted average price per share for all shares of common stock purchased by the plan administrator in the open market in connection with the dividend or distribution. Although each participant may from time to time have an undivided fractional interest in a share, no certificates for a fractional share will be issued. However, dividends and distributions on fractional shares will be credited to each participant’s account.

Functional Currency

Functional Currency

The functional currency of the Company is the U.S. Dollar and all transactions were in U.S. Dollars.

XML

INVESTMENTS (Tables)

3 Months Ended

Mar. 31, 2024

Investments, Debt and Equity Securities [Abstract]

Schedules of Investments at Fair Value

As of March 31, 2024 and December 31, 2023, our investments consisted of the following (dollar amounts in thousands):

	March 31, 2024						December 31, 2023
	Amortized Cost		Fair Value		% of Fair Value		Amortized Cost		Fair Value		% of Fair Value
First-Lien Term Loans	$	1,610,637	$	1,596,352	88.95	%	$	1,450,120	$	1,427,492	86.95	%
Subordinated Debt1	$	178,330	$	166,502	9.28	%	190,454		183,387		11.17	%
Equity Investments	$	26,018	$	31,705	1.77	%	25,595		30,807		1.88	%
Total	$	1,814,985	$	1,794,559	100.00	%	$	1,666,169	$	1,641,686	100.00	%

_____________________

1As of March 31, 2024, Subordinated Debt is comprised of second lien term loans and/or second lien notes of $84,676, mezzanine debt of $81,113 and $713 of structured debt at fair value and second lien term loans and/or second lien notes of $88,879, mezzanine debt of $86,199 and $3,252 of structured debt at amortized cost.

As of December 31, 2023, Subordinated Debt is comprised of second lien term loans and/or second lien notes of $97,203, mezzanine debt of $83,528 and $2,656 of structured debt at fair value and second lien term loans and/or second lien notes of $100,711, mezzanine debt of $86,495 and $3,247 of structured debt at amortized cost.

The industry composition of our portfolio as a percentage of fair value as of March 31, 2024 and December 31, 2023 was as follows:

Industry	March 31, 2024		December 31, 2023
Aerospace & Defense	3.07	%	3.13	%
Automotive	3.84	%	4.95	%
Banking, Finance, Insurance, Real Estate	3.60	%	3.95	%
Beverage, Food & Tobacco	7.30	%	7.76	%
Capital Equipment	4.62	%	4.21	%
Chemicals, Plastics, & Rubber	1.61	%	2.29	%
Construction & Building	4.50	%	3.90	%
Consumer Goods: Durable	1.05	%	1.51	%
Consumer Goods: Non-durable	3.29	%	3.31	%
Containers, Packaging & Glass	3.89	%	3.97	%
Energy: Electricity	1.61	%	1.75	%
Environmental Industries	3.16	%	2.73	%
Healthcare & Pharmaceuticals	11.91	%	12.72	%
High Tech Industries	10.64	%	8.97	%
Media: Advertising, Printing & Publishing	1.04	%	1.12	%
Media: Diversified & Production	0.87	%	0.96	%
Retail	0.32	%	0.35	%
Services: Business	19.03	%	18.43	%
Services: Consumer	4.98	%	4.86	%
Sovereign & Public Finance	0.76	%	0.65	%
Telecommunications	2.91	%	3.17	%
Transportation: Cargo	3.03	%	3.20	%
Transportation: Consumer	0.70	%	0.13	%
Utilities: Electric	0.81	%	0.89	%
Utilities: Water	0.46	%	—	%
Wholesale	1.00	%	1.09	%
Total	100.00	%	100.00	%

The geographic composition of investments at cost and fair value was as follows:

	March 31, 2024
	Cost	Fair Value	% of Total Investments at Fair Value		Fair Value as % of Net Assets
USA	1,762,869	1,742,508	97.10	%	174.56	%
Canada	38,401	38,391	2.14	%	3.85	%
United Kingdom	13,715	13,660	0.76	%	1.37	%
	1,814,985	1,794,559	100.00	%	179.78	%

	December 31, 2023
	Cost	Fair Value	% of Total Investments at Fair Value		Fair Value as % of Net Assets
USA	1,613,815	1,589,384	96.82	%	212.52	%
Canada	38,462	38,292	2.33	%	5.12	%
United Kingdom	13,892	14,010	0.85	%	1.87	%
	1,666,169	1,641,686	100.00	%	219.51	%

XML

FAIR VALUE MEASUREMENTS (Tables)

3 Months Ended

Mar. 31, 2024

Fair Value Disclosures [Abstract]

Schedule of Fair Value Measurements of Investments, by Major Class, and Cash Equivalents

The following tables present fair value measurements of investments, by major class, and cash equivalents as of March 31, 2024 and December 31, 2023, according to the fair value hierarchy:

As of March 31, 2024	Level 1		Level 2		Level 3		Total
Assets:
First Lien Term Loans	$	—	$	30,955	$	1,565,397	$	1,596,352
Subordinated Debt 1	—		—		166,502		166,502
Equity Investments	—		—		31,705		31,705
Cash Equivalents	52,773		—		—		52,773
Total	$	52,773	$	30,955	$	1,763,604	$	1,847,332

_____________________

1 Subordinated Debt is further comprised of second lien term loans and/or second lien notes of $84,676, mezzanine debt of $81,113 and $713 of structured debt.

As of December 31, 2023	Level 1		Level 2		Level 3		Total
Assets:
First Lien Term Loans	$	—	$	34,481	$	1,393,011	$	1,427,492
Subordinated Debt 1	—		8,691		174,696		183,387
Equity Investments	—		—		30,807		30,807
Cash Equivalents	64,477		—		—		64,477
Total	$	64,477	$	43,172	$	1,598,514	$	1,706,163

_____________________

1 Subordinated Debt is further comprised of second lien term loans and/or second lien notes of $97,203, mezzanine debt of $83,528 and $2,656 of structured debt.

Schedule of Reconciliation of the Beginning and Ending Balances for Investments

The following tables provide a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the three months ended March 31, 2024 and the year ended December 31, 2023:

	First Lien Term Loans		Subordinated Debt		Equity Investments		Total
Balance as of December 31, 2023	$	1,393,011	$	174,696	$	30,807	$	1,598,514
Purchase of investments	196,582		855		496		197,933
Proceeds from principal repayments and sales of investments	(39,657)		(6,082)		(73)		(45,812)
Payment-in-kind interest	260		1,732		—		1,992
Amortization of premium/accretion of discount, net	833		164		—		997
Net realized gain (loss) on investments	(3,830)		140		—		(3,690)
Net change in unrealized appreciation (depreciation) on investments	8,373		(5,003)		475		3,845
Transfers to Level 3 (1)	9,825		—		—		9,825
Balance as of March 31, 2024	$	1,565,397	$	166,502	$	31,705	$	1,763,604
Net change in unrealized appreciation (depreciation) on non-controlled/non-affiliated company investments still held as of March 31, 2024	$	4,445	$	(5,003)	$	475	$	(83)

_______________

(1)Transfers between levels, if any, are recognized at the beginning of the period in which the transfers occur. For the three months ended March 31, 2024, transfers into Level 3 from Level 2 were a result of changes in the observability of significant inputs for certain portfolio companies.

	First Lien Term Loans		Subordinated Debt		Equity Investments		Total
Balance as of December 31, 2022	$	1,016,856	$	133,243	$	27,313	$	1,177,412
Purchase of investments	513,487		65,296		9,110		587,893
Proceeds from principal repayments and sales of investments	(118,469)		(14,915)		(8,667)		(142,051)
Payment-in-kind interest	221		3,047		—		3,268
Amortization of premium/accretion of discount, net	1,386		426		833		2,645
Net realized gain (loss) on investments	(14,339)		238		6,112		(7,989)
Net change in unrealized appreciation (depreciation) on investments	8,871		(4,191)		(3,894)		786
Transfers out of Level 3 (1)	(23,350)		(8,448)		—		(31,798)
Transfers to Level 3 (1)	8,348		—		—		8,348
Balance as of December 31, 2023	$	1,393,011	$	174,696	$	30,807	$	1,598,514
Net change in unrealized appreciation (depreciation) on non-controlled/non-affiliated company investments still held as of December 31, 2023	$	364	$	(4,167)	$	2,154	$	(1,649)

_______________

(1)Transfers between levels, if any, are recognized at the beginning of the period in which the transfers occur. For the year ended December 31, 2023, transfers into Level 3 from Level 2 were a result of changes in the observability of significant inputs for certain portfolio companies.

Schedule of Valuation Techniques and Significant Unobservable Inputs Used in Level 3 Fair Value Measurements of Assets

The valuation techniques and significant unobservable inputs used in Level 3 fair value measurements of assets as of March 31, 2024 and December 31, 2023 were as follows:

Investment Type	Fair Value at March 31, 2024		Valuation Techniques	Unobservable Inputs	Ranges				Weighted Average
First Lien Term Loans	$	1,400,517	Yield Method	Market Yield Discount Rates	8.58	%	20.85	%	10.80	%
First Lien Term Loans	22,199		Market Approach	EBITDA Multiple	6.50x		13.00x		9.37x
First Lien Term Loans	142,681		Recent Transactions	Transaction Price	99.00		100.69		99.56
Subordinated Debt	151,676		Yield Method	Market Yield Discount Rates	12.18	%	24.91	%	15.30	%
Subordinated Debt	2,326		Black-Scholes	EBITDA Multiple	11.50x		11.50x		11.50x
Subordinated Debt	12,500		Recent Transaction	Transaction Price	100.00		100.00		100.00
Equity	161		Yield Method	Market Yield Discount Rates	8.36	%	8.36	%	8.36	%
Equity	31,066		Market Approach	EBITDA Multiple	5.75x		20.00x		11.32x
Total	$	1,763,126

Equity investments in the amount of $478 at March 31, 2024 have been excluded from the table above as the investments are valued using a recent transaction.

Investment Type	Fair Value at December 31, 2023		Valuation Techniques	Unobservable Inputs	Ranges				Weighted Average
First Lien Term Loans	$	1,192,190	Yield Method	Market Yield Discount Rates	6.13	%	18.73	%	10.63	%
First Lien Term Loans	19,519		Market Approach	EBITDA Multiple	6.50x		9.25x		7.21x
First Lien Term Loans	181,302		Recent Transactions	Transaction Price	59.50		100.00		97.52
Subordinated Debt	162,646		Yield Method	Market Yield Discount Rates	9.70	%	24.91	%	14.44	%
Subordinated Debt	12,050		Recent Transaction	Transaction Price	84.75		98.01		89.53
Equity	158		Yield Method	Market Yield Discount Rates	8.36	%	8.36	%	8.36	%
Equity	29,390		Market Approach	EBITDA Multiple	6.50x		19.50x		10.96x
Equity	2		Market Approach	Blended EBITDA Multiple	13.25x		13.25x		13.25x
				Blended Revenue Multiple	1.40x		1.40x		1.40x
Total	$	1,597,257

Equity investments in the amount of $1,257 at December 31, 2023 have been excluded from the table above as the investments are valued using a recent transaction.

Schedule of Carrying Value and Fair Value of Debt Obligations

The carrying value and fair value of the Company’s debt obligations were as follows:

	March 31, 2024				December 31, 2023
	Carrying Value (1)		Fair Value		Carrying Value (1)		Fair Value
Wells Fargo Financing Facility	$	2,500	$	2,500	$	231,000	$	231,000
SMBC Financing Facility	39,000		39,000		37,377		37,377
Revolving Credit Facility	12,000		12,000		126,500		126,500
2022 Debt	342,000		340,307		342,000		338,345
2023 Debt	215,000		217,026		215,000		213,976
2024 Debt	215,000		215,501		—		—
Total	$	825,500	$	826,334	$	951,877	$	947,198

_______________

(1)Carrying value on the consolidated statements of assets and liabilities are net of deferred financing costs.

XML

SECURED BORROWINGS (Tables)

3 Months Ended

Mar. 31, 2024

Debt Disclosure [Abstract]

Schedule of Debt Obligations and Components of Interest Expense and Debt Financing Expenses

The Company's debt obligations consisted of the following as of March 31, 2024 and December 31, 2023:

	March 31, 2024
	Wells Fargo Financing Facility		SMBC Financing Facility		CLO-I		CLO-II		CLO-III		Revolving Credit Facility		Total
Total Commitment	$	150,000	$	150,000	$	342,000	$	215,000	$	215,000	$	185,000	$	1,257,000
Amount Outstanding (1)	2,500		39,000		342,000		215,000		215,000		12,000		825,500
Unused Portion (2)	147,500		111,000		—		—		—		173,000		431,500
Amount Available (3)	147,500		111,000		—		—		—		173,000		431,500

_______________

(1)Amount outstanding on the consolidated statements of assets and liabilities is net of deferred financing costs.

(2)The unused portion on the credit facilities is the amount upon which commitment fees are based.

(3)Available for borrowing on the credit facilities based on the computation of collateral to support the borrowings and subject to compliance with applicable covenants and financial ratios.

	December 31, 2023
	Wells Fargo Financing Facility		SMBC Financing Facility		CLO -I		CLO-II		Revolving Credit Facility		Total
Total Commitment	$	275,000	$	150,000	$	342,000	$	215,000	$	185,000	$	1,167,000
Amount Outstanding (1)	231,000		37,377		342,000		215,000		126,500		951,877
Unused Portion (2)	44,000		112,623		—		—		58,500		215,123
Amount Available (3)	43,837		112,623		—		—		58,500		214,960

_______________

(1)Amount outstanding on the consolidated statements of assets and liabilities is net of deferred financing costs.

(2)The unused portion on the credit facilities is the amount upon which commitment fees are based.

(3)Available for borrowing on the credit facilities based on the computation of collateral to support the borrowings and subject to compliance with applicable covenants and financial ratios.

For the three months ended March 31, 2024 and 2023, the components of interest expense and debt financing expenses were as follows:

	Three Months Ended March 31,
	2024			2023
Interest expense	$	15,337		$	12,041
Unused fees	308			267
Amortization of deferred financing costs	1,296			435
Total interest and debt financing expenses	$	16,941		$	12,743
Average interest rate (1)	7.65		%	6.76		%
Average daily borrowings	$	819,927		$	738,069

_______________

(1)Average interest rate includes borrowing interest expense and unused fees.

Schedule of Contractual Maturities of Debt Obligations

The following tables show the contractual maturities of the Company's debt obligations as of March 31, 2024 and December 31, 2023:

	Payments Due by Period
As of March 31, 2024	Total		Less than 1 Year		1 to 3 years		3 to 5 years		More than 5 Years
Wells Fargo Financing Facility	$	2,500	$	—	$	2,500	$	—	$	—
SMBC Financing Facility	39,000		—		39,000		—		—
Revolving Credit Facility	12,000		—		—		12,000		—
CLO-I	342,000		—		—		—		342,000
CLO-II	215,000		—		—		—		215,000
CLO-III	215,000		—		—		—		215,000
Total debt obligations	$	825,500	$	—	$	41,500	$	12,000	$	772,000

	Payments Due by Period
As of December 31, 2023	Total		Less than 1 Year		1 to 3 years		3 to 5 years		More than 5 Years
Wells Fargo Financing Facility	$	231,000	$	—	$	—	$	231,000	$	—
SMBC Financing Facility	37,377		—		37,377		—		—
Revolving Credit Facility	126,500		—		—		126,500		—
CLO-I	342,000		—		—		—		342,000
CLO-II	215,000		—		—		—		215,000
Total debt obligations	$	951,877	$	—	$	37,377	$	357,500	$	557,000

XML

COMMITMENTS AND CONTINGENCIES (Tables)

3 Months Ended

Mar. 31, 2024

Commitments and Contingencies Disclosure [Abstract]

Schedule of Unfunded Commitments to Fund Delayed Draw Loans and Equity Investments

As of March 31, 2024 and December 31, 2023, the Company had the following unfunded commitments to fund delayed draw loans and equity investments:

Portfolio Company	March 31, 2024		December 31, 2023
360 Training	$	3,094	$	—
Allstar Holdings	7,373		7,373
Alternative Logistics Technologies Buyer, LLC	3,040		—
Anne Arundel	366		366
Apex Companies	1,002		1,115
Aramsco	297		—
ARMstrong	3,847		3,847
ASTP Holdings Co-Investment LP	107		34
Bounteous	—		4,467
BusinesSolver	873		970
Chroma Color	1,379		1,379
ClaimLogiq	3,225		3,225
Classic Collision	16,107		21,867
CMP Ren Partners I-A LP	15		15
Contract Land Staff	3,025		—
Covercraft	4,386		4,386
Crete	148		1,443
CrossCountry Consulting	3,320		3,320
D&H United Fueling Solutions	1,393		1,567
DMC Power	1,671		1,671
E78	2,570		2,570
Elevation Labs	2,188		3,125
Eliassen Group, LLC	1,903		1,903
Engage	8,113		8,113
Ergotech (INS)	1,979		1,979
Evergreen Services Group II	1,122		4,488
EyeSouth	885		885
Fairway Lawns	—		419
Health Management Associates	1,026		1,026
Heartland Veterinary Partners	3,600		—
High Bar Brands	596		596
Image First	143		—
Impact Environmental Group	4,093		7,203
Infobase	—		721
ITSavvy	158		158
Kenco	1,416		1,416
Legacy Service Partners	—		764
Leo Facilities	5,314		6,429
Liberty Group	449		449
Market Performance Group	3,086		—
MEI Buyer LLC	1,814		1,814
MGM Transformer Company	6,388		6,388
Mobile Communications America Inc	5,970		5,970
Mosaic Dental	254		553
National Power	3,051		3,051

Portfolio Company	March 31, 2024		December 31, 2023
NearU	3,291		3,291
NJEye, LLC	489		489
North Haven Spartan US Holdco LLC	3,260		—
Online Labels Group	807		807
Ovation Holdings	343		343
Palmetto Exterminators	109		652
Pinnacle Supply Partners, LLC	3,636		3,636
Precision Aviation Group	4,961		4,961
Propark Mobility	1,797		1,797
Randy's Worldwide Automotive	3,300		3,750
Repipe Specialists	691		691
Rhino Tool House	36		921
Riveron	1,607		1,607
RMA Companies	3,134		3,510
RoadOne	1,397		1,397
RoadOne- Common	—		235
S&S Truck Parts	246		246
Sciens Building Solutions, LLC	1,623		1,623
Sunny Sky Products	1,773		1,773
Tech24	3,550		3,655
Technical Safety Services	2,343		2,429
Tencate	1,540		—
The Facilities Group	4,861		5,028
TIDI Products	4,085		4,085
TPC Wire & Cable Corp	1,715		—
Trilon Group	1,875		4,407
USA Water	3,037		—
Velosio	1,284		—
Watermill Express	2,734		—
Wellspring	3,756		3,756
Wpromote	588		588
WSB / EST	1,307		4,357
Young Innovations	3,448		3,448
Total unfunded commitments	$	179,409	$	180,547

XML

NET ASSETS (Tables)

3 Months Ended

Mar. 31, 2024

Stockholders' Equity Note [Abstract]

Schedule of Total Shares Issued and Proceeds Received

The following table summarizes total shares issued and proceeds received in connection with the IPO and the Company's capital drawdowns delivered pursuant to the Subscription Agreements from inception through March 31, 2024:

Date	Shares Issued	Proceeds Received	Issuance Price per Share
January 29, 2024	5,500,000	$99,275	$18.05
January 5, 2024	7,888,094	$142,381	$18.05
November 3, 2023	5,497,609	$100,000	$18.19
July 17, 2023	4,357,515	$78,565	$18.03
April 20, 2023	2,205,038	$40,000	$18.14
December 21, 2022	3,193,195	$60,000	$18.79
August 1, 2022	2,652,775	$50,082	$18.88
April 25, 2022	1,800,426	$34,964	$19.42
January 21, 2022	1,541,568	$30,000	$19.46
December 9, 2021	1,491,676	$29,207	$19.58
November 1, 2021	1,546,427	$30,000	$19.40
August 23, 2021	2,593,357	$50,000	$19.28
July 26, 2021	1,564,928	$30,000	$19.17
June 22, 2021	1,034,668	$20,000	$19.33
April 23, 2021	1,845,984	$35,000	$18.96
March 11, 2021	785,751	$15,000	$19.09
November 6, 2020	1,870,660	$35,000	$18.71
October 16, 2020	1,057,641	$20,000	$18.91
August 6, 2020	1,105,425	$20,000	$18.09
May 7, 2020	1,069,522	$20,000	$18.70
December 31, 2019	3,310,540	$66,211	$20.00
December 19, 2019	50	$1	$20.00

Schedule of Dividends Declared

The following table summarizes the Company's distributions declared from inception through March 31, 2024:

Date Declared	Record Date	Payment Date	Dividend per Share
January 10, 2024	February 12, 2025	April 28, 2025	$0.10 (3)
January 10, 2024	November 11, 2024	January 28, 2025	$0.10 (3)
January 10, 2024	August 12, 2024	October 28, 2024	$0.10 (3)
January 10, 2024	May 13, 2024	July 29, 2024	$0.10 (3)
January 10, 2024	March 30, 2024	April 29, 2024	$0.45
December 28, 2023	December 29, 2023	January 10, 2024	$0.50
December 28, 2023	December 29, 2023	January 10, 2024	$0.05 (2)
September 28, 2023	September 28, 2023	October 12, 2023	$0.50
September 28, 2023	September 28, 2023	October 12, 2023	$0.05 (2)
June 28, 2023	June 28, 2023	July 12, 2023	$0.50
June 28, 2023	June 28, 2023	July 12, 2023	$0.05 (2)
March 30, 2023	March 30, 2023	April 12, 2023	$0.50
March 30, 2023	March 30, 2023	April 12, 2023	$0.26 (1)
December 29, 2022	December 29, 2022	January 17, 2023	$0.50
September 28, 2022	September 28, 2022	October 11, 2022	$0.47
June 30, 2022	June 30, 2022	July 12, 2022	$0.43
March 30, 2022	March 31, 2022	April 12, 2022	$0.41
December 29, 2021	December 29, 2021	January 18, 2022	$0.40
September 29, 2021	September 29, 2021	October 11, 2021	$0.38
June 29, 2021	June 29, 2021	July 12, 2021	$0.31
March 29, 2021	March 29, 2021	April 19, 2021	$0.30
December 29, 2020	December 29, 2020	January 18, 2021	$0.28
November 4, 2020	November 4, 2020	November 11, 2020	$0.23
August 4, 2020	August 4, 2020	August 11, 2020	$0.28
April 16, 2020	April 16, 2020	April 21, 2020	$0.17

________________

(1)    Represents a special dividend and a supplemental dividend.

(2)    Represents a supplemental dividend.

(3)    Represents a special dividend.

The distributions declared were derived from investment company taxable income and net capital gain, if any. The federal income tax characterization of distributions declared and paid for the fiscal year will be determined at fiscal year-end based upon the Company’s investment company taxable income for the full fiscal year and distributions paid during the full year.

The following table reflects the shares issued pursuant to the dividend reinvestment from inception through March 31, 2024:

Date Declared	Record Date	Payment Date	Shares Issued1
December 28, 2023	December 29, 2023	January 10, 2024	185,541
September 28, 2023	September 28, 2023	October 12, 2023	158,545
June 28, 2023	June 28, 2023	July 12, 2023	128,818
March 30, 2023	March 30, 2023	April 12, 2023	150,703
December 29, 2022	December 29, 2022	January 17, 2023	93,329
September 28, 2022	September 28, 2022	October 11, 2022	68,093
June 30, 2022	June 30, 2022	July 12, 2022	45,341
March 30, 2022	March 31, 2022	April 12, 2022	32,320
December 29, 2021	December 29, 2021	January 18, 2022	23,017
September 29, 2021	September 29, 2021	October 11, 2021	10,639
June 29, 2021	June 29, 2021	July 12, 2021	3,039
March 29, 2021	March 29, 2021	April 19, 2021	1,824
December 29, 2020	December 29, 2020	January 18, 2021	1,550
November 4, 2020	November 4, 2020	November 11, 2020	98
August 4, 2020	August 4, 2020	August 11, 2020	34

________________

(1)    All shares issued to shareholders are newly issued shares.

XML

CONSOLIDATED FINANCIAL HIGHLIGHTS (Tables)

3 Months Ended

Mar. 31, 2024

Investment Company [Abstract]

Schedule of Financial Highlights

The following is a schedule of financial highlights for the three months ended March 31, 2024 and 2023:

	Three Months Ended March 31,
	2024			2023
Per share data:
Net asset value at beginning of period	$	18.13		$	18.32
Net investment income (1)	0.56			0.60
Net realized gain (loss) (1)	(0.07)			0.23
Total net change in unrealized gain (loss) (1)	0.08			(0.39)
Net increase (decrease) in net assets resulting from operations (1)	0.57			0.44
Shareholder distributions from net investment income (2)	(0.45)			(0.76)
Other (3)	(0.04)			0.01
Net asset value at end of period	$	18.21		$	18.01
Net assets at end of period	$	998,233		$	517,544
Shares outstanding at end of period	54,815,740			28,743,877
Per share market value at end of period	$	18.06		N/A
Total return based on NAV (4)	2.93		%	2.39		%
Total return based on market value (5)	2.55		%	N/A
Ratio/Supplemental data:
Ratio of net expenses to average net assets before expense support and waived fees (6) (7)	12.09		%	12.92		%
Ratio of net expenses to average net assets after expense support and waived fees(6) (7)	10.04		%	12.91		%
Ratio of net investment income to average net assets (6)	13.66		%	13.51		%
Portfolio turnover rate (8)	3.20		%	3.22		%
Asset Coverage Ratio	220.92		%	167.31		%

________________

(1)The per share data was derived by using the weighted average shares outstanding during the period.

(2)The per share data for distributions reflects the actual amount of distributions declared during the period.

(3)Includes the impact of different share amounts used in calculating per share data as a result of calculating certain per share data based on weighted average shares outstanding during the period and certain per share data based on shares outstanding as of a period end or transaction date.

(4)Total return is calculated as the change in NAV per share during the period, plus distributions per share, if any, reinvested in accordance with the Company’s dividend reinvestment plan divided by the beginning NAV per share.

(5)Total return based on market value is calculated as the change in market value per share during the respective periods, taking into account distributions, if any, reinvested in accordance with the Company’s dividend reinvestment plan. The beginning market value per share is based on the initial public offering price of $18.05 per share and is not annualized.

(6)Ratios are annualized. Average net assets is calculated utilizing quarterly net assets. Ratio of net investment income (loss) to average net assets includes the effect of expense support for three months ended March 31, 2023 and waived incentive fees for the three months ended March 31, 2024.

(7)The ratio of interest and debt financing expenses to average net assets for the three months ended March 31, 2024 and 2023 was 7.78% and 9.91%, respectively. Average net assets is calculated utilizing quarterly net assets.

(8)Portfolio turnover rate is calculated using the lesser of year-to-date sales or year-to-date purchases over the average of the invested assets at fair value for the periods reported.

XML

SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)	3 Months Ended			12 Months Ended
	Mar. 31, 2024		Mar. 31, 2023	Dec. 31, 2023
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Investments at fair value	$ 1,847,332,000	[1]		$ 1,706,163,000	[2]
Payment-in-kind interest income	1,992,000		$ 321,000
Dividend income	308,000		16,000
Other income	217,000		236,000
Offering costs	0		15,000
Excise taxes	0		$ 0
Non-Accrual Loans
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Investments at fair value	$ 2,326,000			$ 0
Investment Type Concentration Risk | Investment Owned at Fair Value
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
% of Total Investments at Fair Value	100.00%			100.00%
Investment Type Concentration Risk | Investment Owned at Fair Value | Payment in Kind (PIK) Note
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
% of Total Investments at Fair Value	3.86%		0.95%
Investment Type Concentration Risk | Investment Owned at Fair Value | Non-Accrual Loans
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
% of Total Investments at Fair Value	0.13%

[1] Investment valued using unobservable inputs (Level 3). See Note 2 “Significant Accounting Policies – Valuation of Portfolio Investments” and Note 4 "Fair Value Measurements" for more information.

[2] Investment valued using unobservable inputs (Level 3). See Note 2 “Significant Accounting Policies – Valuation of Portfolio Investments” and Note 4 "Fair Value Measurements" for more information.

XML

INVESTMENTS - Schedule of Fair Value Measurements of Investments (Details) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2024		Dec. 31, 2023
Schedule of Investments [Line Items]
Amortized Cost	$ 1,814,985		$ 1,666,169
Fair Value	1,794,559		1,641,686
Investments at fair value	1,847,332	[1]	1,706,163	[2]
Subordinated Debt, Second Lien
Schedule of Investments [Line Items]
Amortized Cost	86,199		100,711
Investments at fair value	84,676		97,203
Subordinated Debt, Mezzanine Debt
Schedule of Investments [Line Items]
Amortized Cost	88,879		86,495
Investments at fair value	81,113		83,528
Structured Debt
Schedule of Investments [Line Items]
Amortized Cost	3,252		3,247
Investments at fair value	$ 713		$ 2,656
Investment Owned at Fair Value | Investment Type Concentration Risk
Schedule of Investments [Line Items]
% of Total Investments at Fair Value	100.00%		100.00%
First Lien Term Loans
Schedule of Investments [Line Items]
Amortized Cost	$ 1,610,637		$ 1,450,120
Fair Value	$ 1,596,352		$ 1,427,492
First Lien Term Loans | Investment Owned at Fair Value | Investment Type Concentration Risk
Schedule of Investments [Line Items]
% of Total Investments at Fair Value	88.95%		86.95%
Subordinated Debt
Schedule of Investments [Line Items]
Amortized Cost	$ 178,330		$ 190,454
Fair Value	$ 166,502		$ 183,387
Subordinated Debt | Investment Owned at Fair Value | Investment Type Concentration Risk
Schedule of Investments [Line Items]
% of Total Investments at Fair Value	9.28%		11.17%
Equity Investments
Schedule of Investments [Line Items]
Amortized Cost	$ 26,018		$ 25,595
Fair Value	31,705		30,807
Investments at fair value	$ 31,705	[1]	$ 30,807	[2]
Equity Investments | Investment Owned at Fair Value | Investment Type Concentration Risk
Schedule of Investments [Line Items]
% of Total Investments at Fair Value	1.77%		1.88%

[1] Investment valued using unobservable inputs (Level 3). See Note 2 “Significant Accounting Policies – Valuation of Portfolio Investments” and Note 4 "Fair Value Measurements" for more information.

[2] Investment valued using unobservable inputs (Level 3). See Note 2 “Significant Accounting Policies – Valuation of Portfolio Investments” and Note 4 "Fair Value Measurements" for more information.

XML

INVESTMENTS - Schedule of Portfolio Composition by Industry at Fair Value (Details) - Investment Owned at Fair Value - Investment Type Concentration Risk	3 Months Ended	12 Months Ended
	Mar. 31, 2024	Dec. 31, 2023
Schedule of Investments [Line Items]
% of Total Investments at Fair Value	100.00%	100.00%
Aerospace & Defense
Schedule of Investments [Line Items]
% of Total Investments at Fair Value	3.07%	3.13%
Automotive
Schedule of Investments [Line Items]
% of Total Investments at Fair Value	3.84%	4.95%
Banking, Finance, Insurance, Real Estate
Schedule of Investments [Line Items]
% of Total Investments at Fair Value	3.60%	3.95%
Beverage, Food & Tobacco
Schedule of Investments [Line Items]
% of Total Investments at Fair Value	7.30%	7.76%
Capital Equipment
Schedule of Investments [Line Items]
% of Total Investments at Fair Value	4.62%	4.21%
Chemicals, Plastics, & Rubber
Schedule of Investments [Line Items]
% of Total Investments at Fair Value	1.61%	2.29%
Construction & Building
Schedule of Investments [Line Items]
% of Total Investments at Fair Value	4.50%	3.90%
Consumer Goods: Durable
Schedule of Investments [Line Items]
% of Total Investments at Fair Value	1.05%	1.51%
Consumer Goods: Non-durable
Schedule of Investments [Line Items]
% of Total Investments at Fair Value	3.29%	3.31%
Containers, Packaging & Glass
Schedule of Investments [Line Items]
% of Total Investments at Fair Value	3.89%	3.97%
Energy: Electricity
Schedule of Investments [Line Items]
% of Total Investments at Fair Value	1.61%	1.75%
Environmental Industries
Schedule of Investments [Line Items]
% of Total Investments at Fair Value	3.16%	2.73%
Healthcare & Pharmaceuticals
Schedule of Investments [Line Items]
% of Total Investments at Fair Value	11.91%	12.72%
High Tech Industries
Schedule of Investments [Line Items]
% of Total Investments at Fair Value	10.64%	8.97%
Media: Advertising, Printing & Publishing
Schedule of Investments [Line Items]
% of Total Investments at Fair Value	1.04%	1.12%
Media: Diversified & Production
Schedule of Investments [Line Items]
% of Total Investments at Fair Value	0.87%	0.96%
Retail
Schedule of Investments [Line Items]
% of Total Investments at Fair Value	0.32%	0.35%
Services: Business
Schedule of Investments [Line Items]
% of Total Investments at Fair Value	19.03%	18.43%
Services: Consumer
Schedule of Investments [Line Items]
% of Total Investments at Fair Value	4.98%	4.86%
Sovereign & Public Finance
Schedule of Investments [Line Items]
% of Total Investments at Fair Value	0.76%	0.65%
Telecommunications
Schedule of Investments [Line Items]
% of Total Investments at Fair Value	2.91%	3.17%
Transportation: Cargo
Schedule of Investments [Line Items]
% of Total Investments at Fair Value	3.03%	3.20%
Transportation: Consumer
Schedule of Investments [Line Items]
% of Total Investments at Fair Value	0.70%	0.13%
Utilities: Electric
Schedule of Investments [Line Items]
% of Total Investments at Fair Value	0.81%	0.89%
Utilities: Water
Schedule of Investments [Line Items]
% of Total Investments at Fair Value	0.46%	0.00%
Wholesale
Schedule of Investments [Line Items]
% of Total Investments at Fair Value	1.00%	1.09%

XML

INVESTMENTS - Schedules of Portfolio Composition by Geographic Composition of Investments at Cost and Fair Value (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2024	Dec. 31, 2023
Schedule of Investments [Line Items]
Cost	$ 1,814,985	$ 1,666,169
Fair Value	$ 1,794,559	$ 1,641,686
Fair Value as % of Net Assets	179.78%	219.51%
Investment Owned at Fair Value | Investment Type Concentration Risk
Schedule of Investments [Line Items]
% of Total Investments at Fair Value	100.00%	100.00%
USA
Schedule of Investments [Line Items]
Cost	$ 1,762,869	$ 1,613,815
Fair Value	$ 1,742,508	$ 1,589,384
Fair Value as % of Net Assets	174.56%	212.52%
USA | Investment Owned at Fair Value | Investment Type Concentration Risk
Schedule of Investments [Line Items]
% of Total Investments at Fair Value	97.10%	96.82%
Canada
Schedule of Investments [Line Items]
Cost	$ 38,401	$ 38,462
Fair Value	$ 38,391	$ 38,292
Fair Value as % of Net Assets	3.85%	5.12%
Canada | Investment Owned at Fair Value | Investment Type Concentration Risk
Schedule of Investments [Line Items]
% of Total Investments at Fair Value	2.14%	2.33%
United Kingdom
Schedule of Investments [Line Items]
Cost	$ 13,715	$ 13,892
Fair Value	$ 13,660	$ 14,010
Fair Value as % of Net Assets	1.37%	1.87%
United Kingdom | Investment Owned at Fair Value | Investment Type Concentration Risk
Schedule of Investments [Line Items]
% of Total Investments at Fair Value	0.76%	0.85%

XML

INVESTMENTS - Narrative (Details) - Investment Owned at Fair Value - Investment Type Concentration Risk	3 Months Ended	12 Months Ended
	Mar. 31, 2024	Dec. 31, 2023
Schedule of Investments [Line Items]
% of Total Investments at Fair Value	100.00%	100.00%
Debt Securities, Variable Rate
Schedule of Investments [Line Items]
% of Total Investments at Fair Value	94.69%	94.61%
Debt Securities, Fixed Rate
Schedule of Investments [Line Items]
% of Total Investments at Fair Value	5.31%	5.39%

XML

FAIR VALUE MEASUREMENTS - Schedule of Fair Value Measurements of Investments, by Major Class, and Cash Equivalents (Details) - USD ($) $ in Thousands	Mar. 31, 2024		Dec. 31, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	$ 1,847,332	[1]	$ 1,706,163	[2]
First Lien Term Loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	1,596,352		1,427,492
Subordinated Debt
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	166,502		183,387
Equity Investments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	31,705		30,807
Cash Equivalents
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	52,773		64,477
Subordinated Debt, Second Lien
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	84,676		97,203
Subordinated Debt, Mezzanine Debt
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	81,113		83,528
Structured Debt
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	713		2,656
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	52,773		64,477
Level 1 | First Lien Term Loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	0		0
Level 1 | Subordinated Debt
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	0		0
Level 1 | Equity Investments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	0		0
Level 1 | Cash Equivalents
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	52,773		64,477
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	30,955		43,172
Level 2 | First Lien Term Loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	30,955		34,481
Level 2 | Subordinated Debt
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	0		8,691
Level 2 | Equity Investments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	0		0
Level 2 | Cash Equivalents
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	0		0
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	1,763,604		1,598,514
Level 3 | First Lien Term Loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	1,565,397		1,393,011
Level 3 | Subordinated Debt
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	166,502		174,696
Level 3 | Equity Investments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	31,705		30,807
Level 3 | Cash Equivalents
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	$ 0		$ 0

[1] Investment valued using unobservable inputs (Level 3). See Note 2 “Significant Accounting Policies – Valuation of Portfolio Investments” and Note 4 "Fair Value Measurements" for more information.

[2] Investment valued using unobservable inputs (Level 3). See Note 2 “Significant Accounting Policies – Valuation of Portfolio Investments” and Note 4 "Fair Value Measurements" for more information.

XML

FAIR VALUE MEASUREMENTS - Schedule of Reconciliation of the Beginning and Ending Balances for Investments (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2024	Dec. 31, 2023
Total
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	$ 1,598,514	$ 1,177,412
Purchase of investments	197,933	587,893
Proceeds from principal repayments and sales of investments	(45,812)	(142,051)
Payment-in-kind interest	1,992	3,268
Amortization of premium/accretion of discount, net	997	2,645
Transfers out of Level 3		(31,798)
Transfers to Level 3	9,825	8,348
Ending balance	1,763,604	1,598,514
Net change in unrealized appreciation (depreciation) on non-controlled/non-affiliated company investments still held	(83)	(1,649)
Total | Net realized gain (loss) on investments
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	(3,690)	(7,989)
Total | Net change in unrealized appreciation (depreciation) on investments
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	3,845	786
First Lien Term Loans
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	1,393,011	1,016,856
Purchase of investments	196,582	513,487
Proceeds from principal repayments and sales of investments	(39,657)	(118,469)
Payment-in-kind interest	260	221
Amortization of premium/accretion of discount, net	833	1,386
Transfers out of Level 3		(23,350)
Transfers to Level 3	9,825	8,348
Ending balance	1,565,397	1,393,011
Net change in unrealized appreciation (depreciation) on non-controlled/non-affiliated company investments still held	4,445	364
First Lien Term Loans | Net realized gain (loss) on investments
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	(3,830)	(14,339)
First Lien Term Loans | Net change in unrealized appreciation (depreciation) on investments
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	8,373	8,871
Subordinated Debt
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	174,696	133,243
Purchase of investments	855	65,296
Proceeds from principal repayments and sales of investments	(6,082)	(14,915)
Payment-in-kind interest	1,732	3,047
Amortization of premium/accretion of discount, net	164	426
Transfers out of Level 3		(8,448)
Transfers to Level 3	0	0
Ending balance	166,502	174,696
Net change in unrealized appreciation (depreciation) on non-controlled/non-affiliated company investments still held	(5,003)	(4,167)
Subordinated Debt | Net realized gain (loss) on investments
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	140	238
Subordinated Debt | Net change in unrealized appreciation (depreciation) on investments
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	(5,003)	(4,191)
Equity Investments
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	30,807	27,313
Purchase of investments	496	9,110
Proceeds from principal repayments and sales of investments	(73)	(8,667)
Payment-in-kind interest	0	0
Amortization of premium/accretion of discount, net	0	833
Transfers out of Level 3		0
Transfers to Level 3	0	0
Ending balance	31,705	30,807
Net change in unrealized appreciation (depreciation) on non-controlled/non-affiliated company investments still held	475	2,154
Equity Investments | Net realized gain (loss) on investments
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	0	6,112
Equity Investments | Net change in unrealized appreciation (depreciation) on investments
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	$ 475	$ (3,894)

XML

FAIR VALUE MEASUREMENTS - Schedule of Valuation Techniques and Significant Unobservable Inputs Used in Level 3 Fair Value Measurements of Assets (Details) - Level 3 $ in Thousands	Mar. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value	$ 1,763,126	$ 1,597,257
First Lien Term Loans | Yield Method | Market Yield Discount Rates
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value	$ 1,400,517	$ 1,192,190
First Lien Term Loans | Yield Method | Low | Market Yield Discount Rates
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.0858	0.0613
First Lien Term Loans | Yield Method | High | Market Yield Discount Rates
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.2085	0.1873
First Lien Term Loans | Yield Method | Weighted Average | Market Yield Discount Rates
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.1080	0.1063
First Lien Term Loans | Market Approach | EBITDA Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value	$ 22,199	$ 19,519
First Lien Term Loans | Market Approach | Low | EBITDA Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	6.5	6.5
First Lien Term Loans | Market Approach | High | EBITDA Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	13	9.25
First Lien Term Loans | Market Approach | Weighted Average | EBITDA Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	9.37	7.21
First Lien Term Loans | Recent Transactions | Transaction Price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value	$ 142,681	$ 181,302
First Lien Term Loans | Recent Transactions | Low | Transaction Price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	99.00	59.50
First Lien Term Loans | Recent Transactions | High | Transaction Price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	100.69	100.00
First Lien Term Loans | Recent Transactions | Weighted Average | Transaction Price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	99.56	97.52
Subordinated Debt | Yield Method | Market Yield Discount Rates
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value	$ 151,676	$ 162,646
Subordinated Debt | Yield Method | Low | Market Yield Discount Rates
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.1218	0.0970
Subordinated Debt | Yield Method | High | Market Yield Discount Rates
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.2491	0.2491
Subordinated Debt | Yield Method | Weighted Average | Market Yield Discount Rates
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.1530	0.1444
Subordinated Debt | Recent Transactions | Transaction Price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value	$ 12,500	$ 12,050
Subordinated Debt | Recent Transactions | Low | Transaction Price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	100.00	84.75
Subordinated Debt | Recent Transactions | High | Transaction Price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	100.00	98.01
Subordinated Debt | Recent Transactions | Weighted Average | Transaction Price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	100.00	89.53
Subordinated Debt | Black-Scholes | EBITDA Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value	$ 2,326
Subordinated Debt | Black-Scholes | Low | EBITDA Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	11.5
Subordinated Debt | Black-Scholes | High | EBITDA Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	11.5
Subordinated Debt | Black-Scholes | Weighted Average | EBITDA Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	11.5
Equity
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments valued using recent transactions	$ 478	$ 1,257
Equity | Yield Method | Market Yield Discount Rates
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value	$ 161	$ 158
Equity | Yield Method | Low | Market Yield Discount Rates
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.0836	0.0836
Equity | Yield Method | High | Market Yield Discount Rates
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.0836	0.0836
Equity | Yield Method | Weighted Average | Market Yield Discount Rates
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.0836	0.0836
Equity | Market Approach | EBITDA Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value	$ 31,066	$ 29,390
Equity | Market Approach | Blended EBITDA Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value		$ 2
Equity | Market Approach | Low | EBITDA Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	5.75	0.065
Equity | Market Approach | Low | Blended EBITDA Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input		13.25
Equity | Market Approach | Low | Blended Revenue Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input		1.4
Equity | Market Approach | High | EBITDA Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	20	0.195
Equity | Market Approach | High | Blended EBITDA Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input		13.25
Equity | Market Approach | High | Blended Revenue Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input		1.4
Equity | Market Approach | Weighted Average | EBITDA Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	11.32	0.1096
Equity | Market Approach | Weighted Average | Blended EBITDA Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input		13.25
Equity | Market Approach | Weighted Average | Blended Revenue Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input		1.4

XML

FAIR VALUE MEASUREMENTS - Schedule of Carrying Value and Fair Value of Debt Obligations (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Fair Value, Option, Quantitative Disclosures [Line Items]
Total	$ 825,500	$ 951,877
Secured Debt | 2022 Debt
Fair Value, Option, Quantitative Disclosures [Line Items]
Total	342,000	342,000
Secured Debt | 2023 Debt
Fair Value, Option, Quantitative Disclosures [Line Items]
Total	215,000	215,000
Secured Debt | 2024 Debt
Fair Value, Option, Quantitative Disclosures [Line Items]
Total	215,000
Carrying value | Secured Debt
Fair Value, Option, Quantitative Disclosures [Line Items]
Total	825,500	951,877
Carrying value | Secured Debt | Wells Fargo Financing Facility
Fair Value, Option, Quantitative Disclosures [Line Items]
Total	2,500	231,000
Carrying value | Secured Debt | SMBC Financing Facility
Fair Value, Option, Quantitative Disclosures [Line Items]
Total	39,000	37,377
Carrying value | Secured Debt | Revolving Credit Facility
Fair Value, Option, Quantitative Disclosures [Line Items]
Total	12,000	126,500
Carrying value | Secured Debt | 2022 Debt
Fair Value, Option, Quantitative Disclosures [Line Items]
Total	342,000	342,000
Carrying value | Secured Debt | 2023 Debt
Fair Value, Option, Quantitative Disclosures [Line Items]
Total	215,000	215,000
Carrying value | Secured Debt | 2024 Debt
Fair Value, Option, Quantitative Disclosures [Line Items]
Total	215,000	0
Fair Value | Secured Debt
Fair Value, Option, Quantitative Disclosures [Line Items]
Long-term debt, fair value	826,334	947,198
Fair Value | Secured Debt | Wells Fargo Financing Facility
Fair Value, Option, Quantitative Disclosures [Line Items]
Long-term debt, fair value	2,500	231,000
Fair Value | Secured Debt | SMBC Financing Facility
Fair Value, Option, Quantitative Disclosures [Line Items]
Long-term debt, fair value	39,000	37,377
Fair Value | Secured Debt | Revolving Credit Facility
Fair Value, Option, Quantitative Disclosures [Line Items]
Long-term debt, fair value	12,000	126,500
Fair Value | Secured Debt | 2022 Debt
Fair Value, Option, Quantitative Disclosures [Line Items]
Long-term debt, fair value	340,307	338,345
Fair Value | Secured Debt | 2023 Debt
Fair Value, Option, Quantitative Disclosures [Line Items]
Long-term debt, fair value	217,026	213,976
Fair Value | Secured Debt | 2024 Debt
Fair Value, Option, Quantitative Disclosures [Line Items]
Long-term debt, fair value	$ 215,501	$ 0

XML

RELATED PARTY TRANSACTIONS (Details) $ in Thousands				3 Months Ended
	Jan. 29, 2024	Oct. 27, 2023	Dec. 31, 2019	Mar. 31, 2024 USD ($) member	Mar. 31, 2023 USD ($)	Dec. 31, 2023 USD ($)
Related Party Transaction [Line Items]
Management fees				$ 3,264	$ 2,306
Management fees payable				3,264		$ 3,006
Incentive fees on net investment income				4,459	0
Voluntary fees waived				4,459
Administration fees				542	309
Administration fees payable				$ 961		505
Number of board members | member				7
Number of independent directors | member				5
Directors' fees				$ 128	$ 96
Directors’ fees payable				128		96
Accounts payable and accrued expenses				4,065		2,789
Expense Support Agreement
Related Party Transaction [Line Items]
Period of interest expense payment			45 days
Related Party | Investment Advisory Agreements
Related Party Transaction [Line Items]
Incentive fee percentage			32.50%
Daily weighted average principal amount (as a percent)	0.375%
Period of agreement will remain in effect		2 years	2 years
Investment advisory agreement, renewal term	1 year
Period of written notice	60 days
Related Party | Investment Advisory Agreement - Compensation of the Adviser, Management Fee First Five Quarters
Related Party Transaction [Line Items]
Base management fee percentage	0.75%
Related Party | Investment Advisory Agreement - Compensation of the Adviser, Management Fee, Thereafter
Related Party Transaction [Line Items]
Daily weighted average principal amount (as a percent)	1.00%
Related Party | Quarterly Hurdle Rate
Related Party Transaction [Line Items]
Incentive fee percentage	1.50%
Related Party | Annualized Hurdle Rate
Related Party Transaction [Line Items]
Incentive fee percentage	6.00%
Related Party | Pre-Incentive Fee Net Investment Income below Catch-up Threshold
Related Party Transaction [Line Items]
Incentive fee percentage	100.00%
Related Party | Quarterly Catch-Up Threshold
Related Party Transaction [Line Items]
Incentive fee percentage	1.7647%
Related Party | Pre-Incentive Fee Net Investment Income Exceeds Catch-Up Threshold
Related Party Transaction [Line Items]
Incentive fee percentage	15.00%
Related Party | Investment Advisory Agreement - Cumulative Pre-Incentive Fee Net Return
Related Party Transaction [Line Items]
Incentive fee percentage	15.00%
Related Party | Realized Capital Gains
Related Party Transaction [Line Items]
Incentive fee percentage	15.00%
Related Party | Expense Support Agreement
Related Party Transaction [Line Items]
Investment company, fee paid indirectly				2,979
Reimbursement of previously supported expense				1,101
Related Party | Advisor and Administrator
Related Party Transaction [Line Items]
Accounts payable and accrued expenses				$ 904		$ 353

XML

SECURED BORROWINGS - Narrative (Details)								3 Months Ended	12 Months Ended
	Mar. 14, 2024 USD ($)	Dec. 07, 2023 USD ($)	Nov. 21, 2023 USD ($)	Nov. 20, 2023 USD ($)	Jun. 23, 2023 USD ($)	May 20, 2022 USD ($)	May 05, 2022	Mar. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)	Dec. 06, 2023 USD ($)	Mar. 31, 2023	Mar. 31, 2022	Sep. 10, 2020 USD ($)	Dec. 30, 2019 USD ($)
Debt Instrument [Line Items]
Asset Coverage Ratio								220.92%	178.57%		167.31%
Total Commitment								$ 1,257,000,000	$ 1,167,000,000
Amount available								431,500,000	214,960,000
Subscription Facility | Credit Facility | Secured Debt
Debt Instrument [Line Items]
Total Commitment													$ 50,000,000
Wells Fargo Financing Facility | Credit Facility | Secured Debt
Debt Instrument [Line Items]
Total Commitment	$ 250,000,000							150,000,000	275,000,000					$ 275,000,000
Amount available	$ 150,000,000							$ 147,500,000	$ 43,837,000
Covenant asset coverage ratio												1.50
Commitment reduction fee, percentage							1.00%
Line of credit facility, unused capacity, commitment fee percentage, less than forty percent of total commitments	0.50%
Line of credit facility, maximum borrowing capacity percentage	40.00%
Line of credit facility, unused capacity, commitment fee percentage, in excess of forty percent of total commitments	1.50%
Wells Fargo Financing Facility | Secured Overnight Financing Rate (SOFR) | Credit Facility | Secured Debt
Debt Instrument [Line Items]
Percentage of interest rate								2.20%	2.20%
Wells Fargo Financing Facility - Daily Undrawn Amounts During The Period | Credit Facility | Secured Debt
Debt Instrument [Line Items]
Unused commitment fee, percentage	0.25%
Wells Fargo Financing Facility - For Next Six Months And Thereafter | Credit Facility | Secured Debt
Debt Instrument [Line Items]
Unused commitment fee, percentage	0.50%
SMBC Financing Facility | Credit Facility | Secured Debt
Debt Instrument [Line Items]
Total Commitment		$ 150,000,000	$ 150,000,000	$ 300,000,000				$ 150,000,000	$ 150,000,000	$ 300,000,000
Amount available								$ 111,000,000	112,623,000
Unused commitment fee, percentage				0.50%
Subsequent increase			$ 250,000,000
Unused commitment fee percentage, less than fifty percent of total commitments			0.50%
Unused commitment fee percentage, more than fifty percent of total commitments			1.00%
Debt instrument, extension fee			$ 450,000
Annualized fee percentage			0.30%
SMBC Financing Facility | Secured Overnight Financing Rate (SOFR) | Credit Facility | Secured Debt
Debt Instrument [Line Items]
Percentage of interest rate			2.65%	2.15%				2.65%
SMBC Financing Facility | Base Rate | Credit Facility | Secured Debt
Debt Instrument [Line Items]
Percentage of interest rate			1.65%	1.15%
Revolving Credit Facility | Credit Facility | Secured Debt
Debt Instrument [Line Items]
Total Commitment					$ 185,000,000			$ 185,000,000	185,000,000
Amount available								$ 173,000,000	$ 58,500,000
Unused commitment fee, percentage					0.375%
Maximum borrowing capacity, including accordion feature					$ 300,000,000
Revolving Credit Facility | Credit Facility | Bridge Loan
Debt Instrument [Line Items]
Total Commitment					$ 25,000,000
Revolving Credit Facility | Secured Overnight Financing Rate (SOFR) | Credit Facility | Secured Debt
Debt Instrument [Line Items]
Percentage of interest rate								2.25%	2.25%
2022 Debt | Secured Debt
Debt Instrument [Line Items]
Total Commitment								$ 342,000,000	$ 342,000,000
Amount available								0	0
Debt securitization						$ 448,325,000
AAA Class A-1 2022 Notes | Secured Debt
Debt Instrument [Line Items]
Debt securitization						$ 199,000,000
AAA Class A-1 2022 Notes | Secured Overnight Financing Rate (SOFR) | Secured Debt
Debt Instrument [Line Items]
Percentage of interest rate						1.80%
AAA Class A-1F 2022 Notes | Secured Debt
Debt Instrument [Line Items]
Percentage of interest rate						4.42%
Debt securitization						$ 34,250,000
AA Class B 2022 Notes | Secured Debt
Debt Instrument [Line Items]
Debt securitization						$ 47,250,000
AA Class B 2022 Notes | Secured Overnight Financing Rate (SOFR) | Secured Debt
Debt Instrument [Line Items]
Percentage of interest rate						2.30%
A Class C 2022 Notes | Secured Debt
Debt Instrument [Line Items]
Debt securitization						$ 31,500,000
A Class C 2022 Notes | Secured Overnight Financing Rate (SOFR) | Secured Debt
Debt Instrument [Line Items]
Percentage of interest rate						3.15%
BBB Class D 2022 Notes | Secured Debt
Debt Instrument [Line Items]
Debt securitization						$ 27,000,000
BBB Class D 2022 Notes | Secured Overnight Financing Rate (SOFR) | Secured Debt
Debt Instrument [Line Items]
Percentage of interest rate						4.15%
Subordinated 2022 Notes | Secured Debt
Debt Instrument [Line Items]
Debt securitization						$ 79,325,000
AAA Class A-L 2022 Loans to CLO-I | Secured Debt
Debt Instrument [Line Items]
Debt securitization						$ 30,000,000
AAA Class A-L 2022 Loans to CLO-I | Secured Overnight Financing Rate (SOFR) | Secured Debt
Debt Instrument [Line Items]
Percentage of interest rate						1.80%
2023 Debt | Secured Debt
Debt Instrument [Line Items]
Total Commitment								215,000,000	215,000,000
Amount available								0	$ 0
Debt securitization		298,060,000
AAA Class X 2023 Notes | Secured Debt
Debt Instrument [Line Items]
Debt securitization		$ 2,000,000
AAA Class X 2023 Notes | Secured Overnight Financing Rate (SOFR) | Secured Debt
Debt Instrument [Line Items]
Percentage of interest rate		2.00%
AAA Class A-1 2023 Notes | Secured Debt
Debt Instrument [Line Items]
Debt securitization		$ 100,500,000
AAA Class A-1 2023 Notes | Secured Overnight Financing Rate (SOFR) | Secured Debt
Debt Instrument [Line Items]
Percentage of interest rate		2.35%
AA Class B 2023 Notes | Secured Debt
Debt Instrument [Line Items]
Debt securitization		$ 37,500,000
AA Class B 2023 Notes | Secured Overnight Financing Rate (SOFR) | Secured Debt
Debt Instrument [Line Items]
Percentage of interest rate		3.20%
Subordinated 2023 Notes | Secured Debt
Debt Instrument [Line Items]
Debt securitization		$ 83,060,000
AAA Class A-L-A 2023 to CLO-II | Secured Debt
Debt Instrument [Line Items]
Debt securitization		$ 25,000,000
AAA Class A-L-A 2023 to CLO-II | Secured Overnight Financing Rate (SOFR) | Secured Debt
Debt Instrument [Line Items]
Percentage of interest rate		2.35%
AAA Class A-L-B 2023 Loans to CLO-II | Secured Debt
Debt Instrument [Line Items]
Debt securitization		$ 50,000,000
AAA Class A-L-B 2023 Loans to CLO-II | Secured Overnight Financing Rate (SOFR) | Secured Debt
Debt Instrument [Line Items]
Percentage of interest rate		2.35%
2024 Debt | Secured Debt
Debt Instrument [Line Items]
Total Commitment								215,000,000
Amount available								$ 0
Debt securitization	$ 296,970,000
AAA Class X 2024 Notes | Secured Debt
Debt Instrument [Line Items]
Debt securitization	$ 2,000,000
AAA Class X 2024 Notes | Secured Overnight Financing Rate (SOFR) | Secured Debt
Debt Instrument [Line Items]
Percentage of interest rate	1.40%
AAA Class A 2024 Notes | Secured Debt
Debt Instrument [Line Items]
Debt securitization	$ 175,500,000
AAA Class A 2024 Notes | Secured Overnight Financing Rate (SOFR) | Secured Debt
Debt Instrument [Line Items]
Percentage of interest rate	2.00%
AA Class B 2024 Notes | Secured Debt
Debt Instrument [Line Items]
Debt securitization	$ 37,500,000
AA Class B 2024 Notes | Secured Overnight Financing Rate (SOFR) | Secured Debt
Debt Instrument [Line Items]
Percentage of interest rate	2.65%
Subordinated 2024 Notes | Secured Debt
Debt Instrument [Line Items]
Debt securitization	$ 81,970,000

XML

SECURED BORROWINGS - Schedule of Debt Obligations (Details) - USD ($)	Mar. 31, 2024	Mar. 14, 2024	Dec. 31, 2023	Dec. 07, 2023	Dec. 06, 2023	Nov. 21, 2023	Nov. 20, 2023	Jun. 23, 2023	Dec. 30, 2019
Debt Instrument [Line Items]
Total Commitment	$ 1,257,000,000		$ 1,167,000,000
Amount Outstanding	825,500,000		951,877,000
Unused Portion	431,500,000		215,123,000
Amount available	431,500,000		214,960,000
CLO-I | Secured Debt
Debt Instrument [Line Items]
Total Commitment	342,000,000		342,000,000
Amount Outstanding	342,000,000		342,000,000
Unused Portion	0		0
Amount available	0		0
CLO-II | Secured Debt
Debt Instrument [Line Items]
Total Commitment	215,000,000		215,000,000
Amount Outstanding	215,000,000		215,000,000
Unused Portion	0		0
Amount available	0		0
CLO-III | Secured Debt
Debt Instrument [Line Items]
Total Commitment	215,000,000
Amount Outstanding	215,000,000
Unused Portion	0
Amount available	0
Secured Debt | Wells Fargo Financing Facility | Credit Facility
Debt Instrument [Line Items]
Total Commitment	150,000,000	$ 250,000,000	275,000,000						$ 275,000,000
Amount Outstanding	2,500,000		231,000,000
Unused Portion	147,500,000		44,000,000
Amount available	147,500,000	$ 150,000,000	43,837,000
Secured Debt | SMBC Financing Facility | Credit Facility
Debt Instrument [Line Items]
Total Commitment	150,000,000		150,000,000	$ 150,000,000	$ 300,000,000	$ 150,000,000	$ 300,000,000
Amount Outstanding	39,000,000		37,377,000
Unused Portion	111,000,000		112,623,000
Amount available	111,000,000		112,623,000
Secured Debt | Revolving Credit Facility | Credit Facility
Debt Instrument [Line Items]
Total Commitment	185,000,000		185,000,000					$ 185,000,000
Amount Outstanding	12,000,000		126,500,000
Unused Portion	173,000,000		58,500,000
Amount available	$ 173,000,000		$ 58,500,000

XML

SECURED BORROWINGS - Schedule of Components of Interest Expense and Debt Financing Expenses (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Debt Disclosure [Abstract]
Interest expense	$ 15,337	$ 12,041
Unused fees	308	267
Amortization of deferred financing costs	1,296	435
Total interest and debt financing expenses	$ 16,941	$ 12,743
Average interest rate	7.65%	6.76%
Average daily borrowings	$ 819,927	$ 738,069

XML

SECURED BORROWINGS - Schedule of Contractual Maturities of Debt Obligations (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Debt Instrument [Line Items]
Total	$ 825,500	$ 951,877
Less than 1 Year	0	0
1 to 3 years	41,500	37,377
3 to 5 years	12,000	357,500
More than 5 Years	772,000	557,000
Wells Fargo Financing Facility | Credit Facility
Debt Instrument [Line Items]
Total	2,500	231,000
Less than 1 Year	0	0
1 to 3 years	2,500	0
3 to 5 years	0	231,000
More than 5 Years	0	0
SMBC Financing Facility | Credit Facility
Debt Instrument [Line Items]
Total	39,000	37,377
Less than 1 Year	0	0
1 to 3 years	39,000	37,377
3 to 5 years	0	0
More than 5 Years	0	0
Revolving Credit Facility | Credit Facility
Debt Instrument [Line Items]
Total	12,000	126,500
Less than 1 Year	0	0
1 to 3 years	0	0
3 to 5 years	12,000	126,500
More than 5 Years	0	0
CLO-I | Secured Debt
Debt Instrument [Line Items]
Total	342,000	342,000
Less than 1 Year	0	0
1 to 3 years	0	0
3 to 5 years	0	0
More than 5 Years	342,000	342,000
CLO-II | Secured Debt
Debt Instrument [Line Items]
Total	215,000	215,000
Less than 1 Year	0	0
1 to 3 years	0	0
3 to 5 years	0	0
More than 5 Years	215,000	$ 215,000
CLO-III | Secured Debt
Debt Instrument [Line Items]
Total	215,000
Less than 1 Year	0
1 to 3 years	0
3 to 5 years	0
More than 5 Years	$ 215,000

XML

COMMITMENTS AND CONTINGENCIES (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	$ 179,409	$ 180,547
Investment, Identifier [Axis]: 360 Training
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	3,094	0
Investment, Identifier [Axis]: ARMstrong
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	3,847	3,847
Investment, Identifier [Axis]: ASTP Holdings Co-Investment LP
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	107	34
Investment, Identifier [Axis]: Allstar Holdings
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	7,373	7,373
Investment, Identifier [Axis]: Alternative Logistics Technologies Buyer, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	3,040	0
Investment, Identifier [Axis]: Anne Arundel
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	366	366
Investment, Identifier [Axis]: Apex Companies
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	1,002	1,115
Investment, Identifier [Axis]: Aramsco
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	297	0
Investment, Identifier [Axis]: Bounteous
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	0	4,467
Investment, Identifier [Axis]: BusinesSolver
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	873	970
Investment, Identifier [Axis]: CMP Ren Partners I-A LP
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	15	15
Investment, Identifier [Axis]: Chroma Color
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	1,379	1,379
Investment, Identifier [Axis]: ClaimLogiq
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	3,225	3,225
Investment, Identifier [Axis]: Classic Collision
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	16,107	21,867
Investment, Identifier [Axis]: Contract Land Staff
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	3,025	0
Investment, Identifier [Axis]: Covercraft
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	4,386	4,386
Investment, Identifier [Axis]: Crete
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	148	1,443
Investment, Identifier [Axis]: CrossCountry Consulting
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	3,320	3,320
Investment, Identifier [Axis]: D&H United Fueling Solutions
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	1,393	1,567
Investment, Identifier [Axis]: DMC Power
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	1,671	1,671
Investment, Identifier [Axis]: E78
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	2,570	2,570
Investment, Identifier [Axis]: Elevation Labs
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	2,188	3,125
Investment, Identifier [Axis]: Eliassen Group, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	1,903	1,903
Investment, Identifier [Axis]: Engage
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	8,113	8,113
Investment, Identifier [Axis]: Ergotech (INS)
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	1,979	1,979
Investment, Identifier [Axis]: Evergreen Services Group II
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	1,122	4,488
Investment, Identifier [Axis]: EyeSouth
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	885	885
Investment, Identifier [Axis]: Fairway Lawns
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	0	419
Investment, Identifier [Axis]: Health Management Associates
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	1,026	1,026
Investment, Identifier [Axis]: Heartland Veterinary Partners
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	3,600	0
Investment, Identifier [Axis]: High Bar Brands
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	596	596
Investment, Identifier [Axis]: ITSavvy
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	158	158
Investment, Identifier [Axis]: Image First
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	143	0
Investment, Identifier [Axis]: Impact Environmental Group
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	4,093	7,203
Investment, Identifier [Axis]: Infobase
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	0	721
Investment, Identifier [Axis]: Kenco
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	1,416	1,416
Investment, Identifier [Axis]: Legacy Service Partners
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	0	764
Investment, Identifier [Axis]: Leo Facilities
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	5,314	6,429
Investment, Identifier [Axis]: Liberty Group
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	449	449
Investment, Identifier [Axis]: MEI Buyer LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	1,814	1,814
Investment, Identifier [Axis]: MGM Transformer Company
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	6,388	6,388
Investment, Identifier [Axis]: Market Performance Group
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	3,086	0
Investment, Identifier [Axis]: Mobile Communications America Inc
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	5,970	5,970
Investment, Identifier [Axis]: Mosaic Dental
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	254	553
Investment, Identifier [Axis]: NJEye, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	489	489
Investment, Identifier [Axis]: National Power
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	3,051	3,051
Investment, Identifier [Axis]: NearU
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	3,291	3,291
Investment, Identifier [Axis]: North Haven Spartan US Holdco LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	3,260	0
Investment, Identifier [Axis]: Online Labels Group
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	807	807
Investment, Identifier [Axis]: Ovation Holdings
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	343	343
Investment, Identifier [Axis]: Palmetto Exterminators
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	109	652
Investment, Identifier [Axis]: Pinnacle Supply Partners, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	3,636	3,636
Investment, Identifier [Axis]: Precision Aviation Group
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	4,961	4,961
Investment, Identifier [Axis]: Propark Mobility
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	1,797	1,797
Investment, Identifier [Axis]: RMA Companies
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	3,134	3,510
Investment, Identifier [Axis]: Randy's Worldwide Automotive
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	3,300	3,750
Investment, Identifier [Axis]: Repipe Specialists
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	691	691
Investment, Identifier [Axis]: Rhino Tool House
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	36	921
Investment, Identifier [Axis]: Riveron
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	1,607	1,607
Investment, Identifier [Axis]: RoadOne
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	1,397	1,397
Investment, Identifier [Axis]: RoadOne- Common
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	0	235
Investment, Identifier [Axis]: S&S Truck Parts
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	246	246
Investment, Identifier [Axis]: Sciens Building Solutions, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	1,623	1,623
Investment, Identifier [Axis]: Sunny Sky Products
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	1,773	1,773
Investment, Identifier [Axis]: TIDI Products
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	4,085	4,085
Investment, Identifier [Axis]: TPC Wire & Cable Corp
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	1,715	0
Investment, Identifier [Axis]: Tech24
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	3,550	3,655
Investment, Identifier [Axis]: Technical Safety Services
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	2,343	2,429
Investment, Identifier [Axis]: Tencate
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	1,540	0
Investment, Identifier [Axis]: The Facilities Group
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	4,861	5,028
Investment, Identifier [Axis]: Trilon Group
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	1,875	4,407
Investment, Identifier [Axis]: USA Water
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	3,037	0
Investment, Identifier [Axis]: Velosio
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	1,284	0
Investment, Identifier [Axis]: WSB / EST
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	1,307	4,357
Investment, Identifier [Axis]: Watermill Express
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	2,734	0
Investment, Identifier [Axis]: Wellspring
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	3,756	3,756
Investment, Identifier [Axis]: Wpromote
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	588	588
Investment, Identifier [Axis]: Young Innovations
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	$ 3,448	$ 3,448

XML

NET ASSETS - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands	Jan. 29, 2024	Mar. 31, 2024	Mar. 05, 2024	Dec. 31, 2023
Class of Stock [Line Items]
Common stock, shares authorized (in shares)		500,000,000		500,000,000
Common stock, par value per share (in dollars per share)		$ 0.01		$ 0.01
Share Repurchase Plan
Class of Stock [Line Items]
Stock repurchase program, authorized amount			$ 99,275
IPO
Class of Stock [Line Items]
Sale of stock, number of shares issued (in shares)	5,500,000
Issuance Price per share (in dollars per share)	$ 18.05
Sale of stock, consideration received	$ 99,275

XML

NET ASSETS - Schedule of Total Shares Issued and Proceeds Received (Details) - USD ($) $ / shares in Units, $ in Thousands																							3 Months Ended
	Jan. 29, 2024	Jan. 05, 2024	Nov. 03, 2023	Jul. 17, 2023	Apr. 20, 2023	Dec. 21, 2022	Aug. 01, 2022	Apr. 25, 2022	Jan. 21, 2022	Dec. 09, 2021	Nov. 01, 2021	Aug. 23, 2021	Jul. 26, 2021	Jun. 22, 2021	Apr. 23, 2021	Mar. 11, 2021	Nov. 06, 2020	Oct. 16, 2020	Aug. 06, 2020	May 07, 2020	Dec. 31, 2019	Dec. 19, 2019	Mar. 31, 2024	Mar. 31, 2023
Stockholders' Equity Note [Abstract]
Shares issued (in shares)	5,500,000	7,888,094	5,497,609	4,357,515	2,205,038	3,193,195	2,652,775	1,800,426	1,541,568	1,491,676	1,546,427	2,593,357	1,564,928	1,034,668	1,845,984	785,751	1,870,660	1,057,641	1,105,425	1,069,522	3,310,540	50
Proceeds Received	$ 99,275	$ 142,381	$ 100,000	$ 78,565	$ 40,000	$ 60,000	$ 50,082	$ 34,964	$ 30,000	$ 29,207	$ 30,000	$ 50,000	$ 30,000	$ 20,000	$ 35,000	$ 15,000	$ 35,000	$ 20,000	$ 20,000	$ 20,000	$ 66,211	$ 1	$ 241,657	$ 473
Issuance price per share (in dollars per share)	$ 18.05	$ 18.05	$ 18.19	$ 18.03	$ 18.14	$ 18.79	$ 18.88	$ 19.42	$ 19.46	$ 19.58	$ 19.40	$ 19.28	$ 19.17	$ 19.33	$ 18.96	$ 19.09	$ 18.71	$ 18.91	$ 18.09	$ 18.70	$ 20.00	$ 20.00

XML

NET ASSETS - Schedule of Dividends Declared (Details) - $ / shares	Jan. 10, 2024	Dec. 28, 2023	Oct. 12, 2023	Sep. 28, 2023	Jul. 12, 2023	Jun. 28, 2023	Apr. 12, 2023	Mar. 30, 2023	Jan. 17, 2023	Dec. 29, 2022	Oct. 11, 2022	Sep. 28, 2022	Jul. 12, 2022	Jun. 30, 2022	Apr. 12, 2022	Mar. 30, 2022	Jan. 18, 2022	Dec. 29, 2021	Oct. 11, 2021	Sep. 29, 2021	Jul. 12, 2021	Jun. 29, 2021	Apr. 19, 2021	Mar. 29, 2021	Jan. 18, 2021	Dec. 29, 2020	Nov. 11, 2020	Nov. 04, 2020	Aug. 11, 2020	Aug. 04, 2020	Apr. 16, 2020
Class of Stock [Line Items]
Dividend per share (in dollars per share)	$ 0.45	$ 0.50		$ 0.50		$ 0.50		$ 0.50		$ 0.50		$ 0.47		$ 0.43		$ 0.41		$ 0.40		$ 0.38		$ 0.31		$ 0.30		$ 0.28		$ 0.23		$ 0.28	$ 0.17
Shares Issued (in shares)	185,541		158,545		128,818		150,703		93,329		68,093		45,341		32,320		23,017		10,639		3,039		1,824		1,550		98		34
Supplemental Dividend
Class of Stock [Line Items]
Dividend per share (in dollars per share)		$ 0.05		$ 0.05		$ 0.05
Special and Supplemental Dividend
Class of Stock [Line Items]
Dividend per share (in dollars per share)								$ 0.26
Special Dividend One
Class of Stock [Line Items]
Dividend per share (in dollars per share)	$ 0.10
Special Dividend Two
Class of Stock [Line Items]
Dividend per share (in dollars per share)	0.10
Special Dividend Three
Class of Stock [Line Items]
Dividend per share (in dollars per share)	0.10
Special Dividend Four
Class of Stock [Line Items]
Dividend per share (in dollars per share)	$ 0.10

XML

CONSOLIDATED FINANCIAL HIGHLIGHTS (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023	Dec. 31, 2022
Investment Company, Financial Highlights [Roll Forward]
Net asset value at beginning of period (in dollars per share)	$ 18.13	$ 18.32
Net investment income (in dollars per share)	0.56	0.60
Net realized gain (loss) (in dollars per share)	(0.07)	0.23
Total net change in unrealized gain (loss) (in dollars per share)	0.08	(0.39)
Net increase (decrease) in net assets resulting from operations (in dollars per share)	0.57	0.44
Shareholder distributions from net investment income (in dollars per share)	(0.45)	(0.76)
Other (in dollars per share)	(0.04)	0.01
Net asset value at end of period (in dollars per share)	$ 18.21	$ 18.01
Net assets at end of period	$ 998,233	$ 517,544	$ 747,885	$ 524,957
Shares outstanding at end of period (in shares)	54,815,740	28,743,877	41,242,105
Per share market value at end of period (in dollars per share)	$ 18.06		$ 18.05
Total return based on NAV	2.93%	2.39%
Total return based on market value	2.55%
Ratio/Supplemental data:
Ratio of net expenses to average net assets before expense support and waived fees	12.09%	12.92%
Ratio of net expenses to average net assets after expense support and waived fees(6) (7)	10.04%	12.91%
Ratio of net investment income to average net assets	13.66%	13.51%
Portfolio turnover rate	3.20%	3.22%
Asset Coverage Ratio	220.92%	167.31%	178.57%
Ratio of interest and debt financing expenses to average net assets	7.78%	9.91%

XML

SUBSEQUENT EVENTS (Details) - USD ($)	May 01, 2024	Apr. 09, 2024	Jan. 10, 2024	Dec. 28, 2023	Sep. 28, 2023	Jun. 28, 2023	Mar. 30, 2023	Dec. 29, 2022	Sep. 28, 2022	Jun. 30, 2022	Mar. 30, 2022	Dec. 29, 2021	Sep. 29, 2021	Jun. 29, 2021	Mar. 29, 2021	Dec. 29, 2020	Nov. 04, 2020	Aug. 04, 2020	Apr. 16, 2020	Apr. 08, 2024	Mar. 31, 2024	Dec. 31, 2023
Subsequent Event [Line Items]
Total Commitment																					$ 1,257,000,000	$ 1,167,000,000
Dividend per share (in dollars per share)			$ 0.45	$ 0.50	$ 0.50	$ 0.50	$ 0.50	$ 0.50	$ 0.47	$ 0.43	$ 0.41	$ 0.40	$ 0.38	$ 0.31	$ 0.30	$ 0.28	$ 0.23	$ 0.28	$ 0.17
Subsequent Event
Subsequent Event [Line Items]
Dividend per share (in dollars per share)	$ 0.45
Secured Debt | Subsequent Event | Credit Facility
Subsequent Event [Line Items]
Total Commitment		$ 250,000,000																		$ 185,000,000
Secured Debt | Subsequent Event | CORRA | Senior Secured Revolving Credit Agreement, One Month Borrowings | Credit Facility
Subsequent Event [Line Items]
Percentage of interest rate		0.29547%
Secured Debt | Subsequent Event | CORRA | Senior Secured Revolving Credit Agreement, Three Month Borrowings | Credit Facility
Subsequent Event [Line Items]
Percentage of interest rate		0.32138%